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Chapter 1 
Introduction 
We are not ourselves 
When nature, being oppressed, commands the mind 
to suffer with the bodyl 
Cancer is a major cause of death throughout the world with approximately nine million 
new cases diagnosed annually and five million deaths per year (Koroltchouk 1994). 
Statistically, more than a quarter of a million people in the UK are diagnosed with cancer each 
year. It is estimated than one in three people will develop cancer during their lifetime and the 
incidence of cancer increases with age, with 70% of all new cancers being diagnosed at ages 
over sixty (Cancer Stats. 1995). 
Cancer is more quickly detected, more treatable and is more openly discussed than ever 
before. However the word 'cancer' is still associated with dying, pain and loss of hope. 
Today a cancer diagnosis does not automatically mean a death sentence but it can inflict an 
emotional burden on patients which for some results in psychological illness. "Psychological 
Factors in Illness and Recovery" is the title of a paper by Clarke (1998) in which 
epidemiological factors show the interaction of psychology and physical disease. These are 
reviewed together with the cost to the health services. This article explains how 
psychological factors do significantly affect outcome and the author calls for more research 
into this area. If time is taken in assessing patients for psychological distress, the length of 
time in hospital is shortened and recovery is quicker. 
How do people cope with the news that they have cancer? Initially patients go through a 
period of distress in which they experience many emotions. These feelings can include both 
emotional and cognitive processing as to what cancer means to them, (Moorey, 1990). 
Cancer care has now incorporated these constructs and has moved from the strictly 
biomedical model into a much broader format incorporating psycho-social aspects. 
The most common psychological responses of cancer patients are anxiety and depression 
(These will be further discussed in Chapters 2 and 3). Depression is the classic response to 
loss as is anxiety to danger (Hughes 1991). These are normal responses provided that they are 
1 Shakespeare, William, King Lear, 11, iV,1 05-1 07 
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not unduly severe or prolonged. However, if anxiety and or depression are abnormally high, 
they can interfere with patients' quality of life, decision-making and compliance and, 
accordingly, can affect survival (Massie & Holland, 1990). 
Treatments for cancer can cure or prolong life substantially. However, they too can cause 
a number of physical and psychosocial problems. Radiotherapy is one of the treatments for 
cancer. It can be used alone or in conjunction with surgery and or chemotherapy. It is used 
both radically to cure, and, palliatively, to alleviate symptoms. 
Approximately 50-60% of all cancer patients receive radiotherapy (Crosson 1984). The 
principle aim of radiotherapy is to stop the spread of cancerous cells to the surrounding tissue 
or to treat where the tumour is inaccessible. Radiation alters body cells so that they are either 
destroyed or cannot reproduce. Cancer cells tend to be more radiosensitive than normal 
tissue. This sensitivity, however, depends on the origin of cancer as each cell type varies. 
Radiation treatments vary considerably. A number of different factors need to be 
considered when assessing the patient for treatment. Is the treatment radical or palliative? 
What is the age and physical condition of the patient? What is the histology report on the 
tumour and where is this tumour situated? 
With radical patients, treatment is spread out over weeks to allow normal tissue repair 
and also to try and prevent, or rather minimise, permanent physical injury. For palliative 
patients, treatment can be a single treatment or multiple treatments over weeks. Radiotherapy 
involves a careful balance so that the cancer cells are killed while the normal cells remain 
relatively intact. 
Radiation does, however, affect both healthy and malignant cells so that it can cause a 
number of unpleasant side-effects. These include skin irritation, hair loss, lack of appetite, 
nausea and vomiting, sterility, reduced bone marrow function and extreme tiredness. For 
some patients, these side-effects are disturbing and anxiety can further rise (Andersen et aI, 
1984). However, not all the medical profession acknowledge this problem. Neither are the 
patients always educated in what to expect during their treatment and after it has finished. 
Just the thought that one is experiencing radiotherapy can cause nausea and vomiting as 
exhibited in what would be considered an unethical experiment today, carried out by Parson et 
al (1961). They found that 75% of patients receiving 'sham' radiotherapy experienced fatigue 
and nausea. This study highlights how the mind and body can interact. 
What are the long-term effects of radiotherapy treatment, how long do patients suffer 
from these side-effects and how do patients feel during and after treatment? These aspects 
2 
will be analysed in more depth in Chapter 2. Very few studies have looked at patients for 
more than two years, even though they may still be suffering from side-effects of 
radiotherapy. With regard to how patients feel after their treatment little has been done and 
without this information, it is impossible to assess how to organise help. The survivors in a 
Canadian study reported that psychological and social effects of cancer were of more 
importance than physical effects (Belec 1992). Can psychological distress be predicted post 
treatment on the basis of patients' scores prior to actual radiotherapy treatment? 
Interventions to relieve distress have taken place and helped patients. Interventions can 
take many forms both psychologically and physically. Meyer & Mark (1995) showed the 
efficacy of a wide range of psychological interventions. Evans & Conrus (1995) found that 
both cognitive behavioural therapy and social support therapy brought about a reduction of 
distress symptoms for patients undergoing radiotherapy treatment. The social support group, 
in particular, was still effective in reducing distress six months post treatment. Similarly 
adjuvant therapy has also been shown to be effective (Greer & Moorey 1997). Other studies 
have shown that survival can be extended. Faller et al (1999) found that 
"both coping and emotional distress had a statistically independent effect on 
survival among patients with lung cancer" 
(Faller et a11999) 
This sample size of one hundred and three was not big and the survivors numbered only 
eleven. Sheard and Maguire (1999) undertook meta-analyses on the psychological 
components of anxiety and depression to see if psychological interventions were effective. 
They found that 
"Group therapy was as effective as individual therapy and that anxiety was 
lowered more than depression. For those patients at risk or suffering from 
significant clinical distress, interventions had strong clinical effects". 
(Sheard &Maguire 1999) 
Ross-Petersen et al (1998) studied the literature on psychosocial interventions and 
survival and found that psychosocial intervention had a real effect immediately after the 
intervention. They felt that there could be long-term benefits however all the studies had 
methodological flaws. 
It is apparent that patients' psychological state needs to be ascertained so that appropriate 
interventions, if needed, can be arranged. How can this be done economically in the current 
atmosphere of cutbacks in the health service? One possible answer is by the use of reliable 
well-validated questionnaires that are cheap, easy to administer, use and mark. 
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Aims 
The aims of this study were 
• To observe, using questionnaires, the emotional functioning of patients attending 
a radiotherapy clinic before, during and five years after treatment has finished. 
• To ascertain the times of greatest distress for patients. 
• To identify factors that could indicate which patients are the most vulnerable to 
psychological morbidity. 
• To find out what and how patients feel and need during this period 
• To see if predictions can be made on the basis of psychological tests at simulation. 
• To see ifthere are indicators for survival. 
Accordingly, the results of this study will give a 'snapshot' view of the emotional distress 
incurred by patients before, during and after their radiotherapy treatment. It is hoped that 
guidelines to radiotherapy departments can be suggested, either in the form of further research 
in specific areas or in positive recommendations, so that the patient's quality of life can be 
improved during this stressful period. 
Why? 
All patients attending the radiotherapy clinic at Mount Vernon Hospital during the month 
of October 1993 were asked to participate. 
Why a longitudinal study? To assess where patients' needs are. For example, Johnston 
(1980) in her study on anxiety found that patients did not generally peak in anxiety levels just 
before an operation but earlier. Patients needed, and thus gave themselves time, to adjust 
mentally to the anxiety of the operation. Therefore when do patients having treatment that 
lasts for weeks feel distressed? Does the distress occur when the treatment has finished and 
they are left unsupported having attended the hospital regularly for weeks or is it when they 
first attend for planning of their treatment. Do men and women react differently to their 
distress? Is age a factor? Breast patients tend to have more counselling available, so will this 
show in the results? 
Why ask all patients? 
It is known that radiotherapy can cause distress in patients (Holland et al 1979). Mount 
Vernon was in the process of opening a centre - the Lynda Jackson Macmillan Centre. One 
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of its aims was to alleviate distress in patients. With limited resources it is difficult to know 
which patients are in most need so that they can be treated in the most appropriate way. 
A radiotherapy unit consists of radiotherapists, radiographers, nurses and other hospital 
staff who attend patients suffering from cancer and who need radiotherapy treatment. Staff 
involved in treating patients are not restricted to one particular cancer site - although breast 
patients predominate: neither are they restricted by age, gender or social class. The patients 
entering for treatment are a mixed cohort. The aim of this study was to look at this 
heterogeneous population being treated for radiotherapy during one specific calendar month 
by the same team of professionals. It would have been more satisfactory to continue the study 
for another month or more but financial constraints restricted this. The patients were 
regularly tested over a five-year span. Anxiety could change over time for the cancer patient. 
For example, those who have been hospitalised for a lengthy time and then return home or to 
work could be subject to higher anxiety levels. As already mentioned, radiotherapy can effect 
anxiety and depression. There are very few longitudinal studies to show how long these 
feelings continue. Similarly, there is a dearth of material about what patients think or want. 
Health carers tend to make assumptions about what they think the patient requires. This study 
should help a little in addressing these issues and ascertaining the needs of the patients. 
Questionnaires were given instead of interviews to assess how patients feel. Some 
questions were based on answers from the last questionnaire given or patient led. Others were 
based on interviews with survivors or were suggested by the Lynda Jackson team. This was 
combined with psychological questionnaires. The psychological questionnaires given were 
all well validated. 
Finally, it is also hoped that this longitudinal study may be able to assess indicators of 
survivorship. 
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Chapter 2 
Literature Review 
The literature review is divided into five sections: the first being research pertaining to 
anxiety and cancer; the second to anxiety and radiotherapy; the third to depression, cancer and 
radiotherapy, the fourth to gender and age differences, and the fifth to the side-effects of 
radiotherapy especially fatigue. 
The primary search engines used were Medline (1966-2002), Psychlit (to 2002), Cancerlit 
(to 2002) and Web of Science (1982-2002). In general studies were excluded which did not 
focus on adult cancer patients. Keywords used were radiotherapy, anxiety, depression, gender 
and psychological distress. 
Anxiety and Cancer 
Anxiety is a normal reaction to cancer with levels of anxiety varying from patient to 
patient. Anxiety if prolonged and left untreated can interfere with patients' and their family's 
quality of life (Davis-Ali et al 1993, Payne 1992). Some doctors may not recognize the 
symptoms of anxiety or may think that these are 'normal' feelings for patients with a 
diagnosis of cancer. Patients similarly feel their anxiety is understandable even if it persists 
for some considerable time and therefore do not seek medical advice. If symptoms of 
anxiousness persist beyond a seven to ten day period, advice should be sought (Massie 1990) 
as there is a clear distinction between what is considered normal fear/anxiety and a reaction 
that becomes more intensive and prolonged. It is then referred to as a psychiatric illness, 
which under DSM111 is called an adjustment disorder. This is confirmed by Massie (1990), 
who stated that the most frequently encountered type of anxiety, is reactive anxiety 
(situational), which would be expected to be high in a newly diagnosed cancer patient, but 
which should adapt. Thus these anxious symptoms can be transient. Only if these feelings 
become prolonged and or out of control can the anxiety be categorised under DSMll1. 
Most patients with adjustment disorder have no previous history of other psychiatric 
disorders. Severe nervousness, worry, jitteriness, inability to function properly, maladaptive 
behaviour and/or moods in response to cancer can be classified 'adjustment disorder'. This 
requires intervention. Interventions can take a variety of forms: relaxation technique, 
reassurance, low doses of quick acting benzodiazepines, support and education (Maissie 
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1990). When the anxiety is caused by such variants as pain or a hormone-secreting tumour, 
prompt treatment can lead to immediate lowering of anxiety levels (Briebart 1995). Often 
depression can co-exist with anxiety in cancer patients. Maguire (1992) and Greer (1994) 
found that approximately 25-30% of cancer patients during the first two years of diagnosis 
develop clinically significant anxiety or depression. Anxiety can seriously affect patients' 
quality oflife. It can increase with pain (Glover et al 1995, Velicova et al 1995), cause sleep 
disturbance, affect appetite and it has even been shown that it can lead to premature death if 
left untreated (Sirois 1993). 
Some specific cancers, for instance pancreatic cancer, are particularly prone to produce 
symptoms that are similar to anxiety-related psychiatric illness. Lung metastasis and/or lung 
cancer, which can cause shortness of breath, can sometimes lead to extreme anxiety and panic 
attacks if not controlled. 
Some patients are more at risk of developing anxiety disorders. Those patients who have 
previously suffered from an anxiety disorder are at greater risk of relapse when suffering from 
cancer. Patients who suffer from psychological problems such as phobias often feel ashamed 
of their condition and fail to mention it to their oncologist and their anxiety can accelerate. 
Other factors that can affect anxiety are lack of support, lack of communication by the 
patient to friends and family and the advancement of the disease especially if it is 
accompanied with severe pain (Breibart 1995). Similarly, anxiety can increase if the patients 
have experienced someone dying from cancer. 
Age and gender can be contributing factors towards increased anxiety. Women and those 
who have cancer at a young age have been shown to be at more risk (Friedmann et al 1994). 
A number of studies have looked at the prevalence of anxiety in cancer patients. Studies 
have shown that 44% of patients with cancer report some anxiety, with 23% reporting 
significant anxiety (Schag et al 1989). For most patients, this is short lived. Information 
seeking, support and adjustment usually control anxiety to normal levels. 
One of the most frequently cited studies is Derogatis et al (1983), which found that one 
hundred and one patients from a total of two hundred and fifteen were assigned a psychiatric 
diagnosis. That is a prevalence rate of 47% for DSM Ill-defined psychiatric disorders in a 
cancer patient population. To put this into perspective, what would be the expected number in 
a normal population and in a medical patient population? Hoeper et al (1979), found cancer 
patient rates for psychiatric illness three times higher than the general population (at 15%) and 
twice as high as a medical patient population. Jenkins et al (1998) reports on the prevalence 
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of anxiety disorders in the general population as between 3-16%. In Derogatis's study, a total 
of 32% suffered from adjustment disorder, 12% depressed mood, 13% mixed emotional 
features, 6% anxious mood and 1% emotion and conduct. Major affective disorders 
accounted for 13% and anxiety disorders 2%. It should also be noted that, in the Derogatis 
study, all the patients were new admissions to the cancer unit. Therefore the largest 
percentage of these psychological cases is patients trying to adjust to their cancer. Only a 
very small percentage of these patients had a history of previous psychiatric illness. Farber et 
al (1984) found lower levels of anxiety when one hundred and forty one cancer patients were 
tested. Of this population, 13% had high levels of anxiety and 14% intermediate levels of 
anxiety. In contrast to the other studies, however, 60% were in remission and 33% were not 
receiving treatment. A study carried out by Massie & Holland (1987), assessed reasons for 
referral to a psychiatrist. The largest group, (54%), suffered from reactive distress, which 
consisted of anxiety, depression or mixed mood. 
From a long-term perspective, Maguire et al (1978), found medium to severe anxiety in 
21 % of breast patients, which continued for up to four months after their mastectomy and, in 
19% of patients, for up to one year. They also found, un surprisingly, a significant difference 
between mastectomy patients and those with benign breast disease. 
However, it should be noted that this study was carried out in 1978, before mastectomy 
counselling was introduced. Indeed, in the 70s and 80s, little or no counselling or psychiatric 
referrals took place with cancer patients. It was mainly in the mid 80s that professionals 
started to respond to articles written by Derogatis and his colleagues. This gradually began to 
have an affect in making health professionals more aware of their patients' feelings and 
anxieties. 
Payne et al (1999) in a more recent study studied ambulatory breast patients attending 
two cancer clinics and still found significant psychological distress in this population. 
Fallowfield et al (1994) with a sample of breast cancer patients over a three year period found 
anxiety levels of between 17-23%. 
How long do patients feel anxious after their diagnosis and treatment? A total of one 
hundred and ninety seven patients were studied in a cancer follow-up clinic. Most patients 
reported no or mild anxiety in relationship to their visit. However, one-fifth had moderate or 
severe anxiety. Of this cohort, 46% were worried about recurrence. Those patients who were 
in remission following treatment reported more distress than patients whose treatment had 
finished two or more years before (Lampic et al 1994). The study could be questioned in that 
8 
the test given for anxiety was a visual analogue test only and was not used in conjunction with 
any other well-validated questionnaire. Also the patients were tested three weeks after the 
follow-up clinic and anxiety was higher at this time point. Three weeks post clinic was 
suggested in order to get a 'normal' reading. However many patients could still be waiting 
the results of tests performed at the follow-up clinic at this time. A more appropriate time 
testing time could be six weeks after their hospital appointment when test results have arrived. 
Loge et al (1997) carried out a survey of four hundred and fifty nine survivors of 
Hodgkin's disease. They found that those whom had survived seven to ten years were 
significantly more anxious than those who had survived three to six years. Predictors of 
anxiety were chemotherapy and radiotherapy combined, (radiotherapy treatment only reached 
near significance), low educational status and psychiatric symptoms before or during 
treatment. However, this was a survey not a longitudinal study and no psychological tests had 
been previously performed on the patients. Therefore no comparisons can be made. The 
question 'do patients generally feel more anxious after a cancer diagnosis and for how long?' -
remains largely to be answered. 
According to Nordin & Glimelius (1997), who tested for psychological distress in 
gastrointestinal patients, although the average levels of anxiety were low, some patients had 
high levels of either anxiety or depression or both and this continued over time. This study 
indicates the importance of testing to identify patients so that appropriate treatment can be 
gIven. 
From a slightly different viewpoint Pasacreta & Massie (1990) conducted a survey on 
nurses who have more direct contact with in-patients. Their study involved four hundred and 
seventy five subjects. They specifically wanted to know how many patients: 
• "exhibited psychiatric symptoms, 
• had a psychiatric history, 
• were being seen by psychiatric consultants, 
• required psychopharmacological treatment, 
• required special nursing observation for suicidal thinking or agitated behaviour 
• and had psychiatric symptoms related to acuity of illness" 
(Pasacreta & Maissie 1990). 
Patients were grouped into two groups: high (N=277) and low (N=160) acuity. Acuity 
referred to the extent of disease or hospitalisation of a patient in critical care. In the low 
group, 26% suffered from anxiety, depression or both. In the high group, the figure was 51 %. 
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Although a total of 55% of the patients was recorded as having psychiatric symptoms, 
only 13% were receiving psychiatric help in any form. A small proportion of patients, 11%, 
reported having a history of psychiatric problems prior to admission. Only 5% of these were 
being followed up. Therefore more than half of the patients were considered to be 'at risk', 
but were receiving no psychological help during this distressing time. The findings of this 
study have major implications for patient cancer care. Houts et al (1986) in their study of six 
hundred and twenty nine cancer patients, recommended a more effective screening for 
psycho-social problems and a better referral service. 
An American study highlighted the fact that 50% of terminally ill patients in hospital 
have moderate to severe pain and 25% die with untreated anxiety and depression, Foley K. 
(2000), and Hospice Association of America (1999). 
At what time in the 'cancer journey' do patients require assistance to help them with their 
anxiety? Diagnosis is an obvious time, but treatments also can raise anxiety levels. What 
effect does radiotherapy have on patients psychologically? Does this further increase their 
distress and for how long? This will be discussed further in the literature review on 
radiotherapy. 
Anxiety And Radiotherapy 
Various treatments given to cancer patients such as radiotherapy can further increase 
anxiety. Fears and misconceptions about the aims of radiotherapy treatment and how it works 
cause patients to become worried and anxious. This has been confirmed by several studies 
(Greenberg 1998, Roach et al 1996). In a study carried out by Peck & Bolland (1977), on 
fifty patients, two-thirds of the patients remained anxious throughout their treatment. The 
most feared side-effects were burns (72%), scars (54%) and pain (54%). Gyllenskold (1982), 
cites 'being radioactive' and 'worries about damage to healthy tissue' and 'permanent genetic 
damage' as being high sources of anxiety. 
Radiation cannot be seen; neither can it be felt nor smelt. Therefore to some patients the 
whole experience can be extremely threatening. In addition, some patients have to wear 
perspex masks which are clamped to the treatment bed. Others have to lie immobilised in 
uncomfortable positions. All patients have to be left alone during their treatment, although 
they can be seen on video screens and can talk with and be heard by staff. 
Some patients believe that radiotherapy is only given to palliate symptoms and 
therefore their surgery must have been unsuccessful. Others believe that their cancer 
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must be inoperable. Some experience additional fears concerning the equipment and 
the possible administration of incorrect doses. In recent years, there has been much 
publicity about the effect of ultra violet radiation on the skin and how it is a contributor 
to the increase in skin cancer. For patients this is an anomaly - how can something 
which causes cancer, cure cancer? 
Radiotherapy Departments can look rather bleak and depressing. Patients often have to 
wait for considerable lengths of time, frequently in the company of obviously sick and dying 
patients, and this can be a factor in increasing anxiety levels. In this environment, it is very 
difficult to sustain denial (Fallowfield et al 1986). Mitchell & Glickman, (1977), studied 
patients having radiotherapy treatment and found that 80% would not discuss their emotional 
problems with their referring doctor or their radiotherapist. Is this because patients feel that 
doctors, especially radiotherapists, are highly trained 'technical experts' and they do not want 
to 'waste' their valuable time on their emotional problems? Or is it because they feel 
inhibited? 
Fallowfield et aI, (1986), in their study on mastectomy patients, asked patients 
'Looking back over this past year, can you pick out one period that 
was worse than any other?' 
Most women stated: 
'between finding the lump and hearing the diagnoses, closely followed 
by their experiences during radiotherapy'. 
Can information help the radiotherapy patient? Patients want information and evidence 
shows that they cope better with their diagnosis and treatment if they are given good honest 
information in a sensitive format (Cohen et aI1979). 
Cassileth et al (1980), stated that radiotherapy patients felt poorly informed and desired 
more information, especially from their radiotherapist. Holland et al (1979) carried out a 
study in which women patients were randomly assigned to two groups, an intervention group 
or non-intervention group. The intervention group had a tour of the department, which 
included talks by the staff who would be treating them on the procedures involved, followed 
by a question and answer session. The women were found to be less anxious on their first 
visit. This is a time consuming operation and it would be difficult to organise in a busy 
department. A less disruptive method of giving patients information could be by video 
presentations. Rainey (1985), divided patients into low and high-information groups. The 
low information group only received a booklet, whereas the high-information group was 
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shown a video with information about the staff, treatment, common misconceptions etc. Staff 
was present to answer any problems. Those in the high information group had less anxiety 
and less mood disturbance when they arrived at the radiotherapy department and this 
continued through to the end of their treatment. Thomas et al (2000) found that both anxiety 
and depression were significantly lower in the group that had been given a video to take 
home. They felt that well designed video programmes were very useful sources of accurate 
information. 
An orientation programme given to patients on their initial visit can help anxiety 
depression and distress. McQuellon et al (1998) in their study found that their programme of 
orientation could help patients at the time of their diagnosis. Not only did it help in reducing 
psychological distress but also their overall knowledge on treatments was greater as was 
patients' satisfaction with the care given. 
The role of information in patients' adaptation to radiotherapy was highlighted in an 
Article by Ream and Richardson (1996). They found in the studies they reviewed that the 
role of information was restricted to topics such as self-care strategies and their effectiveness. 
They recommended that other factors be taken into consideration so that information can be 
tailored to patients' needs, for example, anxiety be measured, socio-demographic details and 
medical state noted. Whether the treatment is palliative or radical should also be a factor in 
this equation. 
What is lacking therefore is a broader concept of patient satisfaction. Has the 
information supplied by the hospital covered all the salient points? Do departments ask for 
feedback from their patients on what their requirements are and if the information was 
satisfactory for their needs? In this way the needs of the patients could be dealt with. This 
could have an effect in reducing anxiety and depression. Montgomery et al (1999) undertook 
a study combining satisfaction with information and levels of anxiety and depression. A total 
of 28% were not happy with the information given, 30% were probable subjects of adjustment 
disorder and 13% were suffering from depression. Significance was reached between high 
scorers on the HADS and dissatisfaction with the information. This study only reviewed 
patients before and at completion of their treatment. Nothing was given post treatment. 
If patients are anxious, their recall is low and thus they may not be registering the 
information given to them. Similarly, patients could also be using avoidance techniques and 
deliberately not reading the information. Denial is another method of coping. When and how 
the information is given are important factors. 
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Johnson et al (1997) took a sample of two hundred and twenty six patients and divided 
them into two groups, a control group and an experimental one. The control group was given 
the standard nursing care. The other group was given, at four different times, theory-based 
interventions. The experimental group were not only found to be less pessimistic about their 
outcome but also experienced less disruption in their usual life style both during and after 
their radiotherapy treatment. 
High levels of anticipatory anxiety are common reactions, before, during and after 
treatments. Andersen & Tewfik (1985) state that 
" ... in threatening situations, the level of fear can potentially determine the 
adequacy of adaptation." (Andersen & Tewfik 1985) 
In a Norwegian study by Kaasa et al (1993), two hundred and seventy seven palliative 
radiotherapy patients were tested before their radiotherapy treatment. They found that those 
patients in the most pain with poor performance status were the ones identified as being the 
most distressed. A total of 69% of the two hundred and forty seven patients who agreed to 
participate in the study reported a high level of psychological distress. This is approximately 
five to eight times higher than in a normal population. The psychometric tests used were: 
• Impact of Event Scale, involving 15-item self-report scale and 
• The 20-item version of the General Health Questionnaire. 
Pain was assessed on a five point Likert scale and the doctor involved completed the 
Karnofsky performance status scale. The tests used in this study are all very time consuming 
to fill in and score. 
Rahn et al (1998) studied breast patients at the beginning and at the end of their 
radiotherapy treatment. At the beginning, 40% were anxious and 54% expected side-effects. 
By the end of their treatment, anxiety had dropped. This study was too short. Anxiety was 
still present in patients, how long did it continue? Depression was not measured. Holland et 
al (1979) found that anxiety was at its highest at the onset of treatment. By the end of 
treatment, patients were more depressed, angry and less hopeful. 
Jane Graydon, (1988), with a sample of seventy nine patients, found that those patients 
who were anxious and tense at simulation tended to have poor functioning following their 
treatment. However, Graydon's sample size was small and, although it assessed patients 
twice, once in the first week of treatment and the other time four to thirteen weeks after 
radiotherapy had finished, it did not follow patients through treatment and only did one testing 
post treatment and this was not at a consistent time. 
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As treatments for cancer become more aggressive for the cancer patient, so anxiety can 
be further heightened. Acute anxiety can also be indicative of a change in metabolic state. 
Sepsis and or electrolytic abnormalities can cause raised anxiety levels. Patients with 
metastatic disease can display high degrees of anxiety. This is usually due to uncontrolled 
pain, with high anxiety and agitation, isolation, abandonment and dependency (Hackett et al 
1987). Similarly, drugs such as corticosteroids can cause motor restlessness and agitation as 
well as depression and suicidal thoughts. For those patients who are in active treatment, and 
who have dependency problems with nicotine, alcohol or drugs, anxiety could be raised by 
their having to comply with hospital rules and regulations. 
What emerges from this literature review on anxiety and radiotherapy is that hospitals 
need to find out firstly what is the psychological state of the patients undergoing radiotherapy 
and secondly at what specific times does anxiety occur in order to give appropriate 
information, advice and support. Do the majority of patients adjust to their treatment as 
emphasized in the literature or do they get more anxious when they return home? Do side-
effects make patients more anxious? Do patients carry the burden of their cancer diagnosis 
for years or do they forget and get on with their lives? 
Cancer, Depression And Radiotherapy 
Much was written on anxiety but until recent years little was written on depression with 
cancer patients. Approximately 6% of the general population suffer from depression (Angst 
1992, Lepine et al 1997). Depression is frequently seen in cancer patients and is the most 
frequent psychiatric complication. However it still remains largely undiagnosed and 
untreated. It can include such symptoms as lack of sleep, loss of interest in life, irritation, 
suicidal thoughts, fatigue, changes in sexual desire and anxiety. Each of these symptoms can 
lead to a poor quality of life. Patients who are suffering from depression can also be less 
compliant with their treatments, have longer stays in hospital and have higher mortality rates 
(Spiegel 1996, Bottomley 1998). Faller et al (1999) looked at survival time in lung cancer 
patients and found that emotional distress, depression and depressive coping were associated 
with shorter survival. Similarly Watson et al (1999) found that a high depression score in 
breast cancer patients was linked to a significantly lower chance of survival. 
A diagnosis of depression can be confusing for the physician as symptoms of cancer can 
replicate depressive symptoms. If one looks at the criteria for classification of depression 
DSM-l V it says 
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"At least five of the following symptoms to be present during the same two-
week period and represent a change from previous functioning: at least one of 
the symptoms is either (1) or (2). 
Depressed mood most of the day, nearly every day. 
Markedly diminished interest or pleasure in all or almost all activities most of the 
day, nearly every day. 
Significant weight loss of gain 
Insomnia or hypersomnia nearly every day 
Psychomotor agitation or retardation nearly every day 
Fatigue or loss of energy nearly every day 
Feelings of worthlessness or excessive or inappropriate guilt nearly every day 
Diminished ability to think or concentrate, or indecisiveness nearly every day. 
Recurrent thoughts of death, recurrent suicidal ideation or suicide attempt" 
(American Psychiatric Association 1994) 
Weight loss, a decrease in activity and fatigue are common side effects of cancer and its 
treatments, which can confuse the diagnosis for depression. 
It is estimated that 20-25% of cancer patients suffer from untreated long-term depression. 
However, a lower figure was found in a 1998 study by Berard et al (1998). Their prevalence 
rate was 14%. From this cohort, only 14% had been previously identified. Serious 
depression was estimated by Sellick & Crooks (1999) as being between 6-15% of the cancer 
patient population. This highlights the need for routine screening in oncology departments. 
The most common form of depression in cancer patients is adjustment disorder with 
depressed mood. This can be characterised by dysphoric mood and an inability to perform 
normal functions such as not getting up in the morning or not going to work. If these 
symptoms persist for more than two weeks then treatment should be sought. Newport & 
Nemeroff (1998) point out that: 
'neurovegative symptoms which may be due to secondaries can sometimes 
cloud the picture'. 
If depression is alleviated, quality of life improves as does immune function and length 
of survival time (Mcdaniel et al 1995). It should be noted that approximately 50% of patients 
do adapt naturally. Patients are then able to assess the information given to them, prepare for 
treatment, adjust to family lifestyles around their treatments and maintain a positive attitude to 
their illness (Massie & Shakin 1993). It has also been shown that the presence of anxiety or 
depression in patients can cause an increase in emotional problems in a partner, which can 
reflect into the family (Harrison et al 1995). This reinforces the importance of assessing 
patients for psychological distress. 
15 
Depression is particularly prevalent in a palliative care setting. Indeed, Kuuppelomaki 
and Lauri (1998) interviewed thirty two incurable cancer patients. The most cornmon 
psychological suffering was caused by depression. When they were in pain, tired or in bad 
shape, they felt depressed. This in turn brought about feelings of giving up and wanting to 
die. One third of the patients in this study had experience of wanting to die. 
Breibart (2000) in a paper, 'Depression and Hopelessness Predict Desire for Early Death 
Among Terminally Ill' found that those patients who were suffering from a major depressive 
disorder were four times more likely to want an early death. They also found that scores for 
depression were moderately high in all the assessed patients. Their paper concludes that 
psychiatric and psychosocial care are both essential in the quality of palliative patient care. 
Hopwood & Stephens (2000) in their study of palliative lung patients found that of the nine 
hundred and eighty seven patients studied, a third suffered from depression and another third 
suffered from borderline depression. A total of 34% had high levels of anxiety and 21 % 
suffered from both anxiety and depression. They suggest that, as the incidence is so high, 
perhaps all patients suffering from late stage lung cancer should be assessed. The self-
assessment questionnaire used was the HADS. Jenkins et al (1998) looking specifically at 
radiotherapy patients found one third were suffering from clinically significant depression. 
Again, self-report scores were used. This was the Inventory of Depressive Symptomatology -
Self Report (IDS-SR). Relevant factors, which they found could be helpful in a diagnosis of 
depression, were 
"a personal or family history of depression and or a positive endorsement of 
one of the following three statements: thoughts of suicide or death, feeling 
restless, or diminished mood response to good events". 
Uchitomi et al (2000) found that patients who were not satisfied with their confidante 
were significantly more likely to suffering from depression three months after surgery. 
Indeed, the importance of social support and communication has been shown by other studies 
(Akechi et a11998, Neuling & Winefield 1983). 
Depression can be treated pharmacologically or psychologically or by a combination of 
both methods. The effects of antidepressants on cancer patients require more trials. 
However, they do appear to be safe and effective in the treatment of depression and 
depressive symptoms. Unfortunately, they also appear to be under prescribed. Berney et al 
(2000) wrote 
"While there has been considerable progress in the pharmaceutical development of new 
drugs, antidepressant are still under utilised in patients with advanced disease. A variety of 
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factors, such as lack of effective communication, uncertainties surrounding psychosocial 
aspects of disease, and the lack of clearly established diagnostic and therapeutic procedures 
may be responsible for this unsatisfactory situation". 
It is interesting to note that with tricyclic antidepressants (TCAs), cancer patients need 
much less dose than healthy psychiatric patients. The reason for this is not yet known. 
However, Aapro & Cull ., (1999) recommend that TCAs should be prescribed with caution. 
Instead they recommend selective serotonin reuptake inhibitors (SRRIs), as they have fewer 
side-effects especially anticholinergic effects including dry mouth, constipation, tachycardia, 
blurred vision, urinary retention and delirium (Jenner 1992). SRRIs can also bring about 
sleep without causing day-time drowsiness. Drugs, such as fiuoxetine, which is an SRRI, can 
also reduce pain. However, this is contra indicated if the patient is anxious or under weight as 
they can also be appetite suppressors (Cooper 1988), both common problems with cancer 
patients. Therefore the choice of the antidepressant depends very largely on symptoms, 
medical problems and side-effects. For example, patients with stomatitis after radiotherapy 
need an antidepressant with low anticholinergic side-effects such as bupropion. 
Benzodiazepines can be used if anxiety is associated with the depression. Unsurprisingly, 
high pain scores were correlated with high depressive scores in a study by Pimenta et al 
(1997). Does pain cause depression or does depression cause pain? Spiegel et al (1994) 
studied two groups, one with high pain and one with low. The group with high pain had 
significantly more depressive problems even though the low pain group had a significantly 
higher history of depressive disorders. 
A meta-analysis of fifty eight studies after 1980 was undertaken by van't Spijker et al 
(1997) on the psychological consequences of cancer diagnosis. They found that anxiety and 
general psychological distress did not differ significantly from that in the general population. 
However, cancer patients did exhibit increased depression. Compared with other medical 
patients, they found that cancer patients were significantly less anxious. These findings 
contrast with previous reports and emphasize the need for more research. 
In a more recent article by Sanson-Fisher et al (2000), they found the highest area of need 
of cancer patients undergoing treatment was in the psychological domain. 
In 1981, Petty and Noyes stated that etiological factors associated with cancer are 
primarily responsible for patients experiencing depression. However, factors such as 
radiotherapy can also contribute to depression. 
Looking at long-term effects, Buccheri (1998) found a relationship between 
depression and prognosis in lung patients, the more depressed, the shorter the survival. One 
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could question which comes first. Depression is also considered to be a contributing factor 
with fatigue in patients. Depression could be a cause but it could also be a consequence of 
permanently feeling tired. 
How is depression recognised? Are oncologists successful at recognizing the symptoms 
of depressed patients? Passik et al (1998) found 
"that oncologists frequently assessed their patients' levels of depressive 
symptoms inaccurately. Although physician and patient ratings were 
moderately (and significantly) correlated, most of the actual agreement in 
physician and patient ratings were on the none or mild end of the continuum. 
Physicians accurately classified only 20 of 159 moderately to severely 
depressed patients and rated 78 of these patients as having essentially no 
depressive symptoms. We also found that physicians' ratings were most highly 
correlated with patients' endorsements of more obvious symptoms, such as 
sadness, tearfulness and irritability, while they were less strongly associated 
with more subtle symptoms such as concentration difficulties, anhedonia and 
somatic symptoms" (Passik et al 1998) 
In this study, 36% of 1,109 patients had clinically significant depression, yet less that 3 % 
of those patients were currently seeing a mental health professional. 
These are frightening statistics for cancer patients but they are indicative of a problem, 
which needs attention. This was confirmed by Newell et al (1998) who wrote that: 
"medical oncologists do not accurately reflect their patients' reported levels of 
anxiety, depression, perceived needs or many physical symptoms" 
Fallowfield et a12001, wrote 
"psychological morbidity is still common and that much of it goes unrecognised and 
is not therefore treated" . 
What about other health professionals? McDonald et al (1999) studied nurses' 
assessments of depression in their patients. The results were similar to oncologists. The 
nurses under estimated depression in those who were severely depressed. They again were 
most influenced by overt feelings such as crying. Both these studies emphasize the need for 
more education in depressive symptomology and in a good easy to administer diagnostic tool 
for measuring depression in a cancer patient population. 
Penninx et al (1998) found that when a person suffers from chronic depression for at least 
six years, there is a correlation with a generalized increase in the risk of cancer. Indeed, could 
one hypothesize that those patients already depressed could be at a higher risk of spread? 
Little research has been done in this area. Controlled trials of available pharmacological 
and non-pharmacological treatments are urgently needed. 
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Bottomley in his literature review on depression writes 
"It is now important that health care professionals routinely assess and offer 
treatment for depression in cancer patients" (Bottomley, 1998). 
According to Maguire et al (1978), 80% of clinically depressed mastectomy patients are 
not seen as such by their surgeons. Symptoms such as worry, tension, dread, irritability and 
an inability to relax can be present permanently or can manifest themselves in different forms 
such as unnecessary fear of recurrence, dying and of attending for treatment (Hughes 1991). 
Depression is largely undiagnosed and untreated for cancer patients. Studies have 
shown that about a quarter of people with cancer develop depression. In contrast two 
percent of cancer patients in one study (Stiefel et al 1990) were receiving medication for 
this serious complaint, which may impact on the course of the disease, affect 
participation in treatment and thus affect quality oflife and survival. 
Gender and Age 
Gender 
Gender is a huge subject and was the topic of the American Psychiatric Association 
meeting in 1999. At this meeting Leibenluft (1999) stated that depression was two to three 
times more common in women than men. Nopoulos (1999) showed, through neuroimaging, 
gender differences in emotion as women show more use of their limbic system when sad than 
men. This can be extended to external factors. Kendler et al (1999) found that women 
display more emotions than men. 
Mood disorder has also been shown to have a strong causal relation to stress. Young 
(1999) found a difference in stress levels in men and women. Stress is mediated by the 
hypothalamic-pituitary-adrenal axis. Cortisol is increased with stress. Normal women appear 
to have a stronger HP A response to stress than do normal men. In women, ovarian steroids 
modulate the stress response. At puberty, after birth and during menopause this axis can be 
de-stabilised. This could be one of the reasons for the increase in anxiety disorders in women. 
In fact, depressed women show more hypothalamic pituitary axis deregulation than depressed 
men and this seems to be in part regulated by the sex hormones. This difference is continued 
in response to drugs. Women respond better to SSRIs (selective serotonin reuptake 
inhibitors) than men. Women experience more side-effects with the tricyclics. However, this 
difference appears to change in menopausal women. Schatzberg (1999) further states that 
"exogenous estrogens may speed antidepressant effects in women". Depression is not gender 
specific. However depression in women is twice as common as men (National Comobidity 
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Survey, 1994) though men are more likely to die from suicide (Horton 1995). Wearn et al 
(2002) found that malignant disease was associated with an increase risk for suicide. This 
was gender specific for men. 
A difference has also been noted in how health professionals see men and women. Men 
are perceived as being less ill and women as exaggerating their illness (Macintyre 1993). 
Surveys have shown higher morbidity for women and higher mortality for men (Waldron 
1983; Wingo et al 1995). Men are reported as having better health. However their life 
expectancy is about 7 years lower than women's. In a study on gender differences in cancer 
patients Greimel et al (1998) found that men had significantly less social resources than 
women, more cancer-related problems and more restrictions in daily living. 
Should gender be a consideration when treating patients with radiotherapy? Studies have 
been mixed. Cella et al (1987) found that women experienced more distress. This was 
confirmed by Nordin et al (1996). They showed that women exhibited more anxiety than 
men. These patients were all gastrointestinal cancer patients attending follow-up clinic. 
Similarly, Brandberg et al (1995) found a gender difference with female melanoma patients 
being more depressed than men. In contrast, Pettingale et al (1988), found men were more 
distressed and that their lives had been far more upset by cancer than the women. 
Stefanek et al (1987) found no gender difference. Similarly, Irwin et al (1986) found no 
sex differences in how men and women coped with cancer and radiotherapy treatment. They 
found that both depression and anxiety fell after treatment. 
Depression studies in cancer patients were examined by DeFlorio and Massie (1995). 
They looked specifically at gender differences. From the forty nine studies reviewed, twenty 
nine included gender. However, from the twenty nine studies, six did not stipulate any 
differences or did not look for a difference. From the remaining twenty three studies, 
nineteen were specifically looking at one sex. The remaining studies found no significant 
difference at the 0.05 level. The only study mentioned with radiotherapy patients was Peck & 
Bolland (1972) and gender difference was not cited. Craig & Abeloff (1974) found that, 
while gender differences were not significant, they found a tendency for white females of 
higher social class to have more psychological symptoms. Plumb & Holland (1977) found 
that more men than women were suffering from depression. However, both Craig & Abeloff 
and Plumb & Holland were studying palliative patients and these studies are nearly thirty 
years old. In a more recent study, Holland et al (1986) found that the men's depression and 
distress scores were equal or slightly higher than the women's, though significance was not 
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reached. These patients were all palliative pancreatic or gastric patients. In contrast, Lloyd et 
al (1984) found that women had significantly higher psychiatric morbidity. This was a study 
testing newly diagnosed cancer patients. 
In a paper on the Unmet Needs of Cancer Patients, Sanson-Fisher et al (2000) identified 
age and gender as factors, with women reporting higher levels of unmet needs than men. 
Being female is associated with increased anxiety in medical situations according to Friedman 
et al (1994). Harter et al (2001) found gender differences. Anxiety disorders were more 
common with women who had cancer. The risk of mental disorder was double for women 
with cancer over their lifespan in comparison with men patients. 
Gender differences were studied in patients undergoing chemotherapy. Women's distress 
could primarily be explained by physical impairment such as old age. In comparison men's 
distress was closely related to their psychological state (Keller & Henrich, 1999). 
Leigh et al (1987) in a longitudinal study found a gender difference and suggested that 
men coped by denial and that women's coping was more realistic. Men and women were re-
tested three years after the initial testing. The women who failed to survive had a more 
realistic view of their illness in contrast to the men who rated their illness as only 'somewhat 
serious'. Is it that men take longer to adjust and come to terms with their illness or do they as 
Leigh et al suggest, cope by denial? 
Psychological distress can be a product of a life threatening illness. Patients undergoing 
radiotherapy treatment will be in a vulnerable position. Dysphoric mood is more common in 
women (Weismann & Klerman 1977). Similarly, depression has been shown to reach its peak 
in women between the ages of 25-45 and decreases in subsequent years and with an 
increasing trend in men with age (Schwatz & Blazer 1986). Will this be the case throughout 
treatment? This needs to be tested. More research is required in this area especially with 
radiotherapy patients. 
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Age 
Age is another major factor that has not been extensively studied in connection with 
anxiety and depression in cancer patients. Compas et al (1999) found that younger women 
around the time of diagnosis exhibit more distress and have less means of coping. At six 
months after diagnosis, these patients displayed no significant difference compared with the 
older patients. Similarly, Sanson-Fisher et al (2000) found that patients within the age range 
of 31-60 consistently had more unmet needs that those aged 70 and over. Other research has 
confirmed this (Mor et al 1992). However, this could reflect a change in attitude. Young 
people could be more forward in their needs and more willing to voice their needs in contrast 
to older age people who tend to be more stoic. 
In a Swedish study with breast patients receiving radiotherapy after surgery, Marasate et 
aI, (1991), found that from one hundred and thirty three patients, eighteen (14%) had morbid 
anxiety. In particular, they found a significant correlation between morbid anxiety and 
women aged 50-59 who had a mastectomy. This they felt indicated that menopausal women 
are more at risk of emotional disorder not all of which is specifically linked to cancer and 
radiotherapy. These factors could include hormonal imbalance, children leaving home, plus 
the natural aging process. When these facts are added to the natural anxiety of mutilating 
surgery, emotional distress is heightened. There were only thirty three women in this 
category, so that ideally it should be repeated using a larger number of women to verifY the 
statistics that menopausal women need more emotional support. In this study, a score of 8 
was used to show borderline anxiety on the HADS (Hospital and Anxiety and Depression 
Scale) and 10 to indicate high anxiety. No other tests were used. This anxiety could have 
been short lived, a longitudinal study would have indicated anxiety over time and whether it 
was repeatedly high for menopausal women. 
Other studies have highlighted the higher levels of psychological morbidity among young 
cancer patients (Jarrett et al 1991, Edlund & Sneed 1989). Harrison and Maguire (1995) 
confirmed that younger patients were subject to greater distress when coping with emotional 
issues but older patients were subject to more limitations imposed by treatment and the 
disease. 
How do elderly patients cope with radiotherapy treatment which is arduous and time-
consuming? According to an article by Lindsey et al (1994) they found that the only side-
effects patients suffered from were a decrease in weight and activity. This study was 
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longitudinal over radiotherapy treatment and three months post. However it would have been 
more interesting if it had been coupled with a measurement for depression. The loss of 
weight could be due to a lower calorie intake and this could have been related to feelings of 
depression. 
These studies indicate the importance of studying for differences in gender and in age 
coupled with psychological distress with radiotherapy patients. 
Side-effects of Radiotherapy 
Radiotherapy can cause long-term effects. Non-malignant, healthy cells can be damaged 
by the radiation if they are in the pathway of the area to be treated. Thus previous symptoms 
can be aggravated and new symptoms can develop, such as diarrhoea, frequency, pain, skin 
reactions, nausea and fatigue. The major ongoing symptom of radiotherapy appears to be 
fatigue. This could be caused by or related to cell injury (Aanno et al 1989). In lung patients, 
for example, fatigue could result from fibrosis caused by the treatment, which in turn causes 
shortness of breathe and/or pain, with results in tiredness. Certainly Smets et al (1998) found 
that lung cancer patients had the highest mean fatigue scores of the patients in their study. 
Immobilisation resulting from prolonged bed rest can result in fatigue following resumption 
of normal activity (Sharpe & Bass 1992). Other factors explaining fatigue include pain, 
nausea or sleep disturbance (Irvine et al 1994). Smets et al (1998) found a relationship 
between fatigue and psychological distress, in particular depression. They suggest that 
fatigue is a result of acute physical and psychological stress that is associated with both the 
cancer and its treatment and suggest that interventions to reduce psychological distress may 
reduce fatigue 
Monga et al (1999) in their prospective study with prostate patients found that, at 
commencement of treatment, 8% felt tired. On completion, this rose to 25%. Fatigue is often 
associated with depression. However, this was not the case with these patients. Before 
treatment, eight patients indicated depression. By the end of the treatment seven were 
depressed, with no new cases reported. Indeed Monga et al (1997) thought that subjective 
fatigue is related to a fall in neuromuscular efficiency due to radiotherapy treatment. 
A number of studies have put the incidence of fatigue as a common side-effect of 
radiotherapy treatment between 65%-100%, Peck & Bolland (1977), Kubricht (1984), King 
et al (1985), Greenberg et al (1992). 
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Holmes (1991) studied two cancer patient populations, one group of radiotherapy patients 
and the other chemotherapy patients. Both cohorts were found to have similar levels of 
symptom distress. Tiredness was the most common symptom. Variations did occur. The 
radiotherapy patients reported more significant distress due to pain, altered appearance, 
constipation and appetite change whereas the chemotherapy patients found their inability to 
concentrate, mood changes and alterations in their appearance distressful. However, 
Berglund et al (1991) studying a similar cohort of chemotherapy and radiotherapy patients 
found the radiotherapy patients reported decreased stamina (75%) when compared with the 
chemotherapy patients (61%). It must be noted that this study looked at the late effects of 
treatment and was carried out two to ten years after the patients' treatment had finished, hence 
the difference in the findings. 
Fatigue was also reported to be the most distressing symptom by Oberst et al (1991) in 
their study that assessed self-care, stress and mood in seventy two patients who had 
undergone radiotherapy treatment for an average of four weeks. They found that coming for 
treatment was the most demanding aspect. 
Fatigue can also accelerate physical helplessness and dependency (Charmaz 1983). Can 
patients be helped to combat fatigue? Mock et al (1997) studied forty six women undergoing 
six weeks of radiotherapy treatment for early stage breast cancer. Patients were tested pre and 
post treatment and divided into a control group and an exercise group. The exercise involved 
a self-paced home-based walking programme. Significant differences occurred in the groups. 
The 'walkers' suffered less from fatigue, anxiety and sleeping problems. Depression was not 
assessed. 
Faithfull's (1995) article describes the debilitating symptoms experienced by patients 
both during and after radiotherapy treatment to the pelvis. Men can receive damage to the 
bowels, the rectum and the testes. However, many of the patients felt that the symptoms 
suffered were inevitable in the curing process. Information on side-effects did alleviate 
anxiety, but did not help patients in managing their symptoms - in this case urinary problems. 
The side effects of leakage and incontinence are associated with old age. These side effects 
caused embarrassment, and made the patients feel stigmatized. Similarly, the fear and anxiety 
for women undergoing pelvic radiation is described in an article by Whales, (1991). These 
patients can have damage to the vagina and the ovaries because of the treatment for their 
cancer. 
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Head and neck or pelvic- treated patients appear to be particularly susceptible to 
problems following treatment. Regular support in the form of information and follow-up care 
should assist patients in their adaptation to cancer and its treatments. Wells (1998) undertook 
a study on head and neck patients after their treatment had finished and found that patients 
had a reluctance to ask for help even though this cohort underwent severe physical and 
psychological trauma. This article highlights the need for more care both during and after 
treatment, especially with regard to information and communication. In head and neck 
patients, permanent damage to the salivary glands affecting taste and salivary production can 
result. The worst time for head and neck patients was during and just after finishing treatment 
(Hammerlid et al 1997). 
Patients seemed satisfied with the clinical care they have received (Suomminen 1992, 
Wiggers et al 1990), but were not satisfied with other aspects of their care including 
information about the disease, its treatments, the side-effects of radiotherapy treatment and 
their control. Furthermore patients and their families felt a lack of support. 
In a study in 1999 (Mose et al) carried out in Germany on breast patients receiving 
radiotherapy post surgery, 92% felt they were well informed about the treatment. However 
83% still wanted further information. All the patients (100%) stated that the treatment was 
tolerated because of good communication with the staff. Montgomery et al (1999) found that 
some patients (22%) could not remember signing a consent form. Those who did remember 
signing did not understand fully what they had signed for. Patients were told of side-effects 
but one fourth of patients could not remember being told. Over a quarter of the patients were 
not satisfied with the information given to them. Of this cohort, 30% scored so high on the 
HADS that they could be considered to be suffering from an adjustment disorder. Anxiety 
inhibits recall and, therefore, when giving patients important information on their treatment, 
anxiety levels should be noted. Montgomery et al also found a significant correlation between 
the high scorers on the HADS and dissatisfaction with information given. This limited recall 
could also be the patients' method of coping with the treatment. Similarly, those patients with 
high initial anxiety could be the patients who adapt the quickest to their treatment. This needs 
to be further investigated. Patients can be given information but the content and time of 
giving it needs to be assessed. 
As time evolves, more side-effects can occur. Johansson et aI, (2000) studied seventy 
one patients who had received treatment in 1963 -1965 for cancer of the breast. Survival was 
almost 50%. Late effects started from about five to thirty four years post treatment. 92% of 
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these survivors had paralysis of their arm, 5% suffered from paralysis of their vocal cords. 
This had developed nineteen years after treatment. Indeed, the development of neuropathy is 
slow with an average time of 4.2 years. Over time the neurological problems increase with 
Grade 4 damage obviously taking longer time to emerge, approximately ten years. 61 % of the 
patients developed skin fibrosis, with a mean time for developing it of 1.8 years, with one 
patient developing it eleven years after treatment. 
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Chapter 3 
Specific Longitudinal Studies 
The following five studies were carefully selected. The first study is longitudinal and 
looks specifically at emotional distress over time. This corresponds with the second aim of 
the present study to ascertain the times of greatest distress. The population of bone marrow 
transplant patients have a high attrition rate and are undergoing unpleasant treatment and 
could be compared with cancer patients undergoing radiotherapy treatment. 
The second study is also longitudinal and measures psychological distress using the 
HADS. The population consisted of both radical and palliative patients. Both factors are used 
in the current study. The subjects are either having radiotherapy or brachytherapy. 
The third study looked at predictions made on the basis of tests at diagnosis, using the 
HADS questionnaire. Both radical and palliative patients were included in the study. The 
fifth aim of the current study was to see if predictions can be made on the basis of 
psychological tests at simulation. 
The fourth study was chosen because it looked at psychological predictors of survival in 
radiotherapy patients. This is the last aim of the current study. The ST AI state and trait 
questionnaire was used and are also used in the current study. 
The fifth study is a longitudinal study of head and neck patients undergoing radiotherapy 
treatment. The HADS is used to assess patients' anxiety and depression. However here 
calandrical points are used. This is common in cancer studies, rather than specifically 
important times that are used in the current study. 
First Detailed Study 
Longitudinal Study of Adaptation to the Stress of Bone Marrow Transplant 
Authors: Fife B., Huster G., Cornetto K., Kennedy V N., Akard L P., Brown E 
Journal: Journal of Clinical Oncology Vol 18, No 7 (April) 2000 pp 1539-1549 
This longitudinal study looked at emotional distress. Although bone marrow transplant 
(BMT) is not radiotherapy, both treatments are aggressive therapies and both can cause 
physical, psychological, social and emotional distress for patients and their families. 
This study assessed patients before, during and after transplant. 
1. before hospitalisation 
2. 1/2 days before infusion 
3. 7 days after infusion 
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4. 14 days after infusion 
5. 1 month post 
6. 3 months post 
7. 1 year post 
The testing points, one to six, are all valid. However, the break from three months to one 
year needs to be questioned. Most problems occur in the first year post transplant. Similarly, 
the study was only for one year post transplant. Is this sufficient time for adaptation? The 
authors' reasoning was that previous studies have looked at the long-term problems. 
However, data from a prospective longitudinal study with all the same patients and lasting for 
more than one year would have given a more complete overview of patient adaptation in this 
particular cohort. 
The study addressed three points. 
Firstly: "At what specific time points in the BMT process do individuals experience the 
greatest distress?" 
Secondly "what factors are associated with this distress as well as with the individual's 
ability to cope and adapt successfully?" 
Thirdly "what variables demonstrate the potential to serve as clinical indicators of those 
individuals in greatest need of intervention if the development of psychological emotional and 
social problems secondary to the transplant are to be minimised or prevented?" 
Nine questionnaires were used which were all self-report questionnaires, namely: 
• BiPolar Profile of Mood States where each variable is on a continuum giving negative 
and positive emotions. 
• Social Support was measured by the modified versions of 
• Perceived Family, 
• Perceived Friends Support Scales and 
• Perceived Health Care Provider Support Scale. 
• Stress was measured using the Ways of Coping Checklist, which was modified for 
people with life threatening illness. It consists of forty items. Patients are asked to 
show on a scale of 'never' to 'very often' how often they used a certain strategy. 
• Next a Mastery Scale was given, whose aim is to show, if the patients feel they have 
some control over their lives. 
• Followed by a body image scale, which was developed for this research. - seven items 
with a Likert-type format. 
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• Then patients completed a questionnaire adapted for bone marrow transplant patients 
for cognitive response/meaning, which was labelled a Meaning of illness Scale. 
• Finally, patients had a questionnaire on the symptoms - the Impact of symptomology 
- checklist developed by the team, which ranged from physical, psychological and 
social. This was arranged as sixteen items on a Likert scale. 
These nine questionnaires seem rather excessive for a sick population to fill in and not 
surprisingly the results indicated a lot of missing data. The authors, however, did not subject 
the patients to all the tests at every point. Only the POMS, the symptomology checklist and 
the Mastery Scale were repeatedly used. 
Patients completed all nine questionnaires at three different points only; before 
hospitalisation (baseline), after three months and one year post transplant. Surprisingly, at 
one month after treatment, the body image questionnaire, the social support questionnaire and 
the coping strategies were left out. This is the first testing since leaving the care of the 
hospital and support and coping should have been included. 
With regard to the validity of these questionnaires, only Bipolar Profile of Mood States 
(POMS) has been the subject of debate and is a robust well-validated tool for use with 
medical patients. The other questionnaires were formed or adapted for use with patients on 
this study. 
One of the biggest problems in this study was missing data due to sickness, death and 
non-compliance. The attrition rate was not included in the result section. Missing data was 
replaced by data from previous time point, if the patient was known to be alive, but was a 
non-participant. However, this was only done if results had been obtained from three 
different time points. This can be questioned. There were also the problems of self-selection 
with the healthy replying. The decision was made to analysis the data as two separate studies 
and to test for differences between them. The first group consisted of only the information 
sent by patients, the second group consisted of a much bigger group where data was inserted 
on missing variables. 
The results using T -tests between the two groups showed little difference with few 
significant results. Those significant differences, which did occur, were not recorded in the 
paper, though the authors covered themselves by stating that none of the differences were 
significant for more than one testing. 
The authors therefore used the bigger group to analyse the data as a single sample using 
repeated measure analysis of variance, correlations and regression. 
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The analyses were carried out looking at specific time points and repeated measures 
analysis of variance used to see the changes over time for each variable. If significance was 
attained, the Duncan multiple range test was used to protect against Type 1 error. This 
showed that the period in hospital before the transplant was the most stressful for patients. 
Both depression and anxiety levels fell one week after the transplant. 
To understand what factors were associated with distress, emotional responses over time 
and other factors such as social support, symptoms and self-image were correlated. Fife et al 
found that, one year after BMT, the more symptoms that the patient was suffering from, the 
higher the emotional distress levels. Unfortunately this was where the study ended. 
Extending this study for another year would have given valuable information on symptoms 
and emotional functioning. 
Significant correlations were also found in patients who were distressed before treatment. 
They continued to be significantly more distressed after treatment. Personal control was 
significantly correlated with lower anxiety levels. 
In the area of social support, family support was the strongest. An association was found 
between decrease in depression and support from health carers. 
Using multiple regression analysis, the authors found that emotional distress and personal 
control were the two most important factors in predicting those patients in greatest need of 
intervention. The more avoidance coping, the higher the anxiety. Similarly, the more 
cognitive coping, the less the anger. Personal control was associated with lower anxiety and 
depression. 
Although there were flaws in this study with problems in attrition and in the 
questionnaires used, this study has given thought as to how to cope with analysis in a 
longitudinal study with patients who are at risk of dying. Complete data sets were impossible 
with this particular cohort. However the data analysed from this study does give an accurate 
picture of what actually happens with bone marrow patients with the results biased towards 
the more healthy individuals. 
The highest anxiety, depression, anger and uncertainty levels were measured when 
patients were hospitalised after intensive chemotherapy and before the bone marrow 
transplant. It will be of interest to see if the present study produces similar crucial time 
points. This study showed the importance of, firstly, personal control and, secondly, the 
importance of the health carers in this crucial time in reducing psychological and emotional 
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distress which all help in the adaptation process. A more complete picture would have 
emerged if the study had been carried out for longer. 
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Second Detailed Study 
A prospective Quality of Life Study of Patients with Oral or Pharyngeal Carcinoma Treated 
with External Beam Irradiation with or without Brachytherapy 
Authors: Hammerlid E., Mercke c., Sullivan M., Westin T. 
Journal: Oral Oncology Vol 33 N03 189-196, 1997 
This is a prospective longitudinal study carried out over one year. Patients were oral and 
pharyngeal cancer patients and were divided into two groups according to treatment. One 
group consisted of radiotherapy treatment only and the other group received radiotherapy and 
brachytherapy. Brachytherapy is an increased localised dose by irradium implant. It gives a 
high dose of radiation to a specific tumour volume at very close range, with a rapid fall-off in 
dose to adjacent normal tissues (Dow & Hilderley, 1992) 
The aim of the study was to gain a better understanding of the quality of life of 
pharyngeal/oral cavity cancer patients and to see what symptoms and what side-effects 
distressed patients the most. Finally, the study wanted to assess if there was a difference in 
patients' quality of lives dependant on the type of treatment. 
Patients were tested at 6 points:-
1. At time of diagnosis 
2. 1 month after treatment started 
3. 2 months after treatment started 
4. 3 months after treatment started 
5. 6 months after treatment started 
6. 1 year after treatment started. 
The questionnaires used in the study were:-
The European Organisation of Research and Treatment of Cancer Quality of Life 
Questionnaire Core 30 (EORTC QLQ-C30) to measure patients' quality oflife. 
Psychological distress was measured using the HADS. 
A head and neck questionnaire was used on the first twenty one patients and the next 
eighty four patients answered a more complete but preliminary version of the EORTC 
designed for head and neck patients the EORTC H&N-37. The head and neck component had 
questions that related to the position of the tumour and its treatment. To counteract any 
problems, data was analysed only using questions that appeared in both the head and neck 
module and the EORTC-H&N-37. 
A Sociodemographic and clinical questionnaire contained eight self report questions that 
related to family, education and work, plus smoking. 
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Only the questionnaires given at diagnosis were completed in the hospital - all others 
were by mail. 
The sample size consisted of one hundred and five radical and palliative patients. 
Women formed one third of the sample and ages ranged from 20-85. 
The two groups were not strictly evenly distributed. The radiotherapy group consisted of 
more palliative patients of an older age and were smaller as a group, fifty as opposed to fifty 
five in the combined radiotherapy and brachytherapy group. There was a compliance rate of 
74%. Sixteen of the patients died in this period and ten became non-participants. The 
cumulative response rate was 89%. 
Head and neck patients are cited in the literature as being at more risk of distress and this 
was verified in this study. Probable psychiatric cases were continuously high over the time of 
the study. Anxiety peaked at diagnosis for both groups. In comparison depression was at its 
lowest at diagnosis and peaked at three months for both groups. Depression registered lower 
than anxiety only at diagnosis. The radiotherapy plus brachytherapy group had continuously 
lower scores than the radiotherapy group. After one year, depression was higher than at 
diagnosis for the radiotherapy group. This could be because this group consisted of more 
palliative patients. Seven was used as the cut off point for the HADS as a possible case and 
10 as a probable case. The number of people who scored 7 and over on a scale (anxiety or 
depression scale) were highest at three months post treatment with 44% scoring 7 and over 
and lowest at one year with 24%. A more detailed breakdown of anxiety and depression was 
needed. 
Pain was highest at two to three months but side-effects such as dry mouth were worse 
at one year. With side effects still evident one year was not long enough for this kind of 
study. One third of patients were still having pain and weight problems. The brachytherapy 
and radiotherapy group had lower levels of symptomology. This could be because their 
tumours were not so advanced and the patients were not as old and thus more able to cope 
with the unpleasant side-effects. The radiotherapy and brachytherapy group seemed in better 
shape and weighed more. 
In order to better compare the two groups statistically, the authors used only those 
patients who had cancer of the floor of the mouth. This made the sample size even more 
different with 47/24. The radiotherapy and brachytherapy group had significantly better 
physical functioning at the time of diagnosis and this continued. 
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This study could have produced more complicated statistics with the data available such 
as, correlations and regression analysis. This would have given a better picture of the 
problems involved and the variables associated with them. 
The aim of this study was to look at quality of life in both groups of patients and from 
this study it does appear that patients' quality of life is not affected by the combined treatment 
ofbrachytherapy and radiotherapy. 
However, the patients were not randomised into these groups. The decision as to which 
group to put the patients into was informed. Many of the patients who have these tumours are 
frail. However, to make an accurate statistical test, both groups need to be randomised or at 
least to be of equal numbers in each group. The radiotherapy group did have the smaller, 
weaker, older, and more advanced diseased patients and this showed in the difference from 
diagnosis point onwards. The radiotherapy and brachytherapy group did not appear to have 
more problems except at two month period, in fact, by one year, it had statistically less. As 
the group was a mixed cohort of men and women, it would have been interesting to see if 
gender and treatment intent were factors associated with psychological distress and quality of 
life symptoms. 
Finally, this was the first time the EORTC H&N-37 had been used. 
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Third Detailed Study 
Predicting delayed anxiety and depression in patients with gastrointestinal cancer 
Authors: Nordin, K., Glimelius B. 
Journal: British Journal of Cancer; 79(3-4):525-9, 1999 
This study was designed to see if psychological distress could be predicted on the basis of 
tests at diagnosis on anxiety, depression and coping. 
Patients were tested twice. 
Firstly:- After the biopsy (this was not a set time but was within twelve weeks with a 
mean of three weeks). There is a large variation in time here. The reason given was that it 
was dependent on their physical status. A specific time should have been given to see if and 
when psychological adaptation occurs. It could have happened before physical adaptation 
with these patients. 
Secondly:- At three months and six months for palliative patients and at six months only 
for radical patients after diagnosis/surgery. 
Why were all the patients not tested at three and six months? 
Three questionnaires were used 
• The Mental Adjustment to Cancer (MAC), 
• The Impact of Event Scale (IES) 
• The HADS. 
The sample consisted of one hundred and fifty nine gastrointestinal patients of mixed 
gender with ages ranging from 23-89. 
The authors used scores of between 8-10 on the HADS to classifY 'doubtful' cases, and 
11 and over and was considered a 'case'. 
Analysis was carried out using stepwise regression with scores from the HADS, MAC 
and IES questionnaires together with repeated measures anova for changes over time and two-
tailed unpaired T test to see the difference in observed frequencies. 
A total of ninety eight patients were tested at six months. This gives an attrition rate of 
38% in six months. The mean scores at diagnosis were low, with 4 for anxiety and 4.4 for 
depression. Those who died during the study had significantly higher scores at diagnosis than 
those who survived. There was a significant decrease for both scales of the HADS over the 
period of the study. 
Using stepwise regression analysis, anxiety and depression at diagnosis could account for 
35% of the variance of anxiety and depression at six months, thus showing that the levels of 
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anxiety and depression at diagnosis are predictive. The MAC and IES questionnaires did not 
really help in predicting distress. The HADS was a more useful tool with appropriate cut off 
points to suggest cases 
There were flaws in this study. The authors did not state what treatments patients were 
recelvmg. Two patients who scored less than 8 at diagnosis, subsequently became 'cases'. 
No further information was given about these subjects. Were they borderline at diagnosis? 
What was their gender? Were these palliative patients? Did they become doubtful cases or 
true cases? Were they receiving social support? A record was made of gender intent and 
treatment intent but no statistical analysis was carried out in this paper using these groups. 
The authors divided the HADS scores into 'doubtful cases' and 'cases'. In the analysis, 
the two groups were combined. What proportion of patients who were 'cases' subsequently 
became 'non cases' or 'probable cases' at six months? 
A more substantial database of information would have been to have a baseline before 
surgery, then a set time after diagnosis plus testing at three and six months. 
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Fourth Detailed Study 
Psychological Predictors of Survival in Cancer Patients Undergoing Radiation Therapy 
Authors: Leigh, H., Percarpio B., Opsahl c., Ungerer, J. 
Journal: Psychotherapy Psychosomatic 47: 65-73 , 1987 
This is a prospective study assessing patients who have had radiotherapy treatment. The 
aim ofthis study was to address psychological factors affecting survival. 
The study assessed patients during one of their visits to the radiotherapy department for 
treatment. After three years patients' notes were reviewed to assess 3-year survival in 
conjunction with the psychological variables. 
However, the authors do not specifically say at what point in their treatment were the 
questionnaires given. They say:-
"During one of their daily visits, subjects received a questionnaire" 
This needed to be more specific as treatments can last one day or can continue for six weeks. 
Similarly, the patients were only tested once. As we do not know when the patients were 
tested, we do not therefore know if adaptation had already started. By multiple testing, we 
can ascertain when and how adaptation/coping occurs. 
The study addressed three points:-
• The assessment of anxiety and depression in radiotherapy patients 
• The assessment of how psychological coping mechanisms relate to survival. 
• The assessment of gender differences in psychological predictors of long-versus short-
term survivors. 
All three points have relevance to this thesis. 
Questionnaires used were: 
• STAI State 
• STAI Trait 
• Beck Depression Inventory 
• Health Awareness Questionnaire 
• A General information Questionnaire was also included. This was designed to 
ascertain demographic data, knowledge of diagnosis, procedures and number of 
people living with the patient. 
The ST AI State and Trait together with the Beck Depression Inventory are well-validated 
reliable tests. 
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Tests for significance using correlation coefficients were carried out on the non-survivors 
and the survivors with firstly State anxiety and survival time, secondly with Trait anxiety and 
survival time and thirdly with depression and survival time. 
The variables of depression and anxiety were then correlated with factors such as pain, 
how ill the patients felt, prognosis, nausea, other complications and weight status. 
The results showed that significance was reached with Trait anxiety, the higher the Trait 
anxiety, the higher the chance of survival. Neither State anxiety nor depression reached a 
point of significance. Patients' ratings on how ill they felt were significantly related to 
survival time. The survivors' anxiety and depression scores were significantly related to how 
ill they felt. With the non-survivors, increased anxiety coupled with increased depression was 
predictive of a shorter survival time. No significant difference in anxiety and depression was 
found between radical and palliative patients based on their five year survival prognosis. This 
IS surpnsmg. A significant difference was, however, found between radical patients who 
survived and radical patients who did not. 
A difference was also found with gender. In men, the number of people living with the 
patients correlated positively with their depression scores. Women non-survivors thought 
their condition was more serious than the men non-survivors. The seriousness of the 
women's condition correlated with both State and Trait anxiety. 
The findings of the study enhance the point that the patients' medical condition is 
predictive of their survival. However they found that increased distress is associated both 
with survival and non-survival, rather like a horseshoe effect. The author's explanation is that 
increased anxiety is adaptive in cancer patients. They hypothesized that as the disease shows 
signs of advanced progression, the psychological defence mechanism breaks down, resulting 
in patients feeling both anxious and depressed. In contrast the survivors had high anxiety 
levels because they were more realistic about their disease. 
If the anxiety levels are adaptive then there has to be more than the one test. The anxiety 
tests must be repeated over time to see the adaptation trend. 
The study suggests that the difference in gender is due to coping mechanisms. Women 
appear to be more realistic in their attitude, whilst the men appear to cope by denial. 
This study has flaws. A specified time should have been given to test patients, such as at 
the commencement of radiotherapy treatment. Ifthe study is looking at survival and patients' 
coping/adaptation, these tests need to be repeated over time, both during treatment and after 
treatment has finished. The difference in gender could have been initial and men may need 
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more time to adapt to a diagnosis of cancer. Measurements over time would have been able 
to show how, when and if men adapt and cope with their diagnosis and treatment of cancer. 
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Fifth Detailed Study 
A Prospective Multicentre Study in Sweden and Norway of Mental Distress and Psychiatric 
Morbidity in Head and Neck Cancer Patients. 
Authors: Hammerlid, E., Ahiner-Elmqvist M., Bjordal K., Biorklund A, Evensen 1., 
Boysen M., Jannert M., Kaasa S., Sullivan M., Westin T. 
Journal: British Journal of Cancer 1999, May; 80(5-6):766-774 
This is an interesting longitudinal study the aim of which was to evaluate prospectively 
psychological distress in a heterogeneous population of newly diagnosed head and neck 
cancer patients. 
A total number of three hundred and fifty seven patients were assessed with ages ranging 
from 18-88. The majority of patients (72%) were male. Patients were tested six times in all, 
1. At the time of diagnosis, 
2. One month post treatment 
3. Two months post treatment 
4. Three months post treatment 
5. Six months post treatment and 
6. One year post treatment. 
All questionnaires were mailed, apart from the testing point at diagnosis, when patients 
completed the forms at the hospital. The questionnaires used consisted of 
• TheHADS, 
• The EORTC (not analysed in this paper) 
• A study-specific questionnaire relating to social, educational and vocational matters 
plus smoking habits plus clinical data and 
• The Karnofsky Performance Status. 
The cut-off point for the HADS was over 7 indicated a 'possible' case and over 10 made 
it a 'probable' case. 
The authors state that: 
"the majority of patients had combined treatment, most of them external radiotherapy". 
The numbers for radiotherapy are 88%, surgery 37% and chemotherapy 19%. However, 
analysis is not done on the basis of treatment. Futhermore Hammerlid et al did not say or take 
into account treatments. The measurements started from diagnosis and sometime during that 
year in which patients were treated. What is required is a specific time frame incorporating 
treatments. 
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This study does present data according to gender and age and treatment intent. The 
authors do acknowledge that compliance rates are lower for those with active disease at one 
year post diagnosis and that therefore this study has underestimated the psychological 
problem. The non-participant rate with a mail out questionnaire was low at 18% over the 
year. 
The mean score for the HADS at diagnosis was 4.74, very similar to the previous study, 
and 3.8 for depression. Patients who could be classified as a possible or probable 'case' on 
the anxiety scale was highest at diagnosis, 32%. The table in this study clearly makes the 
distinction between possible and probable cases. 
The authors did find that the patterns of anxiety and depression varied over time. 
Anxiety was highest at diagnosis. However, the number of possible cases was highest at three 
months. In comparison, depression peaked during treatment at the two month mark. 
Palliative patients could have finished treatment by two months and this is not clear. 
However, depression was lowest at diagnosis (17%) and at the one year point. It would have 
been more informative if the authors had presented the figures for treatment intent. 
The authors divided patients up according to scores, 0-7 (no case), 8-10 (possible case) 
and 11 plus (probable case). They then selected three time spots; at diagnosis, at three 
months, which they assessed was at the end of treatment, effectively an arbitrary point, and 
follow-up at one year. They found that some patients shifted from a non-case to a possible or 
probable case at both the three month and twelve month points. This was particularly 
prevalent with the depression scale, especially at the three month point. Anxiety showed a 
marked improvement from diagnosis to three months. They suggest that the HADS be 
repeated during the first year in order to identify patients in need. 
With regard to gender, women were significantly more anxious than men at diagnosis and 
at the one year mark. No differences were found with respect to depression. It is interesting 
to note that on the graphs supplied by the authors, at the two month, three month and one year 
post diagnosis points, the number of men as possible/probable cases on the depression scale is 
larger than the women. However, the authors do not discuss this. In contrast, anxiety is 
consistently higher for the women. It would have been interesting to see if this pattern 
continued. 
With regard to age, patients who had retired were significantly less anxious than those 
who had not, both at diagnosis and at one year. The 'younger' patients were consistently 
more anxious than the older patients for all six testing points. However, the pattern for 
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depression was different. There was a peak at the two month point when the older patients 
out numbered the younger patients and this was repeated at the one year point. 
At one year with the depression component of the HADS using the variable of age and 
gender, the pattern changes and the study ends at this point. The study should have been 
continued. 
Treatment intent was further analysed by combining stages 1 and 11 (radicals) - and 
stages 111 and 1 V (palliative). Anxiety was consistently higher for the Stage 111 and IV 
group, except at the one year point when the combined stages 1 and 11 had more possible 
cases. With the depression component, the patients with more advanced disease were more 
depressed over time for all testing points with the number of cases higher for the patients with 
advanced disease at the one year mark than at diagnosis. 
A logistic regression analysis was carried out using the variables of age, sex, tumour site, 
KPS, living alone or not, and the HADS. The one predictor for psychological distress was 
probable and or possible anxiety or depression at diagnosis. Social support and treatment 
intent should have been included in the analysis. 
In conclusion, this is a good study and the division of the HADS into possible and 
probable cases is clear. However, rather than specific times according to the calendar, 
patients should have been tested at specific threatening periods. When the authors write "at 
diagnosis" what does this mean? Is it immediately after they have been given their diagnosis 
of cancer, or is it at some other time point? Similarly, why were patients not tested when they 
first arrived for treatment, in the middle of treatment and at the end of treatment. These time 
points then become more relevant. The gender component in this study is heavily biased 
towards men. The authors do not say if this cancer specifically affects more men than 
women, but with a proportion of 72% men to 28% women, the numbers are an issue. Finally, 
with changes occurring specifically with the depression component at the one year point, the 
study should have continued. 
From the review of these specific longitudinal studies several points are repeatedly 
emphasised. The variables of gender, social class and treatment intent need to be 
incorporated into further studies. The timings of the questionnaires need to be specific and 
accurate. Patients need to complete the questionnaires under similar conditions. In this way a 
clear picture of the pattern of anxiety and depression before, during and after treatment can be 
assessed. 
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Chapter 4 
Measuring Anxiety And Depression Using A Questionnaire Format, 
Namely Hospital Anxiety And Depression Scale (HADS) and 
Spielberger's State Trait Inventory (STAI) 
Questionnaires have been used with patients to register anxiety and depression. How 
successful are they when used with cancer patients? 
Hospital Anxiety And Depression Scale (HADS) 
A number of studies has been carried out using the HAD Scale to measure anxiety 
and depression in a cancer patient population. The HAD Scale was designed by Zigmond & 
Snaith, (1983). It has two separate components, anxiety and depression. Their aim was to 
design a psychiatric questionnaire that would not be affected by a patient's physical state. It 
could thus be used to screen patients for psychiatric disorder amongst a medical population. 
Therefore in order to differentiate between different mood disorders, the items relating to 
emotional and physical disorder were removed. 
"The eight items composing the depression sub scale were largely based on the anhedonic 
state since this is probably the central psychopathological feature of that form of 
depression which responds well to antidepressant drug treatment (Klein 1974) and 
therefore provides the most useful information for the clinician. The eight items 
composing the anxiety sub scale were chosen from a study of the appropriate section 
of the Present State Examination (Wing et al 1982) and also :from personal research 
(Snaith et al 1982) into the psychic manifestations of anxiety neurosis" 
(Zigmond & Snaith 1983). 
The HADS questionnaire is laid out in an easy to read format. Patients are required to 
tick their appropriate response in relationship to how they have been feeling in the past week. 
If the questionnaire asked patients how they feel now, it might be interpreted too literally. 
Moorey et aI, (1991), carried out an exploratory factor analysis of the HAD Scale on five 
hundred and sixty eight cancer patients. They found not only did it have high internal 
consistency, but the questionnaire also has a reliable, robust factor structure. They were able 
to confirm its usefulness for measuring anxiety and depression in cancer patients. They 
looked at the construct validation of the HADS with not only breast cancer patients but also 
with stroke and myocardial infarction patients. The high levels of internal consistency were 
confirmed. This has been validated by other studies (Dagnan et al 2000, Lisspers et al 1997, 
Spinhoven et al 1997, White et al 1999). 
43 
Greer et aI, (1991), demonstrated that the HADS is an effective tool for cases of anxiety 
and depression in clinically referred cancer patients. It was successfully used by them to 
assess anxiety and depression during treatment of adjuvant psychotherapy. They carried out a 
follow up of this study using not only the HADS but also the Rotterdam Symptom Checklist 
and Mental Adjustment to Cancer and found HADS showed similar sensitivity to changes in 
anxiety levels. 
In a prospective longitudinal study with head and neck cancer patients in Sweden the 
feasibility of the HADS and EORTC was assessed (Hammerlid et al 1997). The 
questionnaires were given six times in one year. Distress was high immediately after 
treatment with an estimated 21% probable cases of psychiatric morbidity. Both 
questionnaires showed similar patterns. 
Studies do confirm that the HADS is not only a useful tool in assessing anxiety and 
depression levels, but it is also effective in assessing changes in emotional distress. 
With regard to the use of the HADS depression component, Hosaka and Aoki (1996) 
found that the depression scale on the HADS split the depressed from the normal. The items 
contained in it were not related to physically ill conditions. However, they did not test it 
against or in conjunction with the golden standard of the psychiatric interview. They 
suggested a cut-off point of 8. Montazeri et aI, (1998) used the HADS in a quality of life 
study with lung cancer patients and found that three months after diagnosis nearly one quarter 
(22%) were depressed. 
Ibbotson et al (1994) in their paper 'Screening for anxiety and depression' found that the 
HADS worked well with patients currently in treatment. They suggest that side-effects do not 
contaminate the results, as there are no somatic items present in the questionnaire. 
The HADS was designed for patients in hospital and may not be suitable for using in 
comparisons with the general population. Groenvold et al (1999) did not find a significant 
difference in "cases" of psychological distress between a group of breast cancer patients and 
women randomly selected. They question the suitability of the HADS for a normal 
population. But the HADS was not designed for a 'normal' population, it was designed for 
patients in a hospital setting and the questions reflect this. 
Hall et al in a paper written in 1999, six years after this study was started, questions the 
use of the HADS. They used it in conjunction with a shortened version of the Present State 
Examination (PSE). They found that if a cut-off point of 11 was used, that sensitivity was 
low with anxiety at 24.2% and depression 14.1%. With a cut off point of 7, sensitivity was 
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improved on the anxiety scale to 72%, but the depression scale was sti11low at 37.4%. Using 
the combined scores, they found that even reducing the cut-off point to 12, the sensitivity was 
only 42.7%. This study needs to be questioned. The patients were interviewed in their own 
homes. The HADS was left for them to complete and return in a sealed envelope. The 
timescale is not necessarily the same nor are the circumstances and this should have been 
taken into account. It would have been better to ask them to fill in the forms at the same time 
as their interview. Their breast patients could have been at various stages of radiotherapy or 
chemotherapy treatment in this three month period. The PSE is designed to measure how 
patients felt within the last four weeks, the HADS is designed to see how patients are feeling 
within the last week. These different time frames could allow for inconsistencies in the 
accuracy of the emotional functioning recorded if the patients answer the PSE and HADS 
correctly, especially if they are about to undergo treatment or have just started treatment. 
Stark et al (2002) in a paper just published used the HADS, STAI State and Trait and PSE to 
assess anxiety disorders in cancer patients. They found that the questionnaires were useful 
tools. The HADS and the STAI State were assessed as the most accurate questionnaires, but 
they did not recognise abnormal anxiety adequately enough. As with Hall et al the time 
frame was inconsistent. The HADS was given on touch screen monitors, in out patient 
clinics. The STAI State and Trait and PSE was given within three weeks in patients own 
homes or in the consulting room, as the patients preferred. Neither the environment nor the 
time scale is the same for the questionnaires used in this study. The PSE, which is given 
within three weeks of the HADS is the closest on time. It measures how patients feel within 
the last four weeks. The HADS measures how patients feel in the last week, there will be a 
time difference here. In contrast the STAI State measures how patients are feeling 'at that 
moment in time'. It should not accurately correlate with the PSE given at the same time. The 
STAI Trait measures how patients 'generally feel' and could therefore be better equated to the 
PSE than the State questionnaire in this specific study. 
Hammerlid et al (1999) emphasized the stability on the HAD scale. They found it had a 
high internal consistency - Cronbach's a was 0.89 for anxiety, and 0.82 for depression. One 
question could be considered as having a dual slot of either anxiety or depression - 'I can sit 
at ease and feel relaxed'. They also found the psychometric performance of the HADS were 
consistent over time. 
Johnston et al (2000) attempted to validate the HADS, and found that the HADS 
performed satisfactory, and had high internal consistency. This was further confirmed in a 
45 
very recent paper by Smith et al (2002). They studied 1474 cancer patients and found 
stability in the factor structure for different variables such as gender, age and different 
metastatic cancers. 
In a discussion document, Depression and Anxiety in Oncology (2001) Jones, Berard, 
Nutt and Davidson all confirm the usefulness of the HADS. With respect to depression: 
"In terms of a compromise of time, specificity and sensitivity, it seems the best we 
have ..... we have compared it with a structured interview and the Beck Depression Inventory 
and found it a very useful and robust tool" 
The HADS has been translated and used successfully in Europe, for example in Italy 
(Costantino et al 1999). It has also been used successfully in Japan (Kugaya et al 1998). 
Therefore, it does seem to be a particularly robust questionnaire, as it can be used effectively 
cross-culturally. 
From this literature review, the HADS does appear to be able to measure both anxiety 
and depression in patients who are undergoing treatment such as radiotherapy. In a study by 
Pinder, Ramirez et aI, (1993) using the HADS questionnaire, they found that patients in lower 
socio-economic class were at higher risk for psychiatric disturbance. This could be due to a 
number of reasons. Members of this social group tend to be less financially secure, have less 
education, and are frightened of asking the 'professionals' questions. They also tend to have 
more frequent stressful life events. These factors could lead them to feel more anxious. This 
increased anxiety could inhibit their recall which in turn reduces the absorption of the 
information given. This highlights why other factors such as social class and treatment intent 
need to be incorporated in this study. 
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Spielberger's State-Trait Inventory (STAI) 
This has been a frequently used tool both in research and in a clinical setting. It consists 
of two questionnaires; the State component investigates how 'one' is feeling at this moment, 
whilst the Trait part looks at how 'one' generally feels in order to identify levels of neurotic 
anxiety. The idea of State and Trait anxiety began in the 1960s with Catell & Scheier (1961). 
Catell further expanded this idea in 1966. Spielberger elaborated on this theory and his ideas 
were incorporated into a single scale, which had different instructions to measure either State 
or Trait (Spielberger 1966). The STAI was first used with the two separate components of 
State and Trait in 1970 (Spielberger et al 1970) and further expanded during the 70s. The 
current format has been used since the 1980s (Spielberger et al 1980). The STAI has now 
been used extensively and has been shown to be reliable and well validated in medical and 
psychiatric trials. Indeed, over 2000 studies have been listed (Spielberger 1983). 
Marie Johnston, (1980), used the STAI to measure anxiety in patients before and after 
surgery. She found that patients experienced high anxiety at various times, before admission, 
between admission and after surgery. Only a small percentage 'peaked' on the morning of 
their surgery. Williams et aI, (1972), felt high anxiety increased risks in surgical patients. 
Those with high anxiety required more anaesthetic, which, in turn, increases the risks in 
surgery. 
A number of studies with cancer patients have used the ST AI. Cassileth et aI, (1986), 
used the STAI with three hundred and seventy eight cancer patients and three hundred and 
seventy nine matched relatives. Those patients who were palliative had significantly higher 
scores than radical patients. A correlation between the State and Trait scores was carried out 
on the palliative patients and was so high that Cassileth suggest that State and Trait become 
'fused' as death approaches. Female patients gave significantly higher scores on the Trait 
Scale. Similarly, relatives of palliative care patients exhibited significantly higher scores, 
showing the need for more supportive intervention in the family. 
Andersen & Tewfik, (1985), used the STAI to measure anxiety in 45 patients receiving 
radiotherapy. They investigated the pre and post-treatment anxiety scores for State and Trait. 
They found significant changes in State anxiety and no change in Trait anxiety levels. Those 
who registered high anxiety at the pre-treatment stage were still the highest group at the end, 
but their scores did fall from their original values. Those with moderate anxiety remained 
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static and those with low initial anxiety showed an increase. This could be indicative of 
patients' coping strategies. 
In a study on the emotional impact of cancer on patients and their families the Stait Trait 
Inventory was used to assess anxiety. In contrast to expectation, no difference was found 
between the adolescent patients and a control group. However this was only three weeks after 
diagnosis and follow-up data was not included (Allen et al 1997). 
Jacobsen, Bovbjerg & Redd, (1993), used the STAI to measure levels of anxiety of 
seventy seven women who were to have chemotherapy infusions. An association was found 
between Trait anxiety and anticipatory anxiety on the first and second infusion. They also 
found that young women suffered from more severe pre-treatment anxiety. They suggest that 
patients at risk of having high anxiety could be identified in the first instance by their Trait 
anxiety levels. 
Millar et al (1995) used both the HADS and STAI together with a visual analogue scale 
(VAS) to assess anxiety in patients awaiting surgery for breast cancer. They found a strong 
correlation between the HADS, STAI and VAS, with an 89% agreement in anxiety scores 
between the HADS and the STAI. The strongest relationship was with the STAI and the 
HADS, the weakest was with the STAI and the VAS. Patients were only tested the once and 
at a particularly anxious time. 
Morris et al (1981) evaluated patients prior to their breast biopsy using the STAI and 
found that the patients who had cancer were more stressed than the patients with benign 
disease. They also found that age was a variable in that young patients had a tendency to 
suppress feelings of anger more than their age-matched control group. 
Very few longitudinal studies have been undertaken. Leigh et al (1987) looked at anxiety 
and depression scores over three years and compared the survivors to the non-survivors. This 
study involved testing only twice, once at the beginning of treatment and after the three years. 
They found that higher Trait anxiety was significantly associated with survivors. They 
suggest that realistic anxiety may be adaptive in cancer patients. With only two readings of 
the anxiety levels, it is difficult to get a total picture. Also 'five' years is considered to be 
survival in cancer terms. Therefore this study is lacking in both time and number of 
assessments. 
The drawback of the ST AI is that it consists of a total of forty questions, twenty State and 
twenty Trait. 
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In 1992, Marteau & Bekker compiled a short-form of the STAI State, which consisted of 
six items. They found that this shortened form produced similar scores to the long-form of 
the ST AI. Therefore coupled with the long Trait test, the overall questions are now reduced 
to twenty six, which is a more manageable number for an anxious population waiting in a 
radiotherapy department. This short-form ST AI State has been used successfully with a 
number of different populations but it has not been used in oncology. 
Throughout the literature studies, there is an emphasis on psychological distress, 
particularly on first diagnosis and when having treatment, especially, radiotherapy. To 
improve the quality of patient care, patients 'at risk' have to be identified. To man a team of 
psychologists to assess patients would be far too expensive. Accordingly a cheaper but still 
effective means of screening needs to be put into operation. 
From the literature reviewed, the Hospital Anxiety and Depression Scale seems an 
appropriate tool for a radiotherapy population. Similarly, the ST AI State and Trait has been 
used by previous studies to assess distress in a cancer patient population. The ST AI is a well-
validated tool as far as the Trait component is concerned, but it is the first time this shortened 
version of the State component has been used with a radiotherapy patient population. 
These questionnaires will therefore be used to assess patients both prior to, and during 
radiotherapy treatment and for five years after. 
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Main Issues from tlte literature review 
Anxiety has been shown to differ wildly from 17-50% (Derogatis et al 1984, Fallowfield 
et al 1994). What causes these differing values? One of the main problems appears to be the 
differing time frame and context the patients were tested in. Leigh et al (1987) says 'during 
one of their visits subjects received a questionnaire'. In a treatment, which can span between 
one day or six weeks this is lacking an accurate time frame. Some studies mention 
'diagnosis' (Hammerlid et al 1997). Specificity is also lacking in this statement. Were they 
tested at the exact time the diagnosis was given, when patients are normally in shock or was it 
pre or post? Other Studies mention testing in an out patient clinic (Derogatis et al 1984), but 
with no other information. Anxiety and depression can vary according to disease progression 
but in many studies patients are grouped together with no selection into specialised cohorts 
such as gender or treatment intent. 
The literature review also shows a dearth of longitudinal studies especially in the field of 
radiotherapy. In 1977 Peck and Bolland found two third of patients remained anxious 
throughout their treatment. Have these levels now changed with a more 'open' society and 
more cancer information given to the patients. 
The literature review has also highlighted the conflicting information on gender studies 
(Holland et al 1986, Lloyd et al 1984). Rahn et al (1998) studied breast patients at the 
beginning and end of treatment. Anxiety had dropped at the end, but patients were still 
anxious. How long did this continue? Do other cancer sites cause similar results or is this 
related to women who are known to be at more risk of anxiety than men (Friedman et al 
1994)? Side effects exist with radiotherapy patients. These can affect patient's emotional 
state (Andersen et al 1984). How long do these side effects continue? 
Depression and anxiety affect up to 25% of cancer patients. These are serious conditions, 
which can be treated. Patient's quality of life and or survival can thus be improved. However 
their needs tend to go unrecognised. Feelings of sadness and anxiety are expected with a 
cancer diagnosis and are therefore not recognised by medical staff or family. Screening needs 
to be implemented. It is therefore necessary to see what specific times are considered 'peak' 
times for distress, and which population is at most risk. Therefore gender, age, site of tumour, 
social class, and treatment intent are all confounding variables which need to be addressed. 
The HADS and ST AI have been chosen as well validated psychological screening 
questionnaires. The HADS measures anxiety and depression in the last week. The ST AI 
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State measures anxiety at this moment, and the ST AI Trait measures anxiety generally. Will 
this difference be apparent in the patient's scores? 
In the light ofthis review the following aims and objectives were proposed. 
AIMS 
• To observe, using questionnaires, the emotional functioning of patients attending a 
radiotherapy clinic before treatment, during and five years after treatment had 
finished. 
• To ascertain the times of greatest distress for patients. 
• To identify factors that could indicate which patients are the most vulnerable to 
psychological morbidity. 
• To find out what and how patients feel and need during this time. 
• To see if predictions be made on the basis of psychological tests at simulation? 
• To see if there are indicators for survival. 
OBJECTIVES 
• To suggest guidelines to radiotherapy departments so that patients' quality of life can 
be improved during this stressful period 
• To identify areas of further research 
• To make positive recommendations, for example to health workers so that patients' 
quality of life can be improved after treatment at the hospital 
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The Radiotherapy Centre 
Chapter 5 
Methodology 
The radiotherapy department at Mount Vernon Hospital in Middlesex is a large regional 
centre catering for an approximate area of 1300 square miles. Nine clinical oncologists work 
in the department, which gave over 4,600 courses of radiotherapy in 1993. The department is 
supplied with four linear accelerators and one superficial machine. These are manned by 
twenty seven radiographers. 
The Lynda Jackson Macmillan Centre was opened in 1993 at Mount Vernon Hospital to 
cater for the psychosocial needs of the cancer patient. This study was carried out in 
collaboration with this centre. 
A surgeon or an oncologist transfers patients to the radiotherapy department for further 
treatment of their cancer. The patient's first appointment in the radiotherapy department is for 
assessment and very careful planning. This planning is referred to as simulation and is 
extremely important. The consultant radiotherapist together with a physicist and radiographer 
make an informed decision on the amount of radiation the patient will require. This depends 
on a number of factors; whether the patient is being treated radically or palliatively; the 
position of the tumour, whether it is close to vital organs, the age and general medical 
condition of the patient; the type and grade of tumour. When the overall dosage is agreed, it 
is then divided into a daily treatment dose. This is referred to as a fraction. The patient might 
require further tests and scans before planning can be done. The radiotherapy treatment can 
vary in length from one day to six weeks. 
Instruments 
Two anxiety questionnaires were consistently used, the Hospital Anxiety and Depression 
Scales (HADS) and Spielberger's State-T'fait anxiety inventory (ST AI). Both these 
questionnaires require patients to rate their emotional state. Familiar verbal statements are 
used in a category rating scale. A further in-house Research Questionnaire was added to get 
feedback from the patients at the end oftreatment and for five years after. 
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The Hospital Anxiety and Depression Scale (HADS) - (See Appendix 1) 
Controversy still exists as to the cut-off point of both the anxiety and depression 
component of the HADS. Furthermore, should this questionnaire score of two components be 
combined for an overall level of distress or should they be considered separately? 
Razavi et al (1990), in their study with two hundred and twenty six cancer in-patients 
used the total score of 13 as the low cut-off point for adjustment disorder, as they found that 
this gave them 75% sensitivity and 75% specificity and only 25% false +ve rate. Sensitivity 
refers to the correct proportion of identified cases. That is the number of true cases (true 
positives) divided by the number of true cases plus number of false cases. Specificity refers 
to the proportion of correctly identified non-cases (number of non-cases [true negatives] 
divided by the number of non-cases plus number of false cases). A high cut-off point of 19 
detected major depressive disorder, which gave them 70% sensitivity and 75% specificity. 
They used the HADS in conjunction with a psychiatric interview, which lasted 45 minutes. 
The HADS scores varied significantly. Similarly, the psychiatrist interviewing the patients 
found a comparable difference in his psychological assessment. They ascertained that, in 
screening for adjustment disorders and major depressive disorders, the incidence of a high 
score of 15 correlating with a case was 90% and, in the case oflow scorers, 74%. It is also 
important to note that all patients were interviewed and tested by the questionnaires under 
similar conditions in hospital. 
Thus their study was able to validate the HADS as a good tool to be used with 
hospitalised cancer in-patients with appropriate cut-off points to indicate psychological 
distress. 
Moorey et al (1991) used a cut-off point of 8 for each subscale and recorded clinical 
anxiety levels of 27% and depression levels of 9%. This patient sample was newly diagnosed 
patients, within three months of their initial diagnosis, and they were nearly all outpatients. 
Gender and treatment intent were not included in the variables. Furthermore, Moorey did not 
use a psychiatric interview for verification of their results. 
Is the HADS a suitable instrument to use with a palliative care population to assess 
anxiety and depression and what cut-off point should be used? Hopwood et al (1991) 
undertook a study using the HAD Scale looking at eighty one women with advanced breast 
cancer. They used the Rotterdam Symptom Checklist in combination with the HADS. 
Patients who achieved high scores on either questionnaire, were further interviewed by a 
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psychiatrist, who had no knowledge of the questionnaire results. In this study the cut-off 
point of 11 was used on the individual scales. Some low scorers were further randomised to 
an interview assessment too. Using the HADS total score with a cut-off at 19 for major 
depressive disorders, the scores were very similar to Razavi et al (1990), though they found 
their cut-off point of 18 to be more accurate with sensitivity further improved to 81 %. When 
the two subsets are used with a cut-off point of 11, they found the anxiety scale to be more 
effective than the depression. 
A study by Pinder et al (1993) used 11 as the cut-off point on the separate scales. Their 
patient population was one hundred and thirty nine women with advanced breast cancer. A 
total of 19% had scores of 11 and above on the anxiety sub scale and 12% depression, with an 
overall percentage of 35. Other studies have shown a similar rating with approximately 25-
50% of patients suffering from clinically significant anxiety and depression (Plumb & 
Holland 1981). 
Carroll et aI, (1993), screened for anxiety and depression in a total of eight hundred and 
nine in and outpatients with cancer. They used both the low cut-off (8) and high cut-off (11) 
for both subscales. Previously only fourteen patients had been referred by the doctor for 
psychological screening. With the low cut-off point, 47.6% of this population needed further 
psychiatric intervention. This is remarkably similar to Derogatis' (1983) figure. With the 
higher cut-off point of 11, a total of 23% fell into this high score category. The depression 
sub scale of 11 was found more frequently in inpatients, though there was no significant 
difference in anxiety levels between in and outpatients. A total of 89% of the subjects had 
active disease, but again their scores showed that there was no significant difference in their 
anxiety or depression scores. However, the HADS was the only instrument used in this study. 
It was not specified if patients were having treatment or not. Neither did they specify if any 
patients were receiving anxiolytic drugs or if they had any previous psychiatric history. 
Ibbotson et al (1994) stated that: 
"at a score of over 15, the sensitivity was 85% specificity 71 % and positive predictive 
value of 47%" 
Using a cut-off point of 19 they found it was effective in patients whose cancer was in 
remISSIon 
'sensitivity was 92%, specificity was 95% and the positive predictive value 72%.' 
That is % of the high scorers would be cases. For those patients with stable disease they 
suggest a cut-off point of 15 
"with sensitivity of 85% and specificity of77% and positive predictive value of 47%" 
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Aass et al (1997) using the HADS found a prevalence rate of 13% for anxiety and 9% for 
depression in a radiotherapy hospital, with female patients exhibiting significantly more 
anxiety than their male counterparts. The HADS was used with a cut-off point of 11 for 
cases. In a comparison with other malignancies, gynaecological patients were the most 
anxious cohort. This was not a longitudinal study. 
Kygaya et al (1998) found that the HADS was sensitive and specific for Japanese cancer 
patients. Using both psychiatric interviews and the HADS, they found that the optimal cut-off 
point was 10/11 for adjustment disorders. This gave a high sensitivity of 9l.5% and 
specificity of 65.4%. For depressive disorders a 19/20 cut-off point was needed. This gave 
an 82.4% sensitivity and 96.3% specificity. 
The HADS has also been used successfully on older cancer patients. A cut-off point of 
15 was used by Roth et al (1998) on elderly prostate patients. 
Young and Maher (1992) in their study showed that the HADS identified 75% of patients 
to be in need of extra support, when compared with a trained counsellor's assessment. They 
ascertained that 44% of radiotherapy patients had high anxiety levels. Young & Maher used 
the separate subscales of the HADS score, with the low cut-off point of 8 and considered 10 
as high. According to Murphy et al (1987), a high sensitivity cut-off point should be utilised 
where the prevalence rate is high. Therefore, in a radiotherapy department where the stress 
levels are high, a higher cut-off level is needed to screen more accurately. 
From the review of the cut-off points of the HADS it appears that both the separate and 
unitary scales should be used. Patient's scores will, therefore, be assessed at the 8 cut-off 
point to indicate a 'possible' case and at the 11 cut-off point to indicate a 'probable' case, for 
the separate subscales of anxiety and depression. Using the combined scores, the cut-off 
points of 13 and 18 will be used, which suggest adjustment disorder and major depressive 
disorder respectively. These points were used successfully in previous studies in conjunction 
with a psychiatric interview. 
The HADS was given to patients on twelve separate occasions. The HADS asks patients 
to tick the response "which comes closest to how you have been feeling in the past week". 
Spielberger's State-Trait Anxiety Inventory 
This is a self-report questionnaire (see Appendix 2 & 3), which has two components that 
measure two different aspects of anxiety, Trait and State. The Trait was given only at 
simulation, but the State ST AI was given all twelve times. 
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The Trait anxiety refers to an individual's proneness to anxiety generally. In contrast 
State anxiety refers to the individual's response to stress at that moment in time. Each item on 
the scale is scored one to four. 
The ST AI Trait has been used to identify people with neurotic anxiety. It is a self-
evaluation questionnaire. No time limit is imposed, however, each component should take 
five minutes to answer. Instructions are written on the forms. The Trait form consists of 
twenty questions. Scores range from 20 to 80. If one or two items are missing, the mean for 
the questions answered is taken and multiplied by twenty and then rounded to the following 
highest number. The form is discarded if three items are missing. The average Trait score for 
patients without psychiatric complications was 41.33 (Spielberger 1983) and this was used as 
the cut-off point for Trait anxiety. 
The State form was given first and then the Trait. The State form of the ST AI consisted 
of six items only. Marteau and Bekker 1992, modified the twenty item test to six. The 
reliability coefficient for this six item ST AI State test was a= 0.82. and for the 20 item STAI 
was a= 0.91. Furthermore Marteau & Becker found no difference in the mean scores between 
the three sets of subjects whom were tested with both questionnaires. Therefore as patients 
were already having one anxiety questionnaire (HADS) and the State component unlike the 
Trait was being repeated over time, this shortened version was thought to be an appropriate 
tool with sick patients who had a number of forms to fill in. It was further hoped that this 
shortened version would maximize the response rates and reduce the number of response 
errors and unanswered items, which in turn would improve the validity of the findings. 
The mean given for general medical and surgical patients without psychiatric 
complications by Spielberger was 42.6 and this were used as the cut-off point to indicate a 
possible anxiety 'case'. A score of 46 was used as the cut-off point to indicate a probable 
anxiety 'case'. Normal scores range between 32 and 39.5 depending on the sex and age of the 
person, with women showing a slightly higher score than men on average. However, women 
aged between 25 and 29 have the highest scores and women aged between 55 and 59 have the 
lowest score overall. 
In-House Research Questionnaire 
A number of other questions need to be asked when assessing cancer patients during and 
after radiotherapy. This is predominately in the area of patients' needs. It is only through 
56 
direct contact with patients and asking relevant questions that assessment on patients' 
requirements can be made. What staff think patients' needs are and what patients feel their 
needs are could be very different. 
One of the aims of the current study is to identify factors to improve patients' quality of 
life. In order to do this, patients' wants and needs have to be assessed. The in-house 
Research Questionnaire (See Appendix 7,1 0,12,14,18,20,22,24) was specifically planned. It 
was designed from feedback from patients and staff. Some questions were patient-led on their 
experience of radiotherapy treatment, others were introduced from interviewing past sufferers 
at the Lynda Jackson Macmillan Centre. To obtain some feedback on the Lynda Jackson 
Macmillan Centre staff suggested other questions. The centre had only recently opened and 
information was needed to ascertain which areas were being satisfactorily addressed or not. 
Specific questions related to specific areas were considered to be more appropriate. 
The questions for the in-house research questionnaire were designed into four principal 
sections namely; psychological well-being, information seeking, social support, and physical 
well-being. 
Psychological Well being: 
Sanson-Fisher et al (2000) in a large study in Australia of one thousand four hundred and 
ninety two cancer patients tried to assess some of cancer patients' unmet needs. The area of 
highest need was in psychological support. Patients still had many fears concerning the 
cancer spreading or returning and general uncertainty about the future with regard to 
themselves and their families. 
With regard to this study, it is important to know if patients feel more anxious and 
depressed when their treatment finishes, or at weekends when they do not have contact with 
the hospital staff. Do patients feel frightened during their treatment and why. Once a need is 
found that issue should be addressed. Questions therefore might follow on to see how 
patients feel that their needs can be addressed. 
Information Seeking: 
Sanson-Fisher et al (2000) stated that the next area of need was in information. Patients 
want to be given accurate information about the cancer so that informed choices could be 
made and a sense of control regained. The staff at the Lynda Jackson Macmillan Centre 
wanted to know if the patients had enough information on their cancer. Literature was given 
to patients and feedback was required. It is a difficult balance and it is easy to swamp a patient 
with information. Also information needs alter and this should be assessed continuously. 
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Patients were finally asked in the Sanson-Fisher study for a perceived need with regard to 
services or resources. The overwhelming response was for 'Easy car parking at the hospital 
or clinic'. This was followed by 'monetary allowance for travel and library of books and 
videos about cancer and related issues. Brochures about services and benefits followed. The 
next item was a 24-hour telephone support and cancer advisory centre. All these requests are 
needs which patients felt would improve their quality of life. These items could be labelled as 
'information services' in the current study. 
Social Support 
It is important to know if patients have a confidante, as the literature shows that patients 
are less depressed if they have someone to confide in. This information will therefore be 
analysed with the results of the HADS. Did patients get enough support while undergoing 
radiotherapy? Other areas such as counselling, relaxation classes, home support and support 
groups would be discussed. 
Physical Well Being 
Side-effects especially fatigue are a problem with radiotherapy patients and these were 
included in the physical well-being section. How long did patients suffered from their side 
effects? Did they start immediately at the time of treatment or sometime after? How 
debilitating was the side effect? Did it affect their psychological state? It was hoped from this 
information obtained from patients that literature on these effects could be given to patients 
prior to treatment or at the end of their treatment. This would explain the risks of side effects, 
how long they last and how patients can be helped. Specific sites could be at more risk of 
side effects and specialised literature should be made available for these specific sites. 
This should, in turn, help patients' psychological state. Patients should feel more 
informed and have more control of their situation. 
The Research Questionnaire also asked general questions on how patients felt and their 
health. We needed to know if patients had received anxiolytic or depressive drugs from their 
GPs , so a question on medicines was inserted. Space was given on the form for patients to 
write how they felt their treatment could have made less stressful. 
Some questions were repeated at each posting, other questions were new. The in-house 
Research Questionnaire was given eight times in all, starting from the time of the last 
treatment for five years. At the end of five years it was important to know how patients felt 
looking back, being assured that no more questionnaires would follow! 
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Materials and Method 
Ethical approval was obtained in two stages for this study. It was first given by the 
Hillingdon District Ethics Committee in July 1993 to study distress in patients receiving 
radiotherapy treatment. A new second application was then submitted to the committee and 
passed in April 1994. This enabled the study to be further extended from six months post 
treatment to five years after the radiotherapy treatment ended. 
Various points were made in the application. As patients' notes were to be used, 
assurance was given on patient confidentiality. All completed forms would be kept in a 
locked cabinet. Care would be taken to insure that bereaved relatives would not be upset. 
Steps would be implemented to ascertain if the patient had died before the postal 
questionnaire was sent out. In the event of a death, a sympathy letter would be sent out. All 
patients, who were eligible for the study, had to give their consent in writing. As ethical 
approval was in two stages, patients' consent had to be given twice, firstly, when they arrived 
in the radiotherapy department and secondly, before the six month postal questionnaires. 
This study commenced in September 1993 and was in conjunction with the Lynda 
Jackson Macmillan Centre, which had just opened. During one calendar month, all patients 
arriving in the radiotherapy department for simulation, were interviewed, provided they were 
not too sick or sedated. A simulator is a diagnostic x-ray machine that can replicate the 
treatment conditions, but which is linked to a closed TV circuit. This enables the staff to 
accurately pin-point the tumour. Appropriate markers are put on the body so that accuracy is 
repeated throughout treatment. 
An explanation was given of the Centre and its purpose and the patients were given 
literature (see Appendix 4) with timetables. For example, Benefits Advice was 11am to 
3.30pm on a Monday. They were told they could visit the centre at anytime during the day. 
A pamphlet was also given called 'Coping with your cancer - A Self Help Guide'. It was 
then explained that, in order to increase the quality of patients care, feedback was needed 
from the patients. An explanation of the study was given. A letter was then handed to the 
patients (see Appendix 4 - Consent Letter), which explained the study and why and how this 
would help the quality of patient care. All patients were also assured that, if they did not wish 
to participate, their treatment would not be affected in anyway. The letter also explained that 
permission was needed to check details of treatment given in their notes. 
Once the patient had signed the forms, he/she was further interviewed for demographic 
details which were entered onto an index card. The patient's address, telephone number, GP 
59 
and date of birth were verified. A number of other factors was noted (see Appendix 5 - List 
1) including gender, marital status, occupation and social class2 . The patient was then given 
an identity number and this was used on all the forms to insure confidentiality The 
researcher was the only person to know any personal details. At this point, some patients took 
the opportunity of talking about the department and their treatment. 
Each patient was then given a pen, clipboard and a booklet of questionnaires, which 
he/she was asked to complete while waiting to be called in for the planning of their 
radiotherapy treatment. 
Other information was secured from the patient's notes. This included treatment intent, 
type and site and stage of tumour. The number of fractions the patient was to receive, plus the 
treatment area and if the patient had secondaries present. Note was also made if the patient 
was receiving anxiolytic or depressive drugs. Other treatments such as surgery, 
chemotherapy, previous radiotherapy, hormone treatment were noted on the index card, 
identified by the identity number. The dates of the current radiotherapy treatment were also 
included so that it could be assessed when the follow-up questionnaires should be given. 
The booklet of questionnaires contained the HADS (see Appendix 1) and STAI. At 
simulation, the ST AI consisted of both the State (See Appendix 2) and Trait components (See 
Appendix 3). The Trait questionnaire consisted of the normal twenty questions, whereas the 
State component consisted of a shortened form of six questions only. 
When the questionnaire booklet was given at the end of treatment and with all subsequent 
postings, it also contained the research questionnaire, which was specifically written for that 
posting. Each patient was also sent an individual letter (See Appendix 11,13,17,19,21,23). At 
first, the purpose of these letters was to remind patients of the study and to personally thank 
them for participating. However, as the study progressed, feedback about the study began to 
be incorporated into the letter. For example, after-care booklets were added or changed and 
given to patients, maps to the department were redone and patients were informed of these 
changes in the letter. These changes were brought about from the feedback obtained from the 
patients. 
At the time of the six month postal questionnaires, a leaflet on the Lynda Jackson 
Macmillan Centre was included giving patients further information should they need it (See 
Appendix 9) and this was repeated in the first year postal questionnaires. At the eighteen 
2 The Market Research Society, 'Occupation Groupings A Job Dictionary' 3rd Ed.(1991) Pub. Twentieth 
Century Press Limited. 
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months postal questionnaires, a booklet 'Coping now that your radiotherapy treatment is 
finishing' and a sheet about the booklet and requesting feedback was included (Appendix 15). 
In this way patients were able to feel that their comments initiated positive action. 
In the first phase, that of testing prior to and during treatment, the number of times the 
patients were tested depended on the number of fractions they were to receive. If a patient 
was only having a single fraction, which is used primarily to alleviate pain, they were referred 
to as the SF group (single fraction). This group of patients would only receive questionnaires 
at simulation and four weeks post treatment. Their maximum number of questionnaires 
during treatment therefore was two. These were all palliative patients. 
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Graph 1: Timings of the Questionnaires 
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Patients who were having two to five treatments filled in the questionnaires three times; 
at simulation, at end of treatment and four weeks post treatment. This group was referred to 
as short multi fractions (SMF). These were all palliative patients 
Patients, who had more than five fractions, were referred to as long-multi fractions 
(LMF). This included both radical and palliative patients and this group was the largest 
cohort. They completed the questionnaires on five separate occasions during treatment; 
namely, at simulation, before the first treatment, mid-treatment, end of treatment and four 
weeks post treatment. Therefore all patients completed the forms at simulation and post 
treatment. 
In the first phase of the study, the patients were given the questionnaires to do while they 
waited for treatment. If they had any problems, staff was on site to assist. Patients' notes 
were perused to see if there was any change to treatment or drugs. Before the four week 
postal questionnaires, all patients' notes were checked to see if the patients were still alive 
before the questionnaires were sent out. If the forms were returned saying the patient had 
died, a letter of condolence was immediately sent out. All the demographic details plus 
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medical records were entered onto an index card (See Appendix 25) so that they could be data 
processed for the computer. 
Six months after treatment, written informed consent from all patients was sought 
according to the Ethical Permission, to see if they would be willing to continue with the study. 
Patients were required to sign a letter (see Appendix 9) if they now longer wished to 
participate and return it in a stamped addressed envelope. Those who agreed to participate 
were then tested at six months, one year, eighteen months, two, three, four and five years after 
treatment. This added up to a maximum of twelve times for the Long Multi-Fraction group. 
Each time before sending out the postal questionnaires, the patients' notes were checked to 
see if they were still alive and changes in treatment noted. In the event of missing notes, the 
GP was contacted to make sure the patient was alive or not. This was to insure that the forms 
arriving did not upset the relatives. Each time that the postal questionnaires were sent out, a 
personal letter (see Appendix 11) was included which also gave the patients some feed back.. 
The problem of incomplete forms was easily rectified when the patient was on site. With 
the postal questionnaires, it was a problem. Once the forms were returned, they were checked 
and if any questionnaire was missed in error, they were sent back to the patients with an 
accompanying letter. If the patients had inadvertently missed data out, this was also returned. 
However, if it was only one item in the questionnaires, then an average was taken, as 
recommended by Zigmond and Snaith (1983) and Spielberger (1983). In the case of two 
patients, the forms were not returned as it was obvious from the research questionnaire that 
they were at the terminal stage of the disease and this was inappropriate. That questionnaire 
was excluded from the analysis. All data from the questionnaires were entered into the 
computer and all were double-checked. 
Method of analysis 
Analysis was carried out using SPSS. Differences in the variables were computed by 
univariate analysis of variance, Tukey Post Hoc tests were used. Independent Ttests for 
unpaired data were undertaken provided the distribution was normal (tested by Levine's test 
for equality of variances) and General Linear Models (GLM) construed. Correlations were 
undertaken. Stepwise multiple regression analysis was used. For all analysis, P equal to or 
less that 0.05 was considered to indicate significance. All data analyses were conducted using 
SPSS 8 and 10.00 for Windows statistical software, 2001. 
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Chapter 6 
Results - Analysis of Questionnaires through Treatment 
Because of the complexity of this longitudinal study the data will be analysed in three 
separate stages. Part 1 will consist of the analysis of patients through treatment and four 
weeks post treatment. This marks the boundary of the first ethical permission. Part 2 will 
show the analysis from six months to five years after treatment. Part 3 will analyse those 
patients who completed all questionnaires for all time points. TIns is a very much smaller 
cohort, as some patients who survived missed a questionnaire due to illness, holidays or the 
postal system. It will look at the differences between those who did not respond to all the 
questionnaires over treatment and those who did. 
Part 1 - Results through radiotherapy treatment 
All patients attending the radiotherapy department during one calendar month for 
radiotherapy treatment were asked to participate. 
A total of three hundred and forty six patients were interviewed in the radiotherapy 
department when they first arrived for simulation - the planning of their treatment. 
A total of two hundred and sixty nine patients (79%) agreed to participate. Non-
participants were perceived as too ill (36), language problems (4), got missed (11), had a 
physical disability (4), were confused and/or highly anxious (9) and forgot to bring their 
glasses (6). There were seven refusals. 
The cohort of two hundred and sixty nine patients who agreed to participate was divided 
into groups. The assignment to a group was dependent on the number of fractions -
(treatments) they were to receive. The Single Fraction group was those patients who received 
only one treatment. These totalled thirty one (12%). The Short-Multi-Fractions group 
received 2 - 5 ii-actions. These totalled fifty two (19%). The Long Multi-Fractions group 
received over 5 fractions. These totalled one hundred and eighty six (69%). 
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Table 1: Demographic And Medical Characteristics 
DEMOGRAPHIC Nos % MEDICAL Nos % 
Gender Sites 
Female 157 59.0 Breast* 106 39.0 
Male 112 41.0 Lung 39 14.0 
Prostate 25 9.0 
Social Class Skiu** 24 9.0 
Other*** 18 7.0 
Class A 13 5.0 Gastro-int 14 5.0 
Class B 41 15.0 Bladder 14 5.0 
Class Cl 84 31.0 Head & Neck 12 4.0 
Class C2 70 26.0 Gynae 10 4.0 
Class D 49 19.0 NHL 4 1.0 
Unclassified 12 4.0 Unknown 3 1.0 
Madtal Status Treatment Intent 
Married 178 66.0 Radical 173 64.0 
Widowed 45 17.0 Palliative 96 36.0 
Divorced 18 7.0 Ages 
Single 17 6.5 18-25 3 1.0 
Separated 6 2.0 26-50 44 16.0 
Unknown 0.5 50-65 86 33.0 
Partner 6 2.0 65+ 136 50.0 
* Includes one male breast patient 
** Includes only superficial tumours, melanoma is included in 'others'. 
*** Includes glioblastoma, sarcoma, mesothelioma, Hodgkin's Disease, melanoma 
Table 1 summarises the patients' demographic and medical characteristics. Ages ranged 
from 20-89 with a mean age of 63. 
Tables 2,3,4 and 5 are in the appendix No 28, 29, 30, 31 respectively. These analyse the 
demographic data at first treatment, mid treatment, end of treatment and four weeks after their 
treatment has finished. 
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In this study, anxiety and depression were analysed first as separate components and then 
as a combined score indicating psychological distress. Each separate component has a range 
of scores fi:om a minimum of 0 to a maxiImul1 of 21 . 
The pattems of anxiety and depression as scored by the HADS exhibit very different 
pattems over the course of radiotherapy treatment. Anxiety shows a decrease from a peak at 
siIl1ulation to 4 weeks after treatment. Depression scores are lower, with mid treatment the 
lowest point with an increase in scores ii-om the end of treatment. Anxiety and depression 
also appear to peak at different tiInes, anxiety at siIl1ulation and depression at 4 weeks post 
treatment. 
Graph 2. Mean Anxiety and Depression Scores through treatment as measured by the 
HADS 
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Anxiety 
Graph 3 shows the distribution of anxiety scores' according to the variables of gender and 
treatment intent. All patients initially show a downward trend from simulation. From mid 
treatment onwards two contrasting h'ends are apparent. Women and radical patients continue 
a downward trend. In contrast men and palliative patients showed an upward trend. 
Graph 3. Mean HADS Anxiety Scores from Simulation to Four Weeks Post Treatment 
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Table 6 gives the mean HADS anxiety scores of the different patient groups as they 
go through treatment. Palliative patients had significantly higher anxiety scores than radical 
patients at each time point throughout the treatment time. Women had significantly higher 
anxiety scores than men at simulation, first h'eatment and at the end of treatment. 
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Table 6: Mean HADS Anxiety Scores of Patients 
from Simulation to Four Weel{S Post Treatment 
Times of All Radical Palliative 
Questionnaires Mean (sd) Mean (sd) Mean (sd) 
Simulation 6.93 6.6* 7.4* 
(4.2) (4.1) (4.3) 
Numbers 269 173 96 
First Treatment 6.47 6.11 * 7.11 * 
(4.19) (4.09) (4.31) 
Numbers 257 166 91 
Mid-Treatment 5.65 5.46* 6.91 * 
(3 .91) (3.9) (3 .8) 
Numbers 168 145 23 
End Treatment 5.27 4.93 * 6.25 * 
(3 .94) (3 .81) (4.18) 
Numbers 215 160 55 
4 Weeks Post 5.15 4.66* 6.37* 
(3 .85) (3 .68) (4.01) 
Numbers 217 155 62 
* Significant difference in treatment intent, F(I ,265)=7.016, p=0.009 
**Significant difference in gender, F(l ,265)=15.885, p=O.OOI 
* Significant difference in treatment intent F(I,253)=8.404, p=0.004 
**Significant difference in gender F(1 ,253)= 13. 738, p=O.OO 1 
* Significant difference in treatment intent (FI ,164), p =0.05 
* Significant difference in treatment intent F(l ,211 )=6. 705, p=O. 001 
**Significant difference in gender F(I ,2 11 )=4, p=0.04 
* Significant difference in treatment intent, F(1,2 J 6)=9.38, p=O. 002 
Females 
Mean (sd) 
7.6** 
(3 .9) 
157 
7.18** 
(4.16) 
147 
6.08 
(4.07) 
115 
5.53 ** 
(3.95) 
131 
5.13 
(3.76) 
133 
Males 
Mean (sd) 
5.9** 
(4.3) 
112 
5.52** 
(4.05) 
110 
4.75 
(3.40) 
53 
4.87** 
(3 .90) 
84 
5.19 
(4.02) 
84 
i 
Palliative patients were significantly more anxious throughout treatment and 4 weeks 
post than the radical patients. Women were more anxious than men at simulation, 1 sl 
treatment and end of treatment. 
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During treatment the variables age, use of complementary medicine, preVIOUS 
radiotherapy, social class, marital status were non significant except for site of tumour. Site 
was significant for both the HADS and STAI State at simulation. A posteriori Tukey-HSD 
test showed that the mean anxiety for skin patients was significantly lower than those patients 
being treated for cancer of the lung, F(lO,258)=2.l2,p=O.028. At first treatment a significant 
difference was fOlUld in anxiety on the HAD Scale between the site of the tumours, 
F(lO,246)=1.96, p=O.038. A posteriori Tukey-HSD test showed that this difference occurred 
between patients who had a head and neck tumour (Mean=9.750) and patients with Non-
Hodgkin's Lymphoma (Mean=7). However, as none of the group sizes is equal, Type 1 error 
is not guaranteed. 
Analysis using cut-off points to indicate psychological problems 
HADS 
In this study, anxiety and depression were analysed separately using an initial cut-off 
point of 8, as recommended by Zigmond and Snaith (1983) to show borderline anxiety and 
depression cases. A further cut-off point of 11 was used as verified by Zigmond and Snaith 
and Hopwood et al (1991) to indicate 'cases' of anxiety and depression. 
Graph 4 shows the percentage of patients through treatment who were either a 'non case' 
with scores ofless than 8, a 'possible case' witll scores of between 8 and 10 and a 'probable 
case, with scores of 11 and over in each subscale. 
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Graph 4: PossiblelProbable or Non Cases of Anxiety and Depression through Treatment 
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Anxiety HADS 
The peak munber of 'cases' for anxiety is at simulation with 40% of patients indicating 
anxiety. At four weeks post treatment this dropped to 24%. These are all the patients scoring 
8 and over on the anxiety subscale of the HADS. A large percentage of patients according to 
gender are indicating anxiety over the course of their radiotherapy treatment as shown in 
Table 7. Women show a decrease in the percentage of cases over tTeatment. Men show a 
decrease until mid treatment and then the munbers rise. By the post treatment point men are 
indicating one more case than the women. 
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Table 7: Percentage of men and women with anxiety levels of 8 and over 
Tl T2 T3 T4 T5 
Women 45 37 30 30 23 
(N=lS7) (N=lS7) (N=llS) (N=131) (N=133) 
Men 33 25 17 24 26 
(N=llO) (N=1l0) (N=53) (N=84) (N=84 
[TJ = Simulation, T2= r t Treatment, T3= End Treatment, T4= End Treatment, T5= 4 Weeks Post Treatment] 
Graph 5 shows the HADS anxiety scores being further broken down into two groups of 
possible anxiety, scoring between 8-10 and probable scoring 11 and over for men and women 
patients undergoing a course of radiotherapy treatment. Overall the percentage of patients as 
possible/probable cases for men and women fell from a high at simulation over the course of 
treatment. A higher percentage of women, 45% are indicating anxiety than men 33%. Over 
the course of treatment the number of 'cases' for women drop to 23%. Men's 'cases' falls at 
fIrst and mid treatment, but then rises. At the four weeks post point the percentage of 'cases' 
for men is higher than for women. 
At the end of treatment the number of 'possible' cases for women rose, but 'probable' 
cases fell. After treatment the munber of 'probable' cases for men and women rose. 
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Graph 5: Possible/Probable Cases of Anxiety through Treatment with variable of 
Gender 
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The division by treatment intent using the cut-off point of 8 shows the degree of 
anxiety which palliative patients especially are experiencing. This is illustrated in Table 8. 
Radical patients show a decline in cases over treatment. Palliative patients exhibit a decline 
until mid treatment. The number of cases then rises. Simulation has the highest number of 
'cases' for both radical and palliative patients, 38% and 44% respectively. 
Table 8: Percentage of radical and palJiative patients with anxiety levels of 8 and over 
T1 T2 T3 T4 T5 
Radical Patients 38 29 25 25 19 
(N=173) (N=1 66) (N=144) (N=160) (N=155) 
Palliative Patients 44 37 33 36 37 
(N=96) (N=91) (N=24) (N=55) (N=62) 
[TJ = Simulation, T2= 1" Treatment, T3 = End Treatment, T4= End Treatment, T5= 4 Weeks Post Treatment} 
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Graph 6 shows tlns data being further analysed into 'possible' and 'probable' anxiety 
cases. The number of cases throughout treatment is velY lUgh for the palliative patients. The 
number of cases for the radical patients is consistently lower. Simulation has the lUghest 
number of 'possible' cases. At four weeks post treatment the number of 'possible' cases has 
fallen but 'probable' cases has risen for both radical and palliative patients. The number of 
'probable' cases for palliative patients throughout treahuent remains lngh. 
Graph 6: Possible and Probable 'cases' of Anxiety for palliative and radical patients 
over treatment 
30~~------------~--------------------~ 
r:/) 
~ (l) 
.-~ 20 
~ 
~ 
0 
(l) 
~ 
~ 10 (l) • palliative possible 
8 (l) 
~ 
• palliative probable 
radical possible 
o radical probable 
T1 (N=269) T3(N=168) T5(N=218) 
T2 (N=257) T 4 (N=215) 
Times of Questionnaires 
rTf = Simulation, T2 = ]" Treatment, T3 = End Treatment, T4 = End Treatment, T5 = 4 Weeks Post Treatment] 
Repeated measures analysis of variance was used to see the effects of gender and 
h'eahuent intent on anxiety over the course of treahuent. Mid treahuent was left out of tlUs 
analysis, as only 15 palliative patients were included at that testing. There was a significant 
effect for anxiety over time, F(3,570)=15.180, p=O.OOl. There was also a significant effect 
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for treatment intent, palliative patients (Mean 6.955), radical patients (Mean 5.178), 
F(1,190)=7.809, p=O.006. However, gender did not reach significance, men (Mean 5.487), 
women (Mean 6.646), F(1,190)=3.316, p=O.070. 
STAI State 
The ST AI State anxiety questionnaire showed the same similar patient trends as the 
HADS. Graph 6 shows the different patterns for the various patient groups. 
Graph 7: Mean STAI Anxiety Scores During Treatment 
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The ST AI State indicated that the time of greatest anxiety was at simulation for all patient 
groups except the palliative patients, who peaked at mid treatment. Women, men and radical 
patients all show a decline in anxiety through treatment. At the end of treahnent men and 
palliative patients, show a trend upwards, with anxiety four weeks post treatment higher than 
at simulation. Radical patients and women have scores at the four week post treatment lower 
than at simulation. Tllis is also confmned by the HADS anxiety questionnaire. Men had the 
lowest score at simulation, by 4 weeks post they have the second highest score after the 
palliative patients who have the highest scores. In conh'ast women and radical patients had 
the highest scores at simulation . Both the HADS and the STAT State registered this same 
peak in anxiety scores at mid-treatment for the palliative patients. The HADS registered 
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simulation as being the highest anxiety for the palliative patients. The STAl State shows that 
mid-treatment is the 'peak' point of anxiety for the palliative patients. 
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Table 9: Mean ST AI State Anxiety Scores of Patients from Simulation to Four Weeks 
Post Treatment 
Anxiety All Radical 
Mean (sd) Mean (sd) 
TraitAnxiety Simulation 37.76 36.97 
(9.5) (9.3) 
Numbers 269 173 
State Anxiety Simulation 41.89 42.06 
(14.22) (14.79) 
Numbers 261 167 
First Treatment 40.48 40.40 
(13.16) (13.66) 
Numbers 259 169 
Mid-Treatment 37.34 36.34* 
(12.11) (11.86) 
Numbers 168 145 
End Treatment 35.05 34.86 
(11.64) (11.61) 
Numbers 212 160 
4 Weeks Post 36.62 35.03* 
(12.20) (11.65) 
Numbers 218 154 
* Significant difference in gender F(1 ,257)=8.25, p=0.004 
* Significant difference in gender F(1,256), =12.15, p=O.OO 1 
* Significant difference in treatment intent F( 1 ,163)=9.19, p=0.003 
* Significant difference in treatment intent F(I,217)=8.43, p=0.004 
Palliative Females Males 
Mean (sd) Mean (sd) Mean (sd) 
39.20 38.17 37.19 
(9.7) (9.32) (9.13) 
96 157 112 
41.60 44.12* 38.73* 
(12.93) (14.26) (13.01) 
94 156 108 
40.64 42.94* 37.10* 
(12.69) (13.16) (12.80) 
90 150 109 
43.62* 37.94 36.03 
(11. 97) (12.11) (12.10) 
23 115 53 
37.42 35.50 35.51 
(11.63) (11.80) (11.46) 
53 131 81 
40.46* 36.11 37.46 
(12.71) (11.93) (12.65) 
64 135 83 
Palliative patients had higher anxiety than radical patients at all testings except 
simulation. Significance was only reached at mid-treatment and 4 weeks post treatment. 
Anxiety was higher for women than men at the four first testing points. A significant 
difference was found only at simulation and 1 s( treatment. 
At 1 st treatment Social Class A had significantly lower State anxiety scores than the 
other classes, F(4,244)=2.78, p=O.027. Similarly after treatment Social Class A was 
significantly less anxious than the other social classes, F(4,204) =3.242, p=O.013. A Post Hoc 
Tukey test also showed a significant difference after treatment in marital status. The married 
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patients (Mean 37.1) were significantly more anxious than the separated patients (mean 26.1). 
F(6,211)=1.186,p=O.007 . However, the numbers in the groups were not even. 
ST AI State - cut-off points 
State anxiety refers to the individual's response to stress at that moment in time. 
Normal anxiety levels for men and women range from 32-36, depending on age and sex on 
the State component. Spielberger, (1983), found that General Medical and Surgical (GMS) 
patients had a mean anxiety of 42.8 with a standard deviation of 13.76. This munber of 42 .8 
has, therefore, been used in this study to indicate abnormally high levels, as this should be a 
comparable figure to the HADS with a cut-off point of 8. Scores above this indicate anxiety. 
A cut-off point of 46 has been used to indicate high anxiety, equivalent to a HADS 'probable' 
case. 
The anxiety 'non' case pattern is similar to that of the HADS. The number of 'possible' 
cases with the STAI State lowers over treatment, with a peak at 1 st treatment. 'Possible' cases 
gradually lower from a peak at simulation over the COlU'se of treahnent, but 4 weeks post are 
indicating a rise. 
Graph 8: Percentage of Patients using STAI State indicating a 'non' case, 'possible' case 
or ' probable' case over treatment 
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The following table shows the further breakdown according to gender of patients with 
anxiety of 42.8 and over indicating a 'possible' case. At simulation the percentage of women 
scoring over 42.8 is higher than the men at 54% and 44% respectively. However from the end 
of treatment onward the men have a higher percentage of cases. This was confnmed by the 
HADS but the percentages are higher with the STAl State. 
Table 10: Percentage of men and women with anxiety levels of 42.8 and over on the 
ST AI State Anxiety Scale 
Tl T2 T3 T4 T5 
Women 54 49 37 29 32 
(N=lS3) (N=lSO) (N=llS) (N=131) (N=13S) 
Men 44 35 34 33 35 
(N=108) (N=109) (N=S2) (N=81) (N=83) 
[Tl = Simulation, T2 = ]'1 Treatment, T3 = End Treatment, T4 = End Treatment, T5 = 4 Weeks Post Treatment] 
Graph 9 looks at anxiety according to gender and divides the anxiety into 'possible' 
cases, that is scores above 42.8 to 46 and 'probable' cases with scores of over 46 . 
Graph 9: Percentage of Men and Women Patients as 'Possible' and 'Probable' Cases 
with STAI State Anxiety Scale 
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The number of 'probable cases for women is very high at simulation. This gradually 
drops over radiotherapy treatment to a quarter, which is still high. The percentage of 
'probable' cases for men is lower at simulation than for women. After treatment the 
percentage of 'probable' cases is higher for men than that those of the women. 
Table 11: Percentage of radical and palliative patients with anxiety levels of 42.8 and 
over on the STAI State Scale through treatment 
II T2 T3 T4 T5 
Radical Patients 48 39 33 28 29 
(N""167) (N=169) (N""144) (N=159) (N=154) 
Palliative Patients 53 49 53 38 45 
(N=94) (N=90) (N=23) (N=53) (N=64) 
----
____ L---.. _ 
[Tl = Simulation, T2= ]'1 Treatment, T3 = End Treatment, T4 = End Treatment, T5 = 4 Weeks Post Treatment] 
Table 11 shows the high percentage of patients recording high anxiety throughout their 
radiotherapy treatment as measured by the STAl State. At simulation 53% of the palliative 
patients are recording levels of over 42.8 and 45% are still registering high anxiety at four 
weeks post treatment. A smaller percentage of radical patients have scores of over 42.8 but it 
is still high with 48% registering at the 42.8 mark at simulation and 29% four weeks post 
treatment. 
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Graph 10: Possible and Probable Number of Cases for Radical and Palliative Patients 
with STAI State Anxiety Scale Through Treatment 
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At simulation there are more radical 'probable' cases than palliative 'probable' cases 
even though there are more palliative patients registering at the 42.8 level. Over half the 
palliative patients at mid treatment could be considered as 'probable' cases. The radical 
patients show a linear decline, the palliative patients show a more erratic pattern, with a peak 
at mid-treatment. 
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STAI Trait 
The STAI Trait was only given once to patients, at simulation. The palliative group had 
the highest mean of all patient groups with respect to their Trait scores and this difference was 
significant, F(1,265)=4.76, p=O.003. Gender was not significant. The cut-off point for Trait 
Anxiety was 41.33 as recommended by Spielberger (1983). 
Table 12: Showing the Statistical Breakdown ofthe STAI Trait Scores 
by Treatment and Gender 
Patient Gt·oup Anxiety Mean Anxiety 
Ove1'41.33 + (std dev) 
All 32% 37.76 (9.5) 
(269) (85) 
Palliative 37% 39.20 (9.7) 
(96) (36) 
Radical 28% 36.97 (9.3) 
(173) (49) 
Females 32% 38.17 (9.32) 
(157) (51) 
Males 31% 37.19 (9.31) 
(112) (34) 
Male Palliative 38% 38.59 (10.28) 
(58) (22) 
Male Radical 23% 35.69 (9.09) 
(53) (12) 
Female Palliative 37% 35.69 (8.83) 
(12) (14) 
Female Radical 31% 37.5 (9.4) 
(103) (37) 
Table 12 shows trait anxiety levels at simulation. It points to the small difference in Trait 
anxiety according to gender. Palliative patients have the highest percentage of patients 
scoring over the cut -off point of 41.33. Although there is a small difference between men and 
women on their mean scores, there is a much lower percentage of male radical patients 23%, 
than female radical patients 31 %. 
Table 13 shows a large difference between the Trait and State anxiety levels for women. 
The men have very similar trait/state scores, as do the palliative patients 
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Table 13: Results of The STAI State/Trait Anxiety According to Patient Groups at 
Simulation 
Patient gl'OUp Trait Mean Anxiety State Mean Anxiety : 
i 
Females 38.180 44.12 
Males 37.180 38.73 
Palliatives 39.200 41.60 
Radicals 36.971 42.06 
I 
The women and the radical patients show state scores as registering much higher than 
their trait scores. The trait and state scores of the males are very similar. 
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Depression Results 
The score of the HADS depression component similarly ranges from 0-21 . Graph 10 
shows the valious results according to treatment intent and gender. Palliative patients have 
the highest depression scores with mid treatment time the peak. Men scores al'e higher than 
women's at all testing points. Two contrasting patterns al'e appal'ent by the end of treatment. 
The palliative patients and the women show an increase in depression scores. The men and 
radical patients show a fractional trend downward. 
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Graph 11: Mean HADS Depression Scores through treatment 
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At simulation patients who had participated in complementary medicines were 
significantly less depressed than patients who had not, t(227)=-1.962, p=0.05. At mid 
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treatment widowed patients were significantly more depressed than separated patients, 
F( 5,162)=2.35, p=O. 04. 
At first treatment patients who had participated in radiotherapy before were 
significantly less depressed t(216)= 1. 8, p=O. 04. 
Table 14: Mean Depression Scores of Patients by Gender and Treatment Intent 
from Simulation to Four Weeks Post Treatment 
Depression HADS All Radical Palliative 
Mean (sd) Mean (sd) Mean (sd) 
At Simulation 4.30 3.62* 
(3 .30) (3.12) 
Numbers 269 173 
First Treatment 4.l3 3.25* 
(3.33) (3.03) 
Numbers 257 166 
Mid-Treatment 3.86 3.35* 
(3.39) (3 .08) 
Numbers 168 145 
End Treatment 4.14 3.60* 
(3.76) (3.60) 
Numbers 215 160 
4 Weeks Post 4.33 3.59* 
(3.79) 
Numbers 217 (3.43) 
155 
* Significant difference in treatment intent, F(1 ,265)=21. 9, p=O. 00 1 
* Significant difference in treatment intent, F{l,253)=32.7,p=0.001 
* Significant difference in treatment intent, F( 1,164)=24.3, p=O.OO 1 
* Significant difference in treatment intent, F(1,211)=10.8, p=0.001 
* Significant difference in treatment intent, F( 1 ,2 17)=20.9, p=O.OO I 
5.60* 
(3.26) 
96 
5.73 * 
(3 .29) 
91 
6.92* 
(3 .61) 
23 
5.72* 
(3.79) 
55 
6.177* 
(4.03) 
62 
Females Males 
Mean (sd) Mean (sd) 
4.04 4.71 
(3.08) (3.18) 
157 112 
3.80 4.57 
(3 .38) (3.20) 
147 110 
3.75 4.l2 
(3.52) (3.08) 
115 53 
3.68 4.87 
(3.53) (4.00) 
l31 84 
4.09 4.71 
(3.87) (3 .66) 
133 84 
Palliative patients were significantly more depressed than the radical patients at all 
testing points. Gender did not reach significance. 
At mid-treabnent widowed patients were significantly more depressed than separated 
patients F(5,162)=2.35, p=0.043. 
By the end of treatment a posteliori Tukey-HSD test showed that head and neck 
patients were significantly more depressed than patients with cancer of the breast, 
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F(1O,204)=2.161, p=0.022. However the sample sizes were not even therefore type 1 errors 
are not guaranteed. 
Analysis using cut-off points to indicate psychological problems 
The HADS depression Scores are similarly divided into 3 sections. 
• 0-7 indicates that there is not a problem. 
• 8-10 indicates a possible case, and 
• Finally 11 and over which indicates a probable case. 
The percentage of depression cases is lower than for anxiety from 16% at simulation to 
20% at 4 weeks post treatment. Simulation marks the lowest number of cases (26) according 
to gender. This rises over the course of treatment. Men have a peak at mid treatment with 
24% indicating a 'case'. The number of 'cases' of depression for women was at its highest 4 
weeks post treatment. Men have consistently more 'cases' of depression than women, apart 
from 4 weeks post treatment. 
Table 15: Percentage of men and women patients with depression levels of 8 and over 
through treatment 
Tl T2 T3 T4 TS 
Women Patients 12 12 12 16 20 
(N=lS7) (N=lS7) (N=US) (N=131) (N=133) 
Men Patients 14 17 24 19 19 
(N=112) (N=110) (N=S3) (N=84) (84) 
[Tl = Simulation, T2= 1'1 Treatment, T3= End Treatment, T4= End Treatment, T5 = 4 Weeks Post Treatment] 
Graph 12 demonstrates the percentage of men and women, which are 'possible' and 
'probable' depression cases. The percentage of male 'possible' cases is consistently higher 
than the women's over the course of radiotherapy treatment. The peak number of 'cases' for 
men is at mid-treatment. In contrast the peak munber of 'cases' for women is 4 weeks post 
treatment. The number of 'cases' for women increases over the course of treatment. 
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Graph 12: Possible and Probable Depression Cases for Males and Females through 
Radiotherapy Treatment 
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The number of 'possible' cases for men is at its highest at simulation, however the 
number of 'probable' cases peaks at the end of treahnent. The number of 'possible' and 
'probable' cases for women peak at four weeks post treatment. 
Table 16 demonstrates the percentage of radical and palliative patients with depression 
levels of 8 and over during radiotherapy treatment. The numbers increase for palliative 
patients with a peak at mid-treatment, 42% indicating a 'case' in comparison with 14% of the 
radical patients. Overall the number of 'cases' for palliative patients is high. By 4 weeks post 
treahnent 32% of palliative patients and 15% of radical patients are indicating a 'case'. This 
table also indicates the rise in the number of cases of depression over treahnent. 
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Table 16: Percentage of radical and palliative patients with depression levels of 8 and 
over through treatment 
Tl T2 T3 T4 T5 i 
Radical Patients 11 13 14 14 15 
(N=173) (N=166) (N=144) (N=160) (N=155) 
Palliative Patients 25 26 42 29 32 
(N=96) (N=91) (N=24) (N=55) (N=62) 
[Tl = Simulation, T2= 1" Treatment, T3 = End Treatment, T4 = End Treatment, T5 = 4 Weeks Post Treatment} 
Graph 13 shows the breakdown of depression into 'possible' and 'probable' cases. It 
indicates that the palliative patients at the mid treatment point consisted of 29% 'possible' 
cases. At four weeks post treatment there is an increase from simulation for both radical and 
palliative 'probable' cases. Radical patients 'probable' cases reaches a peak at the end of 
treatment. 'Possible' cases reach a peak after treatment. 
Graph 13: Possible and Probable Depression 'Cases' According to Treatment Intent 
over radiotherapy treatment 
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Repeated measures analysis of variance for depression over the course of the treatment 
with the variables of gender and treatment intent, (minus the mid-point) showed a significant 
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time effect for depression F(3,570)=2.981,p=O.031 and for treatment intent F(1,190)=15.815, 
p=O.OOl. Gender was not significant F(1,190)=O.629, p=0.429. 
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Psychological Distress 
A combined unitary score of the HADS was used to indicate psychological distress . 
From the total HADS scores, a cut-off point of 13 is used, which suggest adjustment disorder 
and scores of 18 and over to indicate major depressive illness, as confumed by Razavi et al 
(1990). 
The time of greatest distress appears to be at simulation with 40% of the patients having 
scores of 13 and over. 
Assessing distress with the variable of gender shows that women are most distressed at 
simulation and men by the end of treatment. Graph 14 shows an unusual graph with mirror 
images of distress, with the midpoint at mid treatment. 
Graph 14: Mean Combined Scores of HADS to Indicate Psychological Distress through 
Radiotherapy Treatment for Men and Women 
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Both male and female patients at foW' weeks post treatment indicate a downward trend in 
distress. 
Using cut-off points of 13 and 18 
Table 17 shows the percentage of 'cases ' for men and women, that is patients having a 
score of 13 and over on the combined HADS score. 
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Table 17: Percentage of men and women patients with distress levels of 13 and over 
during radiotherapy treatment 
T1 T2 T3 T4 T5 
Women Patients 41 35 29 29 32 
(N=lS7 (N=147) (N=l1S) (N=131) (N=133) 
, 
Men Patients 37 35 25 30 31 
(N= 11 2) (N=lll) (N=S2) (N=84) (N=84) I 
[TJ = Simulation, T2= rt Treatment, T3 = End Treatment, T4 = End Treatment, T5 = 4 Weeks Post Treahnentj 
The overall distress levels over treatment is high, but falls dlUing radiotherapy. The 
percentage of 'cases' fell for women from 41% at simulation to 32% at four weeks post 
treatment. 'Cases' levelled for women from mid treatment to the end of treatment and then 
rose 4 weeks post treatment. The percentage of 'cases' for men fell from 37% at simulation to 
31 % at the four weeks post treatment time with a dip at mid treatment. 
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Graph 15: Psychological Distress Possible and Probable Cases For 
Men and Women during radiotherapy treatment 
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Graph 15 shows the breakdown into 'possible' and 'probable' cases for men and women. 
It shows that the number of male 'probable' cases is higher at the end of treatment and four 
weeks post treatment than at simulation or beginning of treatment. The number of male 
'possible' cases fell during this period. 
The overall distress levels are very high throughout treatment especially for the cohort 
of palliative patients with approximately 50% being distressed throughout their treatment and 
4 weeks after treatment. The levels for both radical and palliative patients fall from 
simulation to 4 weeks post. However palliative patients have the highest number of 'cases' at 
mid-treatment. 
Table 18: Percentage of radical and palliative patients with distress levels of 13 and over 
through treatment 
Tl T2 T3 T4 T5 
Radical Patients 32 26 24 25 26 
(N=173) (N=166) (N=144) (N=160) (N=155) 
Palliative Patients 53 50 56 42 47 
(N=96) (N=92) (N=23) (N=55) (N=62) 
[Tl = Simulation, T2= 1'1 Treatment, T3= End Treatment, T4= End Treatment, T5= 4 Weeks Post Treatment] 
Graph 16 shows the further division into 'possible' and 'probable' cases. The palliative 
patients show an increase in the number of 'probable' cases at the end of treatment and after. 
The number of palliative patients who could be labelled as 'probable' at 4 weeks post 
treatment is nearly 30%. In contrast the number of 'probable' cases for the radical patients 
fell over the course of treatment. 
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Graph 16: Radical and Palliative Percentages of Psychological Distress Levels over 
Radiotherapy Treatment 
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Repeated measures analysis over the radiotherapy treatment (excluding the midpoint) 
showed a significant effect over time for distress, F(3,570)=3267, p=O,021, gender was not 
significant F(1,190)=O.074, p=0.492, but treatment intent was, the mean of the palliative 
patients was 11.458 and that of the radical patients was 7.819, F(1,190)=13.849,p=O.OOl. 
92 
~ 
Was there a difference in anxiety and depression between those patients that completed 
all five questionnaires and those who did not? 
Gi'aph 17 Anxiety and Depression over Treatment of those who finished all five 
questionnaires and those who did not 
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Anxiety for the patients who finished all questionnaires was lower than for those who did 
not. Similarly with the depression scores, those who finished had lower depression scores 
than those who did not. 
Further analysis was carried out on tIus data. Four weeks post was not included in this 
analysis. There was no sigtuficant difference in anxiety between those who [uushed all five 
and those who did not. There was a sigtlificant difference in depression at simulation, 
t(267)=2.512, p=O.013, at first treatment, t(255)=2.8, p=0.005 and at nlid treatment, 
t(166)=2.046, p=0.042 . 
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Sites 
Further analysis was undertaken on the variable site to eliminate a gender bias. Patients 
with cancer of the breast are analysed in more depth. The one male cancer patient is removed 
from this analysis so that it contains only women. Prostate patients are further analysed. 
They are compared with breast cancer patients and non-gender related cancers. The non-
gender related COhOli are divided into female non gender related and male non gender related 
so that these groups can be compared. The non gender related sites consist of the following 
cancers; lung, skin, gastrointestinal, bladder, head and neck, Hodgkins Disease, Non-
Hodgkins Lymphoma and tumours of unknown origin. 
Results 
At simulation the breast Patient (n=104) cohort consists of 82 radical and 22 palliative 
patients. The non gender related sites (n= 128) consisted of 85 males (radical n=42, palliative 
n=43) and 43 females (radical n=29, palliative n=14). The prostate patients (n=25) 11 radical 
and 14 palliative patients. 
Breast Patients 
There was no significant difference between the anxiety levels of the radical and 
palliative breast patients. However significance was reached at all the time points before, 
during and after treatment for depression with palliative patients showing significantly higher 
scores. This repeats the pattern shown for the larger cohort of mixed sites. 
Table 19: Mean Depression of Radical and Palliative Patients over treatment for 
Breast Patients 
Times of Mean Numbers t-test result 
Questionnaire (sd) 
At simulation 
Radical 7.20 (3.88) 83 t(103)=-1.957 
Palliative 8.09 (4.47 22 p=0.05 
First Treatment 
Radical 6.81 (4.14) 81 t(99)=-3.463 
Palliative 7.65 (4.17) 20 p=O.OOI 
Mid Treatment 
Radical 5.92 (3.93) 79 t(85)=-3.814 
Palliative 7.75 (4.09) 8 p=O.OOl 
End Treatment 
Radical 5.00 (3.8) 78 t(87)=-3.099 
Palliative 7.00 (2.9) 11 p=0.003 
4 Weeks Post 
Radical 4.81 (3.8) 76 t(90)=-3.466 
Palliative 5.75 (3.3) 16 p=O.OOl 
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Anxiety of both the radical and palliative patients fell over the course of radiotherapy 
treatment with the palliative patients subject to higher levels of anxiety throughout treatment. 
Similarly the depression levels were higher for palliative patients, with a peak of 8 at mid 
treatment. This fell to 5.5 at the end of treatment but showed an upward trend from that point. 
Prostate Patients 
There were no significant differences between radical and palliative patients on the 
anxiety scale. A significant difference was found with treatment intent on the depression 
component of the HADS at first treatment and mid treatment. 
Table 20: Mean Depression of Radical and Palliative Patients over treatment for 
Prostate Patients 
Times of Mean Numbers t-test result 
Questionnaire (sd) 
At simulation 
Radical 4.45 (4.1) 11 t(24)=1.732 
Palliative 5.93 (4.41) 15 p=0.096 
First Treatment 
Radical 3.9 (2.98) 11 t(23)= 2.038 
Palliative 5.78 (4.54) 14 p=0.05 
Mid Treatment 
Radical 5.10 (5.08) 10 t(9)=2.52 
Palliative 10.00 (2.82) 2 p=0.03 
End Treatment 
Radical 3.72 (3.04) 11 t( 16)= 1. 969 
Palliative 5.71 (4.15) 7 p=0.067 
4 Weeks Post 
Radical 5.54 (4.32) 11 t(19)=1.31 
Palliative 6.90 (3.69) 10 p=0.206 
Analysis was then carried out on breast and prostate patients. A significant difference 
was found in anxiety at simulation. The breast patients were significantly more anxious than 
the prostate patients, t(129)=2.35, p=0.02. Similarly at first treatment the breast patients were 
significantly more anxious t(124)=2.02, p=0.03. Depression was not significant at any of the 
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testing times. With the larger mixed cohort, a significant difference in gender was found at 
simulation, first treatment and end treatment. Similarly no difference in gender was found in 
depression on the analysis of the larger cohort. 
Non gender related sites were divided by gender. Significance was found at all testings 
for anxiety. Women were repeatedly more anxious than the men. With the larger mixed 
cohort a difference was found at simulation, first treatment and end treatment. 
Times of 
Questionnaire 
At simulation 
Women 
Men 
First Treatment 
Women 
Men 
Mid Treatment 
Women 
Men 
End Treatment 
Women 
Men 
4 Weeks Post 
Women 
Men 
------_ ... _----
Table 21: Mean Anxiety over treatment for 
Non-Gender Related Male and Female Patients 
Mean Numbers 
(sd) 
8.23 (4.1) 43 
6.07 (4.34) 85 
7.89 (3.9) 37 
5.65 (4.1) 84 
6.95 (4.76) 20 
4.32 (2.7) 40 
7.0 (4.33) 33 
4.93 (4.04) 65 
6.22 (3.84) 32 
4.75 (3.95) 62 
-~ 
-
t-test result 
t(122)=2.775 
p=O.OO6 
t(115)=3.025 
p=O.OO3 
t(25)=2.284 
p=O.03 
t(93)=2.79 
p=O.OO6 
t(89)=1.99 
p=O.05 
A significant effect due to gender was observed. Anxiety was higher for women 
(M=6. 71) than men (M=4. 8) over the course of treatment, and this difference was significant, 
F(1,51)=4.68,p=0.03. 
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Graph 18: Mean Anxiety Scores over Treatment for men and women with non-gender 
related cancers. 
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Did the breast cancer patients differ significantly from the other women with non gender 
related cancers? A significant difference was found only at the end of treatment when female 
non gender related cancers had significantly higher scores in anxiety than the breast women, 
t(119)=2 .208, p=0.03 . 
No significant difference was fOlUld in depression for men and women who had non 
gender related sites. TIlls replicated the findings of the bigger mixed cohOIt. Men, except for 
nlid treatment, had consistently higher scores than women. 
Graphl9: Mean Depression Scores of Men and Women with Non Gender Related 
Cancers over Treatment 
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At the end of treatment non gender related women had significantly higher depression 
scores than the breast patients, t(119)=2.5, p=O.OI4. Similarly post treatment, non gender 
related women had significantly higher depression scores, t(121)=2.144,p=O.03. 
Was there a difference in anxiety and depression scores between the prostate patients and 
the non gender related male patients? No significant difference was found with either anxiety 
or depression. 
Graph 20: Mean Anxiety Scores of Radical Breast, Prostate, and Non Gender Related 
Patients over Treatment 
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Apart for a rise in anxiety at the end of treatment male and female non-gender related 
radical patients showed a similar pattern of anxiety. The men had consistently lower levels 
throughout. The breast patients displayed a gradual decrease in anxiety over the course of 
treatment. Both radical breast patients and radical non gender related female patients had the 
same levels of anxiety at simulation and flIst treatment. By the end of treatment and after, the 
breast patients showed lower levels of anxiety. 
In contrast the prostate patients showed a more enatic pattern, which was not consistent 
with the non gender related male patients. Prostate patients were fmiher analysed to see if 
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this increase in anxiety was due to symptoms, which they might be experiencing as a result of 
their treatment. Although patients who did have symptoms had higher anxiety scores (mean 
7.6) as opposed to no symptoms (mean 4.9). TIns difference was non significant. 
Graph 21: Mean Anxiety Scores of Palliative Prostate, Breast and Non Gender Related 
Sites through Treatment 
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The non-gender related palliative women and the palliative breast patients exhibit similar 
pattems of anxiety with a decline from simulation. The level is high throughout for the 
palliative patients. Breast patients have consistently lower scores than the non-gender related 
patients. This is especially marked at the end of treatment and after. 
The levels of anxiety for men are much lower. It appears that prostate patients at the nlid 
treatment point go through a particularly anxious time. Further analysis revealed that there 
were only two palliative prostate patients tested at nlid treatment. 
However radical prostate patients also showed a peak at this time. At the end of 
treatment both radical and palliative prostate patients show an upward trend with anxiety after 
treatment being higher than before. The radical and palliative non-gender related males 
exlnbit different pattems from the end of treahnent. The palliative non-gender related patients 
show a rise, in conh·ast to the radical patients whose anxiety is at the lowest point. 
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In contrast the radical depression scores of both non-gender related women and men with 
prostate and breast patients showed little similarities. The non-gender related women had the 
highest scores over the treatment period. It reached a peak at the end of treatment and showed 
a downward slope from that point. Depression was higher after treatment for this group. In 
contrast breast patients with the second highest scores at simulation displayed a fall in their 
mean depression score until the end of treatment with a rise from that point. Simulation was 
the peak depression point for these patients. 
Both male groups started from a similar low point at simulation. After treatment men 
reached their highest depression scores. 
Graph 22: Mean Depression Scores over Treatment for Radical Non Gender Related 
Males and Females, Prostate and Breast Patients 
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Graph 23 showed that regardless of site the palliative patients showed an increase in their 
depression scores at mid treatment. This was especially pronounced for the breast patients 
with a score of eight. 
The women palliative groups showed very similar patterns of depression until the post 
treatment time when non-gender related patients showed a much steeper lise in contrast to the 
more gradual incline of the breast patients. The non-gender related patients strut with the 
lowest scores and end with the highest. 
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The non-gender related men had the highest depression scores at simulation and end with 
the lowest, although there is a tendency to rise from the end of treatment. The prostate 
patients after a peak at the midpoint show a very slight decline from that point. 
Graph 23: Mean Depression Scores of Palliative Breast, Prostate and Non Gender 
Related Sites through Treatment 
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Predictions 
Anxiety, depression and distress at simulation are good predictors of psychological state 
at the end of radiotherapy treatment. 
Anxiety 
Anxiety at simulation was used together with gender, treatment intent, trait anxiety, age, 
and site in a stepwise regression analysis to see if anxiety could be predicted at the end of 
treatment. Anxiety levels at simulation explained 42% of the variance, trait anxiety 3% and 
palliative treatment a further 1 % of the anxiety at the end of treatment 
Table 22: Results of Stepwise Regression Analysis for Anxiety at End of Treatment 
using Dependant Variable as Anxiety at Four Weeks Post Treatment, and the 
Independent Variables of Trait Anxiety, Gender, Treatment Intent and Anxiety at 
Simulation. 
Significant R squat'e B Beta T Significance 
Valiable 
Anxiety 
At Simulation 0.419 0.589 0.647 12.442 0.001 
Anxiety 
At Simulation 0.450 0.429 0.471 6.591 0.001 
+ Trait Anxiety 0.101 0.250 3.496 0.001 
Anxiety 
At Simulation 0.466 0.426 0.468 6.627 0.001 
+ Trait Anxiety 9. 579E-02 0.237 3.352 0.001 
+ Treatment mtent 1.089 0.128 2.540 0.014 
As patients are significantly more anxious at simulation than at any other time, it could be 
better to use the anxiety levels at first treatment to assess predictions. In the Stepwise 
multiple regression analysis, with the variables of anxiety at first treatment, gender, treatment 
and Trait anxiety, anxiety at first treatment explained 42% of the variance in anxiety at the 
end of treatment, Trait anxiety a further 5% and treatment intent a further 1 %. 
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Table 23: Results of Stepwise Regression Analysis using Dependant Variable as Anxiety 
at Four Weeks Post Treatment, and the Independent Variables of Trait Anxiety, 
Gender, Treatment Intent and Anxiety at First Treatment. 
Variable Rsquare B Beta T Significance 
Anxiety 
At First Treatment 0.419 0.593 0.647 12.338 0.001 
Anxiety 
At First Treatment 0.467 0.425 0.464 7.091 0.001 
+ Trait Anxiety 0.116 0.286 4.366 0.001 
Anxiety 
At First Treatment 0.483 0.424 0.463 7.l57 0.001 
+ Trait Anxiety 0.110 0.272 4.180 0.001 
+ Treatment Intent 1.054 0.124 2.468 0.014 
-------- ----
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Depression 
Depression at simulation could explain 40% of the variance at the end of treatment and a 
further 2% were explained by palliative treatment. 
Table 24: Results of Stepwise Regression Analysis for the Dependant Variable, which is 
Depression, at Four Weeks After Treatment, and the Independent Variables of Gender, 
Treatment Intent, Age, Site and Depression at Simulation 
Significant Vatiable Rsqual'e B Beta T Significance 
Depression 
At Simulation 0.401 0.722 0.633 12.002 0.001 
Depression ! 
At Simulation 0.420 0.676 0.594 10.951 0.001 
+ Treatment Intent 1.199 0.143 2.639 0.009 
Depression at first treatment is used to see if it is a better predictor of depression after 
treatment. 
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Table 25: Results of Stepwise Regression Analysis with the Dependent Variable of 
Depression at Four Weeks After Treatment and the Independent Variables of Gender, 
Treatment Intent, Age, Site and Depression at First Treatment 
Significant Vatiable R squat'e B Beta T Significance 
Depression 
At First Treatment 0.493 0.793 0.702 14.324 0.001 
The only predictor of depression at four weeks post treatment was depression at first 
treatment, and this explained 49% of the variance. This shows a higher predictive value than 
at simulation, 
Distress 
Using the combined scores to indicate psychological distress, the following table is 
generated with Stepwise regression analysis. Distress at simulation can explain 45% of the 
variance of the distress levels at the end of radiotherapy, A further 2% can be explained by 
treatment intent with palliative patients being significantly more distressed tllall radical 
patients, 
Table 26: Results of Stepwise Regression Analysis Using the Dependant Variable of 
Distress at the End of Treatment, and the Independent Variables of Trait Anxiety, 
Gender, Treatment Intent, Age, Site and Distress at Simulation. 
Significant Vatiable R square B Beta T Significance 
Distress 
At Simulation 0.455 0.682 0.702 14.324 0.001 
Distress 
At Simulation 0.479 0.650 0.643 12.784 0.001 
+ Treatment Intent 2.378 0.158 3.l48 0.002 
Changing the variable distress at simulation to distress at first treatment, the following 
table was generated. 
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Table 27: Results of Stepwise Regression Analysis Using the Dependant Variable of 
Distress at the End of Treatment, and the Independent Variables of Trait Anxiety, 
Gender, Treatment Intent, Age, Site and Distress at 1st Treatment. 
Significant Variable Rsquare B Beta T Significance 
Distress 
At First Treatment 0.474 0.694 0.488 4.015 0.001 
Distress 
At First Treatment 0.492 0.663 0.658 13.077 0.001 
+ Treatment Intent 2.092 0.140 2.772 0.006 
Distress at first treatment seems a better predictor of distress at the end of treatment, with 
distress at first treatment explaining 47% of the distress at the end of treatment. 
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In-House Research Questionnaires 
The questionnaires (See Appendix 7) were given to patients at the end of their treatment 
and four weeks after their treatment had finished. Questions pertained to information and 
control, social support, psychological well-being and to physical well-being. A total number 
of two hundred and eighteen patients responded to this questionnaire. The patients at the post 
treatment period were a different COhOli from those patients responding to the end of 
treatment questionnaire. At the post treatment period single fraction patients were also 
included. The full analysis of the questionnaires for the end of treatment and four-week post 
treatment is in Appendix 32 and 33 respectively. A short precis of the results follows. 
Information and Control: 
Most patients (90%) thought the booklet given to them before radiotherapy treatment 
was adequate. Those patients who did not were significantly more anxious and depressed, 
F(l ,213)=3 .89, p=0.05 and F(1 ,213)=5.798, p=O.O 17 respectively. 
Support 
Most patients felt supported while undergoing treatment. A quarter did talk to a 
counsellor during this period. 
Psychological Well Being 
A third of patients would have preferred a visit to the department prior to their treatment. 
A total of 20% felt frightened during their treatment and these patients were significantly 
more anxious. Over half of this cohort would have liked to have discussed this with someone. 
A total of 40% experienced anxiety after their treatment had finished and these patients 
were significantly more distressed, F(1,213)=4.9.p=O.027, and anxious, F(1,213)=7.45, 
p=O.007. 
Physical Wellbeing 
Some questions were repeated in all the questionnaires. Patients were asked how they felt and 
if they were still suffering from side effects in all eight questionnaires. 
After treatment 52% were feeling better. Those who felt worse were significantly more 
anxious, F(2,206)=5.52, p-0.005, depressed, F(2.295)=4.5,p=O.012 and distressed, 
F(2,206)= 12.648,p=OOO. 
Table 28 shows the difference in anxiety, depression and distress between those patients 
who had side-effects and those who did at the end of treatment and five weeks post treatment. 
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Table 28: Difference in Anxiety, Depression and Distress between those Patients who 
had Side-Effects and those who did at the End of Treatment and four weeks post 
!rreatment Percentage of Anxiety Depression Distress 
!rimes patients with 
side effects 
lEnd Treatment 60% t(21 0)= 1.142 t(210) = 1.46 t210)=1.4 
:~215) (127) p=0.255 p=0.146 p=0.157 
lFour Weeks 49% t(207)=1.705 t(207)=3.17 t(207)=2.7 
Post Treatment (102) p=0.09 p=0.002** p=0.007* 
218) 
At the end of treatment 60% had side effects, but anxiety, depression and distress were not 
significant. Four weeks post treatment, 49% had side effects and anxiety, depression and 
distress were significant. 
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Chapter 7 
Part 2 - Results from 6 months to five years after treatment has finished 
Further ethical permission had to be sought before the next set of questionnaires was sent 
out. The breakdown of this mixed cohort agreeing to participate in this second ethical study 
is shown in Table 29 
Table 29: Demographic And Medical Characteristics at 6 months post treatment 
DEMOGRAPHIC Nos % MEDICAL Nos % 
Gendel' Sites 
Female 97 64.0 Breast* 70 48.0 
Male 49 36.0 Llmg 13 9.0 
Prostate 12 8.0 
Social Class Skin** 13 10.0 
Other*** 7 4.0 
Class A 7 5.0 Gastro-int 6 4.0 
ClassB 22 16.0 Bladder 2 2.0 
Class Cl 50 35.0 Head & Neck 8 5.0 
Class C2 37 26.0 Gynae 8 5.0 
ClassD 25 18.0 NHL 5 3.0 
Unclassified 0 0.0 Unknown 2 2.0 
Marital Status TI'eatment Intent 
Married 99 69.0 Radical 124 85.0 
Widowed 21 15.0 Palliative 22 15.0 
Divorced 8 5.0 Ages 
Single 7 4.0 18-25 1.0 
Separated 5 2.0 26-50 25 17.0 
Unknown 0 0.0 50-65 55 38.0 
Partner 2 1.0 65+ 65 44.0 
Includes one male breast patient 
** Includes only superficial tumours, melanoma is included in 'others'. 
*** Includes glioblastoma, sarcoma, mesothelioma, Hodgkin's Disease, melanoma 
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The ethical pennission required that all patients were written to individually and asked if 
they would like to continue in an extension of the study. This next part would last for five 
years after treatment. A negative response form was attached with a pre-stamped envelope. 
At this point, thirty five patients had died since the beginning of the study, leaving two 
hundred and thirty four patients, and these patients all received the letter. From this cohort, 
seventeen (8%) returned the forms saying they 110 longer wished to pmticipate. 
These questionnaires were sent to patients six months after the patient's treatment had 
finished in May 1994. Before the postal questionnaires were sent to patients, their status was 
checked again, another thirteen patients had died in the intervening period bringing the 
number of deaths to forty eight (18%) since the start of the study. Questionnaires were sent 
out to the remaining one hundred and seventy five patients. The questionnaires were sent out 
as a postal pack with stamp addressed envelopes for replies. A total of one hundred and forty 
six forms were returned duly completed. This is a response rate of 84% - twenty eight 
patients did not participate. 
Analysing the patients who died six months after treatment reveals the numbers of single 
fractions (SF) was 13, 42% of this cohort. A total of seventeen (33%) was short multi-
fractions (SMF) and eighteen, 10% of the long multi-fractions (LMF). This count contained 
three radical men and women. 
The demographic details and medical characteristics of the patients at the other six testing 
points; from one year to five years - Table 30, one year - Table 31, eighteen months - Table 
32, two yem's - Table 33, three yem's - Table 34, four yem's- Table 35 and five years -m'e 
numbered in the Appendix No 41,42,43,44,45 and 46 respectively. 
The anxiety and depression scores as measured by the HADS continued to show 
different patterns in the period of 6 months post treatment to five years. 
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Graph 24: Mean Anxiety and Depression Scores from 6 months to five years 
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From 6 months post treatment to five years anxiety and depression follow very similar 
patterns. The anxiety scores are continuously higher than the depression scores. Both anxiety 
and depression are lower at the five year point than at the 6 month post treatment time. 
Anxiety for men and women was approximately the same at the 6 months post treatment 
point. However from the 18 months point the men exhibited greater anxiety, and tills 
continued for five years after treatment, apart from year 3. 
Depression for women was continuously lower than the men's over this whole time 
period. 
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Graph 25: Mean Anxiety and Depression Scores from 6 months to 5 years post 
treatment for men and women 
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Graph 26 shows the different patterns of the radical and palliative patients. The 
anxiety of the radical and palliative patients shows velY similar patterns. However the 
palliative patients always have higher mean scores throughout than the radical patients. The 
number of palliative patients from one year post treatment point have rapidly diminished. At 
18 months post treatment only 8 are still participating and this number falls to 5 at two years. 
Therefore the variable of treatment intent no longer applies for statistical purposes. At year 
five 4 palliative patients are still patiicipating. 
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Graph 26: Mean Depression and Anxiety Scores of radical and palliative patients from 6 
months to 5 years. 
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The levels for anxiety continued to fall except at the two year mark. The anxiety and 
depression of the radical and palliative patients follow remarkably similar patterns. The 
scores of the palliative patients are higher for depression and anxiety than the radical patients. 
Tn both cohorts depression rose at year 2 and dropped at years three and four. 
both groups was very stable. 
Anxiety for 
The following table give the means and standard deviation for patient group from six 
month to five years post treatment, using the HADS anxiety subscale. 
112 
I; I; 
Anxiety HADS 
Six Months 
Post Treatment 
!Numbers 
One Year 
Post Treatment 
Numbers 
Eighteen Months 
Post Treatment 
Numbers 
Two Years 
,Post Treatment 
!Numbers 
I 
Three Years 
Post Treatment 
Numbers 
I 
Four Years 
Post Treatment 
Numbers 
Five Years 
Post Treatment 
Numbers 
Table 36: Mean HADS Anxiety Scores of Patients 
from Six Months to Five Years Post Treatment 
All Radical Palliative Females 
Mean (sd) Mean (sd) Mean (sd) Mean (sd) 
5.14 4.81* 7.00* 5.14 
(4.15) (3.96) (4.76) (4.04) 
146 124 22 97 
5.03 4.81 6.47 5.01 
(4.30) (4.13) (5.22) (4.42) 
113 98 15 80 
4.81 4.78 5.13 4.77 
(3.96) (3.94) (4.42) (4.17) 
101 93 8 69 
4.92 4.93 7.00 4.84 
(3.91) (3.83) (5.20) (4.11) 
95 90 5 68 
5.22 5.13 6.50 5.34 
(3.63) (3.63) (3.51) (3.80) 
92 86 6 68 
4.88 4.90 4.50 4.70 
(3.96) (3.98) (4.12) (3.97) 
76 72 4 54 
4.21 4.18 4.75 3.96 
(3.44) (3.48) (3.44) (3.27) 
78 74 4 56 
Males 
Mean (sd) 
5.12 
(4.41) 
49 
5.06 
(4.08) 
33 
4.90 
(3. 51) 
32 
5.11 
(3.41) 
27 
4.88 
(3.08) 
24 
5.32 
(3.98) 
22 
4.82 
(3.86) 
22 
*At 6 months a significance difference in anxiety was found in treatment intent, F(I,145)=5.552,p=0.02. 
I 
Palliative patients were significantly more anxious than radical patients at 6 months 
post treatment F(1,144. 
At four years a post Hoc Tukey showed that the patients in the age groups 26-50 
(Mean 7.23) were significantly more anxious than the patients in the group 50-65 (Mean 
4.069), and the group 65 plus (Mean 4.33), F(2,73)=4.329, p=0.018. A similar difference was 
found at five years post treatment. No other variable was significant. 
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Analysis using cut-off points to indicate psychological problems 
HADS Anxiety 
For the following five years anxiety appears to exist in approximately 20% of this 
population. The percentage of anxiety 'cases' according to gender is shown in table 38. 
Table 37: Percentage of Men and Women with Scores of 8 and over on the HADS 
Anxiety Scale from 6 Months to 5 Years Post Treatment 
T6 T7 T8 T9 TIO Tll Tl2 
(Total Nos) (Total Nos) (Total Nos) (Total Nos) (Total Nos) (TotaINos) (TotaINos) 
Women 25 23 24 22 28 22 12 
(97) (80) (70) (68) (68) (54) (56) 
Men 24 18 19 19 21 23 23 
(49) (33) (31) (27) (24) (22) (22) 
The ftuther breakdown according to possible and probable 'cases' is displayed in graph 27. 
Graph 27: Percentage of PossiblelProbable Anxiety 'Cases' from 6 Months to 5 Years 
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The largest drop of possible or probable cases of anxiety is at year five, the end of the study, 
when, for the first time, the number of 'cases' drops to below 20%. The number of 'possible' 
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and 'probable' cases for men remains stable for years 3 to 5. The number of 'cases' for 
women falls in this period. 
The palliative patient number dwindles from one year post treatment due to death and 
non-participation to only five at the five year mark. From one year onward, palliative patients 
numbers (N=14) are dramatically reduced. This was reduced to nine at eighteen months. 
During tlus period from one year to eighteen months post treatment, forty patients died. The 
absence of these terminally ill patients in the data could be responsible for the dip in anxiety 
levels. 
With the high attrition rate in the palliative patients, treatment intent could not be used as 
a variable from one year post treatment. Repeated measure analysis was carried out on 
anxiety of all twelve testings with the variable of gender. There is no significant effect over 
time for either anxiety or gender. However, there was an anxiety * gender interaction, 
F(11,594)=2.956,p=O.OOl. 
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STAI State 
The anxiety for the radical and palliative patients and men and women is shown on 
Graph 28. The numbers of the palliative patients from year one is 8 and therefore does not 
walTant further statistical analysis. 
Graph 28: STAI State from 6 months to five years after treatment for radical and 
palliative patients 
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The STAl State pattern is very similar to the HADS anxiety scale (Graph 25, 26). Both 
questionnaires show a similar increase in anxiety at year 3 for the palliative patients group. 
From 6 months to year 2 the palliative patients and the men are exhibiting the highest 
levels of anxiety. The numbers of palliative patients in year 2, 3 and 4 is on average 5 and 
therefore statistical analysis is not possible. However the men throughout this post period 
continue to show higher anxiety than the women patients. The STAl State shows that men 
have higher levels of anxiety from 6 months. The HADS shows the men having higher 
levels of anxiety from 18 months onwards. From year 3 both radical patients and women' 
show a downward trend. As before the men, women and radicals patients follow similar 
patterns. The palliative patients show a much more elTatic pattern. All show a downward 
trend at year 5. 
The exact numbers of patients participating, their STAl state mean and standard 
deviation is all shown in Table 35. 
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Anxiety 
Six Months 
Post Treatment 
Numbers 
One Year 
Post Treatment 
Numbers 
Eighteen Months 
Post Treatment 
Numbers 
Two Years 
Post Treatment 
Numbers 
Three Years 
Post Treatment 
Numbers 
Four Years 
Post Treatment 
Numbers 
Five Years 
Post Treatment 
Numbers 
Table 38: Mean Anxiety Scores of Patients Using STAI 
from Six Months to Five Years Post Treatment 
All Radical Palliative Females 
Mean (sd) Mean (sd) Mean (sd) Mean (sd) 
35.27 34.46* 39.64* 35.20 
(11.79) (11.17) (14.16) (11.93) 
146 124 22 97 
34.45 33.87 38.06 33.94 
(12.79) (12.33) (15.33) (12.44) 
113 98 15 80 
32.47 32.29 34.50 31.62 
(10.84) (10.80) (11.92) (10.38) 
101 93 8 69 
33.16 32.70 41.20 32.80 
(11.23) (11.00) (13.66) (10.75) 
95 90 5 68 
33.91 34.04 31.80 34.14 
(10.84) (10.69) (14.32) (10.86) 
92 86 6 68 
33.37 33.24 35.75 32.41 
(12.32) (12.45) (10.87) (12.76) 
76 72 4 54 
31.12 31.23 28.33 30.40 
(10.45) (10.59) (7.23) (11.07) 
78 74 4 56 
At 6 months a significant difference t(216)=3.050,p=0.003. 
Males 
Mean (sd) 
35.42 
(11.59) 
49 
35.58 
(13.63) 
33 
34.28 
(11.74) 
32 
34.04 
(12.51) 
27 
33.29 
(10.97) 
24 
35.73 
(11.08) 
22 
33.00 
(8.58) 
22 
As with the HADS anxiety scale the palliative patients were significantly more 
anxious at 6 months. 
At six months post treatment a Post Hoc Tukey showed a significant difference 
between the State anxiety levels of the separated patients (mean 26.1) and the married patients 
(Mean 37.1), F(4,204)=3.24, F(6,211) = 3.071p=O.007. Also a significant difference was 
found in anxiety according to social class. A Post Hoc Tukey showed that patients from 
Social Class A were significantly less anxious than patients from Social Class B (p=O.039) 
and C2, F(4,204)=3.242,p=O.013. 
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I 
I 
. 
At five years a post Hoc Tukey showed that patients fonTI Social Class A were 
significantly less anxious than patients from Social Class Band C, F(4 ,69)=3 .057,p=0 .022. 
STAI using cut-off points to indicate a 'case' 
Graph 29: Percentage of Possible Anxiety 'Cases' Using STAI State from 6 months to 5 
years post treatment 
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The overall percentage of possible and probable cases from six months to five years 
remains fairly static at over 20% until year 5 when there is an overall drop in numbers, 
The number of 'probable' cases for men is higher than for women throughout this period 
from 6 months to 5 years. The number of 'possible' cases is higher overall for the women 
than the men. 
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Table 39: Percentages of Men and Women Indicating Anxiety from 
6 months to 5 years Post Treatment with STAI State 
Gender T6 T7 T8 T9 T10 TIl 
Females 25% 22% 19% 18% 25% 19% 
(Numbers) (93) (80) (69) (66) (63) (53) 
Males 21% 27% 21% 29% 21% 21% 
(47) (36) (32) (27) (24) (19) 
T12 
18% 
(55) 
19% 
(22) 
T6= 61110nths post treatment, T7= 1 year post, T8=18111onths post, T9=2 years post, T10 = 3 years post, Tll = 4 
years post, T12 =5 years post 
Looking at the levels of anxiety from one year men have a higher percentage of cases, 
except at 6 months and year 4. 
Graph 30: Possible and Probable Anxiety Cases Using STAI State from 6 Months to 5 
Years Post Treatment by Gender 
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The highest number of 'probable' cases for women is a 6 months post treatment. This 
drops lmtil year 3. In contrast the munber of 'possible' cases for men is at its lowest at 6 
months (apart from year 5) and increases over the study. Palliative patients are statistically 
too small, however as with the HADS there are no cases from year 3. 
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Depression 
Levels of depression overall fell from six months to eighteen months post treatment and 
then start rising again, with a fall at year five . 
Table 40: Mean Depression Scores of Patients by Gender and Treatment Intent from Six 
Months to Five Years Post Treatment 
* 
+ 
** 
* 
* 
* 
Depression HADS All Radical Palliative Females 
Mean (sd) Mean (sd) Mean (sd) Mean (sd) 
Six Months 3.64 3.20* 6.09* 3.21+ 
Post Treatment (3.39) (3 .13) (3 .79) (3.28) 
Numbers 146 124 22 97 
One Year 3.49 3.25* 5.07* 2.90** 
Post Treatment (3 .27) (3 .15) (3 .69) (3.1) 
Numbers 113 98 (15) 80 
Eighteen Months 2.96 2.87 4.00 2.45* 
Post Treatment (2.92) (2.89) (3 .34) (2.71) 
Numbers 101 93 8 69 
Two Years 3.24 3.14 5.00 2.84 
Post Treatment (3 .52) (3.47) (4.30) (3.58) 
Numbers 95 90 5 69 
Three Years 3.43 3.41 4.00 2.98* 
Post Treatment (3.50) (3 .52) (3.46) (3.34) 
Numbers 92 86 6 68 
Four Years 3.27 3.28 3.00 2.81 
Post Treatment (3.66) (3 .75) (1.41 ) (3 .79) 
Numbers 76 72 4 54 
Five Years 2.74 2.70 3.50 2.27 
Post Treatment (3 .19) (3 .24) (2.08) (3 .07) 
Numbers 78 74 4 56 
Signifcant difference in treatment intent at 6 months t(215)=4.753 , p=0.001 
Signficant difference in gender at 6 months t(143)=2.227, p=0.027 
Significant difference in gender at one year t(112)=3 .069, p=0.003 
Significant difference in treatment intent at one year in t(11 2)=2.030. p=0.045 
Significant difference in gender at 18 months in t(1 01 )=2.721 , p=0.008 
Significant difference in gender at three years t(88)=2.052, p=0.043 
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Males 
Mean (sd) 
4.52+ 
(3.48) 
49 
4.88** 
(3 .13) 
33 
4.09* 
(3 .09) 
32 
4.26 
(3 .19) 
27 
4.64* 
(3.69) 
24 
4.36 
(3 .13) 
22 
3.95 : 
(3 .24) 
22 
Palliative patients were significantly more depressed than the radical patients at 6 
months and 1 year. Men were more significantly depressed than the women at 6 months, 1 
year, 18 months, 3 years and 5 years. At eighteen months A Post Hoc Tukey revealed those 
patients aged 65 plus were significantly more depressed than those patients aged between 50 
and 65, F(2,110)=4.44,p=0.014. 
At two years a significant difference in depression in marital status was found, 
F(5,89)=2.759,p=0.023. 
At three years a significant difference was found in site, F(l0,79)=2.4, p=0.015. A 
post Hoc Tukey showed that lung patients (Mean 12) were significantly more depressed than 
prostate patients (Mean 2.3). 
At four years the patients in the 65 plus (Mean 4.33) group were significantly more 
depressed than the patients aged 50-65 (Mean 4.07), F(2,72) p=0.09. 
A similar difference was found at five years post treatment. A significant difference 
was found in relationship to depression and age. A Post Hoc Tukey showed that patients aged 
65 plus were significantly more depressed than patients aged 50-65, t(76)=2.151,p= 0.035 
Depression - cut-off points 
Analysis looking at the number of possible and probable 'cases' post treatment showed a 
big drop at five years with 8% indicating a 'case', however, before that time the percentage 
was fairly static at about 15% overall. 
Table 41: Percentage of Men and Women with Scores of 8 and over on the HADS 
Depression Scale from 6 Months to 5 Years Post Treatment 
T6 T7 T8 T9 TI0 Tl1 T12 
(Total Nos) Total Nos) (Total Nos) (Total Nos) (Total Nos) (TotaINos) (TotaINos) 
Women 12 10 8 10 13 15 5 
Men 
(97) (80) (70) (68) (68) (54) (56) 
17 23 16 22 21 18 14 
(49) (34) (31) (27) (24) (22) (22) 
T6= 6 months post h'eatment, T7= 1 year post, T8=18 months post, T9=2 years post, T10= 3 years post, Tll= 4 years post, 
T12=5 years post 
A clear distinction can be seen in the distribution of depression 'cases according to 
gender. Men have consistently higher lUunbers of patients indicating 8 and over on the 
HADS depression scale. 
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Graph 31: Possible and Probable Depression 'Cases' by Gender from 6 Months to 5 
Years Post Treatment 
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None of the palliative patients left in the study showed signs of depression with the 
HADS from year three to the end of the study. 
Although the number of 'cases' of depression is not so high as anxiety, at six months 
14% are indicating a possible/probable case. This rises to 16% at years 3 and 4. The biggest 
drop is at year 5, the end of the study. 
Analysis over the whole period, using repeated measures, with the variable of gender 
showed that depression and gender had a significant effect over the course of the study, 
depression F(1l,572)=2.366, p=O.007, and gender F(1,52)=8.532, p=O.005. There was also a 
gender* depression interaction, F(11,572)=2.665,p=O.002. 
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Psychological Distress using 13 and 18 as cut-off points for unitary HADS scores. 
Overall the levels from 6 months remained fairly consisted. Graph 32 indicates the level 
of distress still occurring in patients over this period. Men's psychological distress has risen 
and is higher than the women's. The number of men at the end of the study still participating 
was only 22 and women 56. 
Graph 32: Psychological Distress as Measured by the Combiued Scores of the HADS 
from 6 Months to 5 Years Post Treatment for Men and Women 
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The women's score show a downward trend apart from year 4. The men's score is not only 
higher but more erratic. At 6 months 29% are indicating a 'case'. At year 4 the percentages 
rise to 41 % and drop at year 5 to 32%. 
Table 42: Percentage of Men and Women Patients with Combined HADS Scores 
of 13 and over from 6 Months to Five Year Post Treatment 
T6 T7 T8 T9 T10 TIl T12 
(Total Nos) (Total Nos) (Total Nos) (Total Nos) (Total Nos) (Total Nos) (Total Nos) 
Women 26 21 19 17 23 19 16 
(97) (80) (70) (68) (66) (54) (56) 
Men 29 27 26 26 29 41 32 
(48) (33) (31) (27) (24) (22) (22) 
T6=6 months post, T7= lyear post, T8=18 months post, 1'9=2 years post, TlO=3 years post, Tll =4 years post, T12 =5 years 
post. 
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A high percentage of the men were indicating 'possible' distress at three, four and five years 
post treatment. 'Probable' cases for men showed a decline from year two. 
Apart from at the 6 month point, 'possible' cases were lower for women. 'Probable' 
cases for women for the first four years seem to be approximately 10% of tins population. 
Graph 33: Percentage of Cases Indicating Psychological Distress for Men and 
Women from 6 Months to 5 Years Post Treatment 
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Treatment intent is not really valid for tIns small COhOli of palliative patients. The number of 
palliative patients in this period is very small. There are 22 at 6 months and tins falls to 15 at 
year 1, 8 at year 2, 5 at year 3, and four thereafter. It is interesting to note however that none 
of the palliative patients are 'probable' cases from 3 years post treatment onwards. 
From one year onward, the numbers of palliative patients declines with fOliy deatIls in the 
second year of the study. 
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Analysis over time for the whole study showed that there was no significant effect for 
distress overtime and treatment intent, however, significance was reached with gender, men 
(Mean 13.244) women (Mean 6.034), F(1,51)=5.8,p=0.019. 
The psychological problems, which patients suffer throughout their treatment and for 
years after, are high. 
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Sites 
At 6 months post treatment breast patients numbered 70, prostate 12 and non-gender 
related 56. At the end of the five year period breast patients numbered 40, prostate 5 and non-
gender related, 27. 
Graph 34: Anxiety from 6 Months to Five Years Post Treatment for Prostate, Breast 
and Non Gender Related Cancers 
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The non-gender related women have higher anxiety levels at simulation. This drops at 
years 1 and 18 months. The men and women then follow similar patterns, though the women 
have consistently higher anxiety. 
The non-gender related male cancer patients had higher anxiety scores than the 
prostate patients from year 1 to year 4. The difference was not significant at any time point. 
The non-gender related female cancer patients had higher anxiety scores throughout 
the five years than the breast patients. The difference was only significant at 6 months post 
treatment, t(87)=4.003, p =O.OOI 
The non-gender related male and female scores were analysed. The females had 
significantly higher scores at 6 months, t(53)=2.641 , p=O.Ol. Similar findings were found 
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I· 
with the larger male and female cohort not divided by site. At 6 months the larger cohOlt 
found no difference in anxiety scores. Similarly at year 4, the low anxiety of prostate patients 
pulled the average scores of the male population down. This explains (Graph 25) why the 
women's anxiety scores were higher than the men's at this time. 
Depression 
Graph 35 showing depression, displays a more erratic pattern than the anxiety graph. 
Non-gender related men have the highest scores throughout fi:om 6 months to five years post 
treatment. Prostate patients show higher scores than the women except years tlu'ee and four. 
Non-gender related site women have higher depression scores at year 3 and four. By year 5 
all groups are showing a downward trend. Breast patients have consistently low levels of 
depression. 
Graph 35: Depression from 6 Months to 5 Years Post Treatment for Prostate, Breast 
and Non-Gender Related Cancers 
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At year 3 there is a significant difference in the depression scores of non-gender related 
male and prostate patients. Non gender related patients are significantly more depressed, 
t(22)=2.6, p=O.019 
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Analysis on the non-gender related males and females showed that the males had 
higher depression scores from one year to five. Significance was reached at year one, 
t(36)=2.578, p=O.014, at two years, t(30)=2.6, p=O.04 and five years, t(25)=2.02, p=0.05. 
These results are very similar to the larger mixed male and female cohort where significance 
was reached at six months, 1 year, 18 months, three years and five years. 
The attrition rate was high in tills study due to deaths, particularly as the cohort included 
palliative patients. It is important to assess the psychological state of those patients who died. 
The following table shows the anxiety and depression results of those patients who died after 
a specific testing point. 
Table 43: Statistical Findings According to 
Anxiety and Depression of Patients who Died by the End of the Study 
Tl'eatment Anxiety Depression 
Times 
Simulation 0.296 0.001 ** 
!First Treatment 0.203 0.001 ** 
~d Treatment 0.372 0.001 ** 
lEnd Treatment 0.092 0.001 ** 
1F0urWeeks 0.007* 0.001 ** 
Post Treatment 
Six Months 0.031* 0.001 ** 
Post Treatment 
lOne Year 0.663 0.084 
1P0st Treatment 
!Eighteen Months 0.515 0.50* 
Post Treatment 
Ifwo Years 0.103 0.010* 
Post Treatment 
Ifhree Years 0.009* 0.113 
1P0st Treatment 
1F0ur Years 0.633 0.736 
1P0st Treatment 
IFive Years N/A N/A 
Post Treatment 
* <0.05 
** <0.005 
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At each testing, the patients who had died had higher mean scores in the previous data 
sets than those who were still alive. For the first eight testing points depression was 
significantly higher for those who had died (except for year 1). As the timescale got larger 
between testings, when it was extended from 6 month to one year, the timescale then became 
too long for accurate data analysis on deaths post testing. 
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Predictions 
Can anxiety at either simulation or fIrst treatment predict anxiety fIve years after treatment 
has fInished? 
With the dependant variable of anxiety after fIve years after treatment, the stepwise 
regression results are shown in the following table 
Anxiety at simulation can explain 15% of the variance of anxiety fIve years later. 
Table 44: Stepwise Regression Analysis Using Anxiety at the End of Five Years as the 
Dependant, and the Independent Variables of Trait Anxiety, Gender, Treatment Intent 
and Anxiety at Simulation. 
Significant Vatiable Rsqual'e B Beta T Significance 
Anxiety 
At Simulation 0.150 0.352 0.387 3.658 0.001 
Would a better predictor be anxiety at fIrst treatment? 
Table 45: Results of Stepwise Regression Analysis Using the dependant variable of 
anxiety at the end of five years, and the Independent Variables of Trait Anxiety, 
Gender, Treatment Intent and Anxiety at 1st Treatment. 
Significant Vatiable R squa.'e B Beta T Significance 
Anxiety 
At First Treatment 0.232 0.459 0.481 4.754 0.001 
Using anxiety at the fIrst treatment gives a higher predictive rate than at simulation, from 
15% to 23%. Is this also the case with depression? 
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Depression 
If depression at five years post treatment is used at the dependant variable, then 
depression at simulation explains 14% of the variance and a further 5% by male gender. 
Table 46: Stepwise Regression Analysis Using the Dependant Variable of Depression at 
the End of Five years, and the Independent Variables of Trait Anxiety, Gender, 
Treatment Intent and Depression at Simulation. 
Significant Variable R square B Beta T Significance 
Depression 
At Simulation 0.137 0.416 0.370 3.470 0.001 
Depression 
At Simulation 0.197 0.420 0.374 3.615 0.001 
+ Treatment Intent 1.732 0.246 2.377 0.020 
+ Gender 
A total of 14% of the variance can be attributed to depression at first treatment and a 
further 6% to gender, with men being significantly more depressed than women. 
Depression at first treatment could be a better predictor of depression after five years. 
Table 47: Stepwise Regression Analysis Using the Dependant Variable of Depression at 
the End of Five Years, and the Independent Variables of Trait Anxiety, Gender, 
Treatment Intent and Depression at 1st Treatment. 
Significant Variable R squal'e B Beta T Significance 
Depression 
At First Treatment 0.235 0.650 0.485 4.802 0.001 
J 
Depression at 4 weeks 0.384 0.646 0.619 6.6 0.001 i 
post treatment 
I 
Using the depression at simulation gave a 14% variance of depression five years after 
treatment. Using depression scores at the first treatment increased the variance to 23%. 
Using depression at the 4 weeks post time explained 38% of the variance 5 years later. 
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Psychological Distress 
Looking at the distress scores from simulation to the end of the study, distress at 
simulation explained 15% of the variance of the distress five years later and gender another 
5%, with male patients being more distressed than females. 
Table 48: Stepwise Regression Analysis Using the Dependant Variable of Distress at the 
End of Five years, and the Independent Variables of Trait Anxiety, Gender, Treatment 
Intent, Age, Site and Distress at Simulation. 
Significant Val"iable Rsquare B Beta T Significance 
Distress 
At Simulation 0.149 0.390 0.386 3.644 0.001 
Distress 
At Simulation 0.208 0.420 0.415 12.784 0.001 
+ Gender 3.199 0.245 3.148 0.021 
Distress at 4 weeks post 
treatment 0.417 0.657 0.645 7.07 0.001 
Similar findings were also attained with distress at first treatment. 
A total of 26% of the distress five years post treatment being explained by the distress at 
first treatment. The predictive value has thus increased from 15% to 26%, when the variable 
of distress at first treatment is used as opposed to distress at sinmlation. 
A better predictor of distress at five years is distress at 4 weeks post treatment. Forty-two 
percent of distress at five years can be explained by distress at 4 weeks post treatment. 
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Table 49: Stepwise Regression Analysis Using the Dependant Variable of Distress at the 
End of Five years, and the Independent Variables of Trait Anxiety, Gender, Treatment 
Intent, Age, Site and Distress at 1 st Treatment. 
Significant Valiable R square B Beta T Significance 
Distress 
At First Treatment 0.263 0.555 0.513 5.175 0.001 
Distress 
At First Treatment 0.313 0.572 0.529 5.477 0.001 
+ Treatment Intent 2.916 0.225 2.325 0.023 
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In-House Research Questionnaire 
Full analysis of the research questionnaires is in the appendix. (Appendix 34- RQ at 6 
months, Appendix 35- RQ at 1 year, Appendix 36- RQ at 18 months, Appendix 37- RQ at 2 
years, Appendix 38- RQ at 3 years, Appendix 39- RQ at 4 years, Appendix 40- RQ at 5 
years. 
A short precis of their findings follows: 
Information and Control 
At the end of treatment 91 % of patients thought the information given was adequate. 
By six months post treatment 25% did not think it was adequate and 40% wanted more 
information. At one year post treatment 19% wanted more information. At 18 months 
patients were sent a booklet 'Coping now your radiotherapy treatment has finished'. By the 
third year only 12% needed more infonnation. 
Cancer had an affect on patients' lives and they appeared to be exerting more control. A 
total of 82% were eating more healthily, 14% had changed their diet, 22% had changed their 
smoking habits. 
Support 
In the six months post treatment questionnaire patients were asked if they would have 
found a telephone call helpful during the period directly after treatment. Nearly half, 43% 
stated they would. Some already had contact with breast care nurse and district nurse. Even 
after one year patients were still feeling insecure and although 80% felt they had enough 
emotional support, 23% would have liked some more emotional support from staff. By five 
years only 9% felt they needed more support. 
Psychological Well Being 
Looking back on their treatment, over 50% found it made them anxious, 20% frightening, 
62% caring, 53% reassuring, 18% depressing, 22% sore and painful, 12% distressing and 15% 
powerless. 
By year 2, 91% felt cancer had affected their lives in a positive manner. Only 6% felt 
fearful, 22% uncertain but 61% were thankful and 47% happy. Life had changed for 37%. 
134 
By the end of the study 22% were participating in positive self help, exercise, support groups, 
diet and 9% had started complementary medicines. 
When the study had finished patients were asked how they felt about taking part. 
A total of 91 % of patients found it helpful to participate in something that would help 
other patients. 
Only seven (9%) found it helpful as it reminded them of their cancer. The seven included 
foID' patients being treated for breast cancer, two had skin cancer and one head and neck 
patient. 
A total of 41 % thought that the study helped them to come to tenns with their illness, 
twenty women and thirteen men. 
One third of the patients thought the study had made them more confident to talk with 
their doctor. Over half (52%) thought that the study made them realize that their reactions 
were nonnal and only five (6%) felt worried by the study. 
Patients were also asked to make comments about the treatment. The following are 
quotes from patients and are divided into the following sections, 
1. Their feelings. 
2. The questionnaires. 
3. Support issues. 
4. Positive attitudes in coping with cancer. 
5. The altruistic aspect of this study 
6. Their physical condition 
7. Positive responses to the staff. 
1. Their Feelings 
'Taking part in this series of questionnaires actually helped me to think about and admit what 
r was feeling about my treatment. r am not very good at admitting how r feel about things, 
but just being able to circle or tick something which affected me helped me to face the way 1 
was feeling at the time' 
'1 could not discuss my feelings with anyone and even now only a few people know so that 
the questionnaires dealt with my deep mind' 
'It made me feel lucky that 1 had not many problems and came to tenn with my illness' 
'This study seemed to sum up how 1 was feeling and this made me realize my feelings were 
"nonnal". 
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'This is not something 1 like doing too frequently' 
'I am glad I took part in the research, I knew that there were a lot of other people taking part 
in it and it made me feel I was not alone in my illness' . 
2. The Questionnaires 
'I fmmd the to-ing and fro-ing of the questions a bit dizzying. The "strongly disagree", 
"agree" gets me cross-eyed. I never knew if I put what I intended' . 
'Sometimes how I answered the questions depended upon how I felt at the time which may 
not have any bearing on the cancer, e.g. answering questionnaire following a heavy cold or a 
difficult time at work. Some questions felt repetitive some I had mixed feelings about which 
made them difficult to answer' 
'A bit laborious but OK as it is only once a year' 
'When you believe yourself to be cured it is rather irritating to keep answering the same 
questions. The same questions put another way is also very armoying. I understand however 
why the information is useful. The questions are rather black and white and one carmot 
qualify. The questions make one realize what it would be like if incurable cancer was ever 
one's diagnosis' 
'Questions about my physical and mental state were quite easy and straight forward' 
'Occasionally I felt confused when answering the questions because I wasn't sure whether 
problems I experienced were attributable to my cancer or not. Also self-evaluation - are we 
supposed to evaluate our moods/state of mind in general terms or only as relating to our 
cancer'. 
'I sometimes found it difficult with the negative questions I find it easier with the positive 
questions. I have also found it difficult with degrees of answer e.g. as in disagree- strongly, 
moderately, slightly'. 
3. Support Issues 
"I fmmd the chemotherapy very frightening and would have given up after three months if I 
had not had the support of my husband' 
'Yes, Macmillan nurses seem to take an interest when diagnosed with cancer and then they 
never seem to be there anymore. Anyhow I'm really well and getting on with my life' 
'Normally at the 5 year mark appointments are gradually trailed off - She wants to keep me, 
still once a year. It is extremely reassuring to have this support'. 
4. Positive Attitudes in Coping with Cancer 
'I would like to say that one has to be positive and each day/year is a bonus' 
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'Although I wanted to help I didn't like being reminded. Being a positive person I don't like 
looking backwards' 
'I found being positive about having cancer helped me to cope with it' 
'Having a positive mental attitude throughout I believe has helped me through it along with a 
little help from my friend' 
5. The Altruistic Aspect of tIus Study 
'I tlllnk if more people's reactions were asked for and collated and expressed by the medical 
profession cancer wouldn't appear so scaring. Tills is why it is important for patients to help 
other it may apply to' . 
'I hope the responses you have received will help fellow sufferers' 
'The study has been helpful to me in respect I felt in some small way helping future sufferers 
and that I wasn't just forgotten about after treatment. The trouble was radiotherapy didn't kill 
off all the cancer cells so I am told' 
'Taking part in the survey made me realize that there are many more people who are going 
through the same traumas as me and knowing that the survey may help others has helped me 
6. Their Physical Condition 
'Drugs I need to take would appear to have adverse result i.e. blood pressure, heati, gout, 
water retention, diabetes, thyroid' 
'I do not tillnk my trouble was too serious (skin patient), I would not have been too concerned 
if I had to have further treatment' 
'The Zoladex injections I have once a month in the surgety have reduced the CatlCer level and 
I am extremely grateful for this' . 
7. Positive Response to the Staff 
'To thatlk staff for their kindness and help in taking worry away'. 
'I was treated very well indeed and everyone so very kind and helpful' 
'Thatlk you for all you do' 
'It's good to know that you and others care' 
'It's mce to know that somewhere somebody cares. At 76 years of age, it's more unusual. 
Thank you' 
'I found everybody so kind right :£i'om start to fimsh' 
'The treatment from surgeon to doctors and nurses at the hospitals both MV and Watford G 
were so wonderful, they helped me through the whole time. There is always an exception to 
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this and that was a nurse who was supposed to be a cancer patient support - But she was soon 
sorted - so for all forgotten' 
'To express my gratitude for immediate and effective treatment received which has extended 
my life by 5 years so far' 
'Thanks to all the people at MV who helped me to reach where I am now. A very successful 
businesswoman in the cleaning business called Supennaids' 
Finally, two miscellaneous comments 
'I now would like to be left alone to get on with my life and try to forget the past as much as 
possible' 
'My sense of humour helps when I feel a bit down in the mouth'. 
Physical Wellbeing 
Side effects 
The number of patients with side effects from their radiotherapy treatment fell from 60% 
at the end of treatment to 28% at five years post treatment. However, at two years post 
treatment, only 20% had any side effects and therefore some side effects develop later. 
Having side-effects did not appear to affect patients' anxiety and depression. Patients, who 
had side effects at 2 years were significantly more anxious,p=0.03 
Table showing if there is a difference in anxiety, depression and distress between those 
patients who had side-effects and those who did from the end of treatment to 5 years post 
treatment 
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Table 50: Percentage of Patients with Side Effects from 6 Months to 5 Years Post 
Treatment 
Treatment Percent/Nos. of 
Times patients with 
side effects 
Six Months 33% 
Post Treatment (41) 
One Year 29% 
Post Treatment (29) 
Eighteen Months 41% , 
Post Treatment (42) 
Two Years 20% 
Post Treatment (18) 
i 
Three Years 29% 
Post Treatment (26) 
Foll' Years 23% 
Post Treatment (17) 
Five Years 28% 
Post Treatment (22) 
The following is a series of comments from the patients on the side effects they were 
suffering from. 
Breast patients wrote: 
'Excess heat and numbness in upper ann. Also some swelling of the wrist' 
• Lymphodaema' 
'Weakness in left arm' 
'I fmd movement in my left ann on the side I had radiotherapy quite painful at time' 
'Very occasional pain the hollow of neck. Ditto breast pain' 
, Scarring of the tissues' 
'Displaced implant following Sll'gelY and radiotherapy' 
'When tired feel sick in area of radiotherapy - more like nausea' . 
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Three of the five remaining cancer of the prostate patients had problems: 
'Sex' 
'Still have little energy' 
'Nocturnal bathroom visits, continued flatulence' 
Patients suffering from cancer of the cervix made the following comments: 
'Regular diarrhoea and appearances of blood in my urine from time to time' 
'Greater frequency on passing water' 
A colon patient wrote 
'Wind and bowel irregularities - side-effects from HRT' 
A skin patient wrote 
'Itchy at times' 
Non Hodgkins Lymphoma patients wrote: 
'Tightness of the skin' 
'Bad arm/shoulder, swollen ankle' 
Patients who had tumours of the head and neck immediately after treatment suffered quite 
badly. On the present survey, only one patient made a comment: 
'Very dry mouth' 
and the only surviving lung patient wrote 
'Sore chest' 
A patient being treated for Hodgkin's Disease wrote: 
'Knackered circulation - especially in cold weather and increased tiredness as a result', 
and the one patient suffering from a tumour of unknown origin wrote: 
'Neck and right shoulder pain'. 
Fatigue 
Fatigue is a common side-effect of radiotherapy treatment. How long do patients 
continue to feel tired and is their psychological state affected? The question on tiredness was 
only included fi'om questionnaire 8, given at eighteen months. Nearly half the patients five 
years post treatment felt tired. Those patients who felt tired were significantly more anxious, 
depressed and distressed than those who did not. At eighteen months 48% felt tired. This 
dropped to 32% at two years but increased to 45% at five years post treatment. 
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Table 51: Showing the statistical difference for those patients who still feel tired after 
their radiotherapy and those who do not, provided they completed all the 12 
questionnaires 
Treatment NoslPercentages of Anxiety Depression Distress 
Times patients feeling tired 
~ighteen Months 48% 0.012* 0.024* 0.007* 
Post Treatment (35) 
Two Years 32% 0.001 ** 0.002** 0.001 ** 
Post Treatment (21) 
Three Years 47% 0.001 ** 0.002** 0.001 ** 
Post Treatment (35) 
Four Years 40% 0.001 ** 0.001 ** 0.001 ** 
Post Treatment (28) 
Five Years 45% 0.042* 0.018* 0.014* 
Post Treatment (34) 
i 
* <0.05 
** <0.005 
At the end of the study 50% of the patients were experiencing sleeping problems and 
these patients were significantly more anxious and depressed, p=O.Ol 
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Chapter 8 
Part 3 - Results of Patients with Complete Data Sets 
The final part of the results section consists of those patients who answered every 
questionnaire. A number of patients who responded to the final questionnaire had missed a 
questionnaire out through the vagaries of the postal system, holidays, or sickness. These were 
excluded from this fmal analysis. 
Table 52: Demographic And Medical Characteristics of Patients with Complete Data 
Sets 
DEMOGRAPHIC Nos % MEDICAL Nos % 
Geodet" Sites 
Female 41 73.0 Breast 30 54 
Male 15 27.0 Lung 2.0 
Prostate 4 7.0 
Social Class Skin 2 7.0 
Hodgkin Disease 2 4.0 
Class A 3 5.0 Gastro-int 2 4.0 
Class B 15 27.0 Bladder 2 4.0 
Class Cl 19 34.0 Head & Neck 2 4.0 
Class C2 9 16.0 Gynae 5 9.0 
Class D 10 18.0 NHL 4 7.0 
Unknown 2.0 
Matital Status Treatment Intent 
Married 41 73.0 Radical 53 95.0 
Widowed 5 9.0 Palliative 3 5.0 
Divorced 2 4.0 Ages 
Single 5 9.0 26-50 13 23.0 
Separated 2 4.0 50-65 22 40.0 
Partner 6 2.0 65+ 21 37.0 
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Results of HADS 
The graph depicting the anxiety and depression of the 56 survivors looks very similar to 
that of the larger mixed cohOlt. The anxiety is consistently higher than depression throughout 
treatment and for the five years after. Anxiety is at its peak at simulation, falls during 
treatment and has two small peaks at year 1 and year 3. From year fom anxiety and 
depression both show a decline. 
Depression throughout the five years is more unifOlm. During treahnent the highest point 
is at the end of h'eahnent, with another small peak at one year and fom years post h·eatment. 
Graph 36: Anxiety and Depression of survivors from simulation to five years post 
treatment 
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As with the larger mixed cohort, the anxiety of women was much higher at simulation 
and falling over the course of treahnent (graph 37). In contrast the anxiety of the men, which 
was low at simulation, rose over h·eahnent. As with the larger cohOlt this rise was seen at the 
mid treahnent point. However the rise is steeper witll the smvivors. After treahnent the 
pattern again is similar for the sexes, with men's anxiety being nearly always at a higher level 
than the women's. 
Significance was reached with the survivors at simulation, with women having 
significantly higher anxiety, t(54)=2.179, p=0.03, similarly at first h-eahnent t(54)=2.014, 
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p=O.049. These findings occurred with the original cohort. Significance was also found at 
the end of treatment but this did not occur with the 56 in the complete data cohOlt. 
Graph 37: Mean Anxiety of Men and Women with Complete Data Sets over the Study 
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The survivors consisted of only 3 palliative patients, therefore further statistical analysis 
is not relevant. However it is interesting to note that the pattem of these three patients during 
treatment and after reflects the anxiety that the larger cohOlt of palliative patients indicated. 
Anxiety fell over h'eatment, but showed an increase at the end of treatment. Throughout the 
first four years of the study anxiety is consistently higher for the palliative patients. 
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Graph 38: Mean Anxiety for Radical and Palliative Patients through the Study for 
Patients with Complete Data Sets 
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HADS - using the cut-off points to indicate psychological problems 
Anxiety 
The basic pattern of the larger group appears to be the same with tills smaller cohort. 
The overall number of cases registering at the 8 and over level on the HADS anxiety scale fell 
from 29% at simulation to 20% at five years. 
Table 53 shows the number of men and women with anxiety 8 and over for the whole 
five years of the study. 
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Table 53: Percentage of Anxiety Cases According to Gender Over the Whole 
Study for Patients with Complete Data Sets. 
Tl T2 T3 T4 T5 T6 T7 T8 T9 TI0 Tll T12 
Women 34 24 22 22 17 17 19 19 l7 22 19 15 
Men 13 7 13 27 13 27 27 20 13 27 27 33 
Tl =simulation, T2= 1"" treatment, T3 =mid treatment, T4 =end treatment, T5 =4 weeks post, T6=6 months post, T7=lyear 
post, T8 - l8 months post, 1'9- 2 years post, TlO - 3 years post, Tll - 4 years post, Tl2 - 5 years post. 
Table 53 highlights the change of anxiety between the sexes. At simulation, through 
treatment and after women had more 'possible' and 'probable' cases of anxiety. Simulation 
and 1 st treatment especially were anxious times for the women of tins' completers' cohort 
With only 56 patients split between 41 women and 15 men it is a small uneven sample to 
split into 'possible' and 'probable' cases. The females have more 'possible' and 'probable' 
cases at simulation and at first treatment. However at the end of treatment the number of 
'probable' cases for men is lngher than for women. By the end of the study both 'possible' 
and 'probable' cases for men are lligher than for women. 
Graph 39: Percentage of Possible and Probable Anxiety Cases According to Gender 
Through the Study. 
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Repeated measures analysis of variance for anxiety with the variable of gender over the 
study showed no significant effect for anxiety or gender. 
STAI State 
The anxiety scores when measured with the STAI achieved similar results to the HADS. 
They replicated the findings that anxiety over the course of treatment fell from a high at 
simulation. Two small peaks occurred at 18 months and year 4 and were measured by both 
anxiety instnunents. 
Graph 40: Mean STAI State Scores According to Gender for Patients with Complete 
Data Sets throughout the Study 
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State 12=5 years post. 
Women were more anxious than men at simulation, and through treatment. After 
treatment the anxiety levels of the men were higher than the women . Significance was 
reached at first treatment, t(54)= 1.98, p=O.05. 
Repeated measures analysis of variance for anxiety showed a significant effect for 
anxiety but not for the variable of gender, F(lI,528)=3.9, p =O.OOI. 
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Analysis using the cut-off points 
The following graph shows the decline in the munber of 'possible' and 'probable' 
cases of anxiety from simulation. The number of 'probable' cases at 45% at simulation is 
very high. The number of 'possible' cases was at its highest at first treatment and mid-
treatment. 
Graph 41: Percentage of Possible and Probable Cases Measured by STAI State 
for Complete Data Sets through Radiotherapy Treatment. 
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Gender findings were similar to the larger cohort. Women (n=41) had a higher number 
of 'probable' cases at simulation. This number was extremely high at 49%. With the original 
COhOli of 157 women, 54% had anxiety over 42.8, with 42% registering as 'probable' cases. 
Men (n= 15) had 29% of 'probable' cases at simulation. With the OIiginal cohort of 112 men, 
30% were 'probable' cases. 
The munber of 'possible' and 'probable ' cases for men at mid treatment was high 
and this was the peak anxiety point for men. This should be further investigated with larger 
munbers. The original cohort of men patients did not show this peak at mid treatment. 
An.'(iety was higher than at first treatment, but not as high as simulation. 
148 
~- : 
1-; 
I' 
I 
Table 54: Percentage of Patients with Complete Data Sets with Scores over 42.8 
on the STAI State through treatment 
Tl T2 T3 T4 T5 
Women (41) 56 46 27 27 17 
Men (15) 33 13 42 20 27 
Ti =iiimli/a/iun, T2 =jirii//rea/men/, T3 =mid treatment, T4=end treatment, T5 =4 weekiipuii/ 
The percentage of patients indicating anxiety in the five years following treatment is just under 
20%. Men, apart from year 5, are exhibiting a higher percentage of 'cases'. 
Table 55: Percentage of Patients with Complete Data Sets with Scores over 42.8 
on the STAI State from 6 Months to Five Year Post Treatment 
T6 T7 T8 T9 TI0 TIl T12 
Women 17 20 14 14 14 17 17 
{41) 
Men 20 27 13 20 20 20 7 
(15) 
T6=6111onths post, T7=lyearpost, T8=18 months post, T9 =2 years post, TlO =3 years post, Tll=4 years post, 
T 12 - 5 years post. 
It is apparent that the number of cases of anxiety regardless of sex, falls from 18 months 
post treatment onwards. However, apart from year 5, anxiety of between 14-20% is evident 
in these patients from 18months. 
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Graph 42: STAI State Anxiety of Men and Women with Complete Data Sets 
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What was the STAl Trait scores for this group of completers at simulation? The overall 
mean for this cohort was 34.73 (sd 7.27). TIns is low. The one palliative male patient had a 
mean trait anxiety level of 53, the radical men 33.43 (sd 6.28), 2 palliative women 36.50 (sd 
6.3) and the radical women 34.64 (sd 7.23). Ten patients had anxiety over the cut-off point of 
41.33, 7 women and 3 men. The palliative patients also showed very high STAI State and 
HADS scores at simulation. 
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HADS - Depression 
The depression scores for the 'completers' were low at simulation. The overall pattem of 
depression showed a gradual rise. Levels were consistently lower than anxiety scores. 
In the larger original COhOlt men had consistently higher scores than the women through 
treatment. This pattem is repeated with this smaller group of survivors. This same pattem is 
continued after treatment for the full five years for both COhOltS. 
Graph 43: Complete Data Set - Mean Depression Scores of men and women throughout 
the Study 
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The pattem of depression for men and women was different. The women's average scores 
over the whole study remained remarkably stable. In contrast the men's scores show a steady 
mcrease. 
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Women 41 
Men 15 
Table 56: T-tests between Men and Women on Depression Scores Through 
Treatment on the 56 Patients with Full Data Sets 
Tl T2 T3 T4 T5 
(Mean +sd) (Mean +sd) (Mean+sd) (Mean +sd) (Mean +sd) 
t(54)=0.208 t(54)=1.107 t(54)=1.44 t(54)=2.38 t(54)=1.74 
p=0.836 p=0.273 p =0.155 p = 0.021 p=0.068 
(2.66 + 2.29) (1.98 +1.71) (2.51 +2.37) (2.32 + 3.2) (2.34 +3.20) 
(2.80 + 2.18) (2.60+ 2.26) (3.64 +2.98) (4.47+4.36) (4.0+2.98) 
T1=simlliatioll, T2= 1st treatmellt, T3=mid treatmellt, T4=end treatmellt, T5=4 weeks post 
The average depression score was not high at the beginning of treatment. Throughout 
radiotherapy the depression scores for women remained low. From the mid-point onwards 
the depression scores for the men began to rise, with a significant difference in the scores 
between the men and women at the end of treatment. 
Table 57: T-tests between Men and Women on their Depression Scores Post 
Treatment on the 56 Patients with Full Data Sets 
, 
I 
T6 T7 T8 T9 TlO Tl1 Tl2 I 
(Mean+sd) (Mean+sd) (Mean+sd) (Mean+sd) (Mean+sd) (Mean+sd) (Mean+sd)I 
t(54)=2.82 t(54)=3.9 t(54)=2.72 t(54)=3.53 t(54)=2.236 t(54)=2.79 t(54)=3.051 I 
p=0.007 p= 0.001 p=0.009 P =0.001 p=0.03 P =0.008 P =0.004 
Women (2.05+2.21) (2.22+2.60) (2.17+2.55) 1.93+2.69) (2.41+2.89) (2.45+3.3) (2.0+2.33) 
Men (4.07+2.76) (5.47+3.16) (4.40+3.14) (5.0+3.38) (4.40+3.09) (5.20+3.19) (4.47+3.48) 
T6=6monthspost, T7=lyearpost, T8=18monthspost, T9=2yearspost, TlO=3yearspost, Tll =4 years post, 
T12=5 years post. 
Depression was significantly higher for men than women at all testing points from 6 
months post treatment to the five year post treatment point. The munbers of the men are 
considerable smaller than the women. However this pattern was repeated with the larger 
cohort, but significance was only reached at 1 year, 18 months, 3 years and 5 years. The men 
in the larger cohort had consistently higher depression scores than the women. 
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Using the cut-off points of the HADS to indicate a 'possible' or 'probable' depression 
case, the following data is produced. The number of 'cases' is far less than the anxiety 
component. However the pattern is very different. The number of 'cases' fell over the course 
of the study for the anxiety component of the HADS. In comparison, apart from year 5, the 
number of 'cases' rose with depression. At simulation only 2% could be considered a 'case', 
by year 4 this had risen to 16%. 
Table 58: Indicating the Percentage of Depression 'Cases' through Treatment for 
Patients with Complete Data Sets 
Tl T2 T3 T4 T5 
Women (41) 1 0 2 5 7 
Men (15) 0 0 14 7 13 
1'1 =simu/ation, 12= ]'1 treatment, 1'3=mid treatment, 1'4=end treatment, 1'5=4 weeks post 
The numbers of men scoring above 8 is higher for the men than the women through 
treatment. 
Table 59: Percentage of Patients with Complete Data Sets with Scores over 8 on the 
Depression Scale from 6 Months to Five Year Post Treatment 
T6 T7 T8 T9 TI0 TIl T12 
Women 2 5 5 5 10 12 2 
(41) 
Men 7 33 20 27 20 27 20 
(15) 
T6=6 /IIonths post, T7=Jyearpost, T8=J81110nths post, T9=2 years post, TJO=3 years post, TJ J=4 years post, T12=5 years post. 
At every testing point after treatment is fInished the men patients have more depression 
'cases' than the women. 
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Graph 44: Percentage of Possible and Probable Depression Cases According to Gender 
For Patients with Complete Data Sets 
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months post, T9 =2 years post, TlO=3 years post, Tll =4 years post, T1 2=5 years post. 
Repeated measures analysis of variance for depression over the course of the study with 
the variable of gender showed a significant effect for depression F(11,572)=2 .36, p=0.03. and 
for gender F(1,52)=8.5,p=0.005. 
Using the combined scores to indicate psychological distress 
Distress levels of 23% occUlTed at simulation. This dropped to 20% at the end of 
treatment. Post treatment it fell fiuther to 18%. From 6 months to five years post treatment 
distress remained at approximately 20% for tIus population overall. However the distribution 
according to gender was not even. 
Gender 
At the beginning of the study psychological distress was lllgher for the women COhOli. 
This changed from the end of treatment onwards. Men had lllgher scores than women from 
the end of treatment to the end of the study. Significance was reached at year 1, (Men 
mean=11.4, women mean=7 .07), t(1,54)=2.19, p=0 .03, at year 3 (Men mean=10.l3, women 
mean=6.29), t(1,54)=2.l4,p=0.03, year 4 (Men mean=l1.4, women mean=6.95) t(1,54)=2.27, 
p=0.02 and year 5, (Men mean=10.6, women mean = 6.02) t(1,54)=2.37,p=0.02. 
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Graph 45: Psychological Distress as Measured by the Combined Scores of the HADS for 
Patients with Complete Data Sets over the Course of the Study 
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Repeated meastrres analysis over the whole study period with the variable of gender 
showed no significant effects. 
Using the cut-off points of the combined scores to indicate a 'case' 
At simulation women displayed twice as many patients 'cases' at the cut-off point of 13 
as men. From mid treatment onward this changes, and by the 4 weeks post treatment point 
the pattern has reversed with nearly twice as many men indicating ' caseness' as women. 
Table 60: Percentage of Men and Women with Mean Combined Scores 13 and over 
throu!!h Treatment for Patients with Comolete Data Set 
= 
Tl T2 T3 T4 T5 
Women 27 19 14 19 15 
Men 13 7 21 20 27 
.-
TI=sillllliatioll, T2= 1" tre{/tment, T3=miti tre{/tmellt, T4=e/ll/ tre{/tment, T5=4 weeks posl, 
From 6 months onward the number of 'cases' for men is considerably more than for 
women, especially in the last three years of the study. 
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Table 61: Percentage of Men and Women with Combined Scores 13 and over on 
the HADS Post Treatment for 5 Years with Complete Data Sets 
T6 T7 T8 T9 TlO Tll T12 
Women(41 ) 19 19 17 10 12 15 17 
Men (15) 27 47 27 33 40 53 47 
T6=6 months post, T7=lyearpost, T8=18 months post, T9=2 years post, T10=3 years post, Tll=4 years post, T12=5 years post. 
The number of men indicating a 'case' during this five year period is high. Year one and year 
four seem particularly bad years. Even in year five when a lowering of anxiety and 
depression for all patients occurs, distress although lower than year four is still high with 47% 
of men patients having scores above 13 and over on the unitary scale of the HADS. 
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Graph 46: Percentages of Probable and Possible 'Cases' for Patients with Complete 
Data Sets through the Study with 13 and 18 Cut-off Points to Indicate a 'Case'. 
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Site 
With this small cohort it is difficult to further analysis the data into the variable of site. 
Breast patients consist of30 of this COh0l1, non-gender related women patients make up 6, 
prostate patients 4 and non-gender related men 11 . 
Graph 47: Mean Anxiety Scores of Breast, Non-Gender Related Males and Females and 
Prostate Patients with Complete Data Sets 
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Ngr=non-gender related site 
The non-gender related females have consistently higher scores over the study. However 
they only number 6. Mid treatment was the most anxious point for this cohort. The breast 
patients have consistently lower scores after a peak at simulation. The overall pattem is very 
snllilar to the pattem of the larger cohort of sW'vivors and non-sW'vivors. Prostate patients 
peaked at mid-treatment and dipped at year 4. The non-gender related men had consistently 
higher scores than the prostate patients. This COh0l1 had the lowest anxiety at simulation. 
Anxiety rose to a peak at mid-treahnent and fell at the end of h'eatment, with two flU1her dips 
in anxiety at 18 months and 3 years. 
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A significant difference in anxiety was found in the non-gender related females (Mean= 
8.66, sd 3.0) having significantly higher scores than the non-gender related males at first 
treatment (Mean=4.75 sd1.5), t(15)=3.110, p=0.007 and at mid treatment, women's anxiety 
(Mean=9.1 sd4.8) was significantly higher than the men's (Mean 4.7 s.d.3.5) t(15)=2.5, 
p=0.02. No difference was found with the prostate and non-gender related male patients. 
However a significant difference was found between the non-gender related female patients 
and the breast patients. 
At first treatment non-gender related females anxiety scores (Mean=8.66 s.d.3.0) were 
significantly higher than the breast patients (Mean= 5.5 s.dJ.2), t(34)=2.27,p=0.003. 
Similarly at mid treatment, non-gender related females (Mean=9.166 s.d 4.8) were 
significantly higher than the breast patients (Mean 4,5 s.d. 3.18), t(34)=2.996, p=O.OOS. 
At end of treatment, non-gender related females (Mean=8.16 s.d.2.0) had significantly 
higher scores than the breast patients (Mean=3.66 s.d.3.0), t(34)=3.42S,p=0.002 
At four weeks post treatment, the non-gender related patients continued to have higher 
scores but significance was not reached. 
At six months post treatment, non=gender related females (Mean=8.16 s.d.5.7) had 
significantly higher scores than the breast patients (Mean 4.0 s.d.3.3), t(34)=2.428,p=0.02. 
This was repeated at the first year, Breast patients (Mean=3.9 s.d.3.5) was significantly 
lower than the non-gender related females (Mean=8.1 s.d.5. 7), t(34)=2.428, p=O.O 19. 
Anxiety continued to be higher for the non-gender related females than the breast patients 
for the next four years but significance was not reached. Depression for these sites showed a 
different pattern. 
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Graph 48: Mean Depression Scores for Patients with Complete Data Sets and Sites, 
Breast, Non-Gender Related Male and Female and Prostate. 
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The depression scores for the men show a gradual upward trend. Through treatment both 
the non-gender related male and female patients have the highest depression scores. From 
year one the non-gender related males and the prostate patients have the highest mean scores. 
There is no significant difference between the male patient sites of non-gender related and 
prostate. 
The breast patients show a continuous low level of scores from first treatment onwards. 
Aprut from yeru' 3, the scores are lower than the non-gender related patients. The breast 
patients have significrultly lower scores on two occasions, at mid treatment, breast 
patients(Mean=2.06 s.d 1.9) score is significantly lower than the non-gender related patients 
(Mean 4.5 s.d. 3.7), t(34)=2.396, p=O.002. Similarly at the end of treatment, Breast patients 
(Mean1.8 s.d.2.1) is significantly lower than the non-gender related patients, (Mean=3.88 
s.d.2.3), t(34)=2.00,p=O.OS. 
At simulation and first treatment women non-gender related patients have just higher 
scores than the men non-gender related sites. From the mid treatment point men have 
continuously higher depression scores for the five yeru's of the study. Significrulce is reached 
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only at year 3, Men (Mean 5.27 s.d.3.5) is higher than the women (Mean=l, s.d 1),t(l5)=2.98, 
p=0.009. 
With respect to the combined scores to indicate psychological distress, the women non-
gender related patients have higher scores than the men through treatment. From six months 
onwards this changes and the men had continuously higher scores for the post five years of 
the study. 
Graph 49: Combined Scores of the HADS to Indicate Psychological Distress for Patients 
with Complete Data Sets with sites of Breast, Non-Gender Related Males and Females 
and Prostate 
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Significance was only found with the breast and non -gender related patients at: 
1st treatment Breast ean=7.266 sd4,2), Non-gender related (Mean 1l.16 s.d.5.4), t(34)=2.245, 
p=0.03 
Mid treatment, breast (Mean=6 .5, s.d 4.3), non-gender related (Mean= 13.66 s.d.8 .2), 
t(34)=3.105, p=0.004 . 
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End of treatment breast (Mean=5.5 s.d 4.7), non-gender related (Mean=12 s.d 4.0), 
t(34)=3. 109, p=0.004 
Six months post treatment, breast (Mean=5.7 s.d4.7), non-gender related (Mean=11.16 
s.d.8.7), t(34)=2.17 ,p= 0.037 
At one year post treatment, breast (mean=5.8 s.d 5.35), non-gender related (Mean=11.5 s.d 
9.0), t(34)=2.109,p=0.03 
Non-gender related female patients had higher distress scores throughout the study than the 
breast patients. 
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Predictions 
Can anxiety after five years be predicted? 
The variables of anxiety at simulation, anxiety at first treatment, gender, treatment intent, 
age, social class and STAl Trait were analysed in a stepwise multiple regression analysis. 
Table 62: Results of Stepwise Regression Analysis using the Dependant Variable-
Depression after five years and the Independent Variables of Anxiety at Simulation, 1St 
Treatment, Gender, Treatment Intent, ST AI Trait and Age. 
Significant R square B Beta T Significance 
variable 
Anxiety at 1 st 0.296 0.618 0.544 4.76 0.001 
treatment 
Anxiety at 1 st 0.419 0.727 0.640 2.199 0.001 
Treatment 
+Gender 2.950 0.363 3.346 0.001 
Using anxiety at 1st treatment gave a 30% variance of anxiety five years post treatment. 
When tIus is coupled with gender it increases the variance to 41 %. 
Can depression after five years be predicted? 
Table 63: Results of Stepwise Regression Analysis with Dependant Variable Depression 
at the end of Study and Independent Variables Gender, Treatment Intent, Age, 
Depression at simulation, l~t treatment, Mid Treatment, End Treatment and 4 Weeks 
Post Treatment. 
Significant R square B Beta t Significance 
variable 
Depression 4 0.312 0.503 0.558 4.89 0.005 
weeks post 
treatment 
Depression 4 0.387 0.497 0.497 4.469 0.001 
weeks post 
Treatment 
+Gender 0.282 0.282 2.535 0.014 
Depression at 4 weeks post treatment explained 31 % of the variance of depression at the end 
of the study. Depression at four weeks after treatment plus gender accOlmted for 39% of the 
depression at the end of the study. 
Psychological distress at the end of study was used as the dependant variable in a stepwise 
regression analysis. 
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Table 64: Results of Stepwise Regression Analysis using the Dependant Variable distress 
at the End of the Study and the Independent Variables gender, Treatment Intent, Age, 
Distress at Simulation, Distress at 1st Treatment and Distress at Mid Treatment, Distress 
at the end of Treatment and Depression at 4 weeks post Treatment. 
Significant R square B Beta t Significance 
variable 
Distress at 0.402 0.622 0.634 5.97 0.001 
end of 
treatment 
Psychological distress at the end of treatment explains 40% of the variance at the end of 
five years. 
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Survivors 
Was there a difference in anxiety, depression and distress when patients were having their 
radiotherapy treatment between the 56 'completers' and the rest of the cohort? Table 65 
shows the analysis of these two groups. 
Table 65: Anxiety, Depression and Psychological Distress t-tests Results of the Original 
Cohort of Patients and the 56 Completers through Treatment 
Tl T2 T3 T4 T5 
(Mean sd) (Meansd) (Mean sd) (Mean sd) (Mean sd) 
{Numbers} {Numbers} {Numbers} {Numbers} {Numbers} 
Anxiety did not (7.17 sd 4.3) (6.73 sd 4.3) (5.9 sd 3.88) (5.59 sd 4.0) (5.47 sd 3.9) 
fmish all Qs {213} {201} {l12} {l59} {161} 
56 Completers (5.9 sd 3.5) (5.5 sd 3.19) 
(5.14 sd 3.9) (4.35 sd 3.6) (4.2 sd 3.5) 
{56} {56} {56} {56} {56} 
t(265)=1.9 t(119)=2.3 t(166)=1.202 t(213)=2.03 t(215)=2.09 
p=0.058 p=O.023 p=O.231 p=O.04 p=O.038 
Depression did not (4.7 sd 3.4) (4.68 sd 3.4) (4.3 sd3.6) (4.58 sd 3.8) (4.86 sd 3.8) 
finish all Qs {213} {201 } {113} {159} {l61} 
56 Completers 
(2.69 sd 2.2) (2.1 sd 1.8) (2.8 sd 2.5) (2.89 sd3.1) (2.78 sd 3.2) 
{56} {56} {56} {56} {56} 
t(130)=5.4 t(166)=7.27 t(166)=2.9 t(213)=2.9 t(215)=3.6 
p=O.OOI p=O.OOI p=0.OO4 p=0.004 p=O.OOI 
Distress did not (11.9 sd 6.6) 11.3 sd 6.8 (10.25 sd 6.6) (10.18 sd6.9) (10.34 sd 6.6) 
finish all Qs {213} {202} {1l2} {159} {l61) 
56 Completers 8.67 sd 5.09 (7.6 sd 4.5) (7.7 sd 5.4) (7.2 sd 6.0) (7.0 sd 6.1) 
{56} {56} {56} {56} {56} 
I 
I 
t(267)=3.3 t(256)=3.7 t(165)=2.47 t(213)=2.8 t(215)=3.2 
p=O.OOI p=O.OOI p=O.OI4 p=O.OO5 p=O.OOI I 
The anxiety, depression and distress was significantly higher for the patients who did not 
complete all the questionnaires. The cohort who did not complete all the questionnaires 
during treatment consisted of all the patients who had originally agreed to participate in the 
study. Some were allotted to the Single Fraction and Short Multi-Fractions groups who only 
had one to four treatments and therefore did not return to the radiotherapy department for any 
period. They would not have received the mid-treatment questionnaires and therefore would 
have been included in 'did not finish all questionnaires' group. This group would have also 
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included those patients who died during treatment, and those patients who no longer wanted 
to participate. 
Analysing the patients from the 2nd ethical permission, the patients who responded to 
the fIrst questionnaires given 6 months post treatment (N= 146) were put into two groups. The 
fust group consisted of those who replied to some of the questionnaires, 90 (62%). Some of 
tins COhOli died, others became non-patiicipants. The other group consisted of the 56 patients 
who responded to all 12 questionnaires. 
Table 66: Anxiety and Depression t-tests Results of the Original Cohort of Patients who 
agreed to participate in the 2nd Ethical Permission. This cohort are divided into those 
who did not answer all the questionnaires and the 56 Completers 
T6 T7 T8 T9 TIO Tll T12 
(Mean sd) (Mean sd) (Mean sd) (Meansd) (Mean sd) (Mean sd) (Mean sd) 
{Numbers} {Numbers} {Numbers} {Numbers} {Numbers} {Numbers} {Numbers} 
1.Anxiety (5.4 sd 4.3) (4.89 sd4.3) (4.58 sd 3.8) (5.27 sd 4.2) (5.4 sd4.l) (4.6 sd 4.4) (3.5sd3.0) 
did not {90} {56} {43} {37} {34} {18} {20} 
finish post 
Os 
(4.6 sd3.7) (5.1 sd 4.3) (4.89 sd 4.1) (4.57 sd 3.7) (5.0 sd3.3) (4.9 sd 3.8) (4.4sd3.6) 
56 {56} {56} {56} {56} {56} {56} {56} 
Completers 
t(144)=1.17 t(11O)=0.305 t(97)=0.385 t(91)=0.839 t(88)=0.5 t(72)=0.224 t(74)=1.0 
p=0.241 p=0.76 p=0.7 p=0.403 p=0.6 p=0.823 p=0.3 
Depression (4.3 sd 3.7) (3. 85sd3.4) (3.1sd2.9) (4.0 sd4.0) (4.1 sd4.1) (3.5 sd 4.3) (2.9 s4.0) 
did not {90} {56} {43} {37} {34} (18) {20} 
finish all 
Os 
56 (2.5 sd 2.5) (3.08 sd3.1) (2.8 sd 2.8) (2.7sd3.1) (2.9 sd 3.0) (3.2 sd3.5) (2.6 s2.8) 
Completers {56} {56} {56} {56} {56} {56} {56} 
t(l42)=3.04 t( 111)= 1.25 t(99)=0.588 t(91)=1.6 t«87)= 1.58 t(71)=0.297 t(74)=0.28 
p=O.OOl* p=0.214 p=0.558 p=O.l4 p=O.l17 p=OJ p=0.77 
*Levene's test for equality of variance reached significance p>O.OOltherefore equal variance not assmned 
Further analysis on those patients who responded to all questionnaires (N=56) and those 
who did not (N=90) revealed no signifIcant difference in anxiety, depression or distress. That 
is a statistical difference between patients participating in Part 2 of the analysis and patients 
participating in Part 3 of the analysis was not found apatt from depression at 6 months post 
treatment, those patients who did not finish all questionnaires were significantly more 
depressed thatl the 'completers'. How do the atlxiety scores of the patients with complete data 
sets compare with those who died and with those with non complete sets? 
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Graph 50: Mean HADS Anxiety Scores of Dead, Incomplete Data Set, and Complete 
Data Set Patients over 4 Years of the Study 
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Graph 50 illustrates the high anxiety scores of those patients who died in companson 
with the patients who remained in the study, whether they completed all 12 questionnaires of 
not. The patients who died show much higher mean anxiety scores. Apart from mid 
treatment and year 1, there is little difference in anxiety between those patients who had 
complete data sets and those patients with incomplete sets. Anxiety levels were on average 
lower for the 'non-completers'. The 'completers' showing much more uniform scores 
throughout. 
A similar pattern follows with depression. Graph 51 illustrates the difference in the data 
sets of those who died, those with complete data sets and those who did not complete all the 
questiomlaires in Part 2 of the analysis. 
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Graph 51: Depression Scores of those who finished all 12, those who died and those who 
did not have complete data set. 
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The patients who had complete data set had significantly lower depression scores than 
those who died and those with incomplete data, F(2,265)=10.85, p=O.OOl (Post Hoc Tukey). 
From first treatment to 6 months post, the dead patients had significantly higher scores tlIan 
the complete or incomplete data set patients. 
Table 66 shows no significant differences between the cohort of 'completers' and the 
patients answering the questionnaires from one year onwards. Therefore analyse was 
undeltaken on the patients who responded to the last questionnaire, namely the survivors 
(n=76). This is a larger cohort than the 56 completers. This excludes the number of non-
participants (n=67). Table 70 shows t-test results of smvivors (n=79) with the non smvivors 
(n= 119) using their scores at simulation to see if there are any indicators of survival. 
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Table 67: Showing the Results of t-test plus Means and 
SD of Stateffrait Anxiety and Depression Scores of Survivors and Non-Survivors 
with Respect to their Scores at Simulation. 
Questionnaires Survivors [79] Non-Survivors [119] Test for significance 
Mean (s.d.) Mean (s.d.) 
Trait Anxiety 35.78 (8.17) 38.49 (9.9) t( 196)=2.09 
p=0.038* 
State Anxiety 43.01 (14.24) 40.14 (13.020) T(195)=1.5 
p=0.135 
Depression 3.09 (2.82) 5.12 (3.05) T(196)=4.7 
p=O.OOl ** 
The trait anxiety scores of the survivors and the non-survivors are significantly different. 
The trait anxiety score of the non-survivors is more similar to the State anxiety. This is not 
the case with the survivors. There is no significant difference with the State anxiety. There is 
a significant difference with depression. The non-survivors are significantly more depressed 
than the smvivors. 
Leigh et al (1987) hypothesized that high levels of State anxiety were indicative of long 
or short survival. This study therefore analysed the number of 'cases' of anxiety and 
depression at simulation according to gender to see if this hypothesis could be substantiated 
and developed. 
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Table 68: Possible and Probable Cases 
of Anxiety 'Cases' at Five Years in Relation to Anxiety and Depression at Simulation 
Case at Non-survivor Survivor Non survivor Survivor 
simulation female (48) Female (68) Male (61) Male (24) 
AnxietyHADS 14 10 12 2 
possible 
AnxietyHADS 12 10 9 3 
Probable 
STAl 8 5 10 1 Possible 
STAl 19 26 17 9 Probable 
Depression 8 3 10 2 
Possible 
Depression 2 2 4 0 
probable 
This data shows that men and women appear to respond differently. The women 
who had high anxiety at simulation were approximately split 50:50 as to whether they 
survived or not using both HADS and STAl questionnaires. From the 15 'cases' of 
depression only 5 survived. 
However the men exhibiting high anxiety mostly died. From the 26 HADS 'cases' only 
five survived. From the 38 STAl 'cases' 10 survived. From the 16 'cases' of depression for 
the men, 2 survived. 
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Chapter 9 
Discussion 
This is a long and complicated multivariable study in which the population has a high 
attrition rate. Screening patients with questionnaires was used to attempt to identify 
psychiatric morbidity. The result section was based on the psychometric properties of the 
HADS. The discussion will thus focus on the specific areas of anxiety, depression and 
psychological distress. The discussion starts with a summary of the findings. It then 
discusses the findings of the current study with relationship to those studies that were 
specifically set out in chapter 3. Anxiety, depression and distress are then discussed in 
relationship to the three different analyses given in part 1, 2 and 3 of the results section. 
The aims of this study were 
• To observe the emotional functioning in a cohort of patients attending a 
radiotherapy clinic before, during and five years after treatment has fmished, 
using questionnaires. 
• To ascertain the times of greatest distress for patients. 
• To identify factors that could indicate which patients are the most vulnerable to 
psychological morbidity. 
• To fmd out what patients need and how they feel during tillS time. 
• To see if predictions can be made on the basis of psychological tests at simulation. 
• To see ifthere are indicators for survival. 
Summary of Main Findings 
1. The main outcome of this study is that anxiety and depression are mobile factors 
which change over time. This may account for the varied range of levels of anxiety 
and depression listed in the literature review. 
2. Anxiety and depression peak at different times in the course of treatment. Highest 
anxiety scores occur at simulation. The peak munber of depression cases occur mostly 
at the end of radiotherapy treatment or four weeks after it has finished. 
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3. The psychological effects of radiotherapy treatment manifest themselves at different 
times for men and women regardless of site. 
4. Palliative patients and men are at high risk of psychological distress. 
5. Accurate measurements of anxiety can depend on the wording of the questionnaire. 
6. Some patients have side effects from the radiotherapy treatment five years after 
treatment. In particular high rates of fatigue are found in patients five years after 
treatment for cancer has finished. Those patients who were tired were significantly 
more depressed, anxious and distressed. 
7. Predictions using data generated at simulation can be made. Anxiety at first treatment 
can be predictive of anxiety at five years. Similarly depression at the end of treatment 
can predict a large percentage of depression five years later. 
8. Indicators of survival: - High state anxiety, coupled with lower trait and low 
depression scores could be indicative of a higher survival rate. This requires more 
research. 
This summary of findings will now be discussed in more depth. It will begin with a 
discussion of the findings in relationship to the specific studies in chapter four. It will 
then discuss anxiety, depression and distress in relationship to the three different cohorts 
analysed in the specific sections of Part 1,2 and 3. 
Integration of Findings with Previous Research 
One of the aims of the present study was to find the time of greatest distress for patients. 
Following on from the detailed studies in Chapter 4, Fife et al (2000) in their prospective 
longitudinal study with bone marrow patients found that the period of greatest emotional 
distress was after admission and before transplant. Both anxiety and depression peaked at this 
time. This finding is understandable as patients are in isolation, which can cause severe 
depression. They also receive high dose chemotherapy and sometimes have irradiation prior 
to their bone marrow transplant. These treatments prior to the bone marrow transplant could 
result in high anxiety. 
The findings of the current study are different. The greatest period of overall distress for 
all patients was at simulation, the planning of their treatment. At this time patients are 
positioned for treatment. X rays are obtained, the tumour is accurately localized, the 
treatment fields are planned together with the dose distribution and the treatment regime is 
verified. Patients' bodies are marked with felt tip pens so that the exact area can be treated 
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each day. Some patients need specialized set-ups to avoid vital organs. Head and neck 
patients for example need masks, which are then clamped onto the bed to insure accuracy of 
treatment. 
The present study used the psychometric properties of the HADS, namely anxiety and 
depression. Looking specifically at anxiety, it peaked at simulation prior to the patient's 
radiotherapy treatment. Forty per cent of the patients at simulation had anxiety levels of 8 and 
over on the HADS, indicating a possible anxiety case, and 20% scored 11 and over indicating 
a probable case, with a mean of 6.9. This was the time of highest anxiety for the patients, 
with levels subsequently lowering. These findings were confirmed by a similar pattern in the 
responses to the ST AI State questionnaire, but with a higher percentage, 50%, indicating 
anxiety and 37% indicating extreme anxiety. This anxiety could largely be adaptive as it could 
be in response to danger - the unknown radiotherapy treatment. 
These results were not repeated with the depression component. The results of the 
analysis of depression showed a plateau-effect, with a peak at four weeks post treatment 
(Mean 4.3 sd 3.7). 
Using Fife et ai's study as a model, the differences over time can be observed for the 
bone marrow patients and the radiotherapy patients. 
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Table 69: Means Over Time: Repeated Measures Fife et al study compared with 
Current Study's Results 
Dependant Variable Tl T2 T3 T4 T5 T6 T7 F P 
(Nos) (Nos) (Nos) (Nos) (Nos) (Nos) (Nos) 
Anxiety ofBMT Patients 21.07 17.89 20.87 2l.27 23.71 25.93 25.35 14.29 0.001 
BiPolar Profile of Mood* 
Anxiety ofRT 6.92 6.47 5.65 5.27 5.15 5.14 5.03 7.47 0.001 
Patients 
HADS** 
Depression BMT patients 22.40 19.10 2l.29 22.81 24.65 26.79 25.18 11.47 0.001 
BiPolar Profile of 
Mood*** 
Depression ofRT 
Patients 4.30 4.13 3.86 4.14 4.33 3.64 3.49 0.9 0.492 
HADS**** 
- -
[Tl = Simulation, T2= ]" Treatment, T3= End Treatment, T4= End Treatment, T5 = 4 Weeks Post Treatment, T6=6 months 
T7=lyear] 
* 
** 
*** 
**** 
The lower the score the higher the anxiety 
The higher the score the higher the anxiety 
The lower the score the higher the depression 
The higher the score the higher the depression 
Both studies show a significant difference in anxiety over time. However depression in 
the bone marrow transplant patients was significant, but was not significant in the 
radiotherapy patients. With the bone marrow patients the depression at T2 was probably due 
to the isolation they were experiencing. In contrast the radiotherapy patients peaked at the 
four weeks post treatment time point. This could be due to the impact of side effects and 
absence of hospital staff for support, resulting in similar feelings of isolation. 
Fife et al in their analysis did not breakdown their anxiety and depression scores 
according to gender, neither did the POMS questionnaire allow this study to identify high 
scorers. Fife et al specifically looked at coping/adaptation in their article. They measured 
coping and also made a note of gender, but no reference to gender was given in this paper and 
this must be queried. 
Gender is an important issue. At the time of simulation, in the current study, women are 
significantly more anxious than men. Forty five percent of the women had anxiety scores 
over 8 and 23 % had scores over 11. In contrast, a third of the men had anxiety scores over 8 
and 13% over 11. The number of women high anxiety scorers fell during treatment, and four 
weeks after treatment has finished 23 % have scores over 8 and 13 % have scores over 11. 
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Men's scores fell for the first three testings during treatment, however, at the end of 
treatment the number of cases rise with both cut-off points. At four weeks post treatment the 
proportion of men being a possible or probable case is greater than the women. 
The different patterns of anxiety and depression exhibited by men and women are 
important. Historically women are considered to be more prone to mental disorder than men. 
However, Jenkins (1985) in her article on sex differences questions this historical assumption. 
In her study she found no difference between men and women. This was also confirmed by 
Wilhelm and Parker (1989). They found no sex differences for major and minor depressive 
episodes. It would have been interesting if Fife et al in their study had found similar patterns 
to those found in the current study. 
Fife et aI's study lasted one year. This was not long enough, as both anxiety and 
depression had increased in their bone marrow patients in the period of three months to one 
year. Was this just a small peak or did it indicate a change of pattern? In the current study 
anxiety continued to drop at the one-year mark, but rose at 18 months. This rise in anxiety 
appears to be related to an increase in side effects. At one year, only 28% of patients had 
side-effects. At eighteen months this had risen to 41 %. Half of the patients felt tired and 
these patients were significantly more anxious than those who did not feel tired. The current 
study therefore shows that 18 months post treatment is an important time to focus on patient's 
side effects in order to lower their anxiety, maybe by appropriate information in the Out-
Patient Clinic. 
The number of patients who could be 'possible' depression cases remained static between 
six months and one year but fell at 18 months. This drop could be due to the number of 
palliative patients who died in the intervening six months. However it also occurred with the 
'completers', therefore the reason for this lowering of depression scores remains unknown. 
The second study to be assessed in depth was Hammerlid et aI's longitudinal study of 
1997. They assessed distress in head and neck cancer patients in order to gain a better 
understanding of the quality of these patients' lives and to see if there was a difference 
between those treated by radiotherapy and those treated by radiotherapy and brachytherapy. 
The HADS was used to measure psychological distress. Hammerlid's study tested patients at 
diagnosis and then at monthly intervals. The reader however was not informed if this was 
before or after diagnosis. Anxiety was highest for patients at this point with 37% scoring 
above 7 on the anxiety scale. The current study shows that the highest point of anxiety 
reached for radiotherapy patients was prior to the planning of their treatment with 40% of the 
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patients scoring 8 and over on the HADS. Therefore these two studies have approximately 
the same percentage of anxiety 'cases' at the start of their study. 
The next testing point Hammerlid et al used was one month after treatment started. There 
is no comparable testing point during the treatment section of the current study. However 
their testing point three months after treatment started could be comparable to the current 
study's four weeks post treatment, taking into account that treatment for head and neck 
patients can last six weeks. Hammerlid et al found that depression peaked at this point and 
was higher than at diagnosis with 44% having depression of 7 and over. The result compares 
favourably with the current findings that depression for radiotherapy patients peaked at four 
weeks post treatment but the percentage was lower at 20%. The female to male ratio was 
biased towards men in Hammerlid's study and towards women in the present study. This 
could have been the cause of the higher percentage of depression in Hammerlid et als study. 
The men in the current study were more depressed than the women, but the women to male 
ratio was 2: 1 in favour of women. The percentage of male patients with depression at the 4 
weeks post treatment was 20% in the current study, a much smaller percentage than 
Hammerlid et al. No further statistical analysis was carried out on gender by Hammerlid et al. 
Hammerlid's study contained a mixed cohort of radical and palliative patients totalling 
105. Again, no detailed analyses were given on the differences between the cohorts. The 
current study shows how palliative patients are significantly more anxious and depressed than 
the radical patients. This could also account for Hammerlid et als higher depression numbers. 
The third study which was reviewed in depth was Nordin and Glimelius (1999). Nordin 
and Glimelius had previously used the HADS in combination with other questionnaires to see 
if psychological distress could be predicted using analysis at diagnosis. Nordin and Glimelius 
found that depression and anxiety at diagnosis could account for 35% of the variance of 
anxiety and depression at six months. 
One of the aims of the present study was to see similarly if psychological distress could 
be predicted. The current study, using similar statistical stepwise regression analyses to 
Nordin and Glimelius, found that anxiety at simulation could account for 42% of the anxiety 
at the four weeks post treatment point. Similarly depression at simulation could predict 40% 
of the depression at. four weeks post treatment. However a higher predictive rate was found 
by using data from the 1 st treatment testing. In the present study, because the timings of the 
first two set of questionnaires were close, one at planning and one just before the first 
treatment, the author was able to show that a better predictive time of anxiety four weeks post 
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treatment was by using anxiety at 1 st treatment rather than simulation.. Similarly depression 
at four weeks post treatment could be predictive of 39% of depression at end of the study. 
With respect to the five year study, the 'completers showed that distress at the end of 
treatment could predict 40% of the distress 5 years later. 
Anxiety and depression are mobile factors during radiotherapy treatment and after. The 
current study shows that anxiety, depression and distress could all be predicted five years later 
using data at first treatment for anxiety. Depression and distress are better predicted by data 
generated at the end of treatment. 
In the Nordin and Glomelius study patients (n=151) scored a mean of 4 on the HADS 
anxiety scale (sd 4.2), in contrast to 6.93 (sd 4.2) for patients prior to simulation in the present 
study. Therefore the anxiety at diagnosis is very much lower than for patients in the current 
study. The depression rates of the current study 4.30 (sd 3.3) were more similar to Nordin 
and Glimelius's study of 4.4 (sd 3.9). However, the current study did find the depression 
levels were more level throughout treatment. Nordin and Glimelius also used cut-off points to 
distinguish between possible and probable cases and found 24% of patients came into these 
categories. This was lower than the present study, in which levels at both simulation and first 
treatment were 40% and 37% for anxiety respectively, and 16% and 14% for depression. 
The discrepancy in the anxiety levels appears to be caused by the randomness of the 
timing of the testings in Nordin and Glimelius' s study. The patients were all tested sometime 
after the biopsy, when the patients were physically able. This timing varied with a median of 
three weeks and was not specific enough in comparison with the strict timing of the present 
study. Nordin and Glimelius's patients could have had time to adapt. Indeed the current study 
shows the importance of specificity in timings of questionnaires given to patients, the anxiety 
component especially showed large fluctuations over the treatment time. The patients in the 
current study were all tested at specific times before their simulation or treatment under 
similar conditions. A better estimate of anxiety for Nordin and Glimelius's study would have 
been prior to surgery and one week post surgery. 
Patients were tested only twice in the Nordin and Glimelius study with the second time at 
six months. Both studies found a significant decrease in both scales over the period of the 
study. However with regard to depression the current study shows a gradual lowering of 
levels until the end of treatment when depression increased, a very different pattern from that 
displayed by anxiety. As the fluctuations in depression were not high in comparison to the 
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anxiety component, the levels of depression in the Nordin and Glimelius study and the current 
study are very similar. 
In the Nordin and Glimelius study the threat of surgery is over. However treatments are 
not mentioned in the paper, neither is gender and the current study shows the importance of 
these two variables. 
The fourth discussed study was Leigh et al (1987) who also looked at psychological 
predictors by comparing survivors to non-survivors in a group of radiotherapy patients. The 
site of the cancer was varied, as in the current study, with breast cancer dominant. 
The subjects consisted of 101 consecutive outpatients receiving radiotherapy during the 
period July 1979 to June 1980. The author of the current study interviewed 346 patients in one 
month, so that 101 in eleven months seems a small number. There is no mention of refusals 
in Leigh et aI's study. 
At three years 38% were dead. Survivors therefore numbered 62%, which is high for a 
three year cancer study. However, in Leigh et aI's study patients were only interviewed once. 
They were not re-tested at the three year point. Information was accessed through the 
patients' notes and no further testing of the patients occurred. Consequently there are no 
non-participants over that three year span. In contrast, known deaths in the current study were 
similar at 40% in year three. In Leigh et aI's study, anxiety and depression were measured 
only once, namely: 
"During one of their daily visits as they reported for radiation therapy" 
Thus no accurate specificity in timing was given. This could have affected their results. In 
the present study survivors at five years are compared with the non-survivors. 
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Table 70: T-Test plus Means and 
SD of Trait Scores of Survivors and Non-Survivors 
with Respect to their Scores at Simulation. 
Survivors [No] Non-Survivot's [No] Test for significance 
Mean (s.d.) Mean (s.d.) 
4 Weeks Post [218] [15] t(231)==0.689 
Treatment 37.2 (9.4) 38.93 (8.9) p==0.492 
6 Months Post [146] [48] t(192)==2.64 
Treatment 36.32 (9.18) 40.35 (9.12) p==0.009* 
1 Year Post [144] [59] t(20 1)== l. 94 
Treatment 36.45 (9.2) 39.27 (9.7) p==0.054* 
18 Months Post [102] [86] t(186)==2.213 
Treatment 35.94 (8.5) 38.88 (9.6) p==0.028* 
2 Years Post [95] [99] t(192)==1.46 
Treatment 36.55 (9.21) 38.58 (10.01) P==0.144 
3 Years Post [92] [109] t(199)==0.931 
Treatment 36.89 (9.6) 38.16 (9.9) p==0.353 
4 Years Post [76] [116] t(190)==0.981 
Treatment 36.8 (9.69) 38.22 (9.90) p==0.328 
5 Years Post [78] [119] t(196)==2.09 
Treatment 35.78 (8.17) 38.49 (9.9) p==0.038* 
Table 70 shows Trait anxiety scores taken at simulation and compares them at each of the 
post treatment testing points. The number of survivors decrease (n=218 to 78) and non 
survivors increase (n=15-119) during the five years. The patients who survived the 5 years 
had significantly lower Trait scores than the non-survivors. 
Therefore in contrast with Leigh et al the survivors in the current study did not have 
significantly higher trait anxiety. In the present study the survivors had significantly lower 
Trait anxiety. Cassileth (1986) hypothesized that State and Trait become fused as death 
approaches and this study confirm their findings. At four weeks post treatment, the non-
survivors Trait score was 38.93 and their State score was 38.57 indicating this fusion effect. 
At six months post treatment the Trait is 40.35 and State is 40.81 and this fusing of scores 
continues for the whole five years. This is in sharp contrast to the survivors (n= 78) who at 
simulation have Trait scores of37.2 and State scores of41.9. This pattern, too, is repeated for 
five years, with Trait lowering and State scores rising. The ST AI State score was 43.6 for the 
survivors at simulation. This is a very high mean score taking into account that the cut-off 
point used to indicate a 'possible' case on the State questionnaire was 42.8. If we further 
examine the 56 'completers' the Trait score mean is 34.73 (sd 7.2) whilst the STAI State is 
41.95 (sd 12.58), thus re-enforcing the difference in these two questionnaires and the 
difference in their scores. 
179 
Leigh et al hypothesized that increased levels of anxiety and depression may be 
predictive of survival so that high or low levels of distress could indicate either a short or long 
survival level. This is an interesting hypothesis. Janis & Mann (1982) had previously shown 
that very high or very low levels of distress in response to a fearful stimulus can be indicative 
of survival with patients with extreme anxiety either living longer or dying quickly. They 
suggest that there is an 'inverted-U' -shaped relationship between anxiety and adaptation. In 
the current study the non-survivors had significantly lower state anxiety (Mean 39.2 sd 12.0) 
in comparison with the survivors (Mean 43.6 sd 14.47). However in the further analysis using 
cut-off points, the number of 'cases' at simulation of palliative and radical patients using the 
ST AI State was 52% and 48% respectively, indicating that approximately half of the patients 
in each group were highly anxious. 
All patients in the study have not only been given a diagnosis of a life-threatening disease 
but are entering a strange department for the first time, meeting new staff and are having their 
treatment planned with hi-tech equipment and possibly hi-tech talk. Under the circumstances 
moderate to high anxiety would be considered a normal response to the threat. It could be 
hypothesized that the survivors who responded to the threat of unknown treatment with 
anxiety are exhibiting a healthy psychological reaction and therefore adapt better and have a 
longer life expectancy. To show little or no anxiety could be considered as a maladaptive 
response or an avoidance coping mechanism. It is therefore surprising to find that at 
simulation 5% of the women scored between 0 and 2 on the HADS anxiety scale and 26% of 
the men. In the current study at simulation depression was significantly lower this was 
coupled with State anxiety scores which were significantly higher in the survivors. 
With respect to gender, it has already been stated that more women than men were 
participating in the study. Analysing those who had died (n=15) at four weeks post treatment, 
more men (n=l1) had died than women (n=4). It was found that three of the four women 
could be considered a 'case'. With regard to men, eleven died, one was a possible case and 
one a probable case. For the men therefore 2 out of eleven had anxiety scores of 8 and over in 
comparison with 3 out of 4 of the women. The men who had died in the time between 
simulation and four weeks post treatment appeared to exhibit less anxiety than the women. 
These results appear to indicate that men and women manifest anxiety differently. Leigh 
et al suggested that the women who died had rated their condition as more serious than 
women survivors. This is in contrast to the men. They suggest that men cope with cancer 
with denial whilst women could be realistic about their situation. This could be the case. 
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However from the current results it appears than men and women come to terms with their 
cancer diagnosis and the threat of death at different times. From analysing the data through 
treatment the anxiety levels in women drop steadily through treatment and after. Women are 
significantly more anxious than men at simulation, 1 st treatment and mid-treatment. However 
from the end of treatment onwards the number of anxiety cases for men increases and by four 
weeks post treatment a shift is now apparent with men having higher anxiety levels than the 
women. This is further confirmed by analysing the 'completers'. The women are significantly 
more anxious than the men at simulation and 1 st treatment. Their anxiety is higher than the 
men until 6 months post treatment. The anxiety levels of the men are then higher than the 
women's for the next five years. It could therefore be hypothesized than men at first cope 
with their diagnosis by denial, take longer to register the threat and then react to the stimulus. 
It is difficult to sustain denial if one is attending a radiotherapy department evelY day, 
especially if that department freely uses the word cancer. This defensive failure could be a 
tactical coping skill so that they need not recognize their continuously deteriorating medical 
condition. Leigh et al (1987) hypothesized that: 
'patients with high anxiety and depression in the non-survivor group had a 
massive defensive failure, while those who had high anxiety in the survivor group 
had been more realistic about their disease' . 
With respect to depression, those patients who died in the current study were significantly 
more depressed. Table 69 shows that looking at the scores at simulation, the survivors were 
significantly less depressed. This table examines the depression scores at simulation and 
compares the survivors to the non-survivors from 4 weeks post treatment through the five 
years. The numbers of survivors decreases and the non-survivors increases in number. 
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Table 71: Results of T -Test plus Means and 
SD of Depression Scores of Survivors and Non-Survivors 
with Respect to their Scores at Simulation. 
Survivors [No] Non-Survivors [No] Test for significance 
Mean (s.d.) Mean (s.d.) 
4 Weeks Post [218] [15] t(231)=-3.715 
Treatment 4.11 (3.3) 7.4 (2.9) p=O.OOl ** 
6 Months Post [146] [48] t(192)=5.627 
Treatment 3.59 (3.09) 6.46 (2.9) p=O.OOl ** 
1 Year Post [144] [59] t(20 1 )=4.90 
Treatment 3.59 (3.09) 5.9 (3.04) p=O.OOl** 
18 Months Post [102] [86] t(186)=5.719 
Treatment 3.25 (2.8) 5.69 (2.95) p=O.OOl ** 
2 Years Post [95] [99] t(192)=4.52 
Treatment 3.4 (3.2) 5.44 (3.07) P=O.OOl ** 
3 Years Post [92] [109] t(198)=3.312 
Treatment 3.6 (3.5) 5.16 (2.9) p=O.OOl ** 
4 Years Post [76] [116] t(190)=4.38 
Treatment 3.17 (3.00) 5.14 (3.09) p=O.OOl ** 
5 Years Post [79] [119] t(196)=4.7 
Treatment 3.09 (2.82) 5.12 (3.05) p=O.OOl ** 
The men who died were more depressed than the women. 
Leigh et ai's survivors had higher state and depression scores, but significance was not 
reached. The 56 'completers' in the current study also had high state anxiety, with 56% of the 
women and 33% of the men indicating a 'case' at simulation. The current study shows that at 
simulation and 1st treatment the 56 'completers' had no 'case' of depression for men and lfor 
women and that only at simulation. This did increase over the course of the study with men 
displaying more 'cases' than women from mid- treatment onwards. This again emphasises 
the importance in the specificity of the timings of the testings. 
From the cohort of high scorers at simulation, that is the number of patients scoring 8 and 
over, 45% of them survived 5 years. The number of men who survived from these high 
scorers was lower than the number of women survivors, 37% and 53% respectively. 
The anxiety levels for patients overall were far higher than the depression scores at 
simulation. One third of the patients who had died by four weeks post treatment had high 
anxiety, 40% had depression and 52% had psychological distress. Thus two thirds of the 
patients who died were not anxious even though they were in the terminal stages of their 
cancer. This could be that patients are no longer fearful, uncertain and worried about the 
outcome. They now know that the outcome will be death and they have come to terms with 
that so there is no point in being anxious. Alternatively it could be a maladaptive response to 
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the fear or denial. Eleven men in this small cohort of 15 died and only two indicated anxiety, 
this could confirm the hypothesis of Leigh et al than men cope with cancer by denial. Patients 
who did not survive had significantly higher depression scores (7.4 sd 2.9) than the patients 
who did survive (Mean 4.11 sd 3.3). Indeed in the current study men had significantly higher 
depression scores than the women throughout the study. It should also be noted that the 
HADS is not such a good predictor of depression as anxiety and the number of depression 
cases is likely to be higher. 
The psychological effect of depression is different. Depression levels rose after treatment. 
From the research questionnaire patients who felt worse were significantly more depressed. 
Treatments have been given and now some patients are left with the feeling that nothing more 
can be done to change the outcome. This could result in a feeling of helplessness and 
hopelessness and lack of control. 
The current study could therefore expand Leigh et ai's hypothesis. This study shows that 
the predictors of survival in cancer patients who have undergone radiotherapy treatment have 
high State and lower Trait scores, coupled with low depression scores. The high State could 
indicate a healthy response to the threat of treatment, the lower Trait could indicate that 
generally they were not so highly anxious and the low depression could indicate a sense of 
control and emotional support. This is an hypothesis requiring more research. 
The current study with its changes over time emphasizes the importance of respondents 
being tested at specific time points during treatment and post treatment in order to get 
accurate readings of distress. As simulation is such an anxiety provoking time for patients, 
the best time for testing would be at first treatment. Depression in this study reached its peak 
at the end of treatment and this would be the best time for testing for that variable. 
The fifth study by Hammerlid et al (1999) was a longitudinal study of head and neck 
patients. The HADS was used to assess the levels of distress. Most of the patients, 88%, 
received radiotherapy treatment. Patients were tested six times, at diagnosis and then at 
monthly intervals. 
The levels of anxiety and depression at diagnosis were lower than in the current study. 
Hammerlid et aI's patients scored 4.74 on the anxiety component of the HADS with 32% of 
these patients classified as possible or probable cases. The patients in the current study had a 
higher mean of 6.93 and 40% of the patients were classified as 'cases'. What is causing the 
difference in the mean? Firstly Hammerlid's study only contained head and neck patients. It 
was not the mixed cohort of the current study. Secondly the current study tested patients 
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specifically after registration and before being called for simulation. Hammerlid et al patients 
were tested at the time of diagnosis. Does this refer to immediately after they were given 
their diagnosis? If this is the case, many patients would have been in shock and unfit to 
answer questionnaires. If it referred to a time after diagnosis, then this should have been 
stated. Thirdly Hammerlid et aI's patients were primarily men, (72%). The current study 
shows that before and during treatment men had significantly lower anxiety scores than the 
women. The scores ofthe men were 5.9 at simulation. This dropped to 5.52 and 4.75 at first 
and mid treatment respectively indicating the importance of the specificity of the timing of the 
questionnaires. 
Hammerlid et al further tested patients on a monthly basis and not at specific times of 
stress such as the start of treatment. Although they stated that most of the patients received 
radiotherapy (88%), surgery (33%) and chemotherapy (19%), the article did not state when 
patients received treatment. If they had surgery first, treatment could have been in the second 
month and this could have altered the statistics. They did consider diagnosis to be pre-
treatment and three months as post treatment points in their analysis. 
Depression scores in Hammerlid's study were also lower than in the current study. The 
number of 'cases' of depression in the current study was the same as at the first testing, 17%. 
The depression scores throughout the study were not subjected to the same fluctuations as the 
anxiety scores. 
The current study found similar patterns in the scores of the anxiety and depression 
questionnaires to Hammerlid et al thus emphasising the current study's findings that anxiety 
and depression are transient for the cancer patient. Anxiety was at its highest at diagnosis and 
then lower in the first month, with a slight increase in possible anxiety cases at three months. 
This is equivalent to the rise of cases at the end of treatment in the current study. 
Radiotherapy treatment occurs every day for these patients with a potentially life-threatening 
disease. Suddenly, after six weeks of continuously travelling to the hospital for treatment and 
being supported by the hospital staff, patients leave with an appointment to see the physician 
in six weeks. This could be an explanation for the rise in anxiety at 4 weeks post treatment. 
Hammerlid et al found that women were more anxious initially at diagnosis but this was 
not repeated over time. The current study confirms and elaborates on Hammerlid et al's study 
in that women were more anxious than the men at simulation until the end of treatment. 
However at that point a change occurred and by four weeks post treatment men have higher 
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anxiety scores than women. It is generally accepted that women are more anxious than men 
(Ware & Snow 1993) and this finding is therefore surprising. 
Similarly the current study found that the number of depression 'cases' peaked at four 
weeks post treatment. Hammerlid's study found that depression cases peaked during 
treatment. However, their measuring points are months and not specific points before, during 
and post treatment. Consequently, we are unable to ascertain at what particular time in their 
treatment this monthly point is. The second month testing point, however, could be 
equivalent to four weeks post treatment time, depending on the number of fractions given to 
these patients. 
At simulation the current study, with the larger original cohort, had a higher percentage 
of men than women as depression 'cases'. Women are normally perceived as suffering from 
more depression than men and this finding is different from the norm. Hammerlid et al found 
more women than men were cases at diagnosis. However no further statistics on gender were 
included in their study. The analysis on the 'completers' showed no cases of depression 
among the small male cohort at simulation and 1 st treatment. The females had one depression 
case at simulation only. This again highlights the importance of the timings of the 
questionnaires and the mobility of the variables of anxiety and depression. 
Hammerlid et al also found that patients with more advanced disease suffered from more 
depression. The current study found that palliative patients were significantly more depressed 
than radical patients throughout treatment. Age was also considered in the current study, but 
no significance was found except at five years when those patients over 65 plus were 
significantly more depressed. Hammerlid found that patients who had retired were less 
anxious than those not retired. The current study cannot confirm this finding. In contrast the 
current study showed that in the analysis of the survivors men and those aged over 65 were 
significantly more depressed from six months post treatment until the end of the study. 
Hammerlid et al felt that the HADS needed to be repeated during treatment to identifY 
new possible/probable cases that arise. The author would agree with this statement and would 
suggest testing at first treatment and at the end of treatment with appropriate questionnaires to 
identifY those patients at risk. 
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Anxiety 
Radiotherapy is usually given to patients after their diagnosis has been confirmed and 
quite often following surgery. Therefore a certain degree of adaptation to their cancer 
diagnosis has occurred by the time they arrive at the radiotherapy department. However 
treatments, especially radiotherapy, can heighten anxiety. Patients endure their radiotherapy 
treatment because they understand that it will help eradicate/control their cancer. Many do 
not understand how it works and feel very frightened when they arrive for the planning of 
their treatment. Patients, especially men, further confirmed in this study that after diagnosis 
and test results, radiotherapy was their worst experience. 
This feeling of acute anxiety is a very understandable reaction to the threat of treatment 
and in this study anxiety reached its peak before simulation. Anxiety is the classic response to 
danger in this case the radiation treatment. This fear can manifest itself in a variety of ways, 
in the form of inattention, racing pulse, sweating, short-term memory loss and numbness. 
This is reactive situational anxiety. Philip Snaith (1991) wrote 
"Situational anxiety occurs when the person is in the presence of, or thinking about, 
some situation or circumstance which has assumed an unusual element of threat or 
difficulty" . 
It is obvious therefore that everyone will be at some point subject to the experience of 
anxiety. However if it persists for too long it can be classified as a psychiatric disorder. 
This study shows that anxiety manifests itself at different times during patient's 
radiotherapy treatment and after treatment. Regardless of the degree of anxiety, it can 
substantially interfere with the quality of patient's lives and therefore needs to be evaluated 
and treated. 
The most anxious time for patients overall was at simulation when patients arrive for the 
planning of their radiotherapy treatment. This occurred regardless of whether they were one 
of the 56 who completed all questionnaires, or whether they were the original cohort. At this 
time 40-50% of patients indicated high anxiety, depending on the questionnaire used. Some 
27% were evaluated as probable 'cases' with the HADS by Moorey et al (1991) and in this 
study 20% indicated a probable 'case'. The mean score (Mean=6.9) is higher than in other 
studies that used the HADS questionnaire, (Hammerlid et a11997, Nordin & Glimelius 1999). 
Stark et al (2002), using touchscreens, measured 48% with anxiety at the 8 and over level 
with the HADS. These patients were in Out-Patients and not coming for radiotherapy 
planning. Their anxiety should have been less. Did the touchscreen cause an increase in 
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anxiety? Patients with cancer tend to be 60 plus, and are not very used to computer 
technology. Many are frightened by screens other than a TV screen. This could have given a 
higher than normal average percentage. 
There was a linear decline over the course of treatment in anxiety. Over treatment 
anxiety ranged with the HADS from 40% to 24%. STAI State ranged from 50% to 33%. 
Other studies with cancer patients have shown equally high numbers, Carroll et al (1993) 
reported 48%, Derogatis (1983) reported 47% and Shrag et al (1989) 44%, though neither of 
these studies were specifically radiotherapy patients undergoing treatment. 
This study however emphasises the importance of specifying specific meaningful times. 
Calendrical times of monthly intervals are not appropriate in this population undergoing 
various treatments to cure/palliate their cancer. Anxiety is highly mobile while undergoing 
radiotherapy treatment. This helps to explain the differences in the range of anxiety levels in 
the literature from 0.9% to 49% in one review (van't Spijker et al 1980). This lack of 
specificity can cause inaccuracies. Only in Holland's longitudinal study of 1979 does it 
specifically mention: 
"on the patient's initial visit to the Radiotherapy Clinic, she was examined by the 
radiotherapist who devised a treatment plan with her. She was then seen by one of 
two psychiatrists" 
thus indicating that she was tested after the planning procedure. 
From 6 months to five years post treatment, patients were tested on a different basis as 
treatment had finished. Patients were firstly tested at six monthly intervals, and from two 
years, on a yearly basis. The number of cases, at about 20% of the population, remained 
approximately the same for both anxiety questionnaires, except at the five year mark when it 
dropped. This might be due to the effect of finishing the questionnaires and a feeling of 
success at passing the five year barrier. Analysis of the data by the variable of gender showed 
different results. 
Women: 
The data from simulation to 4 weeks post treatment, which outlines the first ethical 
permission, showed a linear decline in anxiety for the women. This decline to the end of 
treatment was shown by both the STAI and the HADS. The women were the most anxious 
group on arrival for their planning (Mean=7.6 sd 3.9). Studies have confirmed that women 
are more susceptible to anxiety and report more problems (Ware & Snow 1993). Marasate et 
al (1991) found 15% of breast patients with high anxiety. Fallowfield (1994) found 17-23% 
of breast patients with high anxiety over a three year period. The current study had 
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percentages of between 45% and 23% for the breast patients through treatment depending on 
the timing of the questionnaire. The levels of anxiety were also dependant on the anxiety 
questionnaire given, whether it was the STAI or HADS. Aass et al (1997) found twice as 
many cases (16%) with women as with men (8%), and this difference was significant. Aass et 
al did not test patients specifically at simulation. All their patients were tested on a specific 
day. A few would have been having their simulation, but the majority were having routine 
out-patients appointments. This could explain the large variation in the cases compared with 
the current study, which using the HADS found 45% of the women had scores of 8 and over, 
with 23% indicating a 'probable' case, that is 11 plus on the HADS. Higher scores are found 
with the STAI, 54% of the women indicating a 'case', with 42% 'probable'. 
Analysis with the 56 'completers' also showed a similar pattern, with women showing 
highest anxiety at simulation. However the mean scores for this cohort are lower than the 
original cohort (Mean=6.59 sd 3.2). Similarly the number of 'cases' is lower, with 34% 
indicating anxiety over the cut-off point of 8, and 17% indicating a 'probable' case. However 
with the STAI State questionnaire, 56% indicated a 'case', with 49% a 'probable' case. 
What is causing this difference in the number of 'cases' with these two well validated 
questionnaires? It could be the wording on the questionnaires. The HADS asks patients 
'Read each item and place a tick in the box opposite the reply which comes closest to 
how you have been feeling in the past week.' 
The STAI State says: 
'Read each statement and then blacken in the appropriate circle to the right of the 
statement to indicate what you feel right now, that is, at this moment. There are no right of 
wrong answers. Do not spend too much time on anyone statement, but give the answer 
which seems to describe your present feelings best'. Note the bold letters on 'right' and 'at 
this moment' emphasising the present. 
The STAI Trait makes the same statement as the State but ask patients to indicate how 
you generally feel. Again this is in italics and bold. 
From these statements it would appear that the ST AI State would give a more accurate 
response to how the patients are feeling before their planning starts. How you 'generally feel' 
and how you feel 'in the last week' are backward concepts, as opposed to 'how you feel at 
this moment'. The analysis of the ST AI trait and HADS shows a much higher correlation, 
r=0.663, p<O.OOI, than the STAI State and STAI Trait, r=0.460, p<O.OOl. For a population 
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undergoing treatment the ST AI State appears to give more accurate information for specific 
time points during that treatment. 
By the end of treatment anxiety cases for women had dropped to 29% as measured by the 
ST AI and 30% as measured by the HADS. This highlights the sensitivity of the ST AI over a 
condensed period of time to show the fluctuations in anxiety in the population. The women 
displayed a gradual decrease in the number of cases from simulation, 54%, 1 st treatment, 49%, 
mid-treatment 37%, to end treatment 29%. At four weeks post treatment an increase in cases, 
32% occurred. This was not the case with the HADS questionnaire. 
Analysis on the two questionnaires shows that correlation is higher post treatment apart 
from mid treatment when a certain amount of adaptation could have occurred. 
Table 72: Showing Correlations ofHADS and STAI State for the 56 'Completers': 
[Treatment Times Correlations 
Simulation 0.596* 
First Treatment 0.551* 
Mid Treatment 0.815* 
End Treatment 0.684* 
Four Weeks 0.712* 
Post Treatment 
Six Months 0.819* 
Post Treatment 
One Year 0.804* 
Post Treatment 
lEighteen Months 0.870* 
lPost Treatment 
trwo Years 0.767* 
lPost Treatment 
trhree Years 0.798* 
lPost Treatment 
IFour Years 0.782* 
lPost Treatment 
lFive Years 0.780* 
lPost Treatment 
Significance at the <0.05 level 
This table (Table 72) emphasises the point that in a normal time frame 'how you are 
feeling in the last week' and 'how you are feeling at this moment' do not greatly differ in the 
absence of an anxiety provoking situation. 
Looking at the data from 6 months, (Table 73) the number of 'cases' of anxiety fell. 
Apart from year 3, the number of anxiety 'cases' is very similar for the two questionnaires. 
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This could therefore indicate that the HADS is a more appropriate tool to use from 4 weeks 
post treatment, when there is no immediate threat present. When testing through treatment 
the STAI State/Trait are more appropriate questionnaires. 
Table 73: Percentage of Cases for Women Using STAI State and HADS from 6 Months 
to 5 Years Post Treatment 
Questionnaires T6 T7 T8 T9 TI0 Tll T12 
HADS 17 19 19 17 22 19 15 
STAI 17 20 14 14 14 17 17 
T6=6months post, T7=lyearpost, T8=18l11onths post, T9=2 years post, TIO=3 years post, TII=4 years post, T12=5 years post. 
The women cohort contained a high percentage of breast patients. In order to eliminate a 
gender bias the women were split into 2 categories, breast and non-gender related. The non-
gender related was all sites minus breast and cervical cancers. The breast patients had 
continuously significantly lower scores than the non-gender related patients for the whole 
study. Breast patients now are given more psychological support and this seems apparent in 
their scores. The non-gender related females were significantly more anxious that the non-
gender related males throughout treatment. This adds confirmation to the high anxiety of the 
female population at this time. The non-gender related females continued to have higher 
scores for the next five years. In contrast breast patients had the lowest scores. The breast 
patients therefore might be distorting the anxiety scores of the female cohort, especially in the 
latter half of the study. This is further confirmed by the analysis on the 'completers'. The 
non-gender related females have consistently higher scores throughout the study. However 
they only number 6. 
As there were no significant differences between the 'completers' and the larger cohort 
who survived from 6 months to 5 years, the findings of the original cohort can be used. This 
showed persistent anxiety with non-gender related females throughout treatment and five 
years after. More research is needed with this cohort. 
Men 
Men's anxiety scores were not so volatile as the women's. With the larger initial cohort 
the ratio of men to women is 1:2. Men's scores in this cohort were much lower at simulation 
(Mean=38.73 sd 9.1) than women's (44.12 sd 14.26). Women were significantly more 
anxious at simulation and at 1st treatment with both questionnaires. With the ST AI State 44% 
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of the men were still anxious, with 29% 'probable' cases. The HADS showed a smaller 
percentage with 33% indicating anxiety and 12% 'probable' cases. 
During treatment the overall mean falls, but in contrast with the women cohort, from 
mid-treatment onward the scores of the men show a rise with the HADS Questionnaire. This 
rise occurs at the end of treatment with the ST AI State. This could be a response to treatment 
ending and loosing the backup of professional medical advice. At this point an upward trend 
is apparent with both questionnaires. The number of cases anxiety 'cases' overall fell from 
44% at simulation to 35% at four weeks post treatment with the STAI State. There are now 
however more 'cases' of men with anxiety than women (32%). This was also shown with the 
HADS, 26% men in contrast to 23% women. 
Analysis on the 'completers', shows a slightly different picture. The numbers of men in 
this cohort are small (n=15) with a ratio of one man to three women. At simulation 13% 
indicated a 'case', this rises to 27% at the end of treatment. With the HADS there is a peak in 
the number of 'cases' at the end of treatment. With the STAI State 33% indicate a 'case' at 
simulation, at mid-treatment 42% are indicating anxiety. This falls to 20% at the end of 
treatment. 
From 6 months to five years (Graph 25) men's anxiety continues to be higher than 
women's apart from year 3 with both questionnaires. The number of cases similarly 
continues to be higher than the women's. 
Therefore the pattern of anxiety for men and women during treatment is different. 
Women are initially significantly more anxious than the men at simulation and at 1 st 
treatment. By the end of treatment men's anxiety scores are rising. 
After treatment, men became the most anxious group for nearly all the post-treatment 
testing times but significance was not reached. Men's mean score fell over treatment, but rose 
at 4 weeks post treatment. This increase at four weeks post treatment is confirmed by both 
anxiety questionnaires. This confirms Hammerlid et al's (1999) findings when they state that 
women are more anxious initially, at diagnosis, and when they first come for treatment, but 
this is not repeated over time. This finding is different from the literature when women are 
considered more anxious than the men and report more problems (Ware & Snow 1993). What 
is causing these different patterns of anxiety in men and women? 
A number of different theories have been suggested to explain the difference in men and 
women, such as psychological theories on coping behaviour, social theories, biological 
theories and gender identity. However the most likely theories are a complex interaction 
191 
between psychosocial (including cultural) biological, social behaviour, and gender roles. In 
this study when patients arrived for simulation, they were surrounded by highly technical 
equipment, highly skilled staff and an alien clinical atmosphere. It is therefore not surprising 
that in response to what could be considered in evolutionary terms 'danger', anxiety results. 
Did the women, as Leigh et al (1987) suggest, cope with a realistic appraisal, whereas men 
cope with denial. One of the men in the current study wrote "I do not have cancer" on his 
form. A surprising comment as the word 'cancer' is used in the radiotherapy department both 
verbally and written. This is a coping mechanism and the men appear to need greater time to 
adjust to their cancer diagnosis. This denial could also prevent men for seeking appropriate 
help when symptoms the first symptoms are present. Thus when a diagnosis of cancer is 
given are men more angry and depressed because they have not sought medical help early 
enough as they have been denying that anything is wrong? It could be suggested that men 
take longer to confront issues that are painful for them. They have an intermediary step of 
denial, before realization. Although some men had come to terms with this realization 
quicker than others, women tend to be more accepting of their illness and to voice their 
anxieties concerning illness and death (Chiapetta et a11970, Lester 1971). 
Many studies have shown a difference in anxiety in women and men with respect to 
death. Women are more able to express their anxiety and men deny their anxiety with 
relationship to death. This difference in coping styles appears to be due to some extent to 
women's sociability skills, which appears to extend to illness and how the genders cope. 
Leigh et al (1980) as previously discussed suggests that anxiety in men is not admitted and 
that this causes a maladaptive approach to health and emotions. They suggest that when men 
are being treated for a potentially fatal illness, the clinician needs subtly to enquire into their 
health awareness and emotions. In a study in 1999 (Green & Pope) women were found to 
make much more use of medical services than men. One could hypothesize from this either 
that women are more neurotic than men, or that they confront illness quicker and or are more 
realistic. 
Another theory, which could explain this anxiety difference, is related to identity. Our 
culture promotes gender stereotypes. This results in a masculine identity which can include 
behavioural traits such as aggressiveness, invulnerability, competitiveness (Moynihan 1998). 
These attitudes can also encourage inhibitions on men's display of emotions, particularly pain 
or discomfort. It encourages the belief that men should be 'stoic'. These ideas concerning 
their masculinity may affect men's decisions about health behaviour (Eisler 1995). 
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This could result in men and women having different coping mechanisms. The social 
acceptability of admitting an illness, especially cancer, and seeking help may differ between 
men and women. Disclosure of health concerns is evidence of a weakness or vulnerability. 
Illness is often seen as a weakness in men. Admitting to illness is admitting to vulnerability 
and could be considered as a 'chink' in the armour of masculinity, which has been worn since 
childhood. Indeed it has been shown that men are less likely to seek medical care, to report 
symptoms or regularly to visit the physician than women (Waldron 1976, Waldron 1991). 
Health surveys have shown higher morbidity for women and higher mortality for men 
(Waldron, 1983; Wingo et aI, 1995). This could be because men may delay medical help, so 
that by the time assistance is sought the case is urgent (Clarke & FitzGerald, 1999). 
In contrast a woman's stereotypical image is one of taking responsibility for her health 
and the health of her family. Women are socialised to assume health responsibilities. This 
sense of responsibility may enable her to monitor symptoms and hence to take curative action. 
Klemm et al (1999) studied gender differences on internet cancer support groups. Women 
gave comfort, encouragement and support and men information, suggesting that the 
stereotypical role continues. 
Murphy (1998) hypothesized that men are socialised (and maybe biologically 
programmed) to value concrete rather than abstract concepts. That is men wait until the 
disease is obvious (concrete) before seeking help. 
Moynihan (1998) discusses men's social roles. Men discuss sport, politics, business 
among themselves. Emotions and health concerns are private. This could affect their 
information-seeking and health promoting behaviours. Meissner et al (1992) suggests that 
men are more likely to get information from the internet. Leigh et al (1987) suggests that 
men cope with cancer with denial. If we look at the statistics for male cancers, namely 
testicular, prostate and bowel the morbidity and mortality is high, indicating that men may, at 
least at first, respond with denial until the disease has progressed to a state when treatment is 
less effective. In the current study 157 women participated, and 112 men. With regard to the 
palliative cohort (96), 58 were men, showing a much higher proportion of men were palliative 
patients in comparison with women (38). However in the total cohort the number of women 
exceeded the number of men by the ratio of 2: 1. This could add credence to the hypothesis 
that men do not confront illness. Furthermore men's adaptation to cancer appears from this 
study to be less strong than women's. This was confirmed in previous studies (Fife et al 
1994, Greimel et aI1989). 
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This knowledge of gender-specific differences could usefully be applied in general 
patient care and education. Screening, early detection and symptom recognition needs to be 
implemented in a manner which appeals to men. Education and socialisation of young men 
need to take place to show that good health, which entails screening and seeking advice 
creates a positive self image. This proactive behaviour will reduce morbidity and mortality. 
Treatment Intent 
Palliative patients throughout the study showed irregular patterns compared with the 
radical patients with differences in the levels of anxiety measured. Throughout treatment and 
one year post, the palliative patients are significantly more anxious than the radical patients. 
The HADS shows that both palliative and radical patients peak at simulation. The STAI State 
shows a peak at mid treatment for the palliative patients. Indeed the palliative patient cohort 
which had the highest mean scores on all three anxiety scales questionnaires was the palliative 
patients having more than five treatments (the long multi-fraction group LMF) and these 
patients caused this peak at the mid treatment point. This group tends to have advanced 
cancer, stages 3 or 4. Many are newly diagnosed patients whose tumour is advanced on 
diagnosis. Some have had surgery and others are having radiotherapy treatment only to 
shrink the tumour. This particular cohort of patients is extremely anxious and need support. 
Many have not had time to adapt to their terminal diagnosis and the women in particular are 
very vulnerable. They have significantly higher scores than the men. 
Both palliative and radical patients showed a decline over treatment as measured by the 
HADS. The peak was at simulation with 53% of palliative patients scoring 8 and over. This 
percentage fell to 45% at 4 weeks post treatment. In contrast 48% of the radical patients 
indicated a 'case' at simulation and 29% at 4 weeks post. The radical patients indicated a 
more adaptive response to the treatment than the palliative patients. Further analysis was 
carried out to see, at the 4 weeks post treatment point, if this was due to the higher percentage 
of males in the palliative cohort. However 52% of the female palliative patients were 
indicating an anxiety 'case' in comparison with 40% of the male palliative patients. 
Cassileth et al (1986) suggested that as death approaches State and Trait become fused. 
They write 
"these two sets of scores are so closely correlated that they appear to measure a single 
construct or emotional factor in the particular population" 
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The palliative patients in the current study are the most anxious cohort. They are 
significantly more anxious with regard to Trait anxiety than the radical patients. Indeed their 
State and Trait scores are not dissimilar (41.60 and 39.20 respectively), in comparison with 
radical patients (42.06 and 36.97 respectively) indicating that what Cassileth et al suggested 
could be true that many palliative patients are continually in a highly anxious state (see Table 
67). The Trait scores of the non survivors palliative patients was 38.93 and the State score 
was 38.57 at simulation. In contrast the surviving palliative patients mean Trait score at 
simulation was 43 and State score was 51. The Trait score though high, was much lower than 
the State score. 
Some of the palliative patients who had a single fraction were treated and simulated on 
the same day. This group had higher Trait anxiety (Mean = 38.41) and their state anxiety 
(Mean=40.45) and HADS levels (7.1) were similarly high though not as high as the survivors. 
After radiotherapy treatment has finished the hospital physician does not see the patient 
for another six weeks. At four weeks post treatment the patients received by post the next set 
of questionnaires. This was the first time that patients had responded to a postal 
questionnaire. All the other questionnaires had been filled in before treatment in the 
radiotherapy centre. Fifteen patients had died since the study started, 251 questionnaires were 
sent out and 218 were returned, giving a response rate of 87%. The single fraction patients 
are included in the current numbers if they were still alive and willing to participate. Even 
after treatment had finished, 24% of patients are anxious and 12% very anxious. 
After an initial period of relief after coming for daily treatment, patients may become 
more anXIOUS as they now realise they no longer have the daily support of the medical 
personnel. 
Further analysis reveals that at this time point the palliative men patients had more 
'probable' cases of anxiety since simulation. Further analysis was carried out to see if the 
effect of the male palliative patients was due to the single fraction group (SF) who were not 
included at the time of the last testing. The mean for the SF group was higher than the other 
groups but significance was not reached. Indeed there were no significant effects for any of 
the palliative groups, SF, SMF or LMF palliative with regard to anxiety throughout their 
treatment. It could be hypothesized that for these particular palliative men who are very 
anxious, treatment has not cured them, hope has dropped, anxiety has risen as they are no 
longer able to deny their condition. 
At the end of the study four palliative patients were still responding to the questionnaires. 
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In conclusion a high proportion of patients experience anxiety when they come for the 
planning of their treatment. Health professionals need to be aware of how very anxious these 
patients are. Information in the form of literature, videos or prior visits to the department can 
help lessen this distress. As they go through treatment changes in their psychosocial 
equilibrium occur due to adaptation. However, a significant number of patients continue to 
show clinically meaningful anxiety that needs to be treated. The successful management of 
anxiety disorders depends on a judicial management of both psychological and 
pharmacological treatments. In a controlled randomized study looking at the efficacy of 
relaxation and imagery for controlling anxiety and depression in radiotherapy patients, Bridge 
et al (1988) found that the group whom had relaxation and visual imagery had significantly 
less mood disturbance than the control group, with women over 55 years receiving the most 
benefit. Emotional support, religious faith/beliefs, information, positive attitude, distraction 
are all coping strategies that patients have found helpful, Wainstock, J. (1991), Of these 
emotional support was the most helpful and positively correlated with adjustment, Zenmore & 
Shepel (1989). 
The results of this study indicate the importance of specificity in the timing of 
questionnaires when patients are undergoing difficult treatments. It highlights how anxiety 
changes over time. Some anxious patients do adapt, but even years after treatment has 
finished a quarter of patients are still registering as 'possible' cases. Anxiety therefore can 
persist for some cancer patients, unless it is treated. Maher(1993) points out that the term 
'remission' is anxiety provoking as it implies the patient is not cured and that the cancer will 
inevitably return. This induces more anxiety for the patient. 
Patients who need special attention are the palliative patients especially if they were 
having more than five treatments, women at simulation and 1 st treatment and men at the end 
and post treatment. Health professionals need to be aware of the anxious state these patients 
can be in when they arrive the department for treatment and the difference with respect to 
gender. GPs should similarly be informed if patients, especially the men are showing signs of 
raised anxiety at the end of treatment and these patients need to be followed up. Therefore the 
author would suggest testing patients at first treatment and at the end of treatment. The results 
of these tests should be placed in the patient's notes. Physicians should therefore be able to 
see the extent to which the score is lowering or rising and accordingly suggest appropriate 
further testing with a psychologist if needed. This is especially important as anxiety at first 
treatment can predict 42% ofthe anxiety after treatment has finished. 
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The patients who had died by four weeks post treatment, 15 in all, had significantly 
higher depression scores, had lower state scores and higher trait scores than the survivors at 
simulation. Their Trait and State scores had become 'fused'. 
Although a high correlation was found between the ST AI State and the HADS anxiety 
component these two questionnaires do not measure identical anxiety. This was particularly 
noticeable in the beginning of this study when the patients were tested over short intervals. 
The HADS asks patients how they have been feeling in the past week. The STAI State asks 
patients how they feel 'at this moment'. The trait component asks patients how they 
'generally feel'. This indicates the importance of the wording on these questionnaires and 
also illustrates that patients do respond accurately to the wording. Hall et al (1999) criticised 
the HADS they found its results were not consistent with the PSE. However the PSE asks 
patients how they felt within the last four weeks. This time scale is much larger than the 
StateIHADS. 
This paper highlights the fact that though the majority adapt some patients (20% plus) 
continue to feel anxious years after their treatment has finished. This confirms Thomas et als 
(1997) finding that anxiety is persistent in some cancer survivors. 
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Depression 
The pattern of depression in patients undergoing radiotherapy treatment was very 
different to that of anxiety. Anxiety gradually fell over the course of treatment as patients 
adapted to their radiotherapy. This was not the case with depression. 
The incidence of depression in the normal population is approximately 6% (Locke & 
Regier 1985, Lepine et al 1997). With medically ill, hospitalized patients the incidence is 
higher at 22-24% (Schwab et al 1967). Depression in cancer patients varies even more from 
4.5% to 58% (Maissie & Holland 1990). In a literature review Sellick & Crooks (1999) cited 
serious depression as occurring between 6-15% of the cancer population. Previous studies 
have shown that approximately one third of radiotherapy patients report clinically significant 
depression (Jenkins et al 1998). The levels generally were much lower in the current study, 
except for the palliative patients. The variation on these percentages depends on a number of 
factors. This study highlights gender, age, site and treatment intent as being variables 
involved in the depression equation. Other factors which appear to be related; a previous 
psychiatric history, the amount of social support the patient is receiving, lack of control of 
pain and other side effects of cancer. Another factor to emerge from this study is the 
specificity of timings of the questionnaires. The depression levels varied over the five years. 
Other studies have shown variations in the levels of depression depending on the assessment 
tool (Derogatis et al 1983, Hinton 1973). These vary from psychiatric interview to a self-
report questionnaire. This study used a well-validated self-report questionnaire, the HADS 
although its strength on the depression component has been questioned (Hall et al 1999). 
However moderate depression if left untreated can develop in 80% of cases to severe 
depression (McCullough et al 1992). Therefore it is very important that patients are screened 
and treated for the depression when it arises. This study shows that depression develops over 
treatment. The average score of all patients was 4.30 (sd 3.30) when patients first arrived for 
the planning of their treatment. This was lower than the anxiety levels. At simulation the 
number of patients who could be classified as either a probable or possible case was 16% in 
the current study. This increased for palliative patients to 25%. Particular note could be 
made of the male palliative patients with 28% of this cohort registering at eight and over. 
Moorey et al found 9% were probable cases of depression from their cohort of cancer 
patients. This number was confirmed by Aass et al (1997). In the current study therefore a 
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quarter of the palliative patients were indicating depression, but few were receiving treatment. 
Why not? Berney et al (2000) writes: 
"There may be multiple reasons for this unsatisfactory situation. Among them are the 
uneasiness of physicians at the prospect of talking about sensitive issues, such as emotional 
states, or the belief, even among psychiatrists - that depression is somehow inevitable in the 
terminally ill". 
When patients are given the opportunity to talk about their emotions, clinical and 
scientific reports show that the patient's feel a sense of relief (Razavi & Stiefel (1994). 
With a cut off point of 11 to indicate a probable case the percentage was lowered to five 
overall, and with the palliative patients, 7%. The studies ofMoorey et al and Aass et al were 
not specific to patients about to undergo radiotherapy treatment. In the Aass et al study 
patients were tested on two randomly selected days in an out patients clinic. Most are 
returning for check-ups and approximately 20% were receiving radiotherapy or 
chemotherapy. From this cohort the patients who were about to undergo treatment were 
significantly more depressed. This could be one of the reasons why the level of depression is 
lower in the current study. In Moorey et ai's study only patients who were considered to have 
a survival time of more than one year were included. In the current study all patients 
attending radiotherapy department were considered eligible. 
Why is depression so much lower than anxiety for these patients? It could be 
hypothesized that patients first attending for treatment could feel hopeful and optimistic about 
their outcome which could lower their depression levels, especially at the start of treatment. 
This study also shows that the number of depression 'cases' over treatment increased 
from 16% at simulation to 20% at 6 weeks post treatment. Hammerlid et al (1999) found very 
similar figures in their analysis with 16% of patients at simulation and a rise at the end of 
treatment. Montazeri et al (1998) using the HADS found that depression had doubled over a 
three month period. Their findings are very similar to the currents study. Anxiety fell, but 
depression increased significantly from their baseline. 
By the end of treatment depression has risen for all patients and is just under the 
simulation level. This could be associated with the increased burden of coming for treatment 
daily coupled with their symptom/side effect burden. In Holland et aI's (1979) study they 
found similar results. Women were more not less depressed at the end of treatment and this 
was coupled with increased overt anger which Holland et al felt was caused by patients 
feeling worse, less hopeful and more despairing. It could also be caused by the termination of 
treatment which resulted in less emotional support by staff. Nearly half of the patients in this 
199 
study would have liked a telephone call from a member of staff during the period of end of 
treatment to follow-up clinic. A prior time for a telephone call could have been made so that 
patients could voice any fears or worries. The radiographer involved in giving daily treatment 
would be ideal for this and this would assure the patient of continuity of care and give them 
the emotional support they need. 
When asked to consider a number of factors, the fear of cancer diagnosis and progression, 
restriction on activities and side effects of treatment were all considered to rank as number 
one, (Gotay C C 1984). 
For the five years post treatment the levels of depression remained at about the 15% 
mark. Analysing data on the 56 'completers' showed that depression rose from one case at 
simulation to an average of 15% during the last five years. The end of treatment can cause 
more stress because of the lack of support of medics and the unpredictability that isolates 
cancer from other diseases. This increase in depression years after treatment finishes, was 
noted by Bard (1987). 
"Fear of recurrence remains for the cancer survivor, either consciously or subconsciously, 
and uncertainty of outcome reinforces the sense of hopelessness and loss of control that began 
with the cancer diagnosis" (Bard 1987) 
Seligman (1992) stated that: 
"When traumatic events are unpredictable .... safety is also unpredictable: no event 
reliably tells you that the trauma will not occur and that you can relax ... In the absence of a 
safety signal, organisms remain in anxiety or chronic fear" 
These concepts helped to form his hypothesis on how helplessness can lead to depression. 
Patients can remain fearful and anxious after a traumatic event, unless safety can be reliably 
predicted. Because cancer can develop silently, patients lack these safety signals than can 
indicate that the disease has been cured. 
Health practitioners can help patients by gently insisting on the success of their treatment. 
This coupled with information and a reassurance that the patients can ask questions should 
help in providing the very necessary safety signal. 
Do gender differences occur in Depression scores? 
Women 
The women's depression score was lower than the men's throughout the study. At 
simulation the percentage of cases for men was 14% and for women 12%. By 4 weeks post 
treatment the number of 'cases' for women had risen to 20. Lanskyet al (1985) recorded a 
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depression rate of 5% in female cancer patients. Aass et al found no difference in gender 
with number of probable cases as 8 and 9% respectively for men and women. The current 
study found that 6% of women had scores of eleven and over. From six months onwards 
women had significantly lower scores than the males, apart from year four. The non-gender 
related females had lower depression scores than the male non-gender related patients until 
the end of the study. This verified the gender findings that men were more depressed than the 
women in this study. Women's depression rose at the end of treatment, but from 6 months 
onwards depression was always higher for the men. The scores of the breast patients were the 
lowest. This emphasis the importance of the psychosocial back-up that these breast patients 
are now offered and shows that it is effective in reducing both anxiety and depression in this 
population. 
Men 
Men throughout the five years had higher depression scores than the women. Analysing 
the 'completers' at simulation women had one case, men none. The men at simulation and 1 st 
treatment recorded no depression 'cases'. The number of men in this cohort is small (15), in 
comparison with the women (41). However t-test with the larger cohort (Part 2) showed no 
significant differences between these two cohorts. The pattern is remarkably similar, with the 
men consistently having higher depression scores than the women. Analysis over the whole 
period with the larger cohort therefore showed that depression and gender had a significant 
effect over the whole time of the study. 
In a study undertaken in 1992 (Lloyd-Williams) radical patients who had just completed a 
course of radiotherapy treatment were tested with the HADS, 33% scored nine and over on 
the depression subscale. Men were more depressed than the women, 35% and 31% 
respectively. This is higher than the patients in the current study with 15% of men and 
women indicating a 'case' at the end of treatment. Lloyd-Williams (1994) does not say how 
long after treatment that her patients were tested. Neither did Lloyd-Williams evaluate 
patients over time. Also it is impossible to assess if patients who are being continually tested 
in a longitudinal study feel more supported and thus less anxious and less depressed. 
Historically women are considered to be at excess risk of depression, so why are men 
consistently more depressed whilst undergoing radiotherapy treatment and for five years 
after? Is it that men feel the burden of disease more than women? Today theories of etiology 
of both anxiety and depression suggest powerlessness as an important component in both 
anxiety and depression, although other factors do come into account. The American 
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psychologist Seligman (1975) thought that depression was a state of 'learned helplessness, 
hopelessness' brought on by previous failures. This theory has now been combined into a 
theory that states that depression is due to cognitive habits. The habit of misattributing 
success and failure which leaves the patient feeling powerless and incompetent and finally 
depressed. Depressed patients often lack social support and or have unhappy relationships. 
These perceived feelings of inadequacy may lead to a lack of social power. Hann et al (2002) 
showed that the more perceived support and the higher the satisfaction with family 
functioning the less the depression. A larger social support network was associated with less 
severe depression in women cancer patients. 
Gray (1982) suggests that anxiety and depression are linked, that depression occurs after 
a period of sustained anxiety. He believes that neurochemicals that normally cause arousal in 
the brain become depleted due to the continuous anxious state. This could be the explanation 
why women, who at simulation were extremely anxious, became depressed at four weeks post 
treatment. The levels of anxiety had fallen but the numbers of women scoring as possible or 
probable depression cases increased after treatment. This could also explain why men have 
higher depression scores throughout the study, but significance is only reached after treatment 
has finished. If this theory of Gray's is coupled with Seligman's theory of 1992, it gives an 
interesting hypothesis. Namely, that patients remain fearful in the absence of a safety signal 
and this increased and constant anxiety/fear could further deplete the specific neurochemicals 
which could lead to helplessness and depression. This requires more research. 
Penny Hopwood (2000) found a difference in gender with lung patients. Women with 
good performance status were twice as likely to be suffering from depression as the men. 
Carrol et al (1993) screened for anxiety and depression with 809 cancer patients either 
attending clinics or as in-patients. The circumstances of their testing were very different. The 
cohort was mixed, some were having treatment, others were attending for follow-up and 
others were in-patients. However the results are similar to the current study. Male patients, 
60 years old or more, were significantly more likely to have high depression scores. Similarly 
patients who were in-patients, which could suggest they were the palliative patients and the 
more seriously ill patients had higher depression scores that the out-patients. 
Bebbington in an article 'Psychosocial causes of depression (1999) stated that: 
"It is possible that the sex ratio of depression incidence varies according to time and 
place, and this variation is a reflection of women's variable social circumstances" 
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Thus questioning that women have higher rates of depression than men all the time. This 
study confirms this finding in that men throughout radiotherapy treatment had higher levels of 
depression than women, although significance was not reached until post treatment. 
The only other variable to reach significance in this current study is age. Patients aged 65 
plus being significantly more depressed than the other age groups. What is causing this 
increase in depression in the elderly population? Depression has been shown to increase with 
age in the general population (Mourn et al 1991) and illness could further reduce people's 
confidence and self esteem. 
"This dependence on other people enhances the sense of helplessness and vulnerability 
created by the disease process" (Simon & Pardes 1977). 
McCrae R R (1982) studied coping mechanisms with respect to age. The only areas 
where he found a difference with the middle aged and older population was that they 
"were less inclined than younger men and women to rely on the theoretically immature 
mechanisms of hostile reaction and escapist fantasy" (McCrae 1982). 
However, he does point out that his sample were all in good general physical and mental 
health. The current sample are all elderly patients that have all been treated for cancer. They 
could be suffering from physical limitations that, in turn, could limit their environment, which 
could bring about feelings of helplessness and hopelessness. Rodin & Langer (1977) found 
that 
" a sense of control may be particularly important to the well-being and even longevity of 
the elderly". 
It is therefore important that these elderly patients are supported emotionally, socially and 
practically. Fifty percent of the current radiotherapy population was over 65 plus. Older men 
traditionally were in a position of social power. In the hospital, however, they feel sick, 
dependant, vulnerable, powerless and have no control over an alien situation. As a result 
men in particular could suffer from depression. In contrast women are more used to feeling 
vulnerable and dependant and thus may have developed better coping skills. 
Those patients who felt tired continued to be significantly more depressed. Similarly 
those patients who felt worse were significantly more depressed. Aass et al found that fatigue 
was predictive of depression. Mock et al (1997) found that exercise in the form of a walking 
program throughout treatment improved not only patients' physical functioning but also their 
emotional functioning. Symptoms of fatigue were also reduced. This study points to patients 
who have some form of control in their lives which in turn enhances the quality of their lives. 
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Throughout the whole five years plus treatment and follow up, men are more depressed 
than the ~omen. Other studies have shown that women report more depressive symptoms at 
follow up (De Leeuw 2000) and this study contradicts these previous findings. However the 
current study looked specifically at patients undergoing radiotherapy treatment and the side 
effects of treatment could be interfering with the depression rates. This does not explain the 
unexpected finding that men from the start of treatment are more depressed than women. It 
could, however, by hypothesized that male depression is far more prevalent than previously 
thought, especially in the Northern Hemisphere. Here it could be masked for social and 
cultural reasons. Oncologists, GPs and other health professionals need to understand that 
depression occurs more in men than women who are undergoing or who have had 
radiotherapy treatment. Screening needs to be targeted towards this group. 
Treatment Intent 
The palliative patients were the most depressed cohort, and were significantly more 
depressed than the radical patients through treatment and afterwards. Indeed, as a percentage, 
there were twice as many possible and probable cases of depression with the palliative 
patients than the radical. A quarter of the palliative patients had scores of 8 and over at 
simulation. This rose through treatment, to 42% at mid-treatment and 32% 4 weeks post. 
Recent estimates of depression have put the rate of depression as between 15% to 20% 
(Razavi et al 1990, McDaniel et al 1995). However these estimates were not looking 
specifically at palliative patients undergoing radiotherapy treatment. Even in the current 
study there is a huge difference in the level of depression between the palliative patients and 
the 'completers'. The 'completers' contain 3 palliative patients but this cohort had much 
lower percentage of 'cases' ranging from 2% at simulation to 16% at the end of five years. 
Large differences have been found in the depression rate of palliative cancer patients. 
These range enormously from 10 to 50%. Minagawa et al (1996) found 18% had depression. 
The current study shows a much higher rate than this. Kramer (1999) assessed palliative lung 
patients and found 50% had scores of 8 and over at some point in their illness. In particular 
the mean depression scores of the palliative men patients were higher than the women. 
However this difference was not significant. This is in complete contrast to the anxiety scores 
of the male and female palliative patients. Hopwood & Stephens (2000) with palliative lung 
patients found a third suffered from depression and a further third from borderline depression. 
These are higher figures than the current study and may be due to the fact that the lung 
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patients were not actively involved in treatment and secondly lung patients may be 
particularly prone to depression. 
The palliative patients at mid-treatment are a small cohort. They consist of only the Long 
multifraction group (LMF) who received more than five radiotherapy treatments. A total of 
42% of this group indicated 'caseness'. This group appears to suffer more than other patient 
groups from depression but the male palliative patients are the most vulnerable group with 
45% having scores of eight and over. Four weeks after treatment thirty two percent of the 
palliative patients similarly had scores of eight and over, 16% could be considered as 
'possible' cases and 16% as 'probable' cases. Jenkins et al (1998) found one third of 
radiotherapy patients were suffering from clinically significant depression. This study is very 
similar to the current findings. However the numbers of patients indicating depression does 
depend on the timing of the questionnaire, with mid-treatment being a very difficult time for 
palliative patients. 
Depression over treatment shows a very different pattern from anxiety. Adaptation has 
not taken place: many patients are more depressed at the end of their treatment than at the 
beginning. The palliative patients are particularly at risk of depression. Further analysis 
showed that those palliative patients having more than five treatments were particularly at 
risk, regardless of gender. Throughout the course of treatment men were more depressed than 
women, and this is in sharp contrast to normal population data. 
Depression develops after treatment has started. The depression component on the 
HADS has a lower predictive power than the anxiety component (Hopwood et al 1991). 
Depression could therefore be under estimated in this study. 
Repeated measures analysis of variance for depression over the course of the study 
showed a significant effect for gender and depression. 
For the survivors of the study there is a significant difference between the men and the 
women and also between those patients who are, 65plus who are significantly more depressed. 
In sharp contrast Aass et al (1997) found that neither age nor gender had any effect on 
depression in patients receiving radiotherapy treatment. 
At simulation those patients who were participating in complementary medicine were 
significantly less depressed than those who did not. Sollner et al (2001) writes 
"cancer patients consider complementary and alternative therapies supplementary to standard 
medical methods and one way of avoiding passivity and of coping with feelings of 
hopelessness" (Solner et al 200 1). 
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Cognitive behavioural therapy looks at the psychological problem and attempts to 
identify maladaptive thoughts, behaviour and irrational beliefs by confronting them with 
reason. Subjects are then taught coping skills to help with them with restructuring. These 
techniques can help control pain and depression by breaking the circle of hopelessness and 
depression. Nursing interventions in the form of meaning and purpose are advocated by 
Lewis (1989). Weekly support group meetings is recommended by Spiegel et al (1981) for 
patients with metastatic breast cancer. These groups discussed issues such as terminal illness 
and relationships with the family and friends. Emotional support, religious faithlbeliefs, 
information, positive attitude, distraction are all coping strategies that patients have found 
helpful, Wainstock, (1991). Of these emotional support was most helpful and positively 
correlated with adjustment, (Zenmore & Shepel, 1989) and psychotropic medications. 
Psychiatric interventions that induce effective coping and reduce distress do appear to 
have a beneficial effect on the survival time of patients (Fawzy et al 1993). 
Vulnerability factors for depression are: 
a previous history of psychiatric illness. Robinson et al (1985) showed that patients who had 
suffered from anxiety or depression previously had significantly higher scores. 
lack of a confiding relationship 
lack of emotional support 
inability to sleep 
family history of depression 
suicidal thoughts or thoughts of death. 
The incidence of psychiatric illness in terminally ill patients is high. Levels of 25% of 
patients die with untreated depression and anxiety (Foley, 2000). Both can be treated with a 
consequent improvement in patients' quality of life. It is patients who need treatment not the 
just the disease. 
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Distress 
Many patients arnvmg for radiotherapy treatment are psychologically distressed. 
Distress is measured by combining the anxiety and depression scores to give a unitary score. 
Using 13 as a cut-off to indicate psychological distress and eighteen to indicate major 
depressive disorders, the picture at simulation showed high levels of emotional 
dysfunctioning with 53 % of patients scoring levels of thirteen and over including 16% scoring 
18 and over. Aass et al (1997) used 19 as their cut-off point for major depressive disorder 
and found a rate of 13%. The current study similarly found a 13% rate of distress using 19 as 
a cut-off point. Ibbotson et al (1994) used 15 as the cut-off point and had a rate of forty 
percent. With a similar cut-off point the current study had a rate of 29%, a lower rate. 
Derogatis et al (1983) cited 32% as suffering from psychological distress. Derogatis used 
a psychiatric interview, which is a stronger assessment tool than a self-assessment 
questionnaire. Derogatis however tested patients in an Out Patient Clinic, not prior to 
planning for radiotherapy treatment. 
The HADS has been well validated (Johnston 2000). However it is a screening tool not a 
diagnosis. 
From 6 months onward the overall levels of distress remained fairly consistent from 27% 
at 6 months to 25% at year 4. At year 5 there was an inconsistent drop which may have been 
due to the termination of the study, plus a realisation that they had survived five years. 
Using paired T test, Irwin et al (1986) found that levels of distress between start of 
treatment and the end of treatment was significantly lower. The present study showed that 
anxiety was lowered significantly from the time of the first treatment to four weeks post. 
However depression increased significantly. 
Irwin's times for testing were not so specific as the present study. They tested within the 
first week of treatment, in contrast to the present study which tested patients both before 
simulation and before the first treatment. Irwin et al sawall patients before the pre-treatment 
simulation and at this point they signed the consent form. They were not tested at this 
particular point. Patients in the Irwin study were then retested six weeks after the first testing, 
which should be approximately within one week of the end of treatment. However this 
depends on the number of fractions that were given to the patient. In the current study the 
greater specificity in the testing times is likely to have resulted in more accuracy in the results. 
Questionnaires were given to patients to fill in by the radiographers as they waited for their 
last treatment and were then collected on site. 
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Irwin et aI's last testing was at the patients' two month post treatment check up. The 
current study tested patients at four week post treatment. This was the first postal 
questionnaire for the present study. 
Treatment Intent 
One third of palliative patients at simulation had distress levels between thirteen and 
eighteen, and a further 20% scored eighteen and over. In contrast 18% of the radical patients 
could be considered a possible case and 13% a probable case. Those palliative patients having 
more than five treatments scored higher than any other patient group with a mean of 14.07 
(sd 5.82). Minagawa et al (1996) using a structured Clinical Interview for DSM111-R(SCID) 
identified 53.7% palliative patients as suffering from psychiatric morbidity. This study using 
questionnaires identified a similar number, 53%. Simulation does seem to be a particularly 
distressing time for these patients. 
Palliative patients were significantly more distressed than radical patients. By the time of 
the 1st treatment, the overall levels of distress had fallen to 49% as had the mean scores. 
However, the number of possible cases for palliative patients remains static at one third and 
probable cases at 19%. Palliative patients at the start of treatment have significantly higher 
mean scores than the radical patients. 
By mid treatment the overall levels had fallen. However the palliative patients, all of 
whom have been designated into the long multifraction (LMF) group , have reached a peak of 
13.78 (sd 6.31). This is a particularly difficult time for these patients with 26% registering as 
a possible case and 30% as probable cases. Palliative patients are significantly more 
distressed than the radical patients. All other patient groups show a decrease in 'cases'. 
Palliative patients were still more distressed than radical patients and this was significant, 
although the mean for both patient groups had fallen. The LMF palliative group still had the 
highest mean score for distress. At this point in the study the numbers of palliative patients 
numbered 55, and the LMF palliative group numbered 22. It is not a big sample but it is 
indicative of the emotional distress that these patients are suffering. 
Four weeks after treatment had finished and distress overall has risen since the end of 
treatment. Thirty two percent of patients have distress levels of thirteen and over. The 
palliative patients had high scores at simulation, 52%. This has now fallen to 45% after 
treatment, which is still very high. This sample now contains fifteen single fraction (SF) 
patients. It is the first time they have been included since the beginning of treatment. The 
mean of the palliative patients is 13.05 (sd 6.47), when the SF group is removed the mean is 
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lowered to 12.07 (sd 7.31). Therefore the inclusion of this group does have an effect on the 
overall mean. 
The palliative patients having more than five treatments are significantly more distressed 
than the other groups. The distress mean scores for the palliative patients have risen and in 
contrast the radical patients' mean has fallen. This is emphasized by the number of probable 
cases for radical patients - which is 9%: for palliative patients it is 26%. Four weeks after 
treatment over a quarter of patients are registering at the 18 and over level indicating high 
emotional dysfunctioning. There are more very distressed palliative patients four weeks post 
treatment than at any other time point - apart from mid-treatment when the cohort of 
palliative patients was a small specific group ofLMF palliative patients. 
The number of palliative patients in the study dropped from 22 at 6 months to 8 at year 
one. Statistical analysis on this declining cohort was not practical. However the three 
palliative 'completers' did not suffer from anxiety, depression or distress apart from at 
simulation and first treatment when anxiety was present. 
Gender 
Throughout treatment, gender was not significant, however the patterns varied for men 
and women, with women having more distress at simulation. Levels of distress fell from 41 % 
at simulation to 29% at the end of treatment for women. The men are the only patient group 
to show an increase in the mean at this point. The number of 'cases' dropped from 37% to 
25% at mid treatment and an increase to 30% at the end of treatment. However the numbers 
of men and women are not even, 81 and 131 respectively and therefore this can be questioned. 
Palliative women had higher mean score than the men with 45% having scores thirteen and 
over. Levels of distress remained constant for women, but have risen fractionally for men. 
From the end of treatment men had higher mean scores than the women. Graph 23 
illustrated the difference in male and female distress levels through treatment. The graph 
shows a mirror image picture, with women exhibition high distress at simulation and first 
treatment and levels then falling. Men's distress showed a similar pattern but with levels 
rising from mid-treatment until 4 weeks post treatment. 
At the 4 weeks post treatment 32% of women had scores of 13 and over. Gallagher et al 
(2002) looking at distress of breast cancer patients found 34% could be suffering from 
psychological morbidity. At the 6 month testing point this was significantly reduced with 
26% suggesting a 'case'. In the present study 30% of the breast patients indicated 
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psychological distress at 4 weeks post treatment. At six months this had significantly fallen to 
18%, a lower figure than Gallagher et al. 
Irwin et al did find a similar pattern of psychological distress occurring within the male 
and female patients, the male depression mean scores rising at the end of treatment, and 
women being highly anxious at the time of first treatment. Irwin only used three testing 
points, and missed the time of simulation, which has shown to be the most distressing time. 
They also found 8 to 14% of men with higher depression scores than the women. Irwin et al 
found that both men and women with prior distress had the same levels later, therefore, they 
felt that radiotherapy treatment did not have a different effect on men and women. This needs 
to be questioned. They did not test patients prior to treatment or prior to simulation but within 
one week of the start of treatment. 
The current study shows the importance of testing patients at simulation when they were 
the most distressed. This is a baseline from which Irwin et al should have assessed their 
patients. Neither did Irwin et al test patients in the middle of treatment. Their second point 
was six weeks after the first and was when patients had finished treatment. With no pre-
treatment baseline how can Irwin et al refer to prior levels of distress? Their prior levels 
measurements were taken when their patients had already started treatment. However it is 
interesting to note that at the point of time that they did test patients, they did find similar 
differences in gender. 
Looking at the larger cohort of 48 men at 6 months, men have more 'cases' of distress 
and this continues for the 5 years of the study, with declining number of men (at 5 years 
n=22). However the 56 'completers' verify this finding. With only 15 men in this cohort, the 
distress 'cases' are still higher than the women's for the whole 5 years post treatment. The 
levels range from 27% at 6 months to 47% at year 5. By analysing this cohort into non-
gender related cancers, the female non-gender related patients have the highest mean scores at 
simulation. Breast patients have the lowest scores from mid-treatment onwards. They have 
high scores at simulation and first treatment. This confirms the findings of the original larger 
cohort that women were initially more distressed than men. 
At the end of 5 years analysing the 'completers', not only are the men more distressed 
than the women, but distress had increased post treatment. By year 3, 33% indicated distress, 
year 4, 53% and year 5, a drop to 47%. These are high levels and these statistics warrant 
further research. This result confirms Pettingale's (1998) study in which he found men 
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patients more distressed than women and that men's lives were more upset by cancer than 
women's. 
Palliative patients throughout treatment had significantly higher scores than the radical 
patients. At four weeks post treatment over a quarter can be classified as 'probable' case, this 
includes 39% of the Long Multi-Fraction (LMF) group of palliative patients. The cohort of 
LMF palliative patients should be routinely tested as this group are especially susceptible to 
high distress levels both during and post treatment. 
Sites 
Zabora et al (1986) found that lung cancer patients had the highest distress levels at 
simulation and this study confirms this finding. The 'completers' showed that the non gender 
related females had the highest scores at simulation. until 6 months post treatment. At this 
point the non gender related males, who had the lowest scores at simulation, had the highest 
scores until the end of the study. This study therefore showed that men who were had a non 
gender related cancer had the highest distress scores. Further research is needed here. 
This study highlights that some patients continue to feel distressed years after treatment 
has finished. Men were continuously more distressed than the women from the post treatment 
point onwards. Lynch (1977) suggested that sociability creates coping skills that in turn 
develop strategies to cope with illness. As women are more sociable than men, these coping 
skills might be more developed. Men are less willing to admit weakness or distress, in 
contrast, women are prepared to speak about their distress and their illness. Therefore social 
activity could be playing a crucial role in illness and recovery. 
Palliative patients during the course of treatment were particularly distressed. These 
needs should be addressed particularly as these levels appear to be continuously high. 
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How do patients feel and wit at are tlteir needs? 
Just as anxiety is a mobile factor in this study so are the information needs of these 
patients. During the various stages of their 'recovery' period following radiotherapy 
treatment, patient's needs change and this requires attention. 
Six months post treatment 40% of patients who had previously been happy with the 
information they had received when leaving the radiotherapy department, now wanted more. 
At this point in the Out Patient Department leaflets on post radiotherapy should be available 
for patients. These should be site specific. As one patient put it 
'I think if more people's reactions were asked for and collated and expressed by the 
medical profession cancer wouldn't appear so scary.' Knowledge about what to expect and 
look for eases anxiety and depression. 
For the first year following radiotherapy patients seem vulnerable and need more support 
from health professionals. Assurance on the success of treatment and information can provide 
the necessary 'safety' signals that patients appear to need. This should help in lowering both 
anxiety and depression. 
Side effects also seem to change overtime with 60% experiencing side effects at the end 
of treatment. This changed to 20% at year 2. At the end of the study, year 5, 28% are still 
experiencing troublesome side effects. Eighteen months seems a particularly vulnerable time 
with a rise from 28% at year one to 41 % at 18 months. 
Similarly fatigue continues to be an on-going problem with patients. Nearly half of the 
patients felt tired 5 years after treatment, with levels rising from year 3. This population 
largely consisted of patients aged 65 years and over whom will have less energy. However it 
is a major problem with all cancer patients. Fifty-two percent had never spoken about fatigue 
with their doctor even though they had experienced it so some degree (Stone et aI2000). This 
commonly occurring problem needs to be recognised by the medical profession so that 
patients' quality of life can be improved. 
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Predictions 
Can anxiety, depression or psychological distress be predicted? This study confirms that 
firstly anxiety at simulation can predict 42% of the anxiety at the end of treatment. Nordin & 
Glimelius (1999) in their study showed that anxiety and depression at diagnosis could account 
for 35% of the variance of anxiety and depression at 6 months. The current study shows the 
importance of screening for anxiety at simulation. However can anxiety be predicted for five 
years post treatment? This study shows that 15% of the anxiety at simulation can be predicted 
at five years. As simulation is a particularly difficult time, especially for the women, a better 
predictor is anxiety at first treatment. The rate is increased from 15% to 23%. The analysis 
of the 'completers' further showed 42% of anxiety at first treatment could account for anxiety 
at the end of five years. These are high figures and show the importance of screening patients 
for anxiety at either simulation or preferably first treatment. 
Secondly, anxiety reached its peak at simulation and was still very high at first treatment. 
However the pattern for depression was different in that it reached its peak at the end of 
treatment. Testing patients for depression at simulation accounted for 40% of the variance at 
the end of treatment and a further 2% could be explained by palliative treatment. As 
depression manifests itself later than anxiety the best predictor of depression at five years is 
depression at 4 weeks post treatment. Thirty-eight percent of the depression at five years post 
treatment can be explained by depression at 4 weeks post treatment. These results confirm 
the importance of re-screening patients for depression particularly when they come to the 
hospital for their Out Patient appointment. 
Thirdly, psychological distress can similarly be predicted. Distress at first treatment 
seems a better predictor of distress at the end of treatment, with distress at first treatment 
explaining 47% of the distress at the end of treatment. Furthermore distress at the 4 weeks 
post treatment point can account for 42% of the distress five years later. 
This study therefore emphasises the importance of screening patients at specific times so 
that patients' anxiety and depression can be addressed and the patients' quality of life 
improved. With the high predictive rates that this study has shown these issue can now be 
addressed at specific times during and after patients' treatment. 
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Indicators for Sun'ivai 
In this longitudinal study over five years some indicators for survival have emerged, but 
require more research. 
Firstly, Cassileth et al (1986) hypothesized the State and Trait scores of the patients 
became 'fused' as death approached. This study repeats this finding. The two concepts of 
'how you generally feel' and 'how you feel at this moment' become the same with the 
approach of death. 
Secondly, Leigh et al (1987) hypothesized that increased levels of anxiety and depression 
may be predictive of survival. Low or high levels could indicate short or long survival. 
Further analysis showed the 45% of the high anxiety scorers survived five years. This study 
showed that high levels of State anxiety were indicative of long survival for women but not 
necessarily for men. High State anxiety was more indicative of a shorter survival for men. 
With eleven possible anxiety 'cases' for men at simulation, only one survived five years. 
With 26 probable' cases' of anxiety, 17 died. 
In contrast with 45 probable 'cases' of anxiety for women, 26 survived. 
Thirdly, Leigh et al stated that the survivors had higher trait anxiety. This study 
contradicts these findings. This study found that the survivors had significantly lower trait 
scores than the non survivors. 
Fourthly, the patients who died in the current study were significantly more depressed. 
Analysis of the 'completers' showed that at simulation only one woman patient was 
depressed. 
Indicators of survival appear to have lower Trait anxiety, coupled with higher State 
anxiety and low depression. The palliative patients (n=4) who survived five years had high 
Trait anxiety (43. sd 8.83) but their State anxiety was very high, (51.66 sd 1.92) and their 
depression was low (3.25, sd 2.65). Their State and Trait were not 'fused', and their 
depression levels were low. The HADS score for anxiety was similarly high (8.50 sd 4.36). 
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Chapter 10 
Medical implications 
This study highlights the importance of screening for psychiatric distress in patients 
undergoing therapy. Psychological assessments need to be incorporated routinely into 
patients' management of their disease. Whether or not depression is a symptom of the cancer 
is irrelevant. Both anxiety and depression require treatment in order to improve the quality of 
these patients' lives. Psychological questionnaires are a cheap option, however routine 
questions also need to be incorporated into the patient's medical assessment to indicate if the 
patient is at psychological risk. 
In this study the palliative cohort contained more men than women thus emphasising that 
men seek advice on their medical condition too late. Gender specific differences found in this 
study should be incorporated in education and general patient care. 
How can health professionals alleviate the high anxiety found at simulation? In a recent 
article by Harrison et al (2001), it was found that videotapes were very effective in reducing 
anxiety in patients about to be treated by radiotherapy. Other suggestions include speaking to 
someone who has undergone therapy to alleviate the patients' fears, cognitive behavioural 
therapy and relaxation. In the current study patients were asked if they would have liked a 
prior visit to the department. Over a third replied in the affirmative. These were mostly 
women. 
Fear can be caused from ignorance. Informed patients who know what their side effects 
could be and know what their treatment incorporates will be less distressed. Patients need 
good accurate information both prior to and after treatment. Both anxiety and depression has 
been quoted as being caused by a lack or loss of control (Abramson et al 1978). Patients seek 
to have control in what is considered an uncontrollable disease. The use of, and interest in 
complementary medicine is a sign of coping in cancer patients. It can be looked upon as a 
means of information seeking and a problem solving/active coping mechanism (Sollner et al 
2000) and this should be encouraged. With the current use of the internet as a source of 
information, it will be interesting to see if this has an affect on the needs of the patients and if 
a reduction in depression follows. Further research is needed in this area. 
GPs and other health professionals need to be warned that after radiotherapy treatment 
patients can be distressed, particularly men, palliative patients and the elderly. Previous 
studies have highlighted the higher levels of psychological morbidity among young cancer 
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patients (Jarrett et al 1991, Edlund 1989). In Harrison's and Maguires1s (1993) article they 
confirmed that the younger patients were subject to greater distress when coping with 
emotional issues but older patients were subject to more limitations imposed by treatment and 
the disease. The older survivors of this study were subject to significantly more depression. 
Practical support such as shopping, transport and social support could help to alleviate the 
depression rate in this population. Depression can be treated successfully by psychological 
problem solving techniques. This involves patients using their own skills and resources in 
relation to present and future problems. Depression can also be treated successfully 
pharmacologically. However, staff need to be aware of the drug interactions that can occur. 
Similarly drugs should be checked if the patient is depressed as interferon and prednisone can 
induce depression. GPs need to be more aware of these problems with cancer patients. 
In the current study, nearly half of the patients would have liked to have a telephone call 
during the four weeks between end of treatment and follow up. Both anxiety and depression 
was subject to a rise at this point. This could be an economical way of giving support to the 
patients. 
Support needs to be tailored to the patient's requirements. The patient's in this study 
used a variety of support groups. What works for one person does not necessarily work for 
another so that patients do need to know what is available. Breast patients who had support 
from the Breast Care nurse and other professionals were significantly less distressed than any 
other group throughout treatment, apart from simulation. In 1998 the first psychiatric 
consultation-liaison outpatient clinic was opened in Taiwan in a radiotherapy clinic, and this 
has been proven to improve psychiatric evaluation and early detection so that interventions 
can be offered (Chie et aI2001). Patients can thus feel free to accept all treatment available to 
them both physically and psychologically to improve the quality of their lives and possibly 
survival. 
The elderly are often reliant on hospital transport and thus may not be able to make use of 
those facilities in the hospital which offer care and support when they come for treatment. 
There needs to be more co-operation between the radiotherapy departments and hospital 
transport. 
This study has shown that the fusion of State and Trait plus high depression scores could 
be indicative of low survival. This could be helpful in assessing appropriate hospice care, 
however this requires more research. 
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The literature review looked at assessment of psychological distress by health care 
workers and this was not satisfactory. Psychiatric interviews are too expensive. Self-
assessment questionnaires are the most cost effective, even though they can result in false 
positives and negatives. This study has shown that anxiety and depression can be predicted. 
The author would suggest testing patients at first treatment and when they come for their first 
out patient appointment. The radiotherapy receptionist could give patients on arrival for their 
planning and or 1 st treatment, anxiety and depression questionnaires to fill in whilst they wait. 
The patient completes it immediately. It is then placed in a specialized scanner, which scores 
each paper. The receptionist reads off the results and marks the scores for anxiety, depression 
and distress in the patients' notes. This will then give the oncologist a cue to ask more 
relevant questions such as family history of psychiatric illness or social support to see if the 
patient is at risk. The oncologist is then able to make an informed decision as to whether the 
patients needs further tests or assessments by a psychologist. In this way psychological testing 
can be routinely incorporated into patients' assessment. Those with high scores should be 
tested regularly and or assessed further. For patients with high scores at the end of treatment, 
the oncologist should be encouraged to include this data in the letter to the GP. 
GPs need to enquire more into men's psychological state after they have had radiotherapy 
treatment. Contrary to data on the normal population, men are more depressed than women 
and a special note needs to be made of this so that the quality of life can be improved for these 
patients. Information needs to be given to both GPs and patients on what can happen after 
treatment and what can be done to help. If patients are told that feeling depressed is normal 
after radiotherapy treatment then they will not feel so stigmatised and may seek appropriate 
help. 
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Chapter 11 
Problems 
This is a longitudinal study in which patients were assessed at regular intervals pre, 
during and after treatment. This was a very daunting time-consuming task but effective. 
However it is inevitable that a study of this format would be subject to problems. 
The main problem was the high attrition rate of the patients due to death. This is 
inevitable when dealing with a cancer patient population. Compliance was kept to a 
maximum by testing patients in the hospital during treatment, but after treatment the author 
was reliant on information from a postal questionnaire and inevitably not all patients 
answered all questionnaires. This meant that different cohorts are being analysed at each 
testing. The author has tried to deal with the attrition rate by analyzing the data in separate 
parts. Firstly through treatment, when attrition was not so much a problem, although 15 
patients died in this period. Secondly, Part 2 analysed patients from six months to five years 
post treatment. This cohort inevitably contained patients who died and patients who did not 
fully participate. Thirdly, Part 3 contained only the people who completed all the 
questionnaires, all of the times. This reduced the number participating substantially. 
Statistical analysis on site became a problem with such small numbers. However t-tests 
revealed no significant difference between the patients participating in Part 2 of the analysis 
and patients participating in part 3. 
The patients analysed in Part 3, were not a true representation of all radiotherapy patients. 
a bias was introduced with the healthy replying. Comparisons were made between the 
survivors and non-survivors. However, the patients were not matched and therefore this data 
could be questioned. This problem of attrition is a continuous one with a longitudinal study, 
particularly when dealing with cancer patients. However Part 1 and Part 2 contain a true 
representation of patients attending for radiotherapy. 
The sample size should have been larger when dealing with a population with a large 
attrition rate. However financial constraints did not permit this. It could also be questioned in 
that too many variables are used, different sites, gender, age, and treatment intent and social 
class. However the author wanted an overall perspective. Patients are not treated in isolation 
of other patient groups. Health professionals treat them as individuals not as categories and 
guidelines for patients receiving treatment were one of the aims of this study. Would any 
specific group stand out as being more prone to psychological distress? 
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Patients received a battery of questionnaires some of which are not part of this thesis. 
They included the European Organisation of Research and Treatment of Cancer Quality of 
Life Questionnaire Core 30 (EORTC QLQ-C30), the Cancer Locus of control (CLOC), a 
Health Beliefs Questionnaire coupled with a questionnaire on complementary therapies. One 
of these questionnaires patients did not like responding to, and this affected the compliance 
rate. Questionnaires such as SF-36 were not included, as the patients would have been 
overloaded. 
This was the first study to take place from the Lynda Jackson Centre that had only just 
opened. To a large extent staff was unaware ofthe aims and objects ofthe unit. Better liaison 
with the radiographers was needed prior to the study. Meetings should have been held with 
all staff and notices given to them informing them exactly as to what was happening. 
All patients arriving for simulation were interviewed before their appointment by two 
researchers. This was a big undertaking in a busy department. Cooperation of the staff was 
further needed as the radiographers handed out forms to the patients before treatment on the 
first day, at mid treatment and at the end of treatment. Patients were all given identity 
numbers, known only to the researchers, so organization had to be high. Occasionally 
patients were missed when they first arrived as the researchers were trying to do too many 
things. More staff was needed for such a big project. However 316 were interviewed during 
that calendar month. 
Ethical permission was split into two sections, through treatment and four weeks post 
marked the delineation. Patients had to be written to and their permission re-sought for the 
time schedule six months to five years. This inevitably caused the attrition rate to fall further. 
Patients were tested at six monthly and yearly intervals after treatment finished. Most of 
the treatments finished at the end of November beginning of December. This meant that the 
postal questionnaires coincided with the Christmas post. This did not help the attrition rate. 
As patients got increasingly ill some had difficulty filling in the forms. The research 
questionnaire especially has gaps. If it could be ascertained that the gaps were just 
inadvertently missed and that the patient was otherwise healthy the form was returned with 
accompanying letter, however if the patient was obviously not well the forms were not used. 
Many patients wrote personally to the researcher voicing queries or worries and a response 
was given, although this increased the workload. 
With regard to the depression component of this study, information about prior personal 
and family history of depression should have been sought, as these are known risk factors. 
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Only questions with relation to anti-depression drugs were obtained and this is not sufficient. 
The HADS is not so robust on the depression scale. Another questionnaire such as the 
Hamilton rating scale for depression (HRSD) would have made the depression analysis more 
convincing especially as the HSRD includes feelings of hopelessness, helplessness and 
worthlessness as well as cognitive/behavioural disturbance (Hedlund & Vieweg 1973). 
However, this questionnaire, too, has received criticism and patients already had six 
questionnaires to fill in, of which only three are being discussed in this thesis. It was felt that 
patients could not be burdened with more questionnaires. Indeed more questionnaires would 
have possibly increased the attrition rate. 
The question on fatigue should have been included with the first set of research 
questionnaires. It was only included from 18 months post treatment 
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Chapter 12 
Conclusion 
This study provides a number of important findings. Firstly it shows that the prevalence 
of anxiety was greater than that of depression, especially at the start of treatment, thus 
confirming other studies (Carroll et al 1993, Marasate, 1991). Over time most patients 
adapted psychologically to their disease and its treatments. However a significant number of 
patients continued to feel distressed after their treatment had finished. These patients' 
psychological needs should be treated. GPs, district nurses and other health professionals 
need to be more aware of these patients' psychological requirements. This study would 
therefore contradict the findings of the meta-analysis of van't Spijker et al (1997) who stated 
that psychiatric problems in cancer patients did not differ from the normal population. 
Patients attending radiotherapy departments are extremely anxious. Some of the anxiety has 
been shown to be transient, but many patients especially palliative patients have high levels of 
anxiety throughout treatment and afterwards with a hard core remaining distressed for five 
years. 
Secondly anxiety and depression manifest themselves at different times, anxiety at 
simulation, depression after treatment has finished. Health professionals, especially GPs need 
to be more aware of this so that patients can be tested and/or asked appropriate questions at 
these sensitive times and help accordingly given. Sellick & Crooks in 1999 wrote 
"cancer care organisations must develop guidelines of specific emotional maladies and 
set standards of practise for the delivery of service. To do less would be to fail in our often 
stated intent to be truly comprehensive and to provide the necessary treatment and care for 
people living with cancer ........ The need has been established, the importance of addressing 
the need has been clearly stated, the steps required in practice guideline development are 
relatively simple, and the evidence is available to substantiate the various methodologies that 
may be used. What remains is to do it". 
Patients are still waiting. 
Thirdly, gender is an important factor. Previous studies have been mixed. Cella 1987, 
Nordin et al (1996), Brandberg et al (1995) found women more distressed than the men. 
Pettingale et al (1998), found men more distressed than women. Plumb & Holland (1977), 
and Holland et al (1986), cited men as suffering more from depression than women. This 
longitudinal study has shown that both anxiety and depression occur at different times for 
men and women. This could account for the differences found in these studies. Women were 
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initially more anxious but men were more anxious after treatment had finished. Men were 
more depressed than the women throughout the study even with the 'completers' cohort. This 
is in contrast to the general population where women are considered to be at more risk of 
depression. Leibenluft (1999), and the National Cormorbidity Survey (1994) found depression 
two to three times more common in women than men. Therefore the findings of the current 
study are unusual. Lansky et al (1985) found that depression in their female cancer patient 
population was within the range of the general population. The current study's findings are 
similar. Lansky et al were not testing patients having radiotherapy treatment and after, 
although some patients had received chemotherapy and radiotherapy. 
Lamsky et al only tested women, some of which had recently had their diagnosis, whilst 
others had been diagnosed years before. They found a depression rate of 5.3%. According to 
their study predictors of depression for women were physical disability and previous 
depressive episodes. Depression in this study over five years varied for women between 5% 
and 20%. The 5% was unusual and was at five years, probably an artificial result due to the 
completion of the study. Mostly the range was between 12% and 20%. 
More men die of cancer worldwide than women (Silverberg et al 1987, American Cancer 
Society 20003). In this study there are more men non survivors. There are less men than 
women in the current study, but more palliative men than palliative women. This could appear 
to indicate that men arrive for treatment too late. Women are regularly required to attend for 
pap smears, breast mammograms. Men do not have these regular testing procedures, neither 
do they seek medical care as routinely as women. They are socialised to think that illness is a 
sign of weakness, thus ignoring cancer symptoms and delaying medical help. These 
important gender-specific findings should be applied in general patient care and education 
awareness campaigns. 
Fourthly, palliative patients were more anxious and depressed than radical patients 
throughout the study. Those palliative patients having more than five treatments were 
especially at risk from psychological problems. Many of the palliative patients were being 
treated for a recurrence. Wainstock et al (1991) found that 78% of patients with a recurrence 
found it more upsetting than initial diagnosis. It was a greater death threat and also involved 
difficult treatment decisions and resulted in more side effects. Patients were also suffering 
more during the advanced stages of this disease and were thus more tired and more fearful of 
3 Cancer Facts and Figures. (2000) AtIant GA. American Cancer Society. 
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pain (Wainstock 1991). Breibart (1995) cites depression as being in 20-25% of this cancer 
patient population. This study provides similar findings. However Breibart also found the 
incidence of depression increases with advanced disease, illness, pain and disability. The 
current study confirms this finding. Palliative patients had significantly higher levels of 
depression throughout treatment and after. It is necessary for staff to identify early signs of 
depression and various fears as these not only have an effect on the life of the patient but also 
on the patient's family. Kramer (1999) wrote: 
"I suggest that community nurses and GPs be encouraged to use HADS to screen for 
depression in patients receiving palliative care." 
This is endorsed by Sellick & Crooks (1999) who stated that good practise guidelines should 
include screening of 
"every new cancer patient for symptoms of depression using a valid instrument such as 
the HADS or Beck Depression Inventory". 
This study would re-endorse this statement. Questionnaires could be given out when the 
patient is registered by the receptionist. Whilst waiting in the waiting room the patient scores 
the questionnaire and then returns it to the receptionist. She places it in a specialised scanner 
which read off the results. The receptionist then adds the results to the patient's notes. This 
acts as a cue for the oncologist/GP to ask appropriate questions to see if a psychiatric referral 
is necessary. The GP can accordingly inform the district nurse if necessary and also arrange 
for other appropriate help. 
Fifthly this study stresses the importance of specificity in timings of the questionnaires in 
order to get accurate measurements over time. By testing patients immediately before 
simulation, before their treatments and four weeks after treatment, accurate recordings of their 
emotional functioning were made at specific time points. This was then continued for five 
years after treatment. Although these latter testing were all by postal questionnaires, they 
were all given to patients within a specific time frame. Studies with cancer patients had 
previously shown large variations in anxiety and depression levels with patients. This study 
shows the importance of testing all patients at specific time points and not at calendrical times 
Sixthly, no psychiatric interviews were undertaken in this study. The evaluation of 
patients was done strictly by self-administered questionnaires. Both questionnaires have been 
well validated, although the depression component of the HADS is not so reliable and it has a 
tendency to under diagnose. This study does show that accuracy in the wording of the 
questionnaires is important. If patients are being tested continuously over treatment, a 
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questionnaire such as the ST AI State would be more appropriate to assess patients immediate 
response to anxiety. Here the wording is 'at this moment'. This is in contrast to the HADS 
which asks patients 'in the past week'. Patients' answers appear to reflect these differences, 
with a higher percentage of patients being more anxious at simulation and during treatment 
with the ST AI State. This difference overtime evened out, so that post treatment testings gave 
similar readings with both questionnaires. The HADS therefore is more suitable for post 
treatment testing or in an Out Patient Department when the patient is not subjected to an 
anxiety provoking situation which needs to me measured. The ST AI State is better used for 
patients confronted with an anxiety provoking situation. 
The author cannot assume that these patients, especially those scoring 11 and over on the 
HADS would meet the criteria for a mental disorder. The HADS is only a guide as it gives 
estimates rather than accurate measures. It does however indicate that further evaluation is 
needed. 
Seventhly, patients post treatment required more information, especially if they had side 
effects from treatment. Gynaecological cancers, bladder, prostate head and neck and lung 
patients suffered especially from side effects. Staff and GPs need to be more aware of these 
patients' needs. Five years post treatment a quarter of patients still had side effects from 
treatment. Those patients who felt worse were significantly more distressed. Nearly half of 
the patients felt tired five years after treatment. More research needs to be focused on fatigue 
and side effects to see what help would be appropriate. Asking patients how they feel could 
also be incorporated into patient's interviews. 
Finally this study highlights that men's psychosocial adjustment to cancer is poor. After 
treatment has finished men are consistently more psychologically distressed than the women. 
This could be due to a number of factors including men's personal social support mechanism 
and men's different coping skills. More research is required in this specific area. 
This study was hampered by a high attrition rate. It was felt important that all the 
patients were analysed throughout treatment whether they completed or not as this gave a 
picture of the psychological distress that occurs in the radiotherapy department during 
treatment. If the 'completers' only were used in the analyses, it would have failed to show the 
patients at most risk of psychological distress, namely the palliative patients. The third 
analyses of the 'completers' showed how anxiety and depression are still present in 
approximately 20% of this population years after treatment. This study also showed the high 
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predictive value of anxiety and depression at simulation and end of treatment respectively, 
thus emphasizing the importance of screening all patients having radiotherapy treatment. 
Patient cancer care in the 2000s still does not routinely incorporate psychological factors 
in the care of the patient. The Campaign for Effective and Rational Treatment (CERT) has 
calculated that more than 70,000 cancer patients are suffering unnecessarily from the 
debilitating results of cancer and its treatments. Cancer care professionals have the means to 
access the tools required to treat psychological distress, but they often fail to understand the 
importance of this care. Survival has increased but not necessarily patients' quality of life. 
Patients' needs should be assessed. Accordingly there is a need for routine screening of 
patients. Those patients identified can be offered additional services to prevent further 
distress following treatment. Today there is no reason why patients should be left feeling 
truly depressed. However health carers do not routinely test the cancer patient, neither do 
they ask simple questions. A good interview technique before treatment can disclose 
problems. Questions such as: 
'what is your sleeping pattern like?' 'Do you have emotional support?' 'Have you had 
any psychological problems in the past?' 'Does your family have a history of 
depression?' 'Do you have thoughts of death/suicide?' 
Jenkins et al in their article written in 1998 wrote: 
"All patients with clinically significant depression endorsed at least one of the 
following items: thought of death or suicide, feeling restless, or diminished mood 
response to good events. Endorsement of anyone of these symptoms should 
prompt a more through evaluation of depression" (Jenkins et al 1998) 
Is the psychological state of patients ignored because it is too expensive and too 
complicated to assess patients? Or is it because of the lack of appreciation of the potential 
benefits? Work by Maguire & Pitceathly (2002) highlights this problem in their article 'Key 
communication Skills and How to Acquire Them'. They emphasize that communication 
skills were not previously taught. Emotional and social problems were blocked by the 
physician in their patient dialogue to ease the physicians's discomfort.. Maguire & Pitceathly 
list the necessary skills for good communications: 
"Eliciting patients' problems and concerns 
Giving information 
Discussing treatment options 
Being supportive" 
They back this up with effective training methods. With these methods being implemented at 
under-graduate level it bodes well for the future. 
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This current study shows that a significant number of patients, both prior to radiotherapy 
treatment, during and after are anxious and depressed. If it is not economic to test all patients, 
this study has indicated pointers to show which patients are in need. 
This study has shown that a significant number of patients after five years still have side 
effect from radiotherapy. Half of the patients were feeling tired. These patients need to be 
identified and offered help which can improve substantially the quality of their lives. 
Exercise has proven to be effective in treating fatigue. However, support needs to be 
customized for the individual and multidisciplinary - it can vary from: individual therapy, 
group therapy, information, support groups and cognitive behaviour therapy. Helbom et al 
(1998) suggest that those patients who do not truly need psychological treatment drop out 
after a couple of sessions. If drugs are used to control depression, careful consideration needs 
to be used for the appropriate drug as drug-interactions can make the patients psychological 
state worse. Depressive drugs can cause difficulties with the older population especially if 
they are suffering from cardio-vascular problems. Finally with regard to elderly patients, 
social support in the form of financial, equipment and transport is needed and will contribute 
to lowering patients' anxiety and depression. 
The NHS has limited resources to fund psychological testing. More patients are now 
surviving their cancer and quality of life issues are becoming more important for radical as 
well as palliative patients. The results of this study further appear to suggest that depression 
and anxiety can be predicted through treatment from tests at simulation or first treatment. 
Risk factors include previous psychological treatment, a lack of good social and emotional 
support network, depression at simulation/first treatment, male gender and high Trait anxiety. 
With respect to the survivors in this study, men and those 65 plus age groups were 
significantly more depressed. This study also confirms Magruder-Habid et al (1989) finding 
that depression is significantly under-diagnosed in a medical setting. 
The discovery of cancer can cause a deep all-pervading sense of disorientation. This 
disorientation often persists throughout the illness whether the patient recovers or dies4 . 
Overnight the patient's status is changed from a 'healthy' person to a cancer 'patient' with all 
the feeling and emotions that are evoked with that word. This study has shown that some 
patients do adapt more easily than others to their cancer and its treatment. It also highlights 
how anxiety and depression exist in some patients being treated and how these emotions can 
4 The Multidisiplinary Care of Cancer Patients (1992) Council of Europe, Strausbourg, p7. 
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persist for years. Funding and organisation should be made available so that quality of care 
can be inc~eased for these distressed patients. 
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HAD SCALE ,- J 
ID No. Initials O.O.B. Date Schedule Machine 
Read each Item and place a tick in the box opposite the reply which comes closest to how 
you have been feeling In the past week. 
Don't take too long over your replies: your Immediate reaction to each Item will probably 
be more accurate than a long thought-out response 
Tick only one box in each section 
I feel tense or 'wound up': 
Most of the time......................... ..... ........ ... ..•.. .... [j 
A lot of the time ...................................••...•.......... D 
lime to time, occasionally .............•.........••.. ,. ..•. ..... D 
Not at all ..................................•........................• D 
I still enjoy the things I used to enjoy: 
Definitely as much .......•••.•••......•.......•...••..••..•..•••• 0 
Not quite so much............................. .••..•.•....•••..•. 0 
Only a little ..... ~ .....................................•............• 0 
Hardly at all ........................... .... ..... ......... ..•... .•... 0 
I get a sort of frightened feeling as if 
something awful is about to happen: 
Very definitely and quite badly..... ...•..... ..•.. .•.....••.••. 0 
Yes, but not too badly... ..•. .... .•... ...•.....•.••••• ........... 0 
A little, but it doesn't worry me::............................. 0 
Not at all .......................................•...•..•.•....•••••.• 0 
I can laugh and see the funny side of things: 
As much as I always could ........•.........•••.•••.••.•.••.••• 0 
Not quite so much now...... ......•. ....... ....•.•.•.. .......... 0 
Definitely not so much' now....... ..•••..•.•..••••.•.••••••••• 0 
Not at all ............................................................ 0 
Worrying thoughts go through my mind: 
A great deal of the time ......•.................••.•••.......•... 0 
A lot of the time ... ........ ....•.•........ ........•.•• ••.•.••....• 0 
From time to time but not too often.. ..... ..••... ........•.• 0 
Only occasionally..... ... ......................................... D 
I feel cheerful: 
Not at all ........................................................... . 
Not often .. 
Sometimes 
Most of the time ..................... . 
I can sit at ease and feel relaxed: 
Definitely ................................... . 
Usually .................................. . 
Not often ............................................ . 
Not at aU ................ . 
o 
o 
D 
o 
o 
o 
o 
o 
I feel as if I am slowed down: 
Nearly all the time.............................. ... .....•... ...... 0 
Very often................................. ....... ................... 0 
Sometimes ....... '" .... ...............................•........ ... 0 
Not at all ............................................................ 0 
I get a sort of frightened feeling like 'butterflies' in 
the stomach: 
Not at all ..............................••.......•..•....••.••....••.• 0 
Occasionally ...... : ................................................ 0 
Quite often................................ .......... ... ...... ...... 0 
Very often ........................................................... 0 
I have lost interest in my appearance: 
Definitely ... , .••.. ... ..... ..... ...... ...... ......... ..... ............ 0 
I don't take so much care as I should ....................... 0 
I may not take quite as much care ........................... 0 
I take just as much care as ever ...... ... ............... ...... 0 
I feel restless as if I have to be on the move: 
Very much indeed ........ ........ .••...... ....................... D 
Quite a lot ..... ..... ..... •....... ...••. ... ......... ................. 0 
Not very much ..................................................... 0 
Not at all ............................................................ 0 
I look fprward with enjoyment to things: 
As much as ever I did ............................................ 0 
Rather less than I used to ...... ....... ......................... 0 
Definitely less than I used to ........ :..................... ..... 0 
Hardly at all ..... ..... ... ...... ...................................... 0 
I get sudden feelings of panic: 
Very often indeed ................................................ . 
Quite often ....................................................... .. 
Not very often 
Not at all .....•.... 
I can enjoy a good book or radio or TV programme: 
Often ...................................... . 
Sometimes .............. . 
Not often ......................... . 
Very seldom ......................... . 
o 
o 
o 
o 
o 
o 
o 
o 
APPENDIX 2 
SPIELBERGER'S STATE ANXIETY INVENTORY (STAI) 
Long and short version 
I 
10 No. Initials 0.0.8. Date Schedule Machine 
STAI SHORT 
A Self Evaluation Questionnaire 
A number of statements which people have used to describe themselves 
are given below. Read each statement and then circle the most 
appropriate number to the right of the statement to indicate how you feel 
right now at this moment. 
There are no right or wrong answers. Do not spend too much time on 
anyone statement, but give the answer which seems to describe your 
present feelings best. 
Not at all Somewhat Moderately Very much 
1. I feel calm 1 2 3 4 
2. I am tense 1 2 3 4 
3. I feel upset 1 2 3 4 
4. I am relaxed 1 2 3 4 
5. I feel content 1 2 3 4 
6. I am worried 1 2 3 4 
Please make sure that you have answered all the questions 
1. 
2. 
3. 
4'. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
1.3. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
I . 1 
IDNa. Initials O.O.B. Date Schedule 
SELF EVALUATION QUESTIONNAIRE 
DIRECTIONS: A number of statements which people have used to describe themselves are 
given below. Read each statement and circle the right statement to indicate how you feel right now, 
that is, at this moment. There are no right or wrong answers. Do not spend too much time on any 
one statement but give the answer which seems to describe your present feelings best. 
Please make sure that you have answered ALL the questions. 
I feel calm Not At All 
..................... 1 
I feel secure .... ............. 1 
I am tense ...................... 1 
I feel strained .... .......... 1 
I feel at ease ................ 1 
I feel upset ........ ........ .... 1 
I am presently worrying. 
over possible 
misfortunes .................. 1 
I feel satisfied . ............ 1 
I feel frightened .. ........ 1 
feel comfortable ....... 1 
feel self-confident. .. 1 
I feel nervous .. ..... ......... 1 
I am jittery ... ................. 1 
I feel indecisive ........... 1 
I am relaxed .. ................. 1 
I feel content ................ 1 
I am worried .................. 1 
I feel confused .............. 1 
I feel steady .................. 1 
I feel pleasant .............. 1 
Somewhat 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
Moderately 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3· 
Very Much So 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
APPENDIX 3 
SPIELBERGER'S TRAIT ANXIETY INVENTORY (STAI) 
/ 
. SELF-EVALUATION QUESTIONNAIRE 
STAi Form Y·2 
.----" 
N ;1111C Dat c --~-____ _ 
DIRECTIONS: A number.of statements which people have used to 
describe themselves are given below. Read each statement and then 
blacken in the appropriate circle to the right of ,he statement to in-
dicate how you gellerally feel. There arc no right or wrong answers. Do 
not spend to,o much time on anyone statement but give the answer 
which seems to describe how you generally feel. . 
'1" 
. I 
-1" rr) .. 
-'/t:'J; ./ /. r~I" r!/r 'f" 
/ I 1· . r) _I,. ;- // ~;,. .., 
":< Ir"<j. 1,/. '.r. 
21. I rccl pleas(llIt ................... _ ........................... . 
22. fCeI IIcrvous alld restless 
23. recl .~alisficd wilh myselr .............................................................. 
24. (wish I could he as h(lpt>y (IS others secnt to be'; ............... . 
25. I feci like a failure ........................................................ 0'" ..................... .. 
26. I fed rested 
27. (;\111 "calm t cool. (ll1d collected" •..... ~ ........................ . 
28. (fCeI thai difficulties arc pilil1g up so that I cailt10t overcome thelll 
29. (wony too lt1uch over something that really docsn't malleI' ..... . 
30. I alii happy ................................................. . 
31. I have di~lUl'bil1g thoughts ................................... . 
32. I lack !lcI["-collfidcllcc ........................................ . 
33. I feel secllrc ................................................ . 
34. I make dcd,siol1S easily ....................................... . 
35. I reel illadequate ............................................. . 
36. I attl cOlltent ................................................ . 
37. SOl11e ul1impOrl(lllt thought rtlllS thl'c)tlgh nlr mind alld bothcrs tIIC 
38. I t:1kc di~app()inllllel1ts ~o kecnly th:1t I can't put thctTI out or Illy 
tnind ....................................................... . 
39. I :1111 :t steady person 
40. t get in a ~tate orlcmiol1 or turmoil as i think o .... er Illy recent conccrns 
alld illterests ............................................................ 
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10 No. Initials o.O.B. uate Schedule Machine 
Dear Patient 
Quality of Care Study 
We are trying to improve the quality of care for patients coming to the Radiotherapy 
Department and would be very grateful if you could participate in this study. 
In particular we are looking at problems which patients may experience during radiotherapy, 
including anxiety, and the different ways in which they cope with them. '. 
To do this we have to ask a variety of questions which have been helpful in previous 
studies - many of these may seem irritating or irrelevant to you, and we apologise in advance! 
With the benefit of your experience, we hope to be able to help other cancer patients. 
The study involves a number of questionnaires, which we will be asking you to complete at 
various stages during and after your treatment . 
before your treatment begins you will be given 5 short questionnaires. 
if you are returning for a course of treatment, you will be given 3-4 short 
questionnaires, at your first main treatment seSSion, at the mid-point of your course 
of treatment and again at the last session 
one month after the end of your treatment we will either give or post to you further 
short questionnaires, to see how you are getting on at home. 
We also need to ask your permission to check details of your current treatment by looking at 
your notes. 
All responses are in strict confidence, individual information will not be disclosed and 
completed questionnaires will not be retained in your case notes. 
If you do not wish to take part in this study, of course your treatment will not be affected in 
any way. 
Thank you. 
Yours faithfully 
4' l1~euJ"U 
Chris MacKenzie 
~~~ 
lise Feigel 
.......................................................................................................................................................................... 
I agree to take part in the studies looking at different ways in which radiotherapy patients 
cope with their treatment 
Date .................... .. 
Patient name .................................................. Patient signature ................................ .. 
Researcher name ........................ .. Researcher signature ..... 
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r.n 
Sex 
Marital Status 
Age 
Social Class 
Occupation 
Type & Site of Tumour 
Treatment 
List 1 
Male 
Single 
Divorced 
Illn 
Employed 
Unemployed 
Other 
Palliative 
In Patient 
Any Special Immobilisation Devices Used· 
Is the Treatment Simple 
II 
IV 
Female 
Married 
Co-habiting 
Retired 
Housewife 
Radical 
Out Patient 
Complex 
111m 
V 
Number of Treatments ___________________ _ 
Machine Used 
Does the Patient use Hospital Transport Yes No 
APPENDIX 7 
RESEARCH QUESTIONNAIRE 
Given to patients 
At end of treatment and 4 weeks post treatment 
c-- --,---"-1"-' ... ---. 
10 No. Initials O.O.B. Date Schedule Machine 
Research Questionnaire 11--1. t AtJPr..L-'/StS 
For each question, please circle either YES or NO 
and, where appropriate, add comments 
All information received in response to this questionnaire 
will be tr~atecJ in strict confidence 
Do you feel you were given enough 
information before your radiotherapy 
treatment? 
.................................................... YES 
..................................................... NO 
Do you feel you have been given too 
much information? 
........................ .-........................... YES 
................ ~ .................................... NO 
Would you have felt more confident, if 
you had made a visit to the Radiotherapy 
department, before treatment to meet the 
staff whQ would,be looking after you and 
see where you :would be treated? 
.................................................... YES 
..................................................... NO 
Did you feel yo'u needed more support, 
while undergoing radiotherapy? 
' ........................... : ......................... YES 
..................................................... NO 
Did you talk with the counsellor over the 
treatment period? 
.................................................... YES 
..................................................... NO 
Did you ever feel frightened during your 
radiotherapy treatment 
..................................................... YES 
..... : ............................................... NO 
If YES, would you have liked to talk to 
someone about this? 
..................................................... yES 
..................................................... N0 
Did you experience any anxiety or fears 
. about your illness at the weekends? 
.................................................... yES 
..................................................... NO 
Did you experience any anxiety or fears 
afieryourtreatmentended? 
.................................................... YES 
...................................................... NO 
Did the machine you were being treated 
on ever breakdown? 
.................................... · ................ YES 
...................................................... NO 
Were you accompanied when you 
attended the radiotherapy deparbnent for 
treatment? 
.................................................... YES 
...................................................... NO 
Do you now feel ...................... Better? 
....................................... No Change? 
............................................... Worse? 
Do you have any dependants? 
..................................................... YES 
........................................ ; ............. NO 
Are you taking any medicines? 
.................................................... yES 
...................................................... NO 
If YES what ....................................... . 
Are you still suffering from any 
symptoms as a result of your 
radiotherapy? 
.................................................... YES 
............. : ........................................ NO 
Do you have at least one relative or friend 
in whom you can confide? 
.................................................... YES 
...................................................... NO 
P"\(,) 
Do you have any fmancial worries ............. . 
Did you go to the Lynda Jackson Centre? ..... 
If yes what facilities did you use? 
I used counselling .................................. . 
I used relaxation .................................... . 
I used yoga .......................................... . 
I looked at books ................................... . 
I looked at the tapes ................................ . 
I used group therapy ................................ . 
Was there a delay in your diagnosis? ............ . 
Have any of your family had cancer? ........... . 
Is there anyway which your radiotherapy 
treatment could have been made less stressful?. 
If yes, how? .......................................... . 
Other than your current illness have you suffered 
a recent stressful event eg bereavment, divorce? 
Yes ............. No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............ No 
yes ............. No 
APPENDIX 8 
LETTER 
Sent to patients at 
4 weeks post treatment 
Lynda Jackson Macmillan Centre for Cancer Support and Information 
Dear 
Mount Vernon and 
Watford Hospitals 
NHS Trust 
Mount Vernon Hospital 
Rickmansworth Ro~d 
Northwood 
Middlesex HA(1 2RN 
Telephone O<J2] !l261 II 
direct line 0923 1(44177 
f~x 0923 1(44172 
You may remember when we first talked to you about our study that we mentioned that 
we would be sending you a final set of questionnaires one month after your radiotherapy 
treatment finished. Please find them enclosed. 
Please would you kindly make sure that ALL QUESTIONS on all the forms are 
answered. A stamp addressed envelope us enclosed and we should be grateful if you 
would return the completed questionnaires as soon as possible. 
Thank you for your help and patience 
Yours sincerely 
ttvM ~. 
Chris Mackenzie Ilse Feigel 
Director: Dr E lane M~hcr 
M~n~~cr: ludv Youn~ 
APPENDIX 9 
LETTER 
Sent to patients for new ethical permission 
+ 
leaflet on Lynda Jackson Macmillan Centre 
Dear 
MOUNT VERNON HOSPITAL 
Radiotherapy Department 
QUALITY OF PATIENT CARE 
We would like to thank you very much for participating in our study. It has been 
extremely helpful to get direct feedback from you. Your replies are enabling us to 
improve our quality of care for patients attending our radiotherapy department. We are 
particularly looking at problems which patients may experience during their cancer 
treatment, including anxiety, and the different ways in which patients cope. 
The response rate to the questionnaires has been so good that, with your permission, 
we would like to send you a further short set of questionnaires every six months for 
the next two years. Thereafter we would like to send them to you annually for another 
three years bringing it to a total of five years altogether. The first one would be in 
May 1994 and would comprise five short one page questionnaires. It would not be as 
long and detailed as the last set which you so very kindly answered. 
We also need to ask your permission to check details of your current treatment by 
looking at your notes. 
All responses are in strict confidence. Individual information will not be disclosed and 
completed questionnaires will not be retained in your case notes. 
If you do not wish to take part in this study, of course your treatment will not be 
affected in any way. 
Should you not wish to participate further would you please return this letter to us in 
the stamp-addressed envelope provided 
Thank you very much for your help, 
Christine Mackenzie llse Feigel 
....................................................................................................................................... 
I no longer wish to participate in the study 
Patient Name ............................................................... . 
Date ............................................................................ .. 
" 
~. 
~ , 
Lynda Jackson - Macmillan Centre, 
for Cancer Support and I nformatjon 
Dear 
Mount Vernon Hospital 
Rickmansworth' R~ad. Northwood. Middlesex HA6 2RN 
Telephone: 0923 ({l(-WI/.( Facsimile: 0923835803 
Oirecl Dial: e895 278 ' Direct facsimile: 0895 278172 
-rACK 0MDV'\tls .t::t<iP"f~1VRt~t\ G ') . 
~h'~ 
b (& t\<a<H.. ) 
, 
QUALITY OF PATIENT CARE 
Thank you so 'much for agreeing to further participate in our 
study. Enclosed are the questionnaires and we would' be grateful 
if you would complete them and return them in "the stamp,-
addressed envelope proyided. 
Thank you very much for your help. 
Yours sincerely 
I{~ 
Christine Mackenzie 
h d~ 
lise Feigel' 
. '-'---':'- -- ---
~5o 
APPENDIX 10 
RESEARCH QUESTIONNAIRE 3 
Sent to patients at 
6 Months Post Treatment 
RESEARCH QUESTIONNAIRE 3 
For each question, please circle either YES or NO or other answer where 
appropriate, and add comments 
All information received in response to this questionnaire will be treated 
strict confidence 
Do you still have any side-effects as a 
result of your radiotherapy? ................ YES 
.............................................................................. NO 
After your treatment, do you now feel 
................................................................... better? 
............................................................ no change? 
.................................................................... worse? 
What did you feel about the length of 
time between finishing your treatment 
and seeing the consultant in the Out 
Patients Clinic? 
1 .............................. Was it too long to wait? 
2................................................................... OK 
3....................................................... Too short 
Would it have been helpful if someone 
had telephoned you during this time to 
check how you were getting on? 
............................................................................ YES 
.............................................................................. NO 
Did you feel the need to contact your 
GP for advice concerning radiotherapy 
treatment? ................................................... YES 
.............................................................................. NO 
If yes, was your GP able to answer your 
queries ............................................................ YES 
.............................................................................. NO 
Comment .............................................................. . 
Did you feel you were given adequate 
information when you left the 
radiotherapy department? 
............................................................................ YES 
.............................................................................. NO 
How long did it take you to travel TO 
the hospital from home ................................ . 
Have you had any further 
treatments? .................................................. YES 
.............................................................................. NO 
If Yes what? . 
Surgery .................................................... YES/NO 
Radiotherapy ........................................ .YES/NO 
Chemotherapy ....................................... YES/NO 
HormonallT amoxifen ......................... YES/NO 
Complementary .................................... YES/NO 
Additional Medicine/s ...................... YES/NO 
What? .................................................................... . 
Did you feel a need to get more 
information on your illness? 
............................................................................ YES 
.............................................................................. NO 
If yes where did you get your 
information from? 
........................................................... Doctor/GP? 
............................................... 8acup/Cancerlink 
................................................... Family/Friends 
........................................................................ Other 
Have you visited or telephoned the 
Lynda Jackson Cancer Support Centre 
since you received our last 
questionnaires? .......................................... YES 
.............................................................................. NO 
If yes, was the contact at the Lynda 
Jackson Centre helpful? 
1 .................................................................... Very 
2 ........................................................... Adequate 
3............ ........ ....... ......... ...... Not at all helpful 
Other than your cancer which has been 
treated do you have any other 
illness? .......................................................... YES 
. ................................................................. NO 
If yes,what? ....................................................... . 
APPENDIX 11 
LETTER 
Sent to patients at 
1 Year Post Treatment 
I 
l"I r post f~~ 
Lynda Jackson Macmillan Centre for Cancer Support and Infonnation 
Dear 
Mount Vernon and 
Watford Hospitals 
NHS Trust 
Re: Quality of Care Study 
Mount Vernon Hospital 
Ricklll~mworth Ro~o 
Northwood 
Middlc~cx HA(, 2RN 
Telephone 092] R2('( II 
direct line 
fax 
0923 844177 
0923 844172 
Thank you very much for returning our last set of questionnaires in May. We were very 
grateful. The infonnation we are collecting from patients is being used by the hospital to 
assess their quality of care. As a result of some of the infonnation we have received some 
changes have already been made. 
We enclose herewith the next set of questionnaires for you to fill in. 
Thank you very much for your help, 
With best wishes, 
t,~ ~ 
Chris Mackenzie and Ilse Feigel 
Director: Dr E Jane Maher Manager: Judy Young 
APPENDIX 12 
RESEARCH QUESTIONNAIRE 4 
Sent to patients at 
1 Year Post Treatment 
10 No Initials 0.0.8 Date Schedule 
RESEARCH QUESTIONNAIRE 4 
For each question, please circle either YES or NO or other answer 
Where appropriate, and add comments 
All Information received in response to this questionnaire will be treated in 
strict confidence 
Do you have any side-effects from your If YES, what? 
radiotherapy treatment in Autumn 1993? --- YES ---------------------------------------------------
----------------------------------------NO ----------------------------------------------
If YES, have they occurred since the last 
questionnaire-------------------------- YES 
-----------------------------------NO 
Compared with one year ago, do you now feel 
-----------------------------------better? 
---------------------------------------- no chan ge 
-------------------------------------- worse 
Compared with 6 months ago, do you now feel 
-------------------------------------better? 
----------------------------------no change 
----------------------------------- worse 
Would it have been helpful if someone had 
contacted you from the radiotherapy department 
in the last 6 months? 
------------------------------------ YES 
-----------------------------------------NO 
Have you visited your GP about your cancer in 
the last 6 months? 
------------------------------------ YES 
---------------------------------------NO 
Since being diagnosed, have there been any 
changes in your place of work? 
------------------------------------- YES 
----------------------------------------NO 
Since being diagnosed, have there been any 
changes in your income? 
------------------------------------------- YES 
------------------------------------------------NO 
Since May, have you had any further 
treatments? 
---------------------------------------------------------- YES 
---------------------------------------------------------- NO 
Since May, have you felt a need to get further 
information? 
------------------------------------------- YES 
-------------------------------------------- NO 
If YES, where did you get your information from? 
Do you have any suggestions which could have 
made life easier during and after your 
radiotherapy treatment 
--------------------------------------- YES 
--------------------------------------NO 
If YES, what? 
----------------------------~--------------
In the last year, do you feel you have had 
enough emotional support? 
-------------------------------------------- YES 
------------------------------------------------ NO 
If YES, from whom? 
APPENDIX 13 
LETTER 
Sent to patients at 
18 Months Post Treatment 
Lynda Jackson Macmillan Centre for Cancer Support and Information 
Mount Vernon and 
Watford Hospitals 
NHS Trust 
May 1995 
Dear 
Mount Vernon Hospital 
ll...icklllJllsworth Il...o~d 
Northwood 
Middlesex HM, 2RN 
Telephone On] !l2(,111 
direct line 0923 844177 
fax 0923 844172 
It isnow18 months since your radiotherapy treatment has finished. We 
have been busy analysing your responses. Some patients felt that they 
did not receive enough information when they left the radiotherapy 
department concerning normal side effects or how to contact staff. We 
have now produced a series of booklets. We are enclosing a copy of 
the one which now will be given to patients when they leave the 
department. We hope you will find it helpful. We would also be grateful 
. if you could give us some advice on it Does it answer any queries you 
might have? We have enclosed a sheet which we should be very 
grateful if you could fill in for us. 
This study is glvmg us' so . much information as to how patients feel 
during and after their radiotherapy treatment. Thank you so much for. 
taking the time and trouble to fill in all these forms for us. To improve 
our service to patients we must find out patients' needs so that we can 
supply the best possible care. 
With many thanks, 
0~ 
Chris Mackenzie 
Director: Dr E Jane Maher Manacer: Judv YOUI1C 
lit 
APPENDIX 14 
RESEARCH QUESTIONNAIRE 5 
Sent to patients at 
18 Months Post Treatment 
-- I·' 
10 No Initials OOB Date Schedule 
Research Questionnaire 
For each question, 'please circle eit(1er YES or NO, or tick boxes, where 
approp'riate, and add comments 
All information received in response to this questionnaire 
will be treated in strict confidence 
1 the last questionnaire, a number of 
latients said they would have liked to 
lave spoken with a patient who had 
.!ready had radiotherapy treatment. 
Yould this have helped you? 
.................................................... YES 
.................................. : .................. NO 
................................. ~ .............. MAYBE 
Yould you feel able to talk to someone, 
mo was about to have radiotherapy? 
............................................. : ...... YES 
..................................................... NO 
.............................................. MAYBE 
= YES, how soon after your radiotherapy 
reatrnent, do you feel you would be 
'lilling to do so? 
............................... ; ......... 3 MONTHS 
......................................... 6·MONTHS 
........................................ ONE·YEAR 
...................................... 18 MONTHS 
................................ · .............. ·OTHER 
Vhilst waiting for transport or treatment, 
lIould you have liked to have watched 
elevision? 
... · .................... : ............................ YES 
..................................................... NO 
.................................... DON'TKNOW 
)0 you have any other suggestions for 
he waiting room? 
Have you had to change your diet since 
your diagnosis of cancer? 
.................................................. ~. YES 
...................................................... NO 
Do you try to eat a more healthy diet? 
.................................................... YES 
...................................................... NO 
Looking back over your radiotherapy 
treatment, what words best describe 
your experience? Please tick ALL that 
apply 
Anxious .......................................... 0 
Efficient ............... : .......................... 0 
Powerless ........................................ 0 
Frightening ..................................... 0 
Caring ......................... : .................. 0 
Reassuring ..................................... 0 
Angry ....................................... ~ ...... 0 
Friendly .......................................... D 
Distressing ..................................... 0 
Depressing ..................................... 0 
Time-consuming ............................. 0 
Isolating .......................................... 0 
Sore/painful ............... : .................... 0 
Other .............................................. 0 
APPENDIX 15 
BOOKLET ON 
'COPING NOW THAT YOUR RADIOTHERAPY TREATMENT 
HAS FINISHED' 
APPENDIX 16 
SHEET ON BOOKLET 
Sent at 
18 Months Post Treatment 
[ - I . 
.. . .... ID NO Initials 008 Date 
SHEET ABOUT BOOKLET: 
'Coping now that your Radiotherapy Treatment is finishing' 
This is the latest leaflet in the series produced by the Lynda Jackson Macmillan Centre. 
We responded to the needs of the patients who felt they wanted some written infotmation at 
the end of a course of treatment. 
We asked the advice and help of many people in order to produce this leaflet, and now we 
would value your opinion, as you are one of the first in a group of people to receive it. 
We hope that you will be willing to answer these questions and return them to us in the 
stamped addressed envelope supplied. We would like to thank you very much for 
cooperating with us. 
Would you please let us have your cOlTlments, ticking the most suitable answer for you. 
Please continue your comments on the back if you wish. 
1 How easy was the leaflet to read? 
2 How clear was the explanation? 
3 Did it tell you what" you needed to know? 
4 How helpful is this kind of information ? 
very easy ....... . 
quite easy ...... . 
not easy at all .... . 
very clear ....... . 
quite clear . . . . . . . . 
not clear at all ..,.. 
everything ...... . 
most things ... , .. 
nothing useful .... . 
very helpful ..... . 
quite helpful ., ... . 
not helpful at all ... . 
D 
8 
D 
D 
D 
D 
D 
D 
8 
D 
If you didn't find it ·helpful or useful, would you be able to tell us why? 
Can ,you tell us of any questions you had which were not answered by the 
leaflet? 
and just out of interest, have you ever visited the Lynda Jackson Macmillan 
Centre? 
yes 
no , , , . , , .. , 
didn't want to ' ... , 
never heard of it .. ,'. 
if you visited the centre,would you please tell us how you heard of it 
and if so, did you find it helpful 
- yes 
- no 
D 
D 
D 
D 
D 
o 
Schedule 
APPENDIX 17 
LETTER TO PATIENTS 
Sent at 
2 Years Post Treatment 
Lynda Jackson Macmillan Centre for Cancer Support and Information 
Dear 
Mount Vernon and 
Watford Hospitals 
NHS Trust 
Mount Vernon Hospital 
Rickmansworth I:t...oad 
Northwood 
Middlesex HA6 21:t...N 
Telephone 01923 826111 
direct line 01923 844177 
fax 01923 844172 
My sincere apologies for inflicting these forms on you at Christmas. I know it is the 
last thing that you will want to do. I have, however, reduced the forms to a bare 
minimum. I should be extremely grateful if you would return them to me in the 
stamp-addressed envelope. 
The data which we have collected so far has been very helpful in all sorts of ways. 
The staff at Mount Vernon have become much more aware of patient's needs both 
physically and psychologically. Anyone who has returned to the Radiotherapy 
Department will have noticed that it is less crowded and we hope more efficient. 
Your comments and questionnaires have helped us to realise, from a patients point 
of view, what it feels like to have radiotherapy treatment. We have to thank you for 
making this possible. 
With b.est wishes for a very happy Christmas and New Year, 
Christine Mackenzie 
Director: Dr E Jane Maher Manal!cr: Judv Younc 
APPENDIX 18 
RESEARCH QUESTIONNAIRE 6 
Sent at Patients 
2 Years Post Treatment 
10 No Initials DOB Date Schedule 
Research Questionnaire 
For each question, please circle either YES or No, or tick boxes, where appropriate, 
and add comments 
All information received in response to this questionnaire 
will be treated in strict confidence 
Do you still have any problems related to your 
radiotherapy? 
................................................................. yES 
................................................................... NO 
If YES, please vvrite down what the problem is 
Do you feel tired? ........... YES 
:::::::::::::::::::::::::::::::::::::::::::::::::::::: ............. NO 
Have you had any further problems related to 
your cancer, if so what? 
Do you think this is due to your radiotherapy? 
.......................•......................................... YES 
................................................................... NO 
Compared with May 1995 
Do you feel 
Better ........................................................... 0 
Worse .......................................................... 0 
No Change ................................................... 0 
Looking back over your treatment, has your 
experience had a positive effect? 
................................................................. YES 
................................................................... NO 
or a negative effect? 
............. YES 
................................................................... NO 
Has your life changed since your treatment? 
................................................................... YES 
..................................................................... NO 
if YES, can you say how? 
Have you contacted the Lynda Jackson Centre 
at all? 
................................................................... YES 
..................................................................... NO 
if YES, could you please tell us why? 
Please tick the words, that best describe how 
you feel now: 
Happy ............................................................ 0 
Uncertain ....................................................... 0 
Thankful ......................................................... 0 
Fearful ........................................................... O 
Content .......................................................... O 
Depressed ..................................................... 0 
Careful ........................................................... O 
Anxious .......................................................... O 
Listless ........................................................... O 
Other .............................................................. 0 
Have you, since the last questionaire, received 
any new complementary medicine, including 
counselling? 
................................................................. YES 
........................................ NO 
If so, what ......................................................... .. 
.............................................................................. 
APPENDIX 19 
LETTER TO PATIENTS 
Sent at 
3 Years Post Treatment 
-LYllda J(lcboll Maclllill;lI\ CCII(re for CClllcer Support (lild Illforlll,,(ioll 
MOlillt VcrllUIl alld 
\VatfO.rJ Hospitals 
NI-IS Trust 
Nov. 1996 
Dear 
Moult( VcrllOIt Ilo~l'i(;l1 
ll.ickl""~\VClrth It.o~d 
Northwood 
Middlno 111\(, 21t.N 
Tdcl'hl1l1r (1192.1 112(0111 
dilcct litrc 01'12.1 R-i-1I77 
r ~ ~ II 192:\ R-i'fl71 
Once more the Christmas season is here and I am inflicting my now yearly 
questionnaires on you again. I am sure its the last thing you want to do , 
however I should be very grateful if you would return them to me in the 
stamp-addressed envelope. 
The data we have collected is continuing to guide us in your needs. We are 
hoping that our results will have an impact on the care of cancer patients 
nationally. Thank you for making this possible. 
With best wishes for Christmas and the New Year, 
6' [~1-1~ 
Christine Mackenzie 
APPENDIX 20 
RESEARCH QUESTIONNAIRE 7 
Sent at Patients 
3 Years Post Treatment 
_ 1_ n 
to No Initials DOB Date Schedule 
Research Questionnaire 
For each question, please circle either YES or No, or tick boxes, where appropriate, and add comments 
All information received in response to this questionnaire will be treated in strict confidence 
Do you still have any of problems related to your 
radiotherapy that you mentioned before? 
------------------------------------------------------ YE:~ 
--------------------------------------------------------~() 
If YES, please write down what the problem is. 
Have you had any new problems that you think 
are due to radiotherapy? 
-------------------------------------------- YE:~ 
-----------------------------------------~----------~() 
If YES, please write down what the problem is 
Have you had any new problems that you think 
an~ related to your cancer? 
----------------------------------------- YE:~ 
-----------------------------------------------~() 
If so, what? 
Do you feel tired? 
---------------------------------------------- YE:~ 
--------------------------------------~() 
Compared with November 1995, do you feel 
Better? ------------------------------------------ 0 
Wo rse? ~---------------------------------------0 
~o Change? ------------------------------------ 0 
How are you sleeping? 
~o problem ---------------------------------------- 0 
Trouble going to sleep -----------------~-------- 0 
Awake earl y ---------------------------------------- 0 
Oth e r ------------------------------------------------ 0 
How is your appetite? 
Goo d ---------------------------------------------------- 0 
Bad -------------~-----------------------------~--------- 0 
Norm a I ------------------------------------------------- 0 
Have you 
Los t we i g h t? --------------------------------------0 
Gained weight? ----------------------------------0 
Remained the same? ---------------------------0 
Have you tried any new complementary 
medicines in the last year? 
------------------------------------------------------YE:~ 
------------------------------------------------------- ~() 
Do you need to seek any information about your 
cancer now? 
--------------------------------------------------YE:~ 
--------------------------------------------------- ~() 
If so what 
Do you belong to a Cancer Patient Support 
Group? 
----------------------------------------------------YE:S 
------------------------------------------------------ ~() 
Have you had any further radiotherapy treatment 
since September 1993? 
----------------------------- . ------YE:S 
--------------------------------------- ~O 
If YES, did you find the experience any different? 
------------------------------------------------YE:S 
---------------------------------------------------- ~() 
If YES, how? 
Has anything sad/happy happened to you in the 
last year? 
------------------------------------------------------YE:~ 
------------------------------------------------------- ~() 
If so what 
------------------------------------------------------------
------------------------------------------------------------
APPENDIX 21 
LETTER TO PATIENTS 
Sent at 
4 Years PostTreatment 
Lynda Jackson Macmillan Centre for Cancer Support and Information 
15/1/98 
Dear 
Mount Vernon and 
Watford Hospitals 
NHS Trust 
direct line 
fax 
Mount Vernon Hospital 
Rickmlnsworth ROld 
Northwood 
Middlesex HA.6 2RN 
Telephone 01923 826111 
01923 844177 
01923 844172 
I must first apologise for the delay in getting you're annual form-filling package from 
me. I have moved both my office and my home and I became a little over-whelmed! 
I thought you would not mind getting all my forms after Christmas, when you have 
more time to fill them in. 
I do hope that 1997 was a -good year and that you had a wonderful Christmas and 
New Year. 
We are continuing to use your comments in a variety of ways. By studying patients 
feelings overtime we are beginning to understand more fully what the long-term 
needs for patients are and how we can cater for these needs. 
From your response to an earlier questionnaire, many patients would have liked 
more support when their radiotherapy treatment ended. However patients do not 
want to return to the department after weeks of treatment. A study is now taking 
place which links patients up via touch-tone telephone. This enables them to 
discuss problems should they arise and to call on the help of professionals if 
needed. This would give a support group but with professionals available should 
any problem occur. We are currently evaluating this idea. We have therefore 
included a question related to this on the current research questionnaire. 
As it is now over 4 years since we started this project, we have this year enclosed a 
different questionnaire along with the old familiar ones. 
Thank you so much for taking the time to fill in these endless forms. Next year will 
be the last. I really have appreciated all the efforts you have made, your comments 
have been invaluable. 
With very best wishes for 1998 
Yours sincerely 
Christine Mackenzie 
Director: Dr E Jane Maher Manager: Judy Young 
APPENDIX 22 
RESEARCH QUESTIONNAIRE 8 
Sent at Patients 
4 Years PostTreatment 
.. .. • .. .... ~ ,~, .,~~~,~ , •• "" ~,-,.:.\ ........ \.:...,... • .l.&:>..J ... h.-""i~'; :'~Iil"':J 
r -') 
10 No Initials DOB Date Schedule 
Research Questionnaire 
For each question, please circle either YES or No, or tick boxes, w/lere appropriate, and add comments 
All information received in response to this questionnaire will be treated in strict confidence 
Do you still have any of the problems related to 
your radiotherapy that you mentioned before? 
-------------------------------------------------------- l'E:~ 
----------------------------------------------------------~() 
If l'E~, please write down what the problem is. 
Have you had any new problems in 1997 that 
you think are due to radiotherapy? 
---------------------------------------------------- l'E~ 
-----------------------------------------------------~() 
If YE~, please write down what the problem is 
Have you had any new problems in 1997 that 
you think are related to your cancer? 
----------------------------------------- l'E~ 
-----------------------------------------------~ () 
If so, what? 
Have you had any further treatment 
since September "1993? 
------------------------------------------------- lIES 
----- ------------------------ ~() 
If so, what? 
Ra di oth e ra p y -----~----------------------------- 0 
C hem oth e ra p y ----------------------------------- 0 
Hormone Therapy----------------------.:---- 0 
Other medicines e.g. anti-depressants -- 0 
If so, what? 
Do you feel tired? 
------------------------------------------------------- l'E:~ 
--------------------------------------------------------~() 
Compared with November 1996, do you feel 
B etter? ------------------------------------------------ 0 
Wors e? ----------------------------------------------- 0 
No Change? --------------------------------------- 0 
Have you tried any complementary medicines in 
the last year e.g. aromatherapy, acupuncture, 
counselling? 
-------------------------------------------------------- l'E~ 
-------------------------~~-------------------------------N() 
If so, what? 
Since your cancer, have your relationships with 
friends: 
remained the same? --------------------- 0 
got more superficial?------------------------ 0 
got closer? --------------------------------- 0 
Other?---------------------------------------------- 0 
Has your circle of friends 
i ncreased?--------------------------- 0 
decreased? --------------------------- 0 
changed? ---" -------------------- 0 
other? ----------------------------------- 0 
please specify 
We are currently undertaking a study to evaluate a" 
telephone support system. Six patients will talk 
tdgether for approximately an hour each week for 
four weeks. This is done in the privacy of their 
own home via a telephone link. Two professionals 
will also be linked in to offer support, if necessary. 
All these telephone calls are being paid for. Some 
patients will have just completed radiotherapy 
treatment and will be waiting for their first follow-
up appointment. Others will have finished some 
time ago. Each group is either male or female and 
patients can be of any age. Would you be 
interested in participating in such a group? 
-------------------------------------------------------- l'E:~ 
----------------------------------------------------------N() 
If lIES, we would like to contact you by letter when 
a suitable vacancy occurs in a new group and 
give you a more detailed explanation. 
· . - ... --.... '~' ...... ·~'~ .... ,~ .. ~,# .... --"" .... <t.W"""\.1..:.....\':".I,\~..a':'\'AL\~:.:.'.;".~ ,;., ,. 
---------------------------------------------
APPENDIX 23 
LETTER TO PATIENTS 
Sent at 
5 Years Post Treatment 
Lynda Jackson Macmillan Centre for Cancer Support and Information 
2611/99 
Dear 
Mount Vernon and 
Watford Hospitals 
NHS Trust 
Mount Vernon Hospital 
Rickmansworth Road 
Northwood 
Middlesex HA6 2RN 
Telephone 01923 8261 I I 
direct line 01923 844177 
fax 01923844172 
Firstly I must apologise for the lateness with this questionnaire. Last year I was moving 
house and office, this year I have been in hospital. I had an operation to remove a tumour 
from my foot and this limited my mobility. However I am now getting back to normal. 
You will be pleased to note that this is the last set of questionnaires from me. This study 
has now been in operation for five and a half years. This time I have included all the 
questionnaires which you had at the very beginning when you first attended the 
radiotherapy department. 
In the Research Questionnaire I have also asked if you would like to receive a condensed 
write-up of the study. Please feel free to add any comments, nice or not on this 
questionnaire. We would like to know if you particuJarly disliked/liked any of the· 
questionnaires which you have filled in and if so which ones. Our aim has been to get 
feedback from you so that we can help future patients during this difficult time. 
We cannot thank you enough for all the form-filling which you have done for us over the 
past five years. I will certainly miss my annual contact with you. All that remains is to 
thank you most warmly and wish you good health this year and in the years to come. 
With best wishes 
;,,~ fvLA/' ___ .--.----
Chi[;'M~~~:-~ie 
Director: Dr E Jane Maher Manacer: Judv ¥ounc 
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RESEARCH QUESTIONNAIRE 9 
Sent at Patients 
5 Years Post Treatment 
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I Jan 99J 12 
ID No Initials DOB Date Schedule 
Research Questionnaire 
For .each question, please circle either YES or No, or tick boxes, where appropriate, and add comments 
All information received in response to this questionnaire will be treated in strict confidence 
Do you still have any of the problems related to 
your radiotherapy that you mentioned before? 
---------------------------------------------------- 1'E:~ 
------------------------------------------------------~() 
-------------------------------- . CA ~'T R E:ME:M B E:R 
If 1'ES, please write down what the problem is. 
Have you had any new problems in 1998 that 
you think are due to radiotherapy? 
------------------------------- 1'E:~ 
------------------------------------------------~() 
------------------------------------- ~ OT ~ U R E: 
If YES, please write down what the problem is 
Have you had any new problems in 1998 that 
you think are related to your cancer? 
---------------------------- -- 1'E:S 
----.----------------------------~O 
---------------------------- DO~'T K~()W 
If so, what? 
---------------------
Looking back over the last 5 years do you feel 
that you could have received more help for 
any of the problems you have experienced? 
.......................................... '" ... '" ..... 1'E:~ 
......................................................... ~O 
..... , .............................. ~()T APPLICABLE: 
If 1'es, can you suggest what could have 
been done. 
Do you feel tired? 
-------------------------------------------------------- 1'E:~ 
---------------------------------------------------------- NO 
Compared with November 1997, do you feel 
Better? -------------------------------- 1 
Wors e? ---------------------------------------------- 1 
~o Change? ------------------------------ 1 
Have you tried any complementary 
medicines in the last year e.g. 
aromatherapy, acupuncture, reflexology? 
--------- -------- 1'E:S 
--------------------------------~O 
If so, what? 
In the last year have you changed your diet, 
started an exercise program, joined a support 
group or similar which could be labelled self-help? 
------------------------------------------ 1'E:S 
If Yes, what? _____ ~O 
------------------------------
------------- -------------------
Looking back over the last 5 years can you tell us 
what you found were the three most difficult 
experiences for you in order, starting with the 
worst, then the next worse etc? 
E.g. Getting the diagnosis, surgery, radiotherapy, 
chemotherapy, hormone therapy, waiting for test 
results, some other experience 
1st -------------------------------------------------------------
2nd ... ... ... ... ... .......... . .... . ." ... 
3rd -------------------------------------------------------------
Please turn to next page 
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ID No Initials DOB Date Schedule 
Research Questionnaire continued 
I =or/~ach question, please circle either YES or No, or tick boxes, where appropriate, and add comments 
All information received in response to this questionnaire will be treated in strict confidence 
Looking back over the past five years can 
you tell us the worst three times for your 
family/close friends, in order, starting with 
the worse, then the next worse etc? 
Getting the diagnosis, surgery, radiotherapy, 
chemotherapy, hormone therapy, waiting for 
test results, or some other experience like 
waiting between surgery and radiotherapy, or 
after radiotherapy etc. 
1st ........................................................ 
2nd 
Now that the study is finishing, will you tell us 
how you felt about taking part - please tick 
any that apply. 
I found it helpful to be participating in something 
that would help other patients...... .... .... 0 
I found it unhelpful because it reminded me of my 
cancer ........................................................ 0 
It helped me come to terms with my illness..... 0 
3 rd ....................................................... It gave me confidence to talk to my doctor. .. o 
Would you like to be sent a summary of 
our report of this study? 
................................................. YES 
.................................................... NO 
It made me realise my reactions were normal 0 
It made me worry in case I experienced any of 
these problems or feelings.. .......... ........ 0 
Would you be interested to meet others who Do you have any comments you would like to 
took part in this study? make? 
. ............ ............•••.•.•••••••...•••• ... YES .............................•......................... 
................................................... NO ..............................................•................... 
.................................................•................ 
.......... ... ... . .. . ... .. . ......... ............ .................. . 
Would you agree to us contacting you? ................................................................. . 
................................................... YES ................................................................. . 
................................................... NO ................................................................. . 
...............•.................•••...................•.......... 
Thank you for all your 
responses and help during the 
course of this study. 
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1 . 10 NO : 
2. INITIALS 
3. HOSPITAL NO : 
il. DATE OF BIRTH : 
5 • GENDER: MALE(M) OR FEMALE(F) 
j. MARITAL STATUS 
7 • SOCIAL CLASS : 
3. OCCUPATION: 
L RADICAL(R) OR PALLIATIVE(P) 
1 o. PRIMARY SITE : 
11. STAGE: 
12. TREATMENT AREA: 
1 3. NO. OF FRACTIONS: 
1 4. TREATED FROM : TO : 
1 5. SF(1) or SMF(2) or LMF(3) 
1 6. SECONDARIES: 
1 7 • RELAPSE STATUS : 
18. ALlVE(A) OR DEAD(D): 
( 9. OTHER TREATMENTS : 
DATE: 
DATE: 
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Complementary Medicine Questionnaire 
Devised by lise Feigel 
~_""'''''''''''''''''''_/W'''''YlO?~~''''''''''''O''''''''''' ____ ~".~TT~~''''''''''''''T'-;,:"",'''''''''-'''7'-''''I"'o;,,:"?O:-''''""~_T~~_.~~ •.••• _._._.~ ____ ~' __ '_'_'_'_'_'_'_'_'_'_'_' ____ ~.., ____ ._._ 
COMPLEMENTARY THERAPIES QUESTIONNAIRE 
Have you tried any complementary therapies since you last filled in a set 
of questionnaires for this study? .......................................................... YES/NO 
IF NO, you do not need to proceed further. IF YES, what did you try? Please 
list therapies tried, and rate their: effectiveness. 
VERY QUITE A LITTLE NOT AT ALL 
HELPFUL HELPFUL HELPFUL HELPFUL 
1 . ACUPRESSURE ................... . 
2. ACUPUNCTURE ................... . 
3. ALEXANDER TECHNIQUE. ... . 
4. AROMATHERAPY .............. . 
5. ART THERAPy ........•............ 
6. AUTOGENIC THERAPy ......... . 
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4 
4 
7. BEHAVIOURAL THERAPy ... . 
8. BIOFEEDBACK ........•............ 
9. BREATHING TECHNIQUES ... 
1 O. CHIROPRACTiC ...•........... 
11. COLONIC IRRIGATION ... . 
12. COLOUR THERAPy ......... . 
13. COUNSELLING ..........•...... 
14. CRANIAL OSTEOPATHY ... 
15. DRAMATHERAPy ..•.............. 
16. FLOATATION THERAPy ..... . 
17. HEALING ............................. . 
18. HERBALlSM ....•.....•...•.......... 
1 9. HOLISTIC TREATMENTS ..... . 
20. HOMOEOPATHy .................. . 
21. IRIDOLOGY ....••......••............ 
22. MASSAGE ...•••.........•. : ......... . 
23. MEDIT ATION~ •....•.•....••........ 
24. MOVEMENT/EXERCISE 
THERAPy .......................... . 
25. MUSIC THERAPy ...•.....•...... 
26. NATUROPATHy .................. . 
27. NUTRITIONAL MEDICINE. .. 
28. OSTEOPATHy ..................... . 
29. PSyCHOTHERAPy ............... . 
30. REFLEXOLOGy ..................... . 
31. REFLEXZONE THERAPy ...... . 
32. RELAXATION .........•.............. 
33. SHIATZU ............................. . 
34. T AI-CHI-CH'UAN ............... . 
35. ViSUALISATION ................ . 
36. VITAMIN THERAPy ............ . 
3 7 . YO G A ................................... . 
38. CANCER SUPPORT GROUP .. 
39. TELEPHONE SUPPORTIINFO 
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APPENDIX 28 
Table2: Demographic and Medical Characteristics at 1st 
Treatment 
Table 2: Showing Demographic And Medical Characteristics at Ct Treatment 
DEMOGRAPIDC Nos 0/0 MEDICAL Nos 0/0 
Gender Sites 
Female 147 57.0 Breast* 101 39.0 
Male 110 43.0 Lung 39 14.0 
Prostate 25 9.0 
Social Class Skin** 24 9.0 
Other*** 15 7.0 
Class A 13 5.0 Gastro-int 13 5.0 
Class B 39 15.0 Bladder 12 5.0 
Class Cl 79 30.0 Head & Neck 10 4.0 
Class C2 68 26.0 Gynae 10 4.0 
ClassD 48 19.0 NHL 5 1.0 
Unclassified 10 5.0 Unknown 3 1.0 
Marital Status Treatment Intent 
Married 174 68.0 Radical 166 65.0 
Widowed 45 17.0 Palliative 91 35.0 
Divorced 18 7.0 Ages 
Single 16 6.4 18-25 3 1.0 
Separated 6 2.1 26-50 44 17.0 
Unknown 1.0 50-65 83 32.0 
Partner 4 1.5 65+ 127 50.0 
* Includes one male breast patient 
** Includes only superficial tumours, melanoma is included in 'others'. 
*** Includes glioblastoma, sarcoma, mesothelioma, Hodgkin's Disease, melanoma 
APPENDIX 29 
Table3: Demographic and Medical Characteristics at Mid-
Treatment 
Table 3: Showing Demographic And Medical Characteristics at Mid-Treatment 
DEMOGRAPIUC Nos 0/0 MEDICAL Nos % 
Gender Sites 
Female 115 68.0 Breast* 87 51.0 
Male 53 32.0 Lung 8 5.0 
Prostate 12 5.0 
Social Class Skin** 8 5.0 
Other*** 10 6.0 
Class A 8 5.0 Gastro-int 10 6.0 
ClassB 28 16.0 Bladder 7 5.0 
Class Cl 54 32.0 Head & Neck 9 5.0 
Class C2 35 21.0 Gynae 9 4.0 
Class D 36 22.0 NHL 5 3.0 
Unclassified 7 4.0 Unknown 3 3.0 
Marital Status Treatment Intent 
Married 112 66.0 Radical 145 86.0 
Widowed 23 14.0 Palliative 23 14.0 
Divorced 11 6.0 Ages 
Single 14 8.0 18-25 3 2.0 
Separated 4 3.0 26-50 36 21.0 
Unknown 0 0.0 50-65 60 350 
Partner 4 3.0 65+ 69 42.0 
* Includes one male breast patient 
** Includes only superficial tumours, melanoma is included in 'others'. 
*** Includes glioblastoma, sarcoma, mesothelioma, Hodgkin's Disease, melanoma 
APPENDIX 30 
Table4: Demographic and Medical Characteristics at End 
of-Treatment 
Table 4: Showing Demographic And Medical Characte"istics at End of Treatment 
DEMOGRAPIllC Nos 0/0 MEDICAL Nos 0/0 
Gender Sites 
Female 131 61.0 Breast* 89 41.0 
Male 84 39.0 LWlg 25 12.0 
Prostate 18 8.0 
Social Class Skin * * 8 5.0 
Other*** 12 6.0 
Class A 10 4.0 Gastro-int 12 6.0 
ClassB 34 15.0 Bladder 8 4.0 
Class CI 67 31.0 Head & Neck 10 5.0 
Class C2 55 26.0 Gynae 10 5.0 
ClassD 41 20.0 NHL 5 2.0 
Unclassified 8 4.0 Unknown 4 2.0 
Marital Status Treatment Intent 
Married 143 66.0 Radical 160 74.0 
Widowed 33 15.0 Palliative 55 26.0 
Divorced 15 7.0 Ages 
Single 14 7.0 18-25 3 1.0 
Separated 6 3.0 26-50 39 18.0 
Unknown 0 0.0 50-65 72 34.0 
Partner 4 2.0 65+ 101 47.0 
APPENDIX 31 
TableS: Demographic and Medical Characteristics at 4 
Weeks Post Treatment 
Table 5: Showing Demographic And Medical Characteristics at 4 Weeks Post 
Treatment 
DEMOGRAPIDC Nos 0/0 MEDICAL Nos 0/0 
Gender Sites 
Female 134 61.0 .Breast* 92 42.0 
Male 84 39.0 Lung 26 12.0 
Prostate 21 9.0 
Social Class Skin** 20 9.0 
Other**· 10 5.0 
Class A 11 5.0 Gastro-int 12 6.0 
Class B 32 15.0 Bladder 8 4.0 
Class CI 67 32.0 Head & Neck 10 5.0 
Class C2 58 28.0 Gynae 10 5.0 
ClassD 41 20.0 NHL 5 2.0 
Unclassified 0 0.0 Unknown 5 2.0 
Marital Status Treatment Intent 
Married 147 68.0 Radical 155 72.0 
Widowed 33 15.0 Palliative 63 28.0 
Divorced 14 6.0 Ages 
Single 13 6.0 18-25 2 1.0 
Separated 6 3.0 26-50 35 18.0 
Unknown 0 0.0 50-65 72 34.0 
Partner 4 2.0 65+ 108 47.0 
* Includes one male breast patient 
** Includes only superficial tumours, melanoma is included in 'others'. 
*** Includes glioblastoma, sarcoma, mesothelioma, Hodgkin's Disease, melanoma 
APPENDIX 32 
Analysis of Research Questionnaire at End of Treatment 
Analysis of Research Questionnaire at the end of treatment 
The questionnaire was divided into four different sections; information and 
control, social support, psychological well being, and physical well-being. A total 
number of two hundred and fifteen patients (80%) completed the requisite number of 
questionnaires. 
The research questionnaire at the end of treatment consisted of twenty eight 
questions, (See Appendix 7) 
Information and Control 
Question 1, Do you feel you were given enough information before your 
radiotherapy treatment? 
All patients are sent a booklet before they attend the department. Is this 
information adequate? Nineteen patients (9%) only felt it was not sufficient. This 
cohort consisted of twelve women and seven men, ten radical patients and 9 palliative 
and 95% from social classes C and D. These patients were being treated primarily for 
bladder (33%); unknown; (25%); prostate (20%); gastro-intestinal patients (20%). 
Information eases anxiety, Ridgeways & Mathews, 1992)\ further analysis 
was carried out to see if the patients who had enough information were less anxious. 
Although there was a difference in the means, the 'enough' information group having 
a mean of 5.21 as opposed to 5.89. This difference was not significant. Eight patients 
(44%) of the cohort exhibiting high anxiety came into the group of 'not enough 
information' and one (5%) of those patients scoring 11 and over on the HAD Scale. 
Question 2, Do you feel you have been given too much information? 
Only four (2%) patients replied in the affirmative, two palliative men patients 
and two women radical women patients. Those who thought they had been given too 
much information were significantly more depressed, p=0.017. 
Question 18 - Did you go to the Lynda Jackson Macmillan Centre? 
At the end of treatment 18% (39) patients had visited the centre, thirty women 
and nine men. Patients, who came on transport, spoke of their disappointment at not 
being able to go to the centre as they were worried about missing their transport home 
and having to wait hours, or having to keep others waiting. 
The other set of six questions all relate to the above question and were only 
answered by those who had visited the centre. 
Question 19 - I used counselling .... YeslNo 
A total of seventeen patients used the counselling facility, fourteen women and 
three men. 
Question 20 - I used relaxation ... YeslNo 
Seven patients said they had used relaxation, six women and one man. 
Question 21 - I used Yoga ... YesINo 
Three patients used yoga, one woman and two men. 
Question 22 -I looked at the books ... YeslNo 
There is a large display of pamphlets giving information on a wide range of 
topics in the reception area of the Lynda Jackson Centre. There is also a large 
collection of books which patients can browse through to gain information on specific 
cancers and treatments. The number of patients who looked at the books was twenty 
seven, twenty-one women and six men. 
Question 23 - I looked at the tapes ... YeslNo 
The Lynda Jackson Centre is equipped with a number of specialist tapes. 
Videos from recent TV programmes are available for patients to view together with 
other relevant material. The number of patients that used this facility was eight. 
Question 24 - I used group therapy ... YeslNo 
Group therapy only started at the end of this study therefore numbers are low, 
two in all. 
Social Support 
Question 4 - Did you feel you needed more support while undergoing 
radiotherapy? 
Only fourteen patients (6%) felt they needed more support while being treated 
with radiotherapy. Fifty percent of patients suffering from Non-Hodgkin's 
lymphoma and Unknown primary, felt in need of more support during treatment. 
Dividing the patients into groups, the palliative women patients (18%) were the most 
in need and those women in the age group 26-50 particularly if they were single or 
separated. 
Those patients who responded in the affirmative to this question were 
significantly more depressed (p=0.003) and more distressed (p=O.Ol) if they had 
dependants. 
Question 5 - Did you talk with the counsellor over the treatment period? 
A total of 26% of patients said they had talked to a counsellor. A quarter of 
radical patients and 27% of palliative responded in the affirmative and 23% of women 
and 30% of men. There was only a very weak correlation between talking with the 
counsellor and needing more support (FO.1 03). There were no significant differences 
in psychological distress in those patients who had talked with the counsellor and 
those who had not. 
Question 11 - Were you accompanied when you attended the radiotherapy 
department for treatment? 
Approximately half (51%) of the patients were accompanied. The palliative 
patients received more support (61%) than the radical cohort (50%). No significant 
differences in anxiety or depression were found whether patients were accompanied 
or not. 
Question 16 - Do you have at least one relative or friend in whom you can confide? 
A total of 97% said they had a 'confidante'. From the six people who felt they 
had no 'confidante', five were men and one, a palliative women patient. The mean 
for the group without a 'confidante' was higher in both anxiety and depression. 
The group with a 'confidante' had a mean of 5.22 and the group without, 7 for 
anxiety. With depression, the group mean with a 'confidante' was 4.10 and without 
5.50. 
Psychological Well-Being 
Question 3 - Would you have felt more confident if you had made a visit to the 
Radiotherapy Department before treatment to meet the staff that would be looking 
after you and to see where you would be treated? 
Over a quarter of the patients would have liked to make a prior visit to the 
department Of the total of two hundred and nine patients who answered this question, 
six patients had already visited the department. This was evenly divided between 
radical and palliative patients, 26% radical and 28% palliative. More than twice as 
many women wanted a visit compared with the men, 34% and 14% respectively. The 
biggest cohort was the palliative women patients (43%). 
Question 6 - Did you ever feel frightened during your radiotherapy treatment? 
A total of 20% (43) of the patients said they felt frightened, 27% women and 
8% men. Patients who were being treated for tumours of 'Unknown' primary and 
Non Hodgkin's Lymphoma were especially susceptible. The patients who felt 
frightened had significantly higher anxiety rates than those who did not (p<0.007 
HADS, p<0.011 STAI State). 
Question 7 -If yes, would you have like. to talk to someone about this? 
Only those who responded that they had felt frightened replied to this question 
and over half (58%) said they would have liked to speak with someone about the 
problem. One patient wrote that she 
"had a giddy spell on· the couch but that the staff had helped her overcome 
her fear of being left alone" 
Question 8 - Did you experience any anxiety or fear about your illness at the 
weekends? 
Patients did experience fear at the weekend. Altogether 26% (56) replied in 
the affirmative. This was fairly evenly distributed between the women (28%) and 
men (24%). The palliative patients were the most anxious with 38% replying in the 
affirmative, especially the female palliative women (45%). All the patients who had 
'Unknown' origin cancer experienced this fear. A significant difference was found in 
anxiety and depression, with those patients experiencing fears at the weekend being 
the highest group (Anxiety HADS p<O.OOl, anxiety STAI State p<O.OOl, depression 
p<O.OOl) 
Question 9 - Did you experience any anxiety or fears after your treatment ended? 
This question was to be answered only by patients when they received the 
same questionnaire four weeks later. 
Question 10 - Did the machine, you were being treated on, ever break down? 
Having a machine breakdown during treatment is a frightening experience for 
patients. The number who responded in the affirmative to this question is high at 
32%. It was distributed between men and women, 34% and 27% respectively. 
Further analysis revealed no significant results. 
Question 13 - Do you have any dependants? 
Having dependants could alter anxiety levels. An overall total of 68% had 
dependants. This consisted of 60% of the women and 84% of the men, 66% of the 
radicals and 78% of the palliative patients. Further analysis using GLM showed that 
palliative patients were significantly more distressed if they had dependants 
(depression p<0.003 and more distressed p=O.Ol). 
Question 17 - Do you have any money worries? 
Financial problems could be a cause of high anxiety. Only 17% (36) of 
patients felt they had financial worries. No significant effects were found with 
money, or without it in relationship to anxiety or depression. 
Question 25 - Was there a delay in your diagnosis? 
A total of 17% (38) had a delay in diagnosis. In particular, half of the cancer 
of the bladder patients experienced this delay. Further analysis on anxiety and 
depression revealed no significant results. 
Physical Well-Being 
Question 12 - Do you now feel better, no change, worse? 
By the end of treatment 35% (75) felt better, 46% (99) 'no change', and 12% 
(25) felt worse. Dividing into patient groups, 42% of the palliative patients felt better, 
50% 'no change' and 8% worse. All the palliative patients who were 'worse' were in 
the age group 50-65+. 50% of the male palliative group felt better. The radical 
cohort, 36% felt better, 50% 'no change' and 14% worse. With regard to site of the 
cancer, 75% of those patients with Non Hodgkin's Lymphoma felt worse. Further 
analysis revealed a significant difference in depression for patients who felt worse, 
(p=0.031) 
Question 14 - Are you taking any medicines? 
Over 70% was taking medicines, which range from tamoxifen to aspirin. Four 
of the patients were on anxiolytics and three on anti-depressants. 
Question 15 - Are you still suffering from any symptoms as a result of your 
radiotherapy treatment? 
At the time of the end questionnaire, 60% of the patients had symptoms from 
their radiotherapy treatment. The radical patients were suffering more than the 
palliatives - with 64% and 47% respectively having symptoms. The radical women 
were the largest cohort with 67%. Only patients suffering from skin cancer were 
except. 
There appeared to be a difference in anxiety in patients who had side-effects 
from treatment (Mean 5.527) and those who did not (Mean 4.894) but this difference 
was not significant (p=0.255). Similarly, with depression those patients who had 
symptoms from their treatment had a higher mean (Mean 4.433) than those who did 
not (Mean 3.705), but this difference was not significant (p=0.146). A negative 
correlation was found between those patients who felt worse and those suffering from 
any symptoms as a result of their treatment (r=-0.78) 
Question 26 - Has any of your family had cancer? 
To be told one has cancer is frightening - it has even been referred to as the 
"standardized nightmare of our society" Rosser & Maguire, 19822 
If one has already had a friend or relative with cancer, anxiety could be further 
heightened. 
A total of 58% replied in the affirmative. Further analysis with anxiety and 
depression was not significant. 
Question 27 - Is there anyway in which your radiotherapy treatment could have 
been made less stressful? 
At the end of treatment, 57% responded in the affirmative. A space was left 
so that patients could add comments and 22% took the opportunity. These responses 
were subdivided. Positive responses accounted for 35% and comments ranged from 
"No, everyone caring and friendly" and "1 think the radiotherapy staff are 
wonderful. They show so much care, concern and comfort" to 
"Very satisfied" 
Secondly, waiting time was mentioned by 25% of the patients. Their critical 
remarks ranged from 
from 
"Only by less waiting for appointment (know this is difficult)", to 
"Better appointment system" 
Thirdly, travel was cited by 17% as being very stressful. Comments ranged 
"If only it had been carried out at my local hospital", and 
"Travelling was the most stressful part of the treatment" 
Fourthly, information, 14% of patients wanted more information. Remarks such 
as 
"A little more preparation and medical help with the excessive diarrhoea I 
suffered", and 
"The number of treatments wasn't clearly specified". 
Question 28 - Other than your current illness, have you suffered a recent stressful 
event, e.g. bereavement, divorce? 
A total of 26% had suffered a recent stressful event. Analysis was carried out to 
see if anxiety or depression were related to the stressful event. No significant effects 
were found. 
APPENDIX 33 
Analysis of Research Questionnaire at 4 Weeks Post 
Treatment 
Analysis of Research Questionnaire 
The questionnaire (See Appendix 7) sent out to patients four weeks after their 
treatment finished was the same as the questionnaire given to patients at the end of 
treatment and was divided into the same sections. Questions pertained to information 
and control, to social support, to psychological well-being and to physical well-being. 
A total number of two hundred and eighteen patients responded to this questionnaire. 
The patient cohort was different to those responding to the end of treatment 
questionnaire as it contained the single fraction patients. 
Information and control 
Question 1, Do you feel you were given enough information before your 
radiotherapy treatment? 
Patients had all received a booklet giving them information. In this question, 
. one hundred and seventy three (80%) patients felt they were given enough 
information. A significant difference was found on the ST AI State anxiety scale, 
p=0.048. Those patients who responded 'No' were significantly more anxious and 
depressed p=0.025. 
Question 2, Do you feel you have been given too much information? 
Only two patients from a sample size of two hundred and eighteen thought 
they had been given too much information. This cohort consisted of one radical 
female and one palliative man. No significant differences were found. 
Question 18 - Did you go to the Lynda Jackson Macmillan Centre? 
Four weeks post treatment forty one (19%) patients said they had visited the 
centre. This cohort consisted of only four (2%) palliative patients. A total of thirty 
two (24%) women and nine (10%) men had visited. It was only from patient 
feedback that it was realized that patients' friends and relatives were using the centre 
while the patients were being treated. This was therefore not included in the 
questionnaire. 
A set of six questions all relating to the above question were only answered by 
those who had visited the centre. 
Question 19,1 used counselling ..... YeslNo 
A total of seventeen used the counselling facility. This number consisted of 
fourteen female radical patients, and two male radical patients, one palliative female. 
Question 20, 1 used relaxation .. ... YeslNo 
A total of forty two responded to this question. Five replied in the affirmative, four 
radical and one palliative patient. 
Question 21 - 1 used yoga .... YeslNo 
One radical male patient had used yoga. 
Question 22 - 1 looked at the books .... YeslNo 
A total of fifty eight responded, of which 47% (27) replied in the affirmative. 
This cohort consisted of only radical patients, eighteen women and nine men. 
Question 23 -I looked at the tapes .... YeslNo 
There is a large number of tapes on cancer and various treatments in the Lynda 
Jackson Centre. The number of patients who used this facility was six, four radical 
and two palliative women. 
Question 24 - 1 used group therapy . ... YeslNo 
Only one radical woman patients responded 'Yes'. 
Social Support 
Question 4 - Did you feel you needed more support while undergoing 
radiotherapy? 
Four weeks past treatment, twenty six (12%) patients felt they needed more 
support. This cohort consisted of twelve radical females, seven palliative females, 
three radical males and four palliative male patients. The sites involved were breast 
(12%), 'unknown' origin (33%) and NHL (40%) and lung (23%). Those patients who 
felt they needed more support had higher anxiety and depression and this difference 
was significant (anxiety p<O.OOl, depression < 0.001. 
Question 5 - Did you talk with the counsellor over the treatment period? 
A total of forty six (21%) patients had spoken with the counsellor. They 
consisted of twenty one radical and three palliative women and thirteen radical and 
nine palliative men. People might have construed that this question related 
specifically to the counsellor at the Centre. Therefore it should have read 'Did you 
talk with a counsellor during the treatment period? There were no significant 
differences in psychological distress in those patients who had talked with the 
counsellor and those who had not. 
Question 11 - Were you accompanied when you attended the radiotherapy 
department for treatment? 
Over half of the patients were accompanied. The palliative patients (61%) 
received more support than the radical patients (50%). A total of 62% of the male 
palliative patients were accompanied and 59% of the female palliative patients. No 
significant differences were found in anxiety or depression whether patients were 
accompanied or not. 
Question 16 - Do you have at least one relative or friend in whom you can confide? 
Only three patients (1%) felt they did not have someone to confide in. This 
group consisted of one female palliative patient, one radical and one palliative male 
patient. The mean of the group who had a confidante was 4.9 for anxiety. For the 
group, which did not have a confidante, it was 6.75. However, this difference was not 
significant. 
Psychological Well Being 
Question 3 - Would you have felt more confident if you had made a visit to the 
radiotherapy department before treatment to meet the staff that would be looking 
after you and to see where you would be treated? 
Of the total of two hundred and nine patients who answered this question, six 
patients had already visited to the department. A third of the patients would have 
liked to visit the department prior to treatment. More than twice as many women 
wanted to make the visit than men. The women palliative patients were the largest 
cohort with 43% wanting to visit. Three quarters of the NHL patients would have 
liked a prior visit, 42% of the breast patients and two thirds of those with cancer of 
'unknown' origin. 
Question 6 - Did you ever feel frightened during your radiotherapy treatment? 
A total of 20% (43) of the patients said they felt frightened. The highest 
cohort was the radical women, of which 30% felt frightened. One third of the breast 
patients, 30% of the head and neck patients and gynaecological and a quarter of the 
bladder patients all experienced fear during treatment. 
Those patients who felt frightened were significantly more anxious (p<O.OOl) 
and distressed (p=0.039) than those patients whom did not feel frightened. 
Question 7 - If yes, would you have liked to talk to someone about this? 
At the time of the first postal questionnaire, twenty five (58%) patients said 
they would have liked to talk to someone about the problem. At the time of this 
questionnaire thirty (70%) of the forty three who felt frightened would have liked to 
have spoken to someone. 
This cohort consisted of twenty four women, nineteen radicals and five 
palliatives and six men, three radicals and three palliative. The largest cohort with 
reference to site was 50% of the NHL, 'Unknown' origin, and 'other' and 36% of the 
breast patients. 
Question 8 - Did you experience any anxiety or fears about your illness at the 
weekends? 
Patients did experience fear at the weekends. A total of 35% (74) replied in 
the affirmative, with palliative patients (40%), in particular, experiencing anxiety at 
the weekends. The largest group was the female .palliative patients of which 42% 
experienced anxiety at the weekends. Patients who were being treated for cancer of 
'unknown' origin, NHL (66%), lung (54%) and head and neck and gynaecological 
(40% 
Those patients experiencing anxiety or fear were significantly more anxious 
(p<O.OOl) and depressed, (p<O.OOI). 
Question 9 - Did you experience any anxiety or fears after your treatment ended? 
A total of two hundred and sixteen patients responded to this question. From 
this cohort, 40% (87) did experience anxiety after their treatment had ended. This 
number consisted of 39% of the radical women patients, 42% of the palliative women 
patients, 42% of the male radicals and palliatives. Particular sites to note were 
'unknown' origin (100%), NHL (80%), bladder (62%), 50% gynaecological and lung 
patients and 48% prostate. 
Those who experienced anxiety or fear after their treatment were significantly 
more anxious, distressed and depressed than those who were not (p<O.OOl). 
Question 10 - Did tlte mac/tine, you were being treated on, ever break down? 
Having a machine breakdown while undergoing treatment is frightening for 
the patient. Over a third of the patients experienced this. Further analysis revealed no 
significant results. 
Question 13 - Do you Itave any dependants? 
Having dependants could have a psychological effect on the patients. Of the 
patients who answered this question, 71% did have dependants. The mean anxiety for 
those patients who had dependants was 5.42, and those who did not have dependants 
was 4.03. This difference was significant (p=0.031). Similarly, the mean for 
psychological distress was 6.9 for those whom had dependants and 5.8 for those who 
did not and this difference was significant (p=0.05). No significant differences were 
found in depression. 
Question 17 - Do you have any money worries? 
Financial problems could lead to patients feeling more anxious. Only 23% of 
patients felt they had financial worries. No significant effects were found between 
those patients who felt they had money worries and those who did not except in the 
STAI State, p=0.024. 
Question 25 - Was there a delay in you diagnosis? 
A delay in diagnosis could have caused an increase in anxiety. A total of 22% 
(47) did experience a delay. No significant differences were found in depression or 
distress for those patients experiencing a delay. However, those patients who 
experienced a delay in diagnosis were significantly more anxious in both HADS and 
STAI State, than those who did not, p=0.009 and p=0.20 respectively 
Physical well-being 
Question 12 - Do you now feel better, no change, worse? 
Overall 52% felt better, 32% 'no change' and 12% worse. With the radical 
patients, 36% felt better, 50% 'no change' and 14% worse. The palliative patient 
group did better with 66% feeling better, 24% 'no change' and 10% worse. With 
regard to the site of the cancer, 40% of those patients with NHL felt worse as did 20% 
of those patients with head and neck tumours. Further analysis revealed significant 
difference in distress, p<O.OOl, depression, p<O.OOl and anxiety, p<0.05. A post hoc 
Tukey-HSD test showed that in terms of distress, patients, who felt better, had 
significantly lower distress levels than those patients who had 'no change' in their 
condition and those patients who felt worse. Similarly, those, who did not think their 
condition had improved, had significantly lower distress than those who felt worse. 
Similar results occurred with the variable of depression. With anxiety, the patients 
who felt better had significantly lower anxiety levels than both the 'no change' 
patients and the patients who were feeling worse. There was no significant difference 
between those feeling worse and the no different patients. 
Question 14 -Are you taking any medicines? 
Two thirds of the patients were taking medicines. These ranged from 
tamoxifen to aspirin. Four of the patients were on anxiolytics and four on anti-
depressants. 
Question 15 - Are you still suffering from any symptom as a result of your 
radiotherapy treatment? 
Four weeks from the end of their treatment, 49% of the patients still had side-
effects from their treatment. The radical patients were suffering more than the 
palliative, 50% and 46% respectively. With respect to the site of the cancer, 78% of 
the head and neck patients, 70% lung and bladder patients, 47% of the prostate all 
those of 'unknown' origin, and 40% of the breast patients were all having symptoms 
still. 
The means of patients having symptoms was higher than those without 
symptoms. Further analysis to see if those patients having symptoms were more 
anxious, depressed and or distressed revealed . significant results with distress, 
p=0.007, and depression p=0.002. Anxiety was not significant. 
Question 26 -Have any of your family had cancer? 
A total of 58% (124) patients said they had cancer in their family. Analysis 
was carried out to see if anxiety, depression or distress were heightened because of 
this, but no significant results were revealed. 
Question 27 - Is there anyway in which your radiotherapy treatment could have 
been made less stressful? 
Over half (56%) responded that their treatment could not have been made 
more stressful, with 29% (64) patients making comments on the forms. A number of 
patients (33%) made positive comments. These ranged from 
'The staff at Mount Vernon could not have been more kind and helpful', 
to 
'The staff created a confident inspiring atmosphere'. 
Waiting time was cited by ten (16%) of patients. Comments ranged from 
'Just the unknown waiting time was difficult', to 
'The second or third week I became very impatient when I had to wait 45 minutes for 
treatment and then 65 minutes the next day' 
Nine (14%) patients wanted more information. Remarks such as 
'A little more pre-preparation and medical help with excessive diarrhoea I 
suffered', and 
'The number of treatments wasn't clearly specified'. 
Travel and transport was again cited in the postal questionnaire by 10 (16%) 
of patients. Remarks such as 
'If treatment could have been nearer home', and 
'If the journey was shorter', 
were typical of comments made by patients in this instance. 
Eight (12%) of patients' comments were put into 'other' category. These 
comments included 
'Avoid using the word 'cancer' on hospital buildings and notices' to 
'One physician should always attend the same patient - shunting kills a 
patient as new physicians are ignorant' . 
Four (6%) of patients specifically mentioned the lack of post treatment 
contact. These are some of the comments: 
'I would have liked more information on the after-effects' and 
. , 
'5 weeks of treatment - 4 days per week. Saw a doctor each Monday for 
about 10 minutes. The last Friday I just left. Nobody said anything 
except I would hear from a doctor in 4-6 weeks'. 
One final comment: 
'When completed you could be told what to expect until you see the 
Consultant some weeks later'. 
Question 28 - Other than your current illness, have you suffered a recent stressful 
event e.g. bereavement, divorce? 
A quarter of the patients had suffered a recent stressful event. The means for 
depression, anxiety and distress scores for the patients who had suffered were higher 
than for those who had not. However these differences was not significant. 
Analysis of Research Questionnaire 
The questionnaire (See Appendix 7) sent out to patients four weeks after their 
treatment finished was the same as the questionnaire given to patients at the end of 
treatment and was divided into the same sections. Questions pertained to information 
and control, to social support, to psychological well-being and to physical well-being. 
A total number of two hundred and eighteen patients responded to this questionnaire. 
The patient cohort was different to those responding to the end of treatment 
questionnaire as it contained the single fraction patients. 
Information and control 
Question 1, Do you feel you were given enough information before your 
radiotherapy treatment? 
Patients had all received a booklet giving them information. In this question, 
one hundred and seventy three (80%) patients felt they were given enough 
information. A significant difference was found on the ST AI State anxiety scale, 
p=0.048. Those patients who responded 'No' were significantly more anxious and 
depressed p=0.025. 
Question 2, Do you feel you have been given too much information? 
Only two patients from a sample size of two hundred and eighteen thought 
they had been given too much information. This cohort consisted of one radical 
female and one palliative man. No significant differences were found. 
Question 18 - Did you go to the Lynda Jackson Macmillan Centre? 
F our weeks post treatment forty one (19%) patients said they had visited the 
centre. This cohort consisted of only four (2%) palliative patients. A total of thirty 
two (24%) women and nine (10%) men had visited. It was only from patient 
feedback that it was realized that patients' friends and relatives were using the centre 
while the patients were being treated. This was therefore not included in the 
questionnaire. 
A set of six questions all relating to the above question were only answered by 
those who had visited the centre. 
Question 19, I used counselling ..... YeslNo 
A total of seventeen used the counselling facility. This number consisted of 
fourteen female radical patients, and two male radical patients, one palliative female. 
Question 20, I used relaxation .. ... YeslNo 
A total of forty two responded to this question. Five replied in the affinnative, four 
radical and one palliative patient. 
Question 21 - I used yoga .... YeslNo 
One radical male patient had used yoga. 
Question 22 - I looked at the books .... YeslNo 
A total of fifty eight responded, of which 47% (27) replied in the affirmative. 
This cohort consisted of only radical patients, eighteen women and nine men. 
Question 23 - I looked at the tapes .... YeslNo 
There is a large number of tapes on cancer and various treatments in the Lynda 
Jackson Centre. The number of patients who used this facility was six, four radical 
and two palliative women. 
Question 24 - I used group therapy .... YesINo 
Only one radical woman patients responded 'Yes'. 
Social Support 
Question 4 - Did you feel you needed more support while undergoing 
radiotherapy? 
Four weeks past treatment, twenty six (12%) patients felt they needed more 
support. This cohort consisted of twelve radical females, seven palliative females, 
three radical males and four palliative male patients. The sites involved were breast 
(12%), 'unknown' origin (33%) and NHL (40%) and lung (23%). Those patients who 
felt they needed more support had higher anxiety and depression and this difference 
was significant (anxiety p<O.OOl, depression < 0.00 l. 
Question 5 - Did you talk with the counsellor over the treatment period? 
A total of forty six (21 %) patients had spoken with the counsellor. They 
consisted of twenty one radical and three palliative women and thirteen radical and 
nine palliative men. People might have construed that this question related 
specifically to the counsellor at the Centre. Therefore it should have read 'Did you 
talk with a counsellor during the treatment period? There were no significant 
differences in psychological distress in those patients who had talked with the 
counsellor and those who had not. 
Question 11 - Were you accompanied when you attended the radiotherapy 
department for treatment? 
Over half of the patients were accompanied. The palliative patients (61 %) 
received more support than the radical patients (50%). A total of 62% of the male 
palliative patients were accompanied and 59% of the female palliative patients. No 
significant differences were found in anxiety or depression whether patients were 
accompanied or not. 
Question 16 - Do you have at least one relative or friend in whom you can confide? 
Only three patients (1 %) felt they did not have someone to confide in. This 
group consisted of one female palliative patient, one radical and one palliative male 
patient. The mean of the group who had a confidante wa~ 4.9 for anxiety. For the 
group, which did not have a confidante, it was 6.75. However, this difference was not 
significant. 
Psychological Well Being 
Question 3 - Would you have felt more confident if you had made a visit to the 
radiotherapy department before treatment to meet the staff that would be looking 
after you and to see where you would be treated? 
Of the total of two hundred and nine patients who answered this question, six 
patients had already visited to the department. A third of the patients would have 
liked to visit the department prior to treatment. More than twice as many women 
wanted to make the visit than men. The women palliative patients were the largest 
cohort with 43% wanting to visit. Three quarters of the NHL patients would have 
liked a prior visit, 42% of the breast patients and two thirds of those with cancer of 
'unknown' origin. 
Question 6 - Did you ever feel frightened during your radiotherapy treatment? 
A total of 20% (43) of the patients said they felt frightened. The highest 
cohort was the radical women, of which 30% felt frightened. One third of the breast 
patients, 30% of the head and neck patients and gynaecological and a quarter of the 
bladder patients all experienced fear during treatment. 
Those patients who felt frightened were significantly more anxious (p<O.OOl) 
and distressed (p=0.039) than those patients whom did not feel frightened. 
Question 7 -If yes, would you have liked to talk to someone about this? 
At the time of the first postal questionnaire, twenty five (58%) patients said 
they would have liked to talk to someone about the problem. At the time of this 
questionnaire thirty (70%) of the forty three who felt frightened would have liked to 
have spoken to someone. 
This cohort consisted of twenty four women, nineteen radicals and five 
palliatives and six men, three radicals and three palliative. The largest cohort with 
reference to site was 50% of the NHL, 'Unknown' origin, and 'other' and 36% of the 
breast patients. 
Question 8 - Did you experience any anxiety or fears about your illness at the 
weekends? 
Patients did experience fear at the weekends. A total of 35% (74) replied in 
the affirmative, with palliative patients (40%), in particular, experiencing anxiety at 
the weekends. The largest group was the female palliative patients of which 42% 
experienced anxiety at the weekends. Patients who were being treated for cancer of 
'unknown' origin, NHL (66%), lung (54%) and head and neck and gynaecological 
(40% 
Those patients experiencing anxiety or fear were significantly more anxious 
(p<O.OOl) and depressed, (p<O.OOl). 
Question 9 - Did you experience any anxiety or fears after your treatment ended? 
A total of two hundred and sixteen patients responded to this question. From 
this cohort, 40% (87) did experience anxiety after their treatment had ended. This 
number consisted of 39% of the radical women patients, 42% of the palliative women 
patients, 42% of the male radicals and palliatives. Particular sites to note were 
'unknown' origin (100%), NHL (80%), bladder (62%), 50% gynaecological and lung 
patients and 48% prostate. 
Those who experienced anxiety or fear after their treatment were significantly 
more anxious, distressed and depressed than those who were not (p<O.OOI). 
Question 10 - Did the machine, you were being treated on, ever break down? 
Having a machine breakdown while undergoing treatment is frightening for 
the patient. Over a third of the patients experienced this. Further analysis revealed no 
significant results. 
Question 13 - Do you have any dependants? 
Having dependants could have a psychological effect on the patients. Of the 
patients who answered this question, 71 % did have dependants. The mean anxiety for 
those patients who had dependants was 5.42, and those who did not have dependants 
was 4.03. This difference was significant (p=O. 031). Similarly, the mean for 
psychological distress was 6.9 for those whom had dependants and 5.8 for those who 
. did not and this difference was significant (p=0.05). No significant differences were 
found in depression. 
Question 17 - Do you have any money worries? 
Financial problems could lead to patients feeling more anxious. Only 23% of 
patients felt they had financial worries. No significant effects were found between 
those patients who felt they had money worries and those who did not except in the 
STAI State, p=0.024. 
Question 25 - Was there a delay in you diagnosis? 
A delay in diagnosis could have caused an increase in anxiety. A total of 22% 
(47) did experience a delay. No significant differences were found in depression or 
distress for those patients experiencing a delay. However, those patients who 
experienced a delay in diagnosis were significantly more anxious in both HADS and 
STAI State, than those who did not, p=0.009 and p=0.20 respectively 
Physical well-being 
Question 12 - Do you now feel better, no change, worse? 
Overall 52% felt better, 32% 'no change' and 12% worse. With the radical 
patients, 36% felt better, 50% 'no change' and 14% worse. The palliative patient 
group did better with 66% feeling better, 24% 'no change' and 10% worse. With 
regard to the site of the cancer, 40% of those patients with NHL felt worse as did 20% 
of those patients with head and neck tumours. Further analysis revealed significant 
difference in distress, p<O.OOl, depression, p<O.OOl and anxiety, p<0.05. A post hoc 
Tukey-HSD test showed that in terms of distress, patients, who felt better, had 
significantly lower distress levels than those patients who had 'no change' in their 
condition and those patients who felt worse. Similarly, those, who did not think their 
condition had improved, had significantly lower distress than those who felt worse. 
Similar results occurred with the variable of depression. With anxiety, the patients 
who felt better had significantly lower anxiety levels than both the 'no change' 
patients and the patients who were feeling worse. There was no significant difference 
between those feeling worse and the no different patients. 
Question 14 -Are you taking any medicines? 
Two thirds of the patients were taking medicines. These ranged from 
tamoxifen to aspmn. Four of the patients were on anxiolytics and four on anti-
depressants. 
Question 15 - Are you still suffering from any symptom as a result of your 
radiotherapy treatment? 
Four weeks from the end of their treatment, 49% of the patients still had side-
effects from their treatment. The radical patients were suffering more than the 
palliative, 50% and 46% respectively. With respect to the site of the cancer, 78% of 
the head and neck patients, 70% lung and bladder patients, 47% of the prostate all 
those of 'unknown' origin, and 40% of the breast patients were all having symptoms 
still. 
The means of patients having symptoms was higher than those without 
symptoms. Further analysis to see if those patients having symptoms were more 
anxious, depressed and or distressed revealed significant results with distress, 
p=0.007, and depression p=0.002. Anxiety was not significant. 
Question 26 - Have any of your family had cancer? 
A total of 58% (124) patients said they had cancer in their family. Analysis 
was carried out to see if anxiety, depression or distress were heightened because of 
this, but no significant results were revealed. 
Question 27 - Is there anyway in which your radiotherapy treatment could have 
been made less stressful? 
Over half (56%) responded that their treatment could not have been made 
more stressful, with 29% (64) patients making comments on the forms. A number of 
patients (33%) made positive comments. These ranged from 
'The staff at Mount Vernon could not have been more kind and helpful', 
to 
'The staff created a confident inspiring atmosphere'. 
Waiting time was cited by ten (16%) of patients. Comments ranged from 
'Just the unknown waiting time was difficult', to 
'The second or third week I became very impatient when I had to wait 45 minutes for 
treatment and then 65 minutes the next day' 
Nine (14%) patients wanted more information. Remarks such as 
'A little more pre-preparation and medical help with excessive diarrhoea I 
suffered', and 
'The number of treatments wasn't clearly specified'. 
Travel and transport was again cited in the postal questionnaire by 10 (16%) 
of patients. Remarks such as 
'lftreatment could have been nearer home', and 
'lfthe journey was shorter', 
were typical of comments made by patients in this instance. 
Eight (12%) of patients' comments were put into 'other' category. These 
comments included 
'Avoid using the word 'cancer' on hospital buildings and notices' to 
'One physician should always attend the same patient - shunting kills a 
patient as new physicians are ignorant' . 
Four (6%) of patients specifically mentioned the lack of post treatment 
contact. These are some of the comments: 
'I would have liked more information on the after-effects', and 
'5 weeks of treatment - 4 days per week. Saw a doctor each Monday for 
about 10 minutes. The last Friday I just left. Nobody said anything 
except I would hear from a doctor in 4-6 weeks'. 
One final comment: 
'When completed you could be told what to expect until you see the 
Consultant some weeks later' . 
Question 28 - Other than your current illness, have you suffered a recent stressful 
event e.g. bereavement, divorce? 
A quarter of the patients had suffered a recent stressful event. The means for 
depression, anxiety and distress scores for the patients who had suffered were higher 
than for those who had not. However these differences was not significant. 
APPENDIX 34 
Analysis of Research Questionnaire at 6 Months Post 
Treatment 
Analysis of Research Questionnaire Given at 6 Months Post Treatment 
The research questionnaire consisted of fourteen questions (See Appendix 10). 
These questions were divided into four different sections; information and control, 
social support, psychological well-being and physical well-being. 
Information and control 
Question 5 - Did you feel the need to contact your GP for advice concerning 
radiotherapy treatment? 
Only twenty seven patients (18%) had needed to contact their GP for advice 
about their radiotherapy treatment. The large majority did not feel the need. The 
palliative male patients are a small group in this study but 25% (3) did contact their 
GP and 19% (16) of the radical female patients and 18% of the radical male patients. 
Only one palliative women patient contacted the GP about treatment. One respondent 
failed to tick the appropriate box and another replied 
"Under no circumstances - for 6 weeks when first ill he repeatedly sent 
me home with antibiotics". 
Those patients who responded 'yes' were significantly more anxIOUS 
(p=O. 003) and distressed (p=O. 016) than those patients who answered 'no'. 
Question 6 -If yes, was your GP able to answer your queries? 
Although twenty seven patients had responded 'yes' to the above question, 
thirty two patients responded to this question. A total of twenty two replied in the 
affirmative and three with comments 
"Yes, within limits" 
"Yes, had to look things up" and 
"Yes, a little". 
Ten patients said 
'no'. 
One patient wrote 
'I will be seeing him' 
Question 7 - Did you feel you were given adequate information when you left tlte 
radiotherapy department? 
A quarter of the patients did not think the information was adequate. This 
could be specifically related to certain sites. Three quarters of the patients suffering 
from bladder cancer, over half of the lung patients, 37% of the gynaecological 
patients and a third of the prostate patients felt the information was not sufficient. 
Some patients added comments 
"I was not warned of any ill effects to silicon implants", 
and another wrote 
"None at all", and 
"I was told I would in future want to pass water more frequently - not that 
there would be mild incontinence". 
Question 10 - Did you feel a need to get more information on your illness? 
From the one hundred and forty five responses, fifty eight (40%) felt they 
needed to get more information. The biggest cohort was those suffering from lung 
cancer, (82%), bladder (50%), breast (43%) and Non Hodgkin's Lymphoma (40%). 
Over half (54%) of the palliative patients wanted more information. 
Those patients who felt a need to get more information were significantly 
more anxious on both the STAI State and the HAD Scale (p=0.012, and p=0.039 
respectively) 
Question 11 -If yes, where did you get your information from? 
Several of the respondents cited several sources for their information. A total 
of twenty five got their information from the GP/doctor, fourteen from 
CancerlinklBacup, eight from family and friends and fourteen cited 'other'. . Several 
patients specified 'other' by writing comments such as, books, Macmillan nurse, 
breast nurse. Three patients wrote 'nowhere', 'I didn't and 'no one yet'. Only the 
women patients cited family and friends for their information. Over 50% of the men 
got their information from the doctor, two from Bacup and seven from other sources. 
Psychological well being 
Question 3 - What do you feel about the length of time between finishing your 
treatment and seeing the consultant in the Out Patients Clinic? 
The great majority (87%) felt the length of time was OK. Only 13% (17) 
patients felt it was too long to wait and one person ticked it was too short. One 
respondent wrote 
, do not know'. 
Physical well being 
Question 1 - Do you still have any side-effects as a result of your radiotherapy 
treatment? 
A total of forty eight (33%) were still suffering from side-effects of the 
treatment, which finished six months previously. The lung and NHL patients with 
over 60% still suffering together with 50% of the head and neck and prostate patients 
appear to be particularly susceptible to side-effects. At the time of the first postal 
questionnaire, 48% still had side-effects. This number has been reduced by nearly a 
third in the past five months. Approximately a third of the radical patients (34%)and 
30% of the palliative patients still had side-effects. Several of the respondents added 
their side-effects such as 
'persistent pain in shoulder' 
'Thickening of scar tissue which has displaced the silicon implant'. 
Another example was 
'Occasional violent hiccups when eating' 
'Heartburn and occasional pain in the area treated'. 
Further analysis to see if those patients having symptoms were more anxious, 
depressed or distressed revealed no significant results. 
Question 2 - Do you now feel better, no change, worse? 
A total of 48% (70) felt better, 42% (60) 'no change' and 10% (14) worse .. 
At the time of the last questionnaire 52% felt better, 32% no change and 12% worse. 
Two palliative women patients and two palliative men felt worse than at the 
last testing, making up 18% of the palliative cohort. Only 8% of the radical patients 
felt worse. The largest cohort to feel better was the male radical patients (58%). Both 
female and male palliative patients felt equally bad with 18% responding that they felt 
worse. With consideration to the site of the tumour, 75% of the bladder patients felt 
better and 100% of those patients with 'unknown' origin cancer. However, 27% of 
the prostate patients felt worse as did 23% of the lung and 20% of the NHL patients 
Significance was not reached with any of the variables. 
Question 8 - How long did it take you to travel to the hospital from home? 
As radiotherapy is so specialised and Mount Vernon is situated on the 
perimeters of London, its catchment area is large. The time spent travelling to the 
hospital varied from five minutes to two hours. The mean was 40 minutes. Therefore 
the return journey averaged one hour and twenty minutes. Travelling within London 
to a specialized unit would probably take the same time with disruption on London 
Transport and continual heavy traffic on the roads. 
Question 9 - Have you had any further treatment? 
A total of 44% had received further treatment, 52% of the radical cohort and 
47% of the palliatives. The male radical were the highest group with 54% having 
further treatment. One patient wrote 'waiting'. Significance was not reached with 
any of the variables. 
Question 10 If yes, what? Surgery, radiotherapy, chemotherapy, 
hormonalltamoxifen, complementary. 
The largest cohort, thirty five, was taking hormones/tamoxifen. Fifteen 
marked additional medicines, which ranged from distalgesics, steroids and 
suppositories. Eleven ticked chemotherapy treatment, eight complementary medicine 
and five further radiotherapy. 
Analysis was carried out to see if further treatments changed the psychological 
state, but none of the variables were significant. 
Question 14 - Other than your cancer, which has been treated, do you have any 
other illness? 
From the one hundred and forty three patients who responded to this question, 
42% had other illnesses. The most common illness (27%) was circulatory disorders. 
The next was arthritis (15%), four suffered from thyroid problems and a similar 
number from diabetes, three from depression, two from bad backs and another two 
from vertigo. A category of 'other' housed such complains as emphysema, migraine. 
A few patients suffered from two or three disorders. The majority of the patients who 
responded in the affirmative were of the older age group with 52% aged 65 and over 
and 41% aged 50-65. 
Social Support 
Question 4 - Would it have been helpful if someone had telephoned you during this 
time to check how you were getting on? 
A number (43%) of patients did think a telephone call would have helped. 
More women (47%) than men and more radicals (44%) than palliatives (36%) would 
have liked a call. Some patients mentioned that they had contact with the District 
Nurse and or the Breast Care Nurse during this time. 
None of the variables were significant. 
Question 12 - Have you visited or telephoned the Lynda Jackson Cancer Support 
Centre since you received our last questionnaires? 
A total of ten patients had visited the Centre, eight radical women patients, 
one radical male patient and one palliative male patient. 
Question 13 - I/yes, was the contact useful? 
From the nine responses, eight thought it useful and one female radical patient 
did not. One patient wrote 
'I would have liked to visit them for therapy ifI lived nearer'. 
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Analysis of Research Questionnaire Given at One Year Post Treatment 
The research questionnaire consisted of thirteen main questions with sub divisions (see 
Appendix 12). The questions were divided into four different sections; information and 
control, social support, psychological well-being and physical well-being. 
Information and control 
Question 10 - Since May, have you felt a need to get more information? 
Twenty one patients (19%) of the one hundred and eleven who responded to this 
question answered positively. This cohort consisted of eleven (15%) radical female patients, 
three (43%) female palliative patients, three (11%) male radical patients and four (50%) male 
palliative patients. 
The sub division of the question was:-
If yes, where did you get your information from? Dr/GP, Bacup/Cancerlink, 
Family/Friends, Lynda Jackson Centre, Other? 
A total of thirteen patients visited their GP. Only one of the palliative patients did not 
go to the GP - a man. One female radical breast patient got her information from 
Bacup/Cancerlink. Another radical woman patient with a tumour categorized under 'Other' 
got her information from family and or friends. No patients had returned to the Lynda 
Jackson Centre. Seven patients circled 'other' and these included Watford General and Dr 
Maher. Those who needed to get more information were significantly more anxious 
(p=0.003) than those who did not need to get any information. 
Question 6 - Have you visited your GP about your cancer? 
From the one hundred and .sixteen patients who ticked this response, forty three (37%) 
had visited their GP, one third of the female patients who responded and nearly one half of the 
males (46%), and all the lung and head and neck patients. 
The subdivision of this question was 
If yes, was your GP able to answer your queries. 
From the positive responses, thirty one (66%) thought the GP had been able to answer 
their query and seventeen (35%) did not. Eleven of the breast patients were not satisfied with 
their GPs response and fourteen radical and three palliative patients. 
Life threatening disease like cancer can make patients change their life style in order 
to attain a feeling of control. The next question looks at these changes. 
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Question 7 - Since being diagnosed have there been any changes in 
1. your place or type of work? 
Twenty of the twenty one patients who replied in the affirmative were radical patients, 
seventeen female and four male. One person commented that they 
'had moved to a less stressful job earning more money!'. 
For most people, the change in job was related to a loss of income -
'I'm presently working on part-time medical grounds, but have to soon decide 
whether I'm able to work full-time hours'. 
One patient made the comment 
'Lost my job because I could no longer do the repetitive movement required for 
working on scanning tills'. 
No significant differences with relationships to the variables of anxiety of depression were to 
be found. 
2. Income? 
This population tends to be near retiring age and some patients will have taken early 
retirement with its subsequent fall in income, others will have reached retirement age during 
the study. From the one hundred and twelve responses, 27% had experienced a change in 
income. Only two of the palliative patients had experienced a change in income. There were 
no significant differences with the variables of anxiety or depression. 
3. Use of cigarettes? 
Only eleven (22%) had changed their habit of smoking. 60% of the head and neck and 
lung patient made up this cohort with 6% of the breast patients. There were no significant 
difference in anxiety or depression and use of cigarettes 
4. Use of alcohol? 
Nine patients had experienced a change in alcohol habits. However, as with the 
cigarette question it was not ascertained whether it was less or more. The number of men was 
six and women was three. There were no significant differences with change of use of alcohol 
and anxiety and or depression. 
5. Diet? 
A quarter (26%) of the one hundred and eleven patients who responded had changed 
their diet and was evenly distributed between men and women. Half of the male palliative 
patients had changed their diet and 29% of the female radical and palliative patients. Patients 
added a range of comments. 
'I eat more now. A complete disorder. 
Another comment was 
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'1 am much less keen to follow a slimming diet. 1 don't discipline myself as 
much as I used to, as 1 figure shortage of some nutrient might have triggered the 
cancer' 
Another comment was 
'1 am trying to increase healthy eating' and 
'I have stopped eating meat'. 
A final comment was 
'Have been to Weightwatchers and lost 1 stone gained from steroids whilst having 
chemo'. 
No statistical differences were found in anxiety and depression. 
6. Marital Status and important other relationships? 
Nine patients experienced a change in marital status. This number consisted of five 
radical females, one palliative female and three radical male patients. One patient wrote 
'currently in Ward 10 receiving radiotherapy and had just got married'. 
Four patients had further experienced changes in other important relationships. No 
significance was attained with the variables of anxiety and depression. 
7. Moved home? 
Five patients had moved their home. All were radical patients, three women and two 
men. No significance was reached with the variables of anxiety and depression. 
Psychological Well Being 
Question 5 - Would it have been helpful if someone had contacted you from the 
radiotherapy department in the last six months? 
In the last set of questionnaires, patients were asked if they would have liked a 
telephone call from the department, in between the last treatment and seeing the consultant six 
weeks later. A total of 43% of patient would have liked this. After one year 23% (27) would 
have liked contact. This was split evenly between the men and women. The patients who 
would have liked contact from the department are not necessarily the patients who have side-
effects from their treatment. No significant difference in anxiety or depression was found 
between those patients who would have liked a call and those who did not. 
Physical Well Being 
Question 1 - Do you have any side-effects from your radiotherapy treatment in Autumn 
3 
1993? 
Over a quarter (28%) of the patients one year after their treatment still had side-
effects. Six months previously 31% had side effect. Principal sites are prostate, 
gynaecological and lung with 43%. 20% of the breast patients are still having side-effects. 
23% of the palliative and 29% of the radicals still have side-effects from their radiotherapy 
treatment. No significant results were recorded. 
The next question is a subset. 
If yes, have they occurred since the last questionnaire? 
A total of sixty one replied, when only thirty three patients said they had side-effects. 
From this cohort, sixteen patients said they had the side-effects only in the last six months. 
Only three of the patients were palliative. 60% of those being treated for lung cancer thought 
the side-effects had occurred since the last questionnaire. Is this the cancer returning rather 
than side-effects? 
Question 2 - Compared with one year ago do you know feel better, no change, worse? 
Over half of the patients (56%) felt better, a third felt 'no change' and 11% felt worse. 
Patients who felt better were significantly less depressed (p=0.005) and less distressed 
(p=0.048) than patients who felt worse (post Hoc Tukey). A quarter of the palliative patients 
felt worse in comparison with 9% of the radical patients. 
Question 3 - Compared with 6 months ago do you now feel better, no change or worse? 
A total of 51 % felt better since the last questionnaire, 39% no change and 10% felt 
worse. A third of the palliative patients felt worse but 44% felt better. Only 7% of the radical 
cohort felt worse than six months ago. Those patients who felt better had significantly lower 
depression (p=0.012) and distress (p=O.049). A post Hoc Tukey-HSD showed that those 
patients who felt better had significantly lower depression than those patients who felt no 
change. Similarly, the patients who had no change had significantly lower depression than 
those patients who felt worse. 
Question 8 - Since May have you had any further treatment? If yes what? Surgery, 
Radiotherapy, Chemotherapy, hormonalltamoxifen, complementary medicine, additional 
medicines or other? 
Over a quarter of the patients who responded to this question had experienced further 
treatment. Seven had experienced further surgery, one radical and one palliative woman and 
five radical men patients. Three patients had further radiotherapy, one radical and two 
palliative men. Nine had undergone chemotherapy and seventeen hormonal treatments. This 
number included thirteen radical women, three palliative women and one radical man. Four 
had taken complementary medicine and eight had taken additional medicine. Three patients 
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had written 
'other'; 'vagifem vaginal tablets'; 'sodium diclofenac and complementary massage to 
water retention area'. 
Question 11- In the last 6 months have you had any illness? If yes, wltat? 
One third of the patients had been ill, the majority with 'flu or a similar virus, others 
had shingles, arthritis. Angina, anaemia, chest infections and diabetes were also cited. One 
patient wrote 
, recurrence of cancer and inflamed bowel through radiotherapy'. 
Half of the palliative patients had experienced illness. No significant differences were found. 
Social Support 
Question 12 - In the last year do you feel you have had enough emotional support? If yes, 
from whom? 
Over 80% of the patients felt they had enough emotional support. Those patients who 
felt they had not enough support were 18% of the female radical patients, and one female 
palliative patients. Six male radical patients also felt a lack of emotional support. 
The support received was mostly from their family friends (68) and the Macmillan 
nurse (5) and the doctor and hospital (9). Others cited Hospice, colleagues or no one. 
Patients who felt they had emotional support were significantly less anxious 
(p=O.OOI), less depressed (p=O.OOI) and less distressed (p=O.OOI). 
The final question does not fit into any of the above categories 
Question 13 - Do you have any suggestions, which would have made life easier during and 
after your radiotherapy treatment? If yes, What? 
A total of 26% wrote their suggestions. The majority of these refer to the 
psychological aspects of cancer, although one patient wrote 
'to have radiotherapy unit at Luton and Dunstable Hospital'. 
The area which comments were mostly focused on was social support, after care and 
information. The most common comments were similar to the following: 
'more emotional and psychological support' and 
'some form of automatic counseling i.e. as an integral part of my treatment' 
'We have no self help group and I wanted to meet other women with young 
children - we have no started a group which started last week' . 
A breast patient wrote: 
'Some form of compulsory counseling. Although a counselor was available 
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because she was on holiday when I was diagnosed I never saw anyone. Looking 
back I wish 1'd seen someone as the mental side of having cancer is far worse that 
the physical side'. 
One patients suggested 
'S peaking before hand with someone who has been through the same thing'. 
Another patient wrote: 
, to be given the option to talk to other people in the same situation' 
Other comments were focused on aftercare: 
'An invitation to return to Mount Vernon after discharge if there were any queries 
re side-effects'. 
Other comments were practical 
'Stronger elastoplast should be used to secure the shields. It is frightening when 
they fall off because you imagine radiation penetrating your lungs - especially if it 
happens when the nurses are out of the room'. 
Several suggestions about more information came from patients 
'Back up information and extra follow-up from hospital etc'. 
'More information about tamoxifen, its side-effects and history of success'. 
'1 feel I could have been given more information on side or lasting effects from 
treatment' . 
'Being told all the truth about treatment, drugs etc'. 
One final comment from a patient 
'very selfishly would have liked not to have spent so much time waiting for 
treatment - realize that was inevitable because of blood count analysis etc - but 
not really anything to do'. 
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Analysis of Research Questionnaire Given at 18 Months Post Treatment 
The research questionnaire consists of seventeen main questions with some subsets, 
(see Appendix 14). The questions were divided into four different sections: physical 
well-being, information and control, social support and psychological well-being. 
Physical well-being: 
Question 1 - Do you think you may have had any problems related to your 
radiotherapy treatment? lfyes, please list 
One year after treatment, 28% of the patients had side effects. At eighteen 
months post treatment, a total of 41 % of patients felt they had problems related to 
their radiotherapy treatment. 43% of the radical patients and 22% of the palliative 
patients still had problems associated with their treatment. There are only nine 
palliative patients left in the study. With respect to site, 38% of the breast patients, 
60% of gynaecological and gastrointestinal, 50% of the prostate and NHL and a third 
of the bladder patients all felt they had a problem as a result of their treatment. 
The problems varied considerably depending on the area treated. The 
following are a range of comments from the various sites. 
Head and neck patients focused on dryness in the area of the mouth and eating 
problems: 
'Eyes sore and very dry lips', and 
'Unable to eat anything at all' 
One patient raised another point, 
'Slightly deaf in left ear and pain in should bone and muscles' 
Lung patients suffer from 
'Digestive problems and treatment area still "hot spots" at times', and 
'Tiredness' . 
Breast patients complained of difficulties with their arm. 
'Minor arm and shoulder damage', 
'my left arm is continuously swollen', 
'Scar tissue was still painful when using arm', and 
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'As I have an implant it seems to have moved upwards'. 
A prostate patient said 
'their bladder was so damaged by radiotherapy caused by incontinence 
leading to urostomy' . 
A cervix patient wrote down in detail the problems occurring after her treatment: 
, 1. Slight spasmodic bleeding from rectum 
2. Small leak of urine to vagina - consultant suspected fistula but 
could not be located by tests 
3. Bleeding after intercourse'. 
Significance was not reached with the variables of anxiety and depression. 
Question 2 - Since your radiotherapy treatment have you felt more tired? 
With a sub question, 
lfyes, do you feel this is due to your radiotherapy treatment? 
Eighteen months after their treatment over 50% (52) of patients felt more 
tired. This was evenly divided among men and women, however, 43% of the radical 
patients were more tired in contrast to 22% of the palliative patients. The entire lung, 
bladder and those patients of unknown origins in the current study were more tired. 
With respect to age, 55% of the patients aged between 26 and 50 felt more 
tired as did 55% of patients aged 50-65, in contrast to those aged 65 and over where 
45% felt more tired. 
Patients who felt more tired were significantly more anxious (p=0.020) and 
distressed (p=0.025). However, depression did not reach significance. 
From the patients who answered in the affirmative, 59% felt their tiredness 
was due to their radiotherapy treatment. Three patients wrote 'maybe', and this 
category should have been included. A total of 40% of the palliative patients and 
61 % of the radicals attributed their tiredness to the treatment. All the NHL patients 
and 60% of the breast patients also thought that the radiotherapy was responsible for 
their tiredness. 
Question 3 - Has you energy level now returned to normal? 
For the majority of patients (67%), their energy levels have returned. The 
third of patients, who were lacking energy, consisted of 29% of the women cohort and 
42% of the men. All the palliative men were lacking energy in contrast to all 
palliative women who said their energy was back to normal 
Those patients, who lacked energy, were significantly more anxious (p=0.05), 
depressed (p<O.OOI), and distressed (p=0.003) than those patients whose energy levels 
had returned to normal. 
Question 4 - How long did it take? 3 montits, 6 montits, 1 year, 18 montits, not 
hack yet? 
A third of the patients thought it took three months for their energy to return to 
normal after treatment. This consisted of a quarter of the radical female patients, 60% 
of the palliative female patients and 48% of the male radical patients. 
20% thought it took six months for their energy to return to normal. This 
consisted of 25% of the radical females and 15% of the male radical patients. 
9% felt it had taken a year for the energy levels to be normalized. This cohort 
consisted of 11 % of the female radical patients, 20% of the female palliative patients 
and 4% of the male radical patients. 
By eighteen months, another 4% felt their energy levels had returned. This 
number consisted of one female palliative patient and four female radical patients. 
One third of the patients felt their energy had still not returned. This cohort 
consisted of all the male palliative patients. These patients had cancer of various 
sites, bladder, NHL, 'unknown origin' and myeloma. However, two thirds of the 
radical prostate patients and all the radical lung patients felt their energy levels had 
not returned. A third of the female radical patients were suffering from a lack of 
energy. A total of 30% of those being treated for cancer of the breast made up the 
largest group. 
There was no correlation between those who felt their energy levels had 
returned to normal and those who had attributed their tiredness to radiotherapy. 
However, those patients whose energy levels had returned within three months were 
significantly less depressed (p=0.003) and less distressed (p=0.03I) than those 
patients whose energy levels had not yet returned to normal 
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Question 5 - Compared with November last year do you now feel better, no change, 
and worse? 
From the ninety nine responses, 46% felt better, 48% no change and 5% felt 
worse. The group of patients who felt better consisted of 48% of the radical females, 
46% of the radical male, 20% of the palliative females and 50% of the palliative 
males. Those patients who felt worse were 7% of the radical and 20% of the 
palliative women. 
Those patients who felt worse were significantly more depressed (p=0.012) 
than the other groups. 
Question 6 - During the last 6 months have you had a cancer check up with Mount 
Vernon, another hospital? lfyes, please write which hospital. 
A quarter of the patients had returned to Mount Vernon for a foll?w up 
appointment. One patient wrote boldly on his form 
'I do not have cancer'. 
Three quarters of the patients had checkups with other hospitals, eleven had 
been to Luton and Dunstable, nine to Watford General, six to Edgware, five each to 
Barnet General, Northwick Park, Hillingdon and QEll Welwyn Garden City, four to 
the Lister, Stevenage and three to Wexham Park. Others had travelled around the 
region including Charing Cross and the Royal Marsden. 
Some patients (6) had not gone to the hospital for a checkup but ticked the GP. 
A total of eighteen, 25% of the seventy three responses said they had been to the GP. 
In the previous questionnaire, 37% had been to their GP about their cancer. 
Information and control 
Question 16 - Do you try and eat a more healthy diet? 
A total of 82% tried to eat more healthily. This included all the palliative 
patients participating. There was no significant difference in the variables of anxiety 
and depression between those patients who tried to eat more healthily and those who 
did not. 
Question 15 - Have you had to change your diet since your diagnosis of cancer? 
Fourteen (14%) of the ninety six respondents said they had to change their 
diet. This cohort consisted of eight breast patients, two lung and prostate patients, one 
head and neck and one gynaecological patient. 
Question 9 - If you have or had symptoms, which you thought might be your 
cancer coming back, would you contact: your GP, your consultant's secretary, your 
specialist nurse, the casualty department, a support group, or other. 
Over half of the patients (52%) of the hundred replies would contact their GP. 
Another quarter (27%) would contact the consultant's secretary. Eight patients would 
do both and another would also contact the specialist nurse and/or support group. 
One patient said they would contact their GP and wait for a routine appointment. 
Three patients would see the specialist nurse and one would go to casualty. Two 
patients would wait for their routine appointment. A further two said they would 
contact the consultant's secretary and wait for a routine appointment. One patient 
ticked other and wrote 'not sure'. 
Psychological well being 
Question 8 - Have you had to bring forward a routine appointment because you 
were worried? 
A total of sixteen (16%) patients has had to bring forward their appointment, 
as they were worried. This number consisted of eight breast patients, one prostate, 
three 'other', two gastro-intestinal, one gynaecological, and 1 NHL. Three of the 
patients were palliative women, 10 were radical women and 3 radical men. 
Question 17 - Looking back over your radiotherapy treatment, what words 
best describe your experience? Anxious, Efficient, Powerless, Frightening, Caring, 
Reassuring, Angry, Friendly, Distressing, Depressing, Time-consuming, Isolating, 
Sore/Painful, Other. 
Some patients ticked more than one response. Over half of the patients 
thought the treatment made them anxious. Another 58% thought the treatment was 
efficient. Only 15% found it powerless, and 20% found it frightening. In contrast, 
62% found the treatment 'caring' and 53% re-assuring. Only two patients felt angry 
about their experience. Another eight patients found it an isolating experience, 12% 
distressing and 18% depressing. Approximately a third (33%) described it as being 
'time-consuming' and 22% found it sore/painful. A further ten ticked 'Other'. The 
following are comments from patients: 
'uncertainty' 
'I felt sick most of the time' 
'Burning sensation afterwards and needle sharp pains' 
'It was the travelling that was time-consuming not the actual treatment' 
'Very pleased with treatment. Thank you'. 
Social Support 
Question 9 - In the last questionnaire a number of patients said they would have 
liked to have spoken with a patient who had already had radiotherapy treatment 
Would this have helpedyou? 
A total of 46% of the one hundred replies felt it would have helped them, and 
27% thought it might have helped. 24% of the women and 32% of the men said it 
would not have helped them. 
Question 10 - Would you feel able to talk to someone who was about to have 
radiotherapy? 
71 % of the patients thought they would be able to talk to a new patient who 
was about to undergo radiotherapy treatment. This cohort consisted of 68% of the 
women and 80% of the men patients. A further 17% thought 'maybe' they could talk 
to a patient about to undergo treatment. 
Question 11 - If yes, how soon after your radiotherapy treatment do you feel you 
would be willing to do so? 3 months, 6 months, 1 year, 18 months, other? 
From the eighty one responses, forty two (52%) felt they would be ready in 
three months. Some patients wrote on the form 'immediately'. Others wrote that they 
had spoken to patients when they had first arrived and were looking apprehensive. 
Nine patients (11%) felt six months was an appropriate time and another nine patients 
thought one year. Twelve patients suggested eighteen months and nine ticked 'other'. 
Two of the questions did not come into the main categories 
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Question 13 - Whilst waitillg for tram]JOrt or treatmellt would you have like to have 
watched televisioll? 
Over a qualter (29%) of the patients would have like to have watched TV. 
Some patients specifically stated programs such as informational needs of the cancer 
patient, or comic programmes to make them laugh. Ten of the patients ticked 'don't 
know'. 
Question 14 - Do you have allY suggestiollsfor tlte waitillg room? 
A total of twenty nine did come up with suggestions. 
Firstly videos;-
'Peoples programmes who have suffered and any advice for others'. 
'Maybe the chance to see video interviews and diary extracts from 
patients before, during and after treatment and the chance to visit people 
who are willing whilst having chemo and radiotherapy' 
'An informative video on the radiotherapy treatment, i. e. an interview 
. with recent patients would probably ease the worry of new patients' . 
Secondly the following are comments concerning the facilities in the department: 
'Drinking water; the drinking water in the big waiting area was often 
empty'. 
'Few more chairs - each patients seems to bring someone else with them 
for transporting or support. Other than this waiting room quite pleasant' . 
'More chairs' 
'More space' 
'It always seemed rather crowded to me' 
'More space - but as that is not possible, a good job is being done' 
, A bit crowded sometimes but this is understandable' 
'The main waiting room was satisfactory but one end of the corridor was 
drab and uncomfortable' 
'More up-to-date magazines with a more rapid turnover'. 
'Would have liked to have been able to use the facilities such as 
aromatherapy' . 
'Some of the food smells from the coffee shop were off putting due to 
feelings of nausea'. 
11:~m1tr~~T<""'r:r,."""'."'./"':;"'.""'~'-HH'''~''.·~"".",~,,. .. , .... ~.~, •• ~.~,-..... ~.~-, .. ~~~ .... ~--.~--.-
APPENDIX 37 
Analysis of Research Questionnaire at 2 Years Post 
Treatment 
Analysis of Research Questionnaire Given at 2 Years Post Treatment 
The research questionnaire consists of eight main questions, which relate to 
physical well-being, social support and psychological well-being (Appendix 21). 
Physical well being 
Question 1 - Do you still have any problems related to your radiotherapy? If yes, 
please write down what the problem is. 
Six months ago, 41 % of patients had problems. Two years after treatment, 
this has fallen to 20%. This cohort consisted of seventeen (20%) radical patients and 
one (20%) palliative. The most affected sites were gastrointestinal (75%), 
gynaecological (43%), NHL (50%). Those patients who were aged 65 and over had 
far fewer problems than the other age groups. 
Those patients who did not have any problems were significantly less anxious 
than those patients who did (p=0.034). 
The most frequent comment was: 
'Soreness and dryness' 
Other common problems associated with radiation to the pelvic region gave rise to 
comments such as 
'Diarrhoea and flatulence' 
'Intolerance of certain foods' 
Question 2 - Do you feel tired? 
Only 93% of the patients answered this question of which 38% were still tired. 
This cohort consisted of 41 % of radical and 67% of palliative women, 22% of radical 
men and all the palliative men (2). The most commonly affected sites were breast, 
head and neck, gynaecological, NHL and bladder. In the last questionnaire, a third of 
patients said they were tired. 
Those patients who felt tired were significantly more anxious (p=0.009), more 
depressed (p<O.OOl) and distressed (p<0.001) than those patients who were not tired. 
Question 3 - Have you had further problems related to your cancer, if so what? 
A total of 14% had further problems and these included spread of disease and 
more radiotherapy or surgery. A range of comments was written: 
'Poor general health (effects of menopause brought upon by tamoxifen), 
'Not sure, gaining weight due to huge appetite I have now' 
'Modules removed but luckily no cancer' 
'Ultrasound found cyst, yearly mammograms now' 
Do you think this is due to your radiotherapy treatment? 
Six patients did feel that their problems were related to their treatment, two 
breast patients, one skin, one gastrointestinal, two gynaecological, 
Question 4 - Compared with May 1995 Do you feel better, worse or no change? 
A total of 34% of patients was feeling better, 63% 'no change' and 3% worse. 
The patients who felt worse were one radical female breast patient, one radical male 
lung patient and one radical woman skin patient. 
Those patients who felt worse were significantly more depressed (p=0.010, 
Post Hoc Tukey) than those patients who felt better. 
Psychological well being 
Question 5 - Looking back over your treatment, has your experience had a positive 
effect? Or a negative effect? 
A total of 91 % of the patients felt that the experience was a positive one, only 
four radical male and female patients did not. 
Three patients thought it had a negative effect; two were female radical 
patients and one male radical patient. 
Question 8 - Please tick the words that best describe how you feel now - Happy, 
Uncertain, Thankful, Fearful, Content, Depressed, Careful, Anxious, Listless, 
Other. 
Patients could respond to as many words as they felt were appropriate to them. 
Thankful was ticked by 61% (58), happy by 47% (45), content by 42% (40), uncertain 
by 22% (21), careful by 14% (13), listless by 10% (10), 6% still felt fearful, 5% felt 
depressed and 2% (2) ticked' other'. 
Social Support 
Question 7 - Have you contacted tlte Lynda Jackson Centre? If yes could you 
please tell us wlty? 
A booklet was sent out with the questionnaires at eighteen months on 'Coping 
now that your Radiotherapy Treatment is finished', which was produced by the Lynda 
Jackson Macmillan Centre. Patients had also received a pamphlet about the Centre 
with the other postal questionnaires. A total of eleven (12%) of patients had 
contacted the centre, eight radical and one palliative woman and two radical men. 
The reasons were various: 
'1 needed information and they were helpful' 
'Personal problems related to cancer' 
'Immediately after treatment in connection with diet and diarrhoea. They 
were very helpful' 
'To have a massage, but was refused treatment' 
'To talk' 
'Had a talk about my mastectomy' 
'The staff are so friendly and supportive. A chat with them at a relaxation 
session is very reassuring' . 
'To get some literature regarding how to explain my illness to my 
daughter and to buy a relaxation tape and a Christmas card' 
'lfthe end comes earlier than expected' 
Question 8 - Have you since the last questionnaire received any new 
complementary medicine including counselling? 
Only four radically treated women had participated in a new complementary 
medicine. 
A final question, which comes into 'Other' category: 
Question 6 - Has you life changed since your treatment? If yes, can you say how? 
A total of 37% of patients felt their life had changed, 39% of the female 
radicals, 32% of the male radicals. 33% of the female palliative and 50%of the male 
palliative patients. 
The comments varied between negative and positive. 
'I can't do as much as 1 used to' 
'1 worry more about my health' 
'Cancer is now widespread and terminal'. 
'Seemed to have slowed down - very tired' . 
'Cannot do some of the things 1 used to do' 
'More aware that life is short' 
'Makes me appreciate each day that my quality of life improves' 
'Fitter' 
'Taking things more slowly' 
'Made me aware that trivial things are not so important and family and mends 
come first' 
'General outlook - take more time for myself Have more family holidays' 
'Grateful for life' 
'I do as much as I can -life is too precious to waste time' 
'Made me appreciate everything and be very grateful' 
'A very different outlook on life in general' 
'I try to relax more - I try not to get "wound up" about small things' 
'Got better'. 
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Analysis of Research Questionnaire Given at 3 Years Post Treatment 
The research questionnaire consisted on 13 main questions with some subsets. (See 
Appendix 22). The questions were divided into four different sections: physical well-
being, information and control, social support and psychological well-being. 
Physical well being 
Question 1 - Do you still have any of the problems related to your radiotherapy that 
you mentioned before? If yes, please write down what the problem is. 
29% of the patients still had problems. This cohort consisted of 29% radical 
patients and 25% palliative (one patient), and further subdivided into 28% of the 
radical women patients, 32% of the radical male patients and one palliative male 
patient. A year ago, 20% of patients had side-effects. 
The problems varied according to the site. 
Comments from breast patients were: 
'Slight sensitivity on mastectomy scar' 
'Have slight twinges in scar area' 
'Lymphoedaema' 
'Sometimes it's a bit ofa pain' 
Comments from head and neck patients included the following: 
'Pain in my neck and shoulder bone' 
'Surprised to find that neck can still b~ a bit painful- very slight' 
'Difficulty in swallowing' 
'Sore outside of nose' 
'Very dry mouth, unable to eat'. 
Those patients who had radiation to the pelvic area made the following comments: 
'Bladder control is just that bit more difficult - though manageable. Dr 
warned me of this at the time' 
'Dry skin' 
'Radiation colitis - Pains in lower bowel and sometimes bleeding 
'No control with bowels'. 
Patients who had radiation to the upper torso 
'Sore chest, can't eat hot food' 
'Energy level not returned for golf say' 
'Tiredness, lack of concentration', 
Question 2 - Have you any new problems that you think are due to radiotherapy? 
If yes, please write down what the problem is? 
Seven radical patients, two men and five women felt they did have a new 
problem as a result of their radiotherapY,treatment three years earlier. The problems 
were varied: 
'Loss of teeth' 
'My GP thinks stress is a lot to do with radiotherapy' 
'Extreme discomfort on sexual penetration, coupled with slight blood 
loss' 
'Skin area is a bit tight' 
'Osteoporosis in the shoulder' 
'Radiation affected the heart muscle, could not be helped as tumour 
attached there' 
Question 3 - Have you had any new problems that you think are related to your 
cancer? If so, what? 
A total of twelve (14%) felt they did have a new problem related to their 
cancer. This cohort consisted of 13% of the radical women patients, 14% of the 
radical men patients and one palliative female patient. A variety of comments were 
written: 
'Cancer of the lining of the womb' 
'Neck ache' 
'Continued urinary infection' 
'I could feel some pain in my chest but not in the same place every time' 
'I have a stricture, I do not know if it is related' 
'Mood swings' 
'Operation, part breast off, no cancer found', 
'Blood in my water' 
'My scar and behind it is very tender' 
'I think my changed attitude to sexual contact is directly related to my 
cancer' 
'Short of memory and always very tired'. 
Those patients who though they had a new problem related to their cancer 
were significantly more anxious than those who did not (p=0.005). 
Question 4 - Do you feel tired? 
A year ago, 50% of patients were tired. Three years after treatment, 49% are 
tired. 70% of the patients aged between 26-50 are tired as compared with 40% of the 
50-65 and 48% of the 65 plus group. This difference was not significant. All the 
palliative patients were tired, compared with 43% of the radical patients. Last year, 
only one of the palliative patients felt tired. 
Those patients who felt tired were significantly more anxious, (p=O.OOl), more 
depressed, (p=O.OOl) and distressed (p=O.OOI) than those who did not feel tired. 
Question 5 - Compared with November 1995, do you now feel better, worse, no 
change? 
Three years after treatment, 40% are feeling better than they did the previous 
year, 53% feel the same and 7% feel worse than last year. The six patients who are 
feeling worse consisted of a palliative breast patient, a radical 'other' category patient, 
two skin patients and radical gynaecological patient and a NHL patient. Last year, 
46% felt better, 48% felt the same and 5% felt worse. 
Those patients who felt better or the same were significantly less depressed 
than those patients who felt worse (p=O.OOI Post Hoc Tukey). 
Question 6 - How are you sleeping? No problem, Trouble going to sleep, Awake 
early, other? 
Over half (52%) of the patients were experiencing sleeping problems, 18% 
had trouble going to sleep, 24% awoke early and 10% had 'other' problems. Some 
patients who ticked 'Other' wrote comments which include: 
'Wanted to sleep all day' 
'Broken sleep' 
'Disturbed erratic sleep' 
'I wake in the night' 
'Sleep intermittently' 
Those patients who did not have a problem sleeping, or just had trouble going 
to sleep where significantly less anxious (p=O.OOl Post Hoc Tukey) and depressed 
(p=O.OOl Post Hoc Tukey) than those patients who woke early or cited 'other'. 
Question 7 - How is your appetite? Good, Bad, Normal? 
For the majority of patients (61%) it was good, 33% felt it was normal and 7% 
felt it was bad. Those patients who said their appetite was bad consisted of four 
radical breast patients, one radical head and neck patient and one palliative NHL 
patient. 
Those patients whose appetite was normal or good were significantly less 
anxious (p=O.OOl, Post Hoc Tukey) and depressed (p=O.006) than those whose 
appetite was bad. (Group sizes are unequal Type 1 error is not guaranteed). 
Question 8 - Have you lost weigltt, gained weigltt, remained tlte same? 
Six patients had lost weight, five radical breast patients and one radical head 
and neck patient. A total of 42% of the radical patients and one palliative patient had 
gained weight. 51% of the patients weight had remained stable. One patient wrote: 
'Bad appetite she did not think was related to cancer or its therapy but 
HRT. Now stopped HRT but can't lose weight. Eat far less than average' 
Those patients who had lost weight were significantly more anxious than those 
who had not (p=O.OOl, Post Hoc Tukey) (Group sizes unequal Type 1 error not 
guaranteed). 
Question 11 - Have you Itad any furtlter radiotlterapy treatment since September 
1993? If yes did you find tlte experience any different? If yes, How. 
Three patients had more radiotherapy treatment, one radical gynaecological 
patient, one radical NHL patient and one radical 'other' site patient. One patient 
wrote that he found the experience different as this time he had treatment to his penis! 
Information and Control 
Question 9 - Do you need to seek any information about your cancer now? If so, 
wltat? 
Seven radical patients, four female breast patients, one prostate and one NHL 
felt they needed more information. Patients' comments included the following: 
'A six monthly check with Consultant' 
'To make sure I am alright' 
'What problems may I have in the future from radiotherapy'? 
'More information on the pros and cons oftamoxifen' 
'Where I would find anymore lumps' 
'To have a blood sample' 
No significant differences were found with those patients who wanted more 
information. 
Question 8 - Have you tried any new complementary medicine in the last year? 
Five patients had tried new complementary medicine, all were women radical 
patients. No significant differences were found in anxiety or depression for those who 
had participated in complementary medicine and those who had not. 
Social Support 
Question 10 - Do you belong to a Cancer Patient Support Group? 
Four patients belonged to a Cancer Patient Support Group, two radical breast 
women, one head and neck patient and one from site categorised as 'Other'. There 
was no significant difference between those patients who belong to a Cancer Support 
Group and those who did not. 
Psychological well-being 
Question 12 - Has anything sad/happy happened to you in the last year? If so 
what? 
From the eighty seven patients who responded, 45% replied in the affirmative. 
The following are comments from patients who had experienced sadness; 
'My daughter-in-law passed away with cancer and my son tried to commit 
suicide' 
'My husband behaviour has changed. He's depressed all the time, drinks 
a lot and fights with me (physical) which leaves me very stressed all the 
time and very unhappy' 
'My sick 13 year old granddaughter has been put into a residential home 
too far away for them to visit' 
'My daughter is moving to the USA' 
'My daughter has left her husband and living with us and my 
grandchildren' 
'Polyp removed from bowel' 
'Prostate op' 
'6 weeks of shingles in the eye and head' 
'1 have had to retire early on health ground' 
'Financial problems' 
'Moved house' 
The following are 'happy' comments 
'My daughter got 4 'A's at IA' level' 
'Daughter's wedding' 
'Son's wedding' 
'My daughter had a baby' 
'My first grandchild was born and my son gained entry to university and 
passed his driving tesf 
'I became a great grandfather' . 
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Analysis of Research Questionnaire Given at 4 Years Post Treatment 
The research questionnaire (See Appendix 25) consisted of nme mam 
questions with some subsets. The questions were divided into three different sections; 
physical well-being, social support, psychological well-being. 
Physical W ell-Being 
Question 1 - Do you still Itave any of tlte problems related to your radiotlterapy tltat 
you mentioned before? If yes, please write down wltat tlte problem is. 
Last year 29% felt they still had a problem related to their radiotherapy 
treatment. This year, it had fallen to 23% (17), with 23% (16) radicals and 25% (1) 
palliative. This cohort consisted of five radical breast patients, one radical skin 
patient, one radical gastro intestinal, two radical head and neck patients, two 
gynaecological patients, three radical NHL patients and one palliative NHL patient, 
one radical bladder patient and one of 'unknown' origin. None of the prostate 
patients felt they had a problem now. Only one of the remaining palliative patients 
had a problem related to his treatment. All the NHL felt they had side-effects from 
their treatment. Significance was not reached with the variables of gender and 
treatment. The NHL patients wrote: 
'Very dry mouth and very tired still' 
'Persistent dry mouth' 
'Tiredness, lack of concentration and nervousness' 
'Skin is still tight' 
The patient whose tumour was of 'Unknown origin wrote 
'My neck gets spasms of pain on the right and my shoulder' 
Head and neck patients also refer to dry mouth symptoms: 
'Dry mouth, soreness each side of nose, jaw bone, inside of ears and itchy 
head'. 
Breast patients referred to soreness and pain: 
'Cramp down side of ribs and not enough strength to pull myself up (i.e. getting 
out of the bath)' 
'Pain in the arm and across the chest' 
'Painful shoulder' 
'Lymphodaema' 
'Implant pushed out of position caused by combination of surgery and 
radiotherapy' 
The skin patient referred to: 
'My eyebrows and chin get very itchy at times' 
A cancer of the cervix patient cited 
'I.B.S. ' 
and another gynaecological patient 
'Intermittent bouts of diarrhoea but less often than in the last period, but 
none the less just as embarrassing at the time!' 
A colon patient wrote: 
'Irregular bowel function' 
Question 2 - Have you had any new problems in 1997 that you think are due to 
radiotherapy? If yes, please write down what the problem is. 
Only five patients felt they had a new problem, which was due to their 
radiotherapy treatment, four radical breast patients and one radical head and neck 
patient. 
The problems for the breast ladies varied from: 
'Numbness of inner left hand' 
'Cramps' 
'Hardening of breast' 
'Indigestion' 
The only male patient had radiotherapy to his head and neck wrote: 
'Blocked tear duct and watery eye' 
Question 3 ~ Have you had any new problems in 1997 that you think are related to 
your cancer? If so, what? 
Nine (12%) patients felt they had a new problem related to their cancer. Two 
of the palliative patients had developed new cancers. A NHL patient had a tumour 
surgically removed from her eye. Other patients complained of fibroids and lumps 
recurring. A prostate patient cited 
'An increase in PSA levels' 
Significance was not reached in anxiety and depression with those patients who had 
new problems. 
Question 4 - Have you had any further treatment since September 1993? If so 
what? Radiotherapy, Chemotherapy, Hormone therapy, Other, medicines including 
anti-depressants. 
A total of seventeen (22%) patients had received further treatment smce 
September 1993. 
Three patients (4%) had received further radiotherapy treatment. Two had 
treatment for new primaries and one for metastasis following cancer of the breast. 
Four patients (6%) had received chemotherapy including two women breast 
patients and two gastro-intestinal patients. 
Seven patients (9%)had received hormonal therapy. Six were breast patients 
on tamoxifen and one was a prostate patient. 
Three (4%) patients were on antidepressants. Five patients (5%) had written 
that they had undergone more surgery. Unfortunately, this had been left from the list 
and this number could be larger. Four out of the five patients appeared to have new 
primaries and the fifth was a cystoscopy for a prostate patient. 
Question 5 - Do you feel tired? 
Last year, 49% of the patients were tired, this year, 42% of the participating 
patients are tired.' 40% of the radical patients and 75% of the palliative patients felt 
tired. 
Those patients who felt tired were significantly more anxious (p=O.OOI) and 
depressed (p=O.OOI) and distressed (p=O.OOI) than those patients who were not tired. 
There was a significant difference in anxiety and depression according to age 
and whether patients were tired or not (p=O.Ol). A post Hoc Tukey showed that those 
patients who were aged between 26-50 were significantly more anxious than those 
patients aged between 50 and 65 and those aged over 65 if they had responded that 
they were tired.. Similarly, those patients aged between 50-65 were significantly less 
depressed than those patients aged over 65 or aged between 26-50. 
Question 6 - Compared with November 1996, do you feel better, worse or no 
change? 
Fifteen (20%) patients now felt better compared with last year, five (7%) felt worse 
and 72% (55) had remained stable. Last year, 40% of patients felt better, 53% felt the 
same and 7% felt worse. Those patients who felt worse consisted of two radical 
breast patients, two radical skin patients and one palliative breast patient. 
Social Support 
Question 7 - Have you tried any complementary medicines in the last year e.g. 
aromatherapy, acupuncture, counselling? If so what? 
Five patients (7%) had tried complementary medicine. Four of these were 
women, three breast patients and one gynaecological. The man was a head and neck 
patient whom had the occasional massage. One of the breast patients wrote 
'Been to spiritual healing, but this was not for her cancer but for her 
painful legs!' 
The other breast patients used reflexology and relaxation. 
Question 9 - We are currently undertaking a study to evaluate a telephone support 
system. Six patients will talk together for approximately an hour each week for 
four weeks. This is done in the privacy of their own homes via a telephone link 
Two professionals will also be linked in to offer support if necessary. All these 
telephone calls are being paid for. Some patients will have just completed 
radiotherapy treatment and will be waiting for their first follow up appointment. 
Others will have finished some time ago. Each group is either male or female and 
patients can be of any age. Would you be interested in participating in such a 
group? 
A total of thirteen patients said they would be interested. Six of these patients 
were being treated for cancer of the breast, the rest came from assorted sites. Men 
and women.were equally represented. 
Psychological Well-Being 
Question 8 - Since your cancer have your relationships with friend remained the 
same, got more superficial, got closer, other. Has your circle of friends increased, 
decreased, changed, other, please specify· 
The majority (87%) of patients' relationships has remained the same. The 
other 13% felt their relationships had got closer. 
A total of 45% of women felt their circle of friends had increased in 
comparison with 29% of men. As this population tends to be older, patients wrote 
that they had a decrease in relationships as many of the contemporaries had died. 
41 % of the women thought that their relationships had remained unchanged in 
comparison with 62% of the men. 
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Analysis of Research Questionnaire Given at 5 Years 
This fmal questionnaire (see Apendix27) consisted of thirteen questions with 
some subsets. The questions were divided into four different sections: physical well-
being, information and control, social support and psychological well-being. 
Physical well being 
Question 1 - Do you still have any of the problems related to your radiotherapy that 
you mentioned before? If yes, please write down what the problem is. 
This question has been included in all the previous questionnaires. At the time 
of the first research questionnaire, which was given to patients on the last day of their 
treatment, 60% of the patients felt they had symptoms due to their radiotherapy 
treatment. Four years after treatment, 22% felt they still had a problem and, five years 
after, this percentage has risen to 28%, 22 patients. 7%, six patients, all men, said 
they could not remember. 
Three of the palliative patients did not have a problem and one said 
'he could not remember' 
There was an increase in breast and prostate patients with problems. At the 
time of the first questionnaire, 60% of patients being treated for breast cancer had 
side-effects. This had dropped to 13% last year. This year, it has increased to 22%. 
Prostate patients, too, had an increase in problems this year with 60% experiencing 
problems, last year, none of the prostate patients had a problem. Previously, all the 
patients suffering from NHL experienced side-effects, however, by five years post 
treatment, this has fallen to 75%. 
Those patients who said they could not remember if they had mentioned a 
problem before were significantly more anxious (p=0.006) and significantly more 
distressed (p=0.008) than those patients that answered yes or no. 
Not all patients wrote the problem down. Those patients suffering from 
cancer of the breast mainly complained about 
'Excess heat and numbness in upper arm. Also some swelling of the 
wrist' 
'Lymphodaema' 
'Weakness in left arm' 
'I find movement in my left arm on the side 1 had radiotherapy quite 
painful at time' 
'Very occasional pain the hollow of neck. Ditto breast pain' 
'Scarring of the tissues' 
'Displaced implant following surgery and radiotherapy' 
'When tired feel sick in area of radiotherapy - more like nausea' . 
Three ofthe five remaining cancer of the prostate patients had problems: 
'Sex' 
'Still have little energy' 
'Nocturnal bathroom visits, continued flatulence' 
Patients suffering from cancer of the cervix made the following comments: 
'Regular diarrhoea and appearances of blood in my urine from time to 
time' 
'Greater frequency on passing water' 
A colon patient wrote 
'Wind and bowel irregularities - side-effects from HRT' 
A skin patient wrote 
'Itchy at times' 
NHL patients complained of 
'Tightness of the skin' 
'Bad arm/shoulder, swollen ankle' 
Patients who had tumours of the head and neck immediately after treatment suffered 
quite badly. On the present survey, only one patient made a comment: 
'Very dry mouth' 
and the only surviving lung patient wrote 
'Sore chest' 
A patient being treated for Hodgkin's Disease wrote: 
'Knackered circulation - especially in cold weather and increased 
tiredness as a result', 
and the one patient suffering from a tumour of unknown origin wrote: 
'Neck and right shoulder pain' 
Question 2 - Have you had any new problems in 1998 that you thillk are due to 
radiotherapy? If yes, please write down what the problem is. 
Only one woman patient suffering from NHL felt she had a new problem. 
Seven (9%) patients were not sure. The NHL patient wrote: 
'Bad arm, shoulder swollen'. 
A man who had been treated for cancer of the larynx wrote 
'Dryness on my face, blotches over the cheeks' 
A breast patient wrote: 
'Left hand carpel tunnel problem. Beginning now in right hand so may 
not be due to radiotherapy. Have seen Dr. ' 
Question 3 - Have you had any new problems in 1998 that you think are related to 
your callcer? 
Eight (10%) patients now felt they had a problem, which could be attributed to 
their cancer. Only one of the patients was being treated palliatively. These eight 
patients were being treated for a variety of different site cancers; two had cancer of 
the breast, two cancer of the skin, one head and neck, one NHL, one prostate and one 
cervix. The cervix patient wrote 
'Stomach tumour removed. Chemotherapy suggested but I declined' 
The patient being treated for bladder cancer said: 
'I have begun bleeding into my urostomy bag and am undergoing more 
tests' 
The breast patient wrote: 
'Hysterectomy' 
Skin patient wrote: 
'Two more rodent ulcers removed from my face' 
Prostate patient said: 
'Cancer returned to prostate - or did it ever go?' 
Finally, a patient who had previou~ly been treated for cancer of the larynx now stated 
that he had 
'Cancer of the prostate' 
Question 5 - Do you feel tired? 
This question has been asked in the previous questionnaires. Last year, 42% 
of this population felt tired. This year it has risen to 46%. 
Patients that were tired were significantly more anxious, (p=0.032), 
significantly more depressed, (P=0.015) and significantly more distressed (p=O.OlO) 
than patients who were not tired. Further analysis using GLM showed that age and 
tiredness reached significance. Patients that felt tired were significantly more 
depressed p=0.009. Similarly, Post Hoc Tukey showed that patients aged 65 plus 
were significantly more depressed (p=O.OOS) than those patients aged 50-65. 
Question 6 - Compared with November 1997, do you feel better, worse, no change. 
Since the questionnaires last year, fifty (67%) patients felt their condition had 
not changed, twenty two (2S%) felt better and seven (9%) felt their condition had got 
worse. 
One patient wrote that he was feeling worse: 
'Due to recent heart problems' 
One year ago, 21% felt better and 72% felt no change in their condition. 
Analysis showed that those patients who felt better had significantly lower 
anxiety (p=0.002) and depression (p=0.007) and distress (p=0.007). A Post Hoc 
Tukey showed that patients who felt better had significantly lower anxiety than those 
patients who felt worse (p=0.003) and those patients who had 'no change' (p=0.04S). 
Similarly, those patients who felt better were significantly less depressed than those 
patients who felt worse (p=0.005) and less distressed (p=0.007). 
Social Support 
Question 4 - Looking back over the last 5 years do you feel that you could have 
received more help for any of the problems you have experienced? 
Seven (9%) patients felt they could have had more support, three were breast 
patients, one prostate, one head and neck and one NHL. A woman NHL patient 
wrote: 
'More explanations out everything' 
A man wrote: 
'Regular massage/acupuncture form a fully experienced expert'. 
Four breast patients wrote comments: 
'Lymph drainage. Massage regularly on the NHS' 
'I worry more about any unusual pain that I get' 
'A talk, before half my breast was taken away it has taken my over a year 
to get over this. Counselling to patients seems to have been overlooked' 
A man who had returned to the radiotherapy department for further treatment wrote: 
'In the first instance I don't think I was made fully aware of all the help or 
assistance' . 
Finally a cervix patient wrote: 
'A better knowledge of the affect the radiotherapy would have on my 
bowel and bladder in the first instance would have allayed lots of worries 
later associated to these problems'. 
Question 7 - Have you tried any complementary medicines in tlte last year e.g. 
aromatlterapy, acupuncture, reflexology? If so, what? 
Nine patients (11 %) had tried complementary therapies in the last year. All 
were women. None of the palliative patients had participated. Last year, five patients 
responded in the affirmative. The five breast patients had participated in a variety of 
therapies. 
'Reflexology, relaxation, aromatherapy' 
was cited by one patient 
'Aromatherapy, acupuncture and reflexology' 
was cited by another. Another two of the women had participated in aromatherapy 
and one in homeopathy. Two cervix patients had received aromatherapy and a colon 
patient had used chiropractise. A patient suffering from Hodgkin's Disease wrote: 
'Reflexology - once a week. Tell all your clients to have it - as it is 
tremendously helpful - particularly post treatment' . 
Significance was not reached with any of the variables. 
Question 8 ~ In the last year have you changed your diet, started an exercise 
program, joined a support group or similar, which could be labelled self-help? 
Seventeen patients (22%) had participated in some positive self-help. None of 
the palliative patients was in this group. Nine of the patients had changed their diet, 
three of them for other illnesses - two were suffering from diabetes and one from 
arthritis. 
Several patients specifically mentioned low fat diet coupled with exercise. (This 
survey was taken at Christmas). Eight patients wrote 
'Exercise' . 
This ranged form dog walking, joining a gym to ballroom dancing. One patient was 
doing specific exercise for his heart. 
Two patients had joined a support group - one a laryngectomy club and the 
other a telephone support line. 
No significant differences were found in patients whom had used this positive 
self-help and those whom had not. 
Psychological well being 
Question 9 - Looking back over the last five years can you tell us what you found 
were the three most difficult experiences for you, in order, starting with the worse, 
then the nest worse? E.g. getting the diagnosis, surgery, radiotherapy, 
chemotherapy, hormone therapy, waiting for test results, some other experience. 
Getting the diagnosis was the most difficult time for 66% of patients. One 
patient wrote 
'Being given the diagnosis after being assured for 18 months that the lump 
was benign' 
A further 8% felt waiting for test results was the most difficult time, 7% wrote 
surgery, 5% chemotherapy, 5% radiotherapy and 10% 'Other'. 
Other was made up of wide ranging comments, which reflected patients own 
personal difficulties, such as: 
'Not tasting food' 
'Delay in starting treatment' 
'Drinking a lot of water before the scan' 
'Finding my way around Mount Vernon Hospital' 
'Trying to find help - never have cancer in the summer holidays'. 
The second worst experience for patients was surgery (29%), closely followed 
by radiotherapy (24%), then 'getting test results (16%) and then 'getting the diagnosis 
(16%). 3% voted respectively for 'side-effects' of radiotherapy, chemotherapy and 
information on and making of prosthesis. 'Other' accounted for 11 % of the patients, 
which included: 
'Gamma-med' 
, A loss of personal privacy' 
'Giving up golf 
'Discussing it with the family' 
'Unable to go on holiday' 
. 'Finding a parking place' 
'Told cancer returned'. 
The third worst experience for patients undergoing treatment was 
radiotherapy, with 28% of patients, especially men, making this their choice,. Second 
came 'test results' with 23%, followed by surgery (11%), with chemotherapy and 
initial diagnosis (6%) jointly in fourth place. Fifth was 'side effects' of radiotherapy 
(3%). The 'other' category accounted for 20% with comments such as: 
'Recurrent new lump' 
'Unable to eat' 
'Worry about the treatment' 
'Worry about long-term synopsis 
'The length oftime to recover' 
'The almost immediate and extremely disturbing effect the radiotherapy 
had on my bowel' 
'Not being able to walk without someone' 
'Wrong diagnosis' 
'Working while having radiotherapy' 
'Not being able to reach for dressings in my locker' 
'The realization of what one mentally had' 
'The matter of fact way in which things were handled' 
'Waiting between surgery and treatment'. 
Question 10 - Looking back over the past five years can you tell us the worst three 
times for your family/close friends, in order, starting with the worse, then next etc. 
Getting the diagnosis, surgery, hormone therapy, waiting for test results or some 
other experience like waiting between surgery and radiotherapy, or after 
radiotherapy. 
91 % of patients answered this, presumably some patients were not able to ask 
their friends or family. A total of 70% thought getting the diagnosis was the worst 
time, 10% thought 'waiting for the results' and 4% thought chemotherapy. 
Radiotherapy was not mentioned and one patient only mentioned surgery. A further 
8% included such comments as: 
'Side-effects of radiotherapy 
'Travelling for 6 and a half weeks to Mount Vernon for radiotherapy' 
'When the cancer returned' 
'Seeing how upset I was with hair loss etc during chemotherapy' 
The second worse experience was surgery, 43%, then 'test results' (22%), 
radiotherapy (14%), 'getting the diagnosis (5%), 'worry about treatment' (4%). A 
further 12% included such comments as: 
'Worry about long-term' 
'The worry that it might come back again' 
'The waiting and waiting' 
'Being told the cancer has returned' 
'Waiting for surgery' 
'Worry about the length oftime to recover' . 
The third worse experience for friends and family was radiotherapy (30%), 
then 'test results' (7%), surgery (15%), worry about long-term outlook (7%) 
chemotherapy and 'endless waiting (6%) respectively. Comments included: 
'Wrong diagnosis' 
'Matter of fact attitude' 
'Side-effects of radiotherapy' 
One patient did not tick anything but wrote 
'I live on my own and didn't tell the family until I went for surgery. They 
don't live close by and have their own problems'. 
Question 14 - Now that the study is finishing will you tell us how you felt about 
taking part? Please tick any that apply 
I found it helpful to be participating in something that would help other patients 
Ifound it helpful because it reminded me of my cancer 
It helped me come to terms with my illness 
It gave me confidence to talk with my doctor 
It made me realize my reactions were normal 
It made me worry in case I experienced any of these problems or feelings. 
Patients did tick several boxes if it was felt appropriate. 
A total of 91 % of patients found it helpful to participate in something that 
would help other patients. 
Only seven (9%) found it helpful as it reminded them of their cancer. The seven 
included four patients being treated for breast cancer, two had skin cancer and one 
head and neck patient. 
A total of 41 % thought that the study helped them to come to terms with their 
illness, twenty women and thirteen men. 
One third of the patients thought the study had made them more confident to 
talk with their doctor. Over half (52%) thought that the study made them realize that 
their reactions were normal and only five (6%) felt worried by the study. 
Information and Control 
Question 12 - Would you like to be sent a summary oft/tis study? 
Sixty (76%) wanted to receive a summary. Nearly half of the men and 25% of 
the women did not want to receive one. 
Question 13 - Would you be interested to meet others who took part in this study? 
Would you agree to us contacting you? 
A quarter of patients said they would be interested in meeting others who took 
part in the study. One woman wrote: 
'don't know'. 
The cohort who was interested consisted of 26% women and 22% men. One 
patient wrote 
'Sorry No I really want to put the whole thing behind me. I have moved 
on in leaps and bounds over the past five years. 
Nearly three quarters (72%) said they would agree to us contacting them, 77% 
of the men and 70% of the women. 
Finally patients were asked 
Do you have any comments to make? 
The following are quotes from patients and are divided into the following 
sections, 
1. their feelings. 
2. the questionnaires. 
3. support issues. 
4. positive attitudes in coping with cancer. 
5. the altruistic aspect of this study 
6. their physical condition 
7. positive responses to the staff. 
1. Their Feelings 
'Taking part in this series of questionnaires actually helped me to think 
about and admit what 1 was feeling about my treatment. 1 am not very 
good at admitting how 1 feel about things, but just being able to circle or 
tick something which affected me helped me to face the way 1 was feeling 
at the time' 
'I could not discuss my feelings with anyone and even now only a few 
people know so that the questionnaires dealt with my deep mind' 
'It made me feel lucky that 1 had not many problems and carne to term 
with my illness' 
'This study seemed to sum up how 1 was feeling and this made me realize 
my feelings were "normal". 
'This is not something 1 like doing too frequently' 
'I am glad 1 took part in the research, 1 knew that there were a lot of other 
people taking part in it and it made me feel 1 was not alone in my illness'. 
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2. The Questionnaires 
'I found the to-ing and fro-ing of the questions a bit dizzying. The 
"strongly disagree", "agree" gets me cross-eyed. I never knew if I put 
what 1 intended' . 
'Sometimes how 1 answered the questions depended upon how 1 felt at the 
time which may not have any beaiing on the cancer, e.g. answering 
questionnaire following a heavy cold or a difficult time at work. Some 
questions felt repetitive some 1 had mixed feelings about which made 
them difficult to answer' 
, A bit laborious but OK as it is only once a year' 
'When you believe yourself to be cured it is rather irritating to keep 
answering the same questions. The same questions put another way is 
also very annoying. 1 understand however why the information is useful. 
The questions are rather black and white and one cannot qualify. The 
questions make one realize what it would be like if incurable cancer was 
ever one's diagnosis' 
'Questions about my physical and mental state were quite easy and 
straight forward' 
'Occasionally I felt confused when answering the questions because I 
wasn't sure whether problems 1 experienced were attributable to my 
cancer or not. Also self-evaluation - are we supposed to evaluate our 
moods/state of mind in general terms or only as relating to our cancer'. 
'I sometimes found it difficult with the negative questions I find it easier 
with the positive questions. 1 have also found it difficult with degrees of 
answer e.g. as in disagree- strongly, moderately, slightly'. 
3. Support Issues 
"1 found the chemotherapy very frightening and would have given up 
after three months ifI had not had the support of my husband' 
'Yes, Macmillan nurses seem to take an interest when diagnosed with 
cancer and then they never seem to be there anymore. Anyhow I'm really 
well and getting on with my life' 
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'Normally at the 5 year mark appointments are gradually trailed off - She 
wants to keep me, still once a year. It is extremely reassuring to have this 
support' . 
4. Positive Attitudes in Coping with Cancer 
'I would like to say that one has to be positive and each day/year is a 
bonus' 
'Although I wanted to help I didn't like being reminded. Being a positive 
person I don't like looking backwards' 
'I found being positive about having cancer helped me to cope with it' 
'Having a positive mental attitude throughout I believe has helped me 
through it along with a little help from my friend' 
5. The Altruistic Aspect of this Study 
'I think if more people's reactions were asked for and collated and 
expressed by the medical profession cancer wouldn't appear so scaring. 
This is why it is important for patients to help other it may apply to'. 
'I hope the responses you have received will help fellow sufferers' 
'The study has been helpful to me in respect I felt in some small way 
helping future sufferers and that I wasn't just forgotten about after 
treatment. The trouble was radiotherapy didn't kill off all the cancer cells 
so I am told' 
'Taking part in the survey made me realize that there are many more 
people who are going through the same traumas as me and knowing that 
the survey may help others has helped me 
6. Their Physical Condition 
'Drugs I need to take would appear to have adverse result i.e. blood 
pressure, heart, gout, water retention, diabetes, thyroid' 
'I do not think my trouble was too serious (skin patient), I would not have 
been too concerned if! had to have further treatment' 
'The Zoladex injections I have once a month in the surgery have reduced 
the cancer level and I am extremely grateful for this'. 
7. Positive Response to the Staff 
'To thank staff for their kindness and help i'n taking worry away'. 
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'1 was treated very well indeed and everyone so very kind and helpful' 
'Thank you for all you do' 
'It's good to know that you and others care' 
'It's nice to know that somewhere somebody cares. At 76 years of age, 
it's more unusual. Thank you' 
'I found everybody so kind right from start to finish' 
'The treatment from surgeon to doctors and nurses at the hospitals both 
MY and Watford G were so wonderful, they helped me through the whole 
time. There is always an exception to this and that was a nurse who was 
supposed to be a cancer patient support - But she was soon sorted - so for 
all forgotten' 
'To express my gratitude for immediate and effective treatment received 
which has extended my life by 5 years so far' 
'Thanks to all the people at MY who helped me to reach where 1 am now. 
A very successful businesswoman in the cleaning business called 
Supermaids' 
Finally, two miscellaneous comments 
'I now would like to be left alone to get on with my life and try to forget 
the past as much as possible' 
'My sense of humour helps when 1 feel a bit down in the mouth'. 
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Table30: Demographic and Medical Characteristics at 1 
Year Post Treatment 
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Table 30: Showing Demographic And Medical Characteristics at 1 Year Post 
Treatment 
DEMOGRAPIDC Nos % MEDICAL Nos 
Gender Sites 
Female 82 69.0 Breast· 61 
Male 36 3l.0 Lung 7 
Prostate 7 
Social Class Skin" 12 
Other"· 5 
Class A 5 5.0 Gastro-int 4 
Class B 18 17.0 Bladder 3 
Class CI 42 35.0 Head & Neck 5 
Class C2 29 20.0 Gynae 7 
Class D 20 17.0 NHL 5 
Unclassified 4 4.0 Unknown 2 
Marital Status Treatment Intent 
Married 77 67.0 Radical 101 
Widowed 18 14.0 Palliative 17 
Divorced 6 4.0 Ages 
Single 10 8.0 18-25 0 
Separated 5 4.0 26-50 22 
Unknown 0 0.0 50-65 43 
Partner 2 2.0 65+ 53 
Includes one male breast patient 
Includes only superficial tumours, melanoma is included in 'others'. 
* 
** 
*** 
Includes glioblastoma, sarcoma, mesothelioma, Hodgkin's Disease, melanoma 
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Table31: Demographic and Medical Characteristics at 18 
Months Post Treatment 
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Table 31: Showing Demographic And Medical Characteristics at 18 Months Post 
Treatment 
DEMOGRAPHIC Nos 0/0 MEDICAL 
Gender Sites 
Female 70 69.0 Breast* 
Male 32 31.0 Lung 
Prostate 
Social Class Skin * * 
Other*** 
Class A 6 6.0 Gastro-int 
ClassB 18 18.0 Bladder 
Class Cl 34 33.0 Head & Neck 
Class C2 25 24.0 Gynae 
Class D 17 17.0 NHL 
Unclassified 0 0.0 Unknown 
Marital Status Treatment Intent 
Married 67 66.0 Radical 
Widowed 14 14.0 Palliative 
Divorced 6 6.0 Ages 
Single 9 9.0 18-25 
Separated 5 5.0 26-50 
Unknown 0 0.0 50-65 
Partner 1.0 65+ 
Includes one male breast patient 
Includes only superficial tumours, melanoma is included in 'others'. 
* 
** 
*** Includes glioblastoma, sarcoma, mesothelioma, Hodgkin's Disease, melanoma 
-" 
Nos 0/0 
53 52.0 
3 3.0 
6 6.0 
10 10.0 
6 6.0 
5 5.0 
3 3.0 
5 5.0 
5 5.0 
4 4.0 
2 2.0 
93 91.0 
9 9.0 
0 0.0 
20 20.0 
42 42.0 
40 39.0 
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Table32: Demographic and Medical Characteristics at 2 
Years Post Treatment 
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Table 32: Showing Demographic And Medical Characteristics at 2 Years Post 
Treatment 
DEMOGRAPIDC Nos 0/0 MEDICAL 
Gender Sites 
Female 68 72.0 Breast 
Male 27 28.0 Lung 
Prostate 
Social Class Skin * * 
Other*** 
Class A 4 4.0 Gastro-int 
ClassB 20 21.0 Bladder 
Class Cl 29 31.0 Head & Neck 
Class C2 24 26.0 Gynae 
Class D 16 18.0 NHL 
Unclassified 0 0.0 Unknown 
Marital Status Treatment Intent 
Married 66 0.0 Radical 
Widowed 13 0.0 Palliative 
Divorced 3 0.0 Ages 
Single 7 0.0 18-25 
Separated 4 0.0 26-50 
Unknown 0 0.0 50-65 
Partner 2 0.0 65+ 
** 
*** 
Includes only superficial tumours, melanoma is included in 'others'. 
Includes Hodgkin's Disease, melanoma 
Nos % 
51 54.0 
1.0 
5 5.0 
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5 5.0 
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90 95.0 
5 5.0 
0 0.0 
21 22.0 
40 42.0 
34 36.0 
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Table33: Demographic and Medical Characteristics at 3 
Years Post Treatment 
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Table 33: Showing Demographic And Medical Characteristics at 3 Years Post 
Treatment 
DEMOGRAPIDC Nos % MEDICAL Nos % 
Gender Sites 
Female 68 74.0 Breast 48 52.0 
Male 24 26.0 Lung 2 2.0 
Prostate 5 5.0 
Social Class Skin** 8 9.0 
Other*** 5 5.0 
Class A 5 5.0 Gastro-int 2 2.0 
Class B 17 19.0 Bladder 3 3.0 
Class Cl 28 30.0 Head & Neck 7 8.0 
Class C2 21 22.0 Gynae 7 8.0 
Class D 17 18.0 NHL 4 4.0 
Unclassified 0 0.0 Unknown 1.0 
Marital Status Treatment Intent 
Married 64 69.0 Radical 90 95.0 
Widowed 13 14.0 Palliative 5 5.0 
Divorced 3 3.0 Ages 
Single 7 8.0 18-25 1.0 
Separated 3 3.0 26-50 19 21.0 
Unknown 0 0.0 50-65 38 41.0 
Partner 2 2.0 65+ 34 37.0 
** Includes only superficial tumours, melanoma is included in 'others'. 
*** Includes, Hodgkin's Disease, melanoma 
rmrmrm!.~~~~~}?I;~~~~mrmrmu.rrrffrrHffRnZ~T\rm11HnZ~qrmr~"{"m"~HHT':1on""~",~,", _________ ·_._._._ .. 
APPENDIX 45 
Table34: Demographic and Medical Characteristics at 4 
Years Post Treatment 
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Table 34: Showing Demogl'aphic And Medical Characteristics at 4 Years Post 
Treatment 
DEMOGRAPIllC Nos 0/0 MEDICAL 
Gender Sites 
Female 54 71.0 Breast 
Male 22 29.0 Lung 
Prostate 
Social Class Skin** 
Other*** 
Class A 4 5.0 Gastro-int 
Class B 18 24.0 Bladder 
Class CI 23 31.0 Head & Neck 
Class C2 16 21.0 Gynae 
Class D 14 19.0 NHL 
Unclassified 0 0.0 Unknown 
Marital Status 
Treatment Intent 
Manied 55 72.0 Radical 
Widowed 9 12.0 Palliative 
Divorced 2 3.0 Ages 
Single 5 6.0 18-25 
Separated 3 4.0 26-50 
Unknown 0 0.0 50-65 
Partner 2 3.0 65+ 
** 
*** 
Includes only superficial tumours, melanoma is included in 'others'. 
Includes Hodgkin's Disease, melanoma 
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Nos % 
39 51.0 
0 0.0 
5 7.0 
8 10.0 
4 5.0 
3 4.0 
3 4.0 
4 5.0 
5 7.0 
4 5.0 
1.0 
72 95.0 
4 5.0 
0 0.0 
17 22.0 
29 38.0 
30 40.0 
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Table35: Demographic and Medical Characteristics at 5 
Years Post Treatment 
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Table 35: Showing Demographic And Medical Characteristics at five years post 
DEMOGRAPHIC Nos % MEDICAL Nos % 
Gender Sites 
Female 57 72.0 Breast 39 49.0 
Male 22 28.0 Lung 1.0 
Prostate 5 6.0 
Social Class Skin** 7 9.0 
Other*** 5 6.0 
Class A 5 8.0 Gastro-int 3 4.0 
Class B 17 22.0 Bladder 3 4.0 
Class Cl 23 30.0 Head & Neck 4 5.0 
Class C2 17 22.0 Gynae 7 9.0 
Class D 14 18.0 NHL 4 5.0 
Unclassified 0 0.0 Unknown 1 1.0 
Marital Status Treatment Intent 
Married 53 67.0 Radical 75 95.0 
Widowed 11 14.0 Palliative 4 5.0 
Divorced 2 2.0 Ages 
Single 6 7.0 18-25 1 1.0 
Separated 4 5.0 26-50 16 20.0 
Unknown 0 0.0 50-65 32 40.0 
Partner 3 4.0 65+ 30 39.0 , 
** Includes only superficial tumours, melanoma is included in 'others'. 
*** Includes Hodgkin's Disease, melanoma 
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